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Direct arylation via C-H activation has emerged as a powerful tool for the construction of new 
aryl-aryl bonds and provides an alternative to classical cross coupling procedures. Double C-
H activation in particular, represents a more sustainable approach in terms of waste, cost and 
atom economy. 2-Pyrone and 2-coumarin analogues represent privileged biological scaffolds 
and possess broad spectrum biological activity. Importantly, there have been limited reports 
of catalytic methods involving the C-H activation of 2-pyrones and 2-coumarins. The 
cyclisation of 2-pyrones and 2-coumarins via double C-H activation is described in Chapter 2 
of this thesis. The synthesis of a library of 2-pyrone and 2-coumarin substrates was achieved 
using this methodology. Excellent yields were achieved for the 2-coumarin substrates and 
some good regioselectivity was obtained for both the 2-pyrone and 2-coumarin analogues. 
The developed double C-H activation reaction conditions also facilitated a three step synthesis 
of flemichapparin C. The application of this methodology was then transferred to the 
synthesis of meta-substituted dibenzofurans. A variety of mono- and di-substituted 
diarylethers were efficiently cyclised in good to excellent yields.  
In Chapter 3, the cyclisation of mono-halogenated diarylethers via single C-H activation to 
produce dibenzofurans is discussed. Previous methods for the synthesis of dibenzofurans via 
transition metal-mediated catalysis suffer from a number of drawbacks. Thus, focus was 
targeted at addressing many of the limitations existing with the current protocols for the 
intramolecular direct arylation of diarylethers. Substrates with electron withdrawing groups 
were particularly well tolerated and yields of up to 99% were observed. 
The final section of this thesis involved the synthesis and application of a number of carbonyl 
manganese phosphine complexes. The vast majority of C-H activation protocols involve the 
use of precious 4d or 5d transition metal catalysts. However, many of these metals are now 
classed as ‘finite raw materials’. Clearly, there is an urgent need to alleviate the worldwide 
reliance on precious metals, especially palladium. The cost effective and sustainable nature 
of earth abundant first row transition metals, renders the development of C-H activation 
protocols using inexpensive 3d metal catalysts a particularly attractive alternative. In recent 
years, Mn catalysed C-H activation has gained considerable momentum as a more 
environmentally benign and economically attractive alternative to typically used transition 
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metal based catalysts. Despite this, most reports on Mn catalysed C-H activation utilise the 
commercially available MnBr(CO)5 and Mn2CO10 pre-catalysts. The CO ligand cannot be 
optimised, and this represents the bottle-neck for the expansion of Mn catalysis. In contrast 
to more commonly studied metals such as Pd, there has yet to be widespread study of the 
influence of ligands in Mn(I)-catalysis, in many reaction types including C−H bond activation. 
This represents a significant gap in the State-of-the Art. Thus, the future of Mn catalysed C-H 
activation requires the development of new tuneable ligands for Mn, analogous to the past 
developments in Pd catalysis. The work in Chapter 5 involved the synthesis of a range of 
tetracarbonyl- and tricarbonyl Mn phosphine complexes. The complexes were fully 
characterised by spectroscopic, single crystal structure X-ray analysis and elemental analysis 
and applied in a number of C-H activation reactions. Critically, it was demonstrated that these 
carbonyl Mn phosphine complexes are catalytically competent in a proof-of-principle 
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1.1 Aryl-Aryl bond formation 
The biaryl motif is a predominant substructure of many pharmaceutically relevant and 
biologically active compounds (Figure 1) such as the anti-inflammatory Felbinac 1, the anti-
hypertensive Losartan 2, as well as the anti-cancer drug Imatinib 3. In addition, the motif is 
an integral part of important agrochemicals such as the anti-fungal agent, Boscalid 4. As a 
consequence, the utility of the biaryl motif has driven the discovery of highly efficient aryl-













Figure 1. Importance of biaryl structural motif in pharmaceutical products. 
Traditionally, the most common and reliable methods to create an aryl-aryl bond require pre-
functionalisation of both coupling partners, utilising an aryl halide (or pseudohalide) with an 
organometallic reagent (e.g. Stille, Negishi, Suzuki-Miyaura reactions) (Scheme 1 (iii)).1-4 
Whilst high yields and selectivities can be obtained via these traditional methods, they 
inherently suffer from a number of drawbacks. Firstly, the preparation of pre-activated 
substrates often involves several steps which is time consuming and an inefficient process in 
terms of waste, cost and atom economy. Furthermore, the organometallic and/or 
organohalide coupling partners required for Suzuki-Miyaura or Stille reactions are not always 
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readily available. The latter problem is especially prevalent in intramolecular cross-coupling 
reactions.  
As a general guide, there are three main steps in the catalytic cycles of coupling processes 
which are all mediated by palladium0 (Pd0, which is ligated: Pd0Ln) (Figure 2). The first step 
involves oxidative addition of the organohalide to Pd0 to give a PdII intermediate species. This 
intermediate can then undergo transmetallation with an organometallic reagent to give 
another PdII species, with loss of a by-product (salt or other metal halogen species). Finally, 
reductive elimination gives the final aryl-aryl product and allows for regeneration of the Pd0 
species. 
 
Figure 2. General catalytic cycle for palladium catalysed cross-coupling reactions. 
1.2 Direct arylation via C-H activation 
In recent years, direct arylation via C-H activation has proved a valuable alternative to 
traditional cross-coupling reactions (Scheme 1). Direct arylation is a method of biaryl 
synthesis whereby carbon-carbon bond formation occurs through cleavage of a C-H bond in 
the presence of a transition metal. The terms C-H activation and C-H functionalisation have 
been used interchangeably in the literature.5 It is noteworthy that the term C-H activation is 
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used throughout the course of this thesis. Specifically, C-H activation is used to describe 
reactions between a C-H bond and a transition metal complex to generate discrete ‘activated’ 
LnM-R intermediates that do not involve free radicals, carbocations or carbanions.6-8 The 
activated LnM-R intermediate is then functionalised and the catalyst regenerated.  
In contrast to traditional cross-coupling procedures, direct arylation protocols avoid the 
installation of activating groups in one or both of the coupling partners and thereby reduce 
the associated waste products.9-10 As a result, modern methods to synthesise new 
compounds via C–H activation are on the published ‘Wanted List’ of top pharmaceutical 
companies.11 
The most atom economic approach12 would involve the coupling of two aryl C-H bonds 
(Scheme 1 (iii)). Ideally, the only by-products here are hydrogen gas or water. However, there 
are challenges associated with this approach:  
(1) Aromatic C-H bonds are thermodynamically stable and chemically inert (for 
example, the homocoupling of benzene to give biphenyl and dihydrogen is 
thermodynamically disfavoured by 13.8 kJ mol-1).13  
(2) Attaining site selective C-H activation in the presence of a number of C-H bonds 
within a molecule often poses significant regioselectivity and chemoselectivity problems.9-10  
Alternatively, a chemical compromise is reached whereby one of the coupling partners is pre-
activated (single C-H activation) (Scheme 1 (ii)).5 This is a more widely adopted approach and 
can be carried out in an intramolecular or intermolecular fashion.10, 14 Regioselectivity can be 
controlled in terms of a directing group strategy and also manipulation of the steric and 
electronic properties of the system.5, 9 A number of examples of this approach will be 
discussed in this introduction.  





Scheme 1. Methodologies for Ar-Ar bond formation. 
1.2.1 Literature examples of double C-H activation 
One of the first reports of biaryl formation via a double C-H activation involved the oxidative 
cross-coupling of simple arenes (Scheme 2) published by Lu and co-workers in 2006.15 
Subsequently, You and Xia carried out a direct arylation (via a double C-H activation) of simple 
arenes with ferrocenyl oxazolines in the presence of a stoichiometric amount of Pd(OAc)2 
(Scheme 2).16  




Scheme 2. Intermolecular direct arylation via double C-H activation of simple arenes and ferrocene. 
Following on from these seminal reports, in 2007, the Fagnou group achieved a much more 
practical and selective aryl-H-aryl-H cross-coupling.17 They applied their methodology to the 
reaction of unactivated arenes with N-alkyl indoles, with yields of up to 84% reported 
(Scheme 3). Fagnou’s palladium (Pd) catalysed oxidative cross-coupling allows access to both 
C-3 and C-2 arylindoles by varying the terminal oxidant, in combination with Pd(TFA)2 as 
catalyst and the use of catalytic quantities of 3-nitropyridine and caesium carbonate. The 
authors also state that changing from N-acetyl indole to N-pivalyl indole played an important 
role in the selectivity of the reaction.17 




Scheme 3. Fagnou’s direct arylation of N-alkyl indoles and unactivated benzenes via double C-H 
activation. Reaction conditions: a) Pd(TFA)2 (10 mol%), 3-nitropyridine (10 mol%), CsOPiv (40 mol%), 
Cu(OAc)2 (3 equiv.), PivOH (6 equiv.). b) Pd(TFA)2 (10 mol%), 3-nitropyridine (10 mol%), CsOPiv (40 
mol%), AgOAc (2.2 equiv.), PivOH (6 equiv.). 
In 2008, Fagnou and co-workers reported an intramolecular Pd catalysed oxidative biaryl 
synthesis under air using pivalic acid as the reaction solvent.18 This methodology was used in 
the synthesis of three naturally occurring carbazole products: Murrayafoline A (5), Mukonine 
(6) and Clausenine (7) (Scheme 4, (i)). Following on from this, Shi and co-workers made 
significant progress towards more sustainable routes to biaryls. In 2012, they reported the 
first Pd catalysed dual C-H activation of benzophenones to form fluorenone derivatives by 
oxidative dehydrogenative cyclisation (Scheme 4, (ii)).19 Excellent yields and functional group 
compatibility were reported. 
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Scheme 4. Literature examples of direct arylation via double C-H activation. 
1.3 Mechanisms of direct arylation 
In the context of Pd catalysed direct arylation, several mechanisms have been proposed for 
the C-H bond cleavage step.9, 20-21 These include oxidative C-H insertion observed for late 
transition metals in low oxidation states, electrophilic aromatic substitution (SEAr): selective 
for electron rich substrates, Heck-type (carbometalation) and Concerted Metallation 
Deprotonation22 (CMD) or also known as Ambiphilic Metal Ligand Activation23 (AMLA). CMD 
type C-H functionalisations show a preference for acidic C-H bonds. However, the intimate 
reaction mechanism may switch from reaction to reaction as the substrate, solvent, base, 
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1.4 Aims and objectives (Chapter 2)  
The focus of Chapter 2 and Chapter 3 of this thesis is the development of new strategies for 
the C-H functionalisation of important biological compounds. Chapter 2 is directed at 
exploring more environmentally benign C-H functionalisations and application of this 
methodology on delicate molecular frameworks. A key inspiration for this research was the 
work previously reported by the groups of Fagnou18 and Shi19 (Figure 3 (i-ii)). Chapter 3 
describes efforts toward the development of ligand accelerated C-H functionalisation of 
diarylethers as a route to dibenzofurans. 
The functionalisation of 2-pyrones and 2-coumarins is highly sought after and has attracted 
attention due to the interesting biological and pharmacological properties associated with 
these compounds. Classical cross-coupling reactions such as the Suzuki-Miyuara, Negishi and 
Stille reactions provide access to such targets. However, despite their importance in various 
fields there has been very few reports of any catalytic methods involving the C-H 
functionalisation of 2-pyrones and 2-coumarins. Previously, our lab has reported a palladium 
catalysed intramolecular single C-H activation of 4-phenoxy-2-pyrones and 4-phenoxy-2-
coumarins to afford 1H-pyrano[4,3-c]benzofuran-1-one and 6H-benzofuro[3,2-c]chromen-6-
one products.24-27 Although there has been progress in the field of double C-H activation in 
recent years, it has mainly been achieved on more robust substrates. Thus, there have been 
limited reports of effective catalytic systems which can perform this type of transformation 
on more privileged biological scaffolds. Hence, the key goal of Chapter 2 is the palladium 
catalysed double C-H activation of 4-phenoxy-2-pyrones and 4-phenoxy-2-coumarins as a 
novel route to 1H-pyrano[4,3-c]benzofuran-1-ones and 6H-benzofuro[3,2-c]chromen-6-ones 
(Figure 3 (iii)). Additionally, this methodology was extended to dibenzofurans which will also 
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Inspiration for this work 
      
 
 
                    
 
                                                                                                                          
 
 




                             
 
                  
Figure 3. (i-ii) Palladium catalysed intramolecular double C-H activation of robust heterocyclic 
scaffolds and (iii) privileged biological scaffolds as well as less reactive diarylethers described in 
Chapter 2 of this thesis. 
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1.5.1 Biological importance of targeted heterocycles 
2-Pyrone (8) is a six membered cyclic unsaturated ester (Figure 4). 2-Pyrones have similar 
chemical and physical properties to both alkene and aromatic compounds. It is a highly 
abundant moiety in bacteria, plant, insect and animal systems.28 Naturally occurring 2-
pyrones include bufadienolides, peripyrones, herbarins, coumarins, etc. Bufadienolides are 
an important group of steroids containing the 2-pyrone moiety. For example, bufalin (11) is a 
cardio active C-24 steroid that exhibits a variety of biological activities and is of particular 
importance in regulating cardiovascular function. More recently, bufalin (11) is known to 
induce cell cycle arrest and apoptosis in many cancer cells. For this reason it is now considered 
a candidate drug for cancer chemotherapy (Figure 5).28  
 
               
                 8 
              
 
                       9 
 
           
10 
 
Figure 4. 2-(1H)-pyrone and structurally related heterocycles. 
Coumarins (9) (sometimes referred to as 2-coumarins, although the ‘2’ is not required) are a 
class of compounds that are also known as benzopyrones and are structurally related to 
pyrones (Figure 4). Both synthetic and naturally occurring molecules containing the 4-
substituted coumarin moiety have exhibited interesting biological and pharmacological 
properties.28 Of particular interest are 4-aryl coumarins. The synthesis and isolation of 4-aryl 
coumarins has received much attention for a number of years due to their anti-HIV, anti-
malarial and anti-bacterial activity.29 A number of coumarins isolated from the bark of 
Ochrocarpos punctatus have shown to exhibit broad spectrum cytotoxicity against the A2780 
human ovarian cancer cell line.30 The blockbuster drug warfarin (12)  is also a simple 4-
hydroxy-2(1H)-coumarin derivative (Figure 5).28 The structurally related 2(1H)-quinolone 
motif (10) is considered a privileged biological scaffold (Figure 4) and quinolones are among 
the most important synthetic anti-bacterial drugs.31-32 For example, Ciprofloxacin (13) is a 
second generation fluoroquinolone antibiotic (Figure 5). In addition, quinolones possess a 
number of other important biological traits.33  


















   
Figure 5. Examples of biologically active compounds containing the 2-pyrone, 2-coumarin and 4-
quinolone moiety. 
 
1.5.2 Literature examples of palladium catalysed direct arylation of 2-pyrone analogues and 
2-coumarin analogues 
A number of protocols for the C-H activation of 2-pyrone substrates to give five and six 
membered heterocycles have been developed by Majumdar,34-35 Fairlamb36 and 
McGlacken.24-25, 27 Depending on the reaction conditions, these reactions have been proposed 
to proceed via a CMD type mechanism or a Heck-type carbopalladation of the 2-pyrone 
framework.  
In 2007 and 2008, Majumdar and co-workers successfully carried out an intramolecular 
arylation of 2-pyrone, 2-coumarin, 2-quinolone and 2-pyridone derivatives using a Pd0 
catalyzed intramolecular Heck-type process (Scheme 5).34-35 This was an improvement on an 
exisiting methodology by the same group utilising tin hyrides via a proposed radical 
mechanism.37 




Scheme 5. The intramolecular arylation of 2-pyrone and related heterocycles. 
Two years later, Fairlamb reported the catalytic C-H functionalization of 2-pyrones36 with 
regioselectivity observed for the C-3 position (Scheme 6). The authors proposed a Heck-Type 
mechanism involving carbopalladation of the 2-pyrone framework. 
 
Scheme 6. The C-H functionalization of 2-pyrones. 
Fairlamb and McGlacken subsequently reported the intramolecular arylation of 2-pyrones 
without added phosphine ligands in 2014.24 Excellent yields were obtained under the reaction 
conditons and the methodology could also being extended to include 2-pyridones, 2-
coumarins and quinolones (Scheme 7) enabling access to potential biologically active 
candidates.  




Scheme 7. Intramolecular direct arylation of 2-pyrones at C-3 to give six-membered rings. 
The C-5 cyclised product could also be formed if the C-3 position was blocked with a methyl 
group for example (Scheme 8).24 
 
Scheme 8. Intramolecular direct arylation of 2-pyrones at C-5 to give six-membered rings. 
McGlacken and co-workers subsequently developed a complimentary set of conditions for 
the intramolecular direct arylation of 2-pyrones and other related heterocycles using a Pd0 
source and pivalic acid as a crucial additive (Scheme 9). Mechanistic work carried out 
suggested that the reaction probably proceeds via a CMD type pathway.27 
 
Scheme 9. Intramolecular direct arylation of 2-pyrones and related heterocycles to give six-membered 
rings. 
Subsequently, McGlacken and co-workers successfully reported the palladium catalysed 
intramolecular direct arylation of 3-bromo-2-pyrones and 3-chloro-2-pyrones. A change in 
phosphine ligand and increased loading of base was required for the 3-chloro substrates to 
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undergo successful coupling (Scheme 10). This methodology was extended to 2-coumarins 




Scheme 10. Intramolecular direct arylation of 3-halo-2-pyrones and 2-coumarins. 
The second aim of Chapter 2 is focused on applying our double C-H activation protocol to 
molecular frameworks which are more commonly found in drug molecules and natural 
products.  
1.6.1 Biological significance of dibenzofurans 
As previously mentioned, the biaryl motif is a predominant structural feature in many natural 
and synthetic pharmacologically active compounds.39 In particular, dibenzofuran derivatives 
are an important class of structural motifs and are found in many natural products, bioactive 
molecules and pharmaceuticals. Significant biological activity has been exhibited by many 
members of this class of compounds, with a large number of naturally occurring 
dibenzofurans possessing anti-cancer, anti-inflammatory, anti-bacterial (Rhodomyrtoxin 
(14)), anti-malarial and anti-oxidant properties (Figure 6).40-43 As a result, significant efforts 
have been directed towards their total synthesis. However, the synthesis of dibenzofurans is 
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Figure 6. Selected bioactive compounds bearing the dibenzofuran motif. 
 
1.6.2 Previous synthesis of dibenzofurans 
To date, several approaches have emerged for the synthesis of the dibenzofurans. In general, 
there are two main protocols as well as a few other miscellaneous methods:45 i) transition 
metal catalysed carbon-carbon bond formation via cyclisation of 2-substituted phenoxy 
benzenes14, 18, 46-53 and ii) Cu or Pd catalysed O-arylation of 2-arylphenols (Scheme 11).44 
Nevertheless, these methods suffer from a number of significant drawbacks such as substrate 
dependence, tedious purification, unsatisfactory regioselectivity, limited substrate scope and 
harsh reaction conditions.44, 49, 51-52 




Scheme 11. Representative approaches to dibenzofuran synthesis. 
1.6.3 Literature examples of palladium catalysed intramolecular double C-H activation for 
the synthesis of dibenzofurans 
Although a number of reports for the synthesis of dibenzofurans via transition metal catalysed 
carbon-carbon bond formation have emerged in the last number of years, literature examples 
of dibenzofuran synthesis via palladium catalysed double C-H activation of diarylethers are 
scarce and only scattered examples have been reported (Scheme 12). In addition, many of 
these methods of methods suffer from a number of drawbacks (vide supra).44-45 
Invaluable advances were made by Fagnou and co-workers in 2008 whereby a new set of 
reaction conditions for intramolecular palladium catalysed oxidative carbon-carbon bond 
formation under air were developed.18 The authors state that the use of pivalic acid as the 
reaction solvent resulted in greater reproducibility, higher yields and allowed for a broader 
substrate scope. However, this work was mainly limited to the synthesis of carbazole 
containing compounds with only two examples of dibenzofurans just reported. Then in 2014, 
an interesting protocol for the synthesis of carbazoles and dibenzofurans via double C-H 
activation was reported by Ishida and co-workers using a heterogeneous metal oxide-
supported palladium hydroxide catalyst (Pd(OH)2/ZrO2).54 This was found to be an efficient 
catalyst in terms of catalytic activity and selectivity toward the synthesis of carbazoles and a 
number of dibenzofurans. Finally, in 2017, Wang and co-workers reported the synthesis of 
6H-benzo[c]chromenes via palladium catalysed intramolecular dehydrogenative coupling of 
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two aryl C-H bonds.55 This protocol uses molecular oxygen as the terminal oxidant, HFIP as 
solvent and was carried out at a relatively low temperature of 55 ᵒC. Again however, the 
substrate scope was limited and the reaction was extended to the construction of only two 
dibenzofurans. Encouraged by the success of our optimised double C-H activation protocol on 
the 2-pyrone and 2-coumarin scaffolds, we envisioned that this same strategy could be 
applied to the construction of dibenzofuran motifs. 
 
Scheme 12. Palladium catalysed intramolecular double C-H activation of diarylethers. 
In summary, the application of our optimised double C-H activation methodology to a number 
of 2-pyrone and 2-coumarin substrates will be outlined in Chapter 2 of this thesis. As 
previously discussed, there is limited applicability of this methodology on more delicate 2-
pyrone and 2-coumarin molecular frameworks. A broad range of functional group 
compatibility has been observed and the three-step synthesis of the natural product 
flemichapparin C is also detailed in Chapter 2. Our second goal was to apply this double C-H 
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activation methodology as a new route to dibenzofurans. Particular interest was focused on 
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1.7.1 Aims and objectives (Chapter 3) 
The cyclisation of mono-halogenated diarylethers via C-H activation is a particularly useful 
route to form dibenzofurans. Considering the problems associated with traditional and 
dehydrogenative coupling reactions,5, 9, 13 the development of a chemical compromise, which 
involves the coupling of an aryl-X with an aryl-H, would seem the ideal methodology in many 
cases. However, many limitations exist with the current protocols, which will be discussed in 
the following section. Thus, the key goal of Chapter 3 was focused on addressing the 
challenges associated with the current methodologies. Particular emphasis was placed on the 
development of a set of reaction conditions which would drive the reaction to completion 
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1.7.2 Literature examples on the direct arylation of ortho-halo diarylethers 
Seminal work carried out by Ames and co-workers in the 1980s led to the development of a 
convenient method for the cyclisation of substituted 2-bromo diarylethers with no added 
ligand (Scheme 13).46  
 
Scheme 13. Intramolecular direct arylation of ortho-halo diaryl ethers. 
Subsequent work by Fagnou and co-workers utilised an N-heterocyclic carbene/Pd catalyst 
system to promote direct arylation of ortho-chloro diarylether (15) to produce dibenzofuran 
(16) as well as  6H-benzo-[c]-chromene systems (Scheme 14).47  
  
                  15 
 
            16 
Scheme 14. Palladium catalysed direct arylation of ortho-chloro diarylether. 
A year later, the same group reported a phosphine ligand assisted Pd catalysed route for the 
intramolecular cyclisation of ortho-halo benzyl-oxy ethers to form six-membered rings.14 This 
work was extended to include the cyclisation of ortho-iodo diarylether (17) to produce 
dibenzofuran (16) (Scheme 15).  





                  17 
  
     
Scheme 15. Palladium catalysed intramolecular direct arylation of ortho-halo benzyl-oxy ethers and 
ortho-halo diarylethers. 
More recently, Panda and co-workers developed an efficient method for the synthesis of 
dibenzofurans from ortho-iodo diarylethers using a reusable Pd/C catalyst (Scheme 16).48  
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Despite the advances made by Ames, Fagnou and others, there are a number of challenges 
which remain, which dissuades a broader up-take:  
1) Very high reaction temperature (>130 ºC) 
2) Very high catalyst loading (up to 10 mol%)46 
3) Use of inert atmosphere 
4) Use of phosphine ligands  
5) Use of expensive additives  
6) Difficulties in purification  
Thus, addressing some of the above challenges would represent an important advancement 
in the development of a milder set of reaction conditions for the intramolecular direct 
arylation of ortho-bromo diarylethers. 
1.7.3 Nitrogen based ligands in direct arylation reactions  
Direct arylation protocols are often carried out in the presence of palladium complexes 
bearing tertiary phosphines.9-10 However, due to the high cost of phosphine ligands and also 
their sensitivity to oxidation in air,56-57 the development of a cheap and relatively stable 
phosphine free catalyst system would be an important achievement. Nitrogen based ligands 
offer an excellent alternative to phosphine ligands: they are cheap, readily available, easier 
to remove post-reaction and not as easily oxidised as phosphines. In addition, nitrogen based 
ligands also offer scope for electronic tuning by easy functionalisation. In contrast, the 
synthesis of phosphine ligands is more tedious and expensive.57 In addition, the strong σ-
donation by the nitrogen to the metal centre favours oxidative addition and allows for the 
formation of stable intermediates enabling C-H activation to occur.58  This makes them 
suitable candidates for ligands in palladium catalysed direct arylation reactions. Among them, 
pyridine (18), 2,2’-bipyridine (19), 1,10-phenanthroline (20) and quinoline (21) based ligands 
have attracted particular attention and have frequently been utilized as ligands in palladium 
catalysed C-H functionalisation reactions (Figure 8) by the groups of Yu59-63 and Sanford64-66 
in particular among others.62-63 In addition, our lab has recently demonstrated the viability of 
Pd/quinoline pre-catalysts in a one-pot tandem Suzuki-Miyaura/direct arylation reaction with 
di-bromo quinolines.67 Based on these reports, we postulated that quinolines might serve as 
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suitable candidates for ligands in the palladium catalysed direct arylation of o-bromo 
diarylethers. 
    
18 19 20 21 
Figure 8. Heterocyclic sp2 nitrogen donor ligands often applied in transition metal catalysed C-H 
activation reactions. 
Following on from the McGlacken groups interest in the synthesis of heterocyclic frameworks 
using direct C-H activation,24-27, 68-71 the work outlined in Chapter 3 addresses most of the 
above existing limitations discussed in this introduction (Section 1.7.2). ortho-Bromo 
diarylether was chosen as a suitable molecular framework for the intramolecular cyclisation. 
Thus, the goal of developing a new and milder set of reaction conditions aided by a cheap and 
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Chapter 2: Cyclisation of 4-
phenoxy-2-pyrones, 2-
coumarins and related 
heterocycles via double C-H 
activation




In this chapter, the synthesis of a library of 1H-pyrano[4,3-c]benzofuran-1-one and 6H-
benzofuro[3,2-c]chromen-6-one analogues is described. Additionally, the methodology was 
extended to include a 2-quinolone analogue, as well as the synthesis of a natural product. 
2.2 Background 
As discussed in Chapter 1 of this thesis, in recent years direct arylation via C-H 
functionalisation has proved a valuable alternative to traditional cross-coupling procedures.1-
2 The ideal approach would involve the coupling of two C-H groups, representing a green route 
to bi(hetero)aryls.3 However, as outlined previously in Chapter 1, there is limited applicability 
of this methodology on delicate molecular frameworks. The 2-pyrone motif represents a 
privileged biological scaffold with broad spectrum biological activity spanning antibiotic, 
antifungal and cytotoxic activity.4 In addition, the related 2-coumarins display a remarkable 
impressive biological profile.5-7 The McGlacken group has previously utilised direct arylation 
methodologies for the cyclisation of 4-phenoxy-2-pyrone and 4-phenoxy-2-coumarin 
derivatives.8 However, the cyclisation of such substrates required the installation of a halogen 
on one coupling partner.  With this in mind, we sought to gain access to tricyclic pyrones and 
coumarins by the coupling of phenoxy substituted substrates via two C-H activation events 
(Figure 9). This is a far more challenging approach as outlined (vide supra). 
 
Figure 9. Objective of this research. 
2.2.1 Synthesis of 4-phenoxy-2-pyrone substrate 
Initially, research was focused on the double C-H activation of 4-phenoxy-2-pyrone 
derivatives. The first step involved synthesizing 4-phenoxy-6-methyl-2-pyrone (24) as this was 
not commercially available. To begin with, 4-bromo-6-methyl-2-pyrone (23) was prepared in 
an 85% yield using a slightly modified procedure to that described by Kato and co-workers,9 
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by reaction of 4-hydroxy-6-methyl-2-pyrone (22) with TBAB (tetrabutylammonium bromide) 
and P2O5 in toluene (Scheme 17). Multiple grams of 23 could be synthesised at a time and this 
methodology served as a useful precursor for many of the substrates outlined in this Chapter. 
4-Phenoxy-6-methyl-2-pyrone (24) was then synthesized by a base mediated reaction of 
phenol with 4-bromo-6-methyl-2-pyrone (23) in acetone at reflux. The product was isolated 
in a 71% yield by washing the crude reaction mixture with 10% aqueous NaOH, followed by 
recrystallisation from hot ethanol (Scheme 17).  
   
       22    23 (85%)     24 (71%) 
Scheme 17. Two step synthesis of 6-methyl-4-phenoxy-pyrone (24). 
2.2.2 Optimisation of double C-H activation reaction conditions 
Our optimisation work began with two seminal reports by Fagnou10 and Shi11 who reported 
the Pd catalysed intramolecular cyclisation of diphenylamine and benzophenone substrates 
via a double C-H activation. Key to the success of their reactions was the addition of pivalic 
acid (PivOH) and trifluoroacetic acid (TFA). In the case of Fagnou’s work, the pivalate anion is 
proposed to play a key role in the C-H bond cleaving event,10, 12  allowing for increased 
reactivity and selectivity. This enabled the formation of the carbazole products in high yields 
which was in stark contrast to when acetic acid was utilised as reaction solvent. 
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Scheme 18. Literature examples of direct arylation via a double C-H activation. 
These two sets of reaction conditions served as key starting points for the development of 
our methodology towards the synthesis of 1H-pyrano[4,3-c]benzofuran-1-one and 6H-
benzofuro[3,2-c]chromen-6-one analogues. Previous work from the McGlacken group by Dr. 
Marie-Therese Nolan identified the need for an external oxidant to help regenerate the 
catalyst, therefore, Ag2O was included in the reaction conditions.11 Sodium tert-butoxide also 
served as a more efficient base in comparison to K2CO3. These conditions were then applied 
to the 4-phenoxy-2-pyrone system in air and at a higher temperature of 140 ᵒC. Complete 
consumption of starting material 24 and formation of product 25 was observed after 2 hours 
with the product being isolated in a 52% yield (Scheme 19, Conditions A). Direct application 
of Shi’s conditions on the 4-phenoxy-2-pyrone system allowed for complete consumption of 
starting material 24 after 16 hours and a 50% isolated yield of 25 was obtained in this case 
(Scheme 19, Conditions B). 
 
            
       24 
 
 
                                                                        25 
Scheme 19. Double C-H activation reaction of 24. 
The low yields observed could be explained, in the case of Conditions B, by the presence of a 
large excess of trifluoroacetic acid (TFA) in the reaction media. TFA is one of the strongest 
organic acids (pKa: -0.25 (H2O)). This strongly acidic reaction medium may cause degradation 
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of the delicate 2-pyrone motif. Pivalic acid is also quite a strong acid (pKa: 4.04) and again the 
large excess of pivalic in the reaction media acid may lead to degradation of the 2-pyrone 
framework. It may also be possible that the high temperature required (140 ᵒC) could degrade 
the 2-pyrone. Decomposition pathways will be discussed below. 
2.2.3 Optimisation of reaction conditions performed on diphenylamine and benzophenone 
With the above considerations in mind, we decided to perform an optimisation screen with 
the aim of establishing a milder set of reaction conditions. A comprehensive screen of solvents 
and catalysts was performed on diphenylamine (26) and benzophenone (28). These two 
substrates were first chosen because of their more robust structure in comparison to the 2-
pyrone scaffold. It must be noted that Fagnou10 and Shi11 had previously utilised such 
substrates in their work. If our optimization screen produced any promising results using 
these substrates, we could then apply these results to the 2-pyrone system. The results are 
summarised in Table 1 and Table 2 below. Both diphenylamine and benzophenone were 
purchased from a commercial supplier. 
To avoid using a large excess of acid as reaction solvent but also keeping in mind that both 
the TFA and PivOH are proposed to play key roles in the reaction, it was decided that we 
would incorporate both TFA and PivOH into the catalyst to avoid the presumable degradation 
of our 2-pyrone system. Therefore, Pd(OPiv)2 and Pd(OTFA)2 were chosen as the catalysts of 
choice for the reaction. Polar aprotic solvents are generally the solvent of choice for Pd 
catalysed direct arylation reactions. With this in mind, six different solvents were chosen: N,N-
dimethyl formamide (DMF), N,N-dimethyl acetamide (DMA), N-methyl pyrrolidone (NMP), 
dimethyl sulfoxide (DMSO), tetrahydrofuran (THF) and one polar protic solvent, ethanol 
(EtOH). DMF, DMA and NMP are all high boiling point amide solvents, and thus would be 
suitable solvents of choice due to the high temperatures usually required for C-H activation 
reactions.2 In addition, they can act as coordinating solvents and help stabilise organometallic 
intermediates as well as playing a direct role in the formation of the active catalyst.13 THF is a 
polar coordinating solvent (hydrogen bond acceptor) which could potentially facilitate 
catalysis.13 Two environmentally green solvents were additionally examined, EtOH a polar 
protic solvent and DMSO.14-15 For the diphenylamine substrate 26, formation of product 27  
was observed when DMF, DMA and THF were used as the reaction solvents. However, a 
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conversion of less than 10% was determined by ¹H NMR Spectroscopy (Table 1 entries 1, 3 
and 8). In contrast, employing benzophenone (28) as starting material, no cyclised product 29 
was detected by TLC and only starting material was visible by 1H NMR Spectroscopy.  
Table 1. Optimization of reaction conditions performed on diphenylamine (26). 
 
            26 
 
 
           27 
 
Entry Conditions [Pd] Solvent 
 
Conversion (%)a  
 
1 A Pd(OPiv)2 DMF 5  
2 A Pd(OPiv)2 THF 0 
3 A Pd(OPiv)2 DMA 2  
4 A Pd(OPiv)2 NMP 0 
5 A Pd(OPiv)2 EtOH 0 
6 A Pd(OPiv)2 DMSO 0 
7 B Pd(OTFA)2 DMF 0 
8 B Pd(OTFA)2 THF 3  
9 B Pd(OTFA)2 DMA 0 
10 B Pd(OTFA)2 NMP 0 
11 B Pd(OTFA)2 EtOH 0 
12 B Pd(OTFA)2 DMSO 0 
aConversion calculated from ratio of starting material 26 (2H, m at 6.87-6.91 ppm) to product 27 (2H, 
m at 7.23-7.26 ppm) in 1H NMR spectrum of the crude reaction mixture. 
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Table 2. Optimization of reaction conditions performed on benzophenone (28). 
 
 




           29  
 




1 A Pd(OPiv)2 DMF 0  
2 A Pd(OPiv)2 THF 0 
3 A Pd(OPiv)2 DMA 0  
4 A Pd(OPiv)2 NMP 0 
5 A Pd(OPiv)2 EtOH 0 
6 A Pd(OPiv)2 DMSO 0 
7 B Pd(OTFA)2 DMF 0 
8 B Pd(OTFA)2 THF 0  
9 B Pd(OTFA)2 DMA 0 
10 B Pd(OTFA)2 NMP 0 
11 B Pd(OTFA)2 EtOH 0 
12 B Pd(OTFA)2 DMSO 0 
aConversion calculated from ratio of starting material 28 (4H, m at 7.80 ppm) to product 29 (2H, m at 
7.27-7.29 ppm) in 1H NMR spectrum of the crude reaction mixture. 
2.2.4 Optimisation of reaction conditions performed on 4-phenoxy-2-pyrone 
Considering the results obtained in the optimisation screen, we then decided to carry out a 
brief optimization on the 4-phenoxy-2-pyrone substrate 24. Again, Pd(OPiv)2 and Pd(OTFA)2 
were chosen as the catalysts and DMF and THF were chosen as the reaction solvents due to 
the fact that these two particular solvents led to the highest conversions to product for the 
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diphenylamine (26) substrate (albeit marginal). The highest conversion to product 25 was 9% 
(Table 3, entry 1) and this was obtained with Pd(OPiv)2 as catalyst, 30 mol% PivOH as an 
additive and THF as solvent at 70 ᵒC. All other reaction conditions investigated failed to 
provide any satisfactory conversion to product. This result would indicate that pivalic acid 
plays a key role in the reaction and also implies that a higher temperature is required for the 
reaction to proceed.  
Table 3. Optimization of reaction conditions performed on the phenoxy pyrone 24. 
                                
 
                                                                       
 








1 A Pd(OPiv)2 THF PivOH 70 20 9 
2 A Pd(OPiv)2 THF - 70 20 3 
3 A Pd(OTFA)2 THF PivOH 70 16 2 
4 A Pd(OTFA)2 THF - 70 17 0 
5 B Pd(OPiv)2 THF - 70 16 2 
6 B Pd(OPiv)2 DMF - 100 17 0 
7 B Pd(OTFA)2 THF - 70 16 0 
8 B Pd(OTFA)2 DMF - 100 17 0 
aConversion calculated from ratio of starting material 24 (C3-H at 5.21 ppm) to product 25 (C5-H at 




Chapter 2  Results and Discussion 
33 
 
2.3.1 Synthesis of substrates 
2-Pyrones 
Due to the poor results obtained from our optimization screen, it was decided to continue 
our work using the original optimized reaction conditions (Scheme 19, Conditions A and 
Conditions B). An examination of the functional group tolerance was then planned. For this 
investigation, a range of 4-phenoxy-6-methyl-2-pyrone analogues (30-40) was synthesised 
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                          40, 79% 
 
Scheme 20. Synthesis of 4-phenoxy-2-pyrone substrates. 
2.3.2 Demonstration of substrate scope for double C-H activation of 2-Pyrones 
Next, each of the substrates were subjected to the two sets of optimised reaction conditions. 
Overall, Conditions A employing pivalic acid as reaction solvent (Scheme 21) were much more 
successful than Conditions B. Complete consumption of starting material was seen after 2-4 
hours for Conditions A. Moderate to good yields were observed for substrates bearing 
electron donating groups at the para-position 41 and 42 (42%). The substrate bearing a para-
methyl group gave the cyclised product 41 in a 56% yield, this was the highest yield obtained 
overall. In contrast, an electron withdrawing group at the para-position did not work well, the 
presence of a fluoro group 44 completely inhibited the reaction. A ca. 31% yield was obtained 
for the para-nitro product 43, however a number of impurities were still present despite 
numerous purification attempts. Interestingly, the reaction of 37 bearing a methyl group at 
the ortho-position failed to undergo cyclisation. Steric hindrance is the most plausible 
explanation for why the reaction failed to proceed. The meta-substituted phenoxy substrates 
gave the cyclised products 48-50 in moderate yields. For these particular substrates, some 
good regioselectivity toward the least hindered position was observed. For example, the 
reaction of 34 gave 48a:48b in a regioisomeric ratio of 97:3 in favour of the least hindered 
regioisomer. A similar result was obtained for the meta-methoxy substituted product 
49a:49b. The reaction of 36 gave a mixture of regioisomers 50a:50b in a 70:30 ratio, again the 
least hindered regioisomer was favoured under the optimised reaction conditions. Pleasingly, 
under our conditions a naphthyl group was well tolerated and a mixture of regioisomers was 
obtained (51a:51b) in an 80:20 ratio in favour of the least hindered product. Substrates such 
as pyridine (38) and that contained a primary amine group (39) did not work well. Only 
starting material was observed in the ¹H NMR spectrum of the crude reaction mixture for 
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these two particular compounds. Ligation of the pyridyl nitrogen or amine to Pd could have 
the potential to inhibit catalysis and would offer an explanation for the poor result obtained 
for such substrates.16 
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        48a, 44%             48b (not isolated) 
 
                              (93:7)b 
         49a, 20%              49b (not isolated) 
    




  50a, 65%            50b (not isolated) 
                                                                  
                           (70:30)b 
 
       51a, 25%                     51b, 13% 
                                                                  
                           (80:20)b 
 
Scheme 21. Isolated yields of substituted 1H-pyrano [4,3-b] benzofuran-1-ones. aca. 31% yield, this 
compound still contained a number of impurities despite numerous purification attempts. b 
Regiosiomeric ratios determined from the 1H NMR spectrum of the crude reaction mixture. 
Longer reaction times were required for Conditions B (Scheme 22). Complete consumption 
of starting material was observed after 24-48 hours. However, a significant number of the 
phenoxy 2-pyrone substrates failed to cyclise and were also subject to degradation under the 
reaction conditions. Only small amounts of products 41-50 could be detected in the 1H NMR 
of the crude reaction mixtures along with unreacted starting material and degradation of 
starting material (which will be discussed below). In addition, the mass recovery of the 
reaction was very poor in most cases. It was therefore not possible to isolate the compounds 
from the reaction mixtures (hence regioisomeric ratios are only given in Scheme 22). A similar 
trend in terms of regioselectivity was observed for the meta-methyl and meta-methoxy 
substituted phenoxy-2-pyrones, seen for Conditions A. Reaction occurred at the least 
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hindered site for compounds 48-49. Interestingly, the meta-fluoro substrate 50 showed a 
switch in regioselectivity, in this case reaction occurred at the most acidic site (39:61). This 
may offer some insight into the mechanism of the reaction. Pleasingly, the unsubstituted 
phenoxy pyrone 24 successfully underwent reaction to afford the cyclised product 25 in a 50% 
isolated yield. Similarly, the naphthyl group was compatible under the reaction conditions 
and a mixture of regioisomers 51a:51b was obtained in an 85:15 ratio. Again, the least 
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           48a                                  48b  
 
                              (91:9)a 
              49a                               49b  
 
                              (64:36)a 
  
       
          50a                                50b  
                                                                  
                           (31:69)a 
 
       51a, 25%                     51b, 14% 
                                                                  
                40% combined yield 
                          (80:20)a 
 
Scheme 22. Attempted double C-H activation of phenoxy pyrone substrates employing Conditions B. 
aRegiosiomeric ratios determined from the 1H NMR spectrum of the crude reaction mixture. 
An explanation for the poor yields obtained could be the decomposition of the 2-pyrone motif 
under the reaction conditions. Degradation pathways are an important limitation for 
intramolecular arylation reactions, as reported by Fairlamb and co-workers.17 The pyrone unit 
itself is susceptible to ring opening and this has been documented in the literature by Fairlamb 
among others.18-19 Generally, substrates with electron withdrawing groups on the phenoxy 
ring of the 2-pyrone are more prone to decomposition.20 Burns and co-workers proposed that 
following deprotonation at C-7 (methyl group) of the 2-pyrone, CO2 is subsequently lost which 
in turn enables loss of the aryloxide group and this may be a major step in the degradation 
pathway (Scheme 23).21 The product 52 generated could be lost as a gas or undergo 
polymerisation under the reaction conditions. The poor yield and mass recovery observed for 
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the substrates possessing para-NO2 and para-F substituents could be attributed to this 
process. 
 
                                                                                                                           52 
Scheme 23. Possible degradation pathway for phenoxy 2-pyrones. 
To test whether the reactions conditions were affecting our 2-pyrone framework, four test 
reactions were carried out (Table 4). The percentage mass recovery of 4-phenoxy-2-pyrone 
24 was 55% when it was simply heated at 140 ᵒC for 2 hours (Table 4, entry 1). Interestingly, 
when 4-phenoxy-2-pyrone 24 was heated at 140 ᵒC for 2 hours in the presence of Ag2O or TFA 
(Table 4, entries 2 and 4), the mass recovery decreased even further to 42%. In contrast, 
heating 4-phenoxy-2-pyrone 24 at 140 ᵒC in the presence of PivOH led to a mass recovery of 
73% which is significantly higher (Table 4, entry 3). This would explain why the mass recovery 
and thus the yields were substantially higher using Conditions A. These results would indicate 
that degradation of the 2-pyrone framework does occur under our reaction conditions 
particularly when TFA and Ag2O are present and also at the high temperature required (140 
ᵒC). Table 4. Test reactions carried out on the 4-phenoxy-2-pyrone (24). 
Entry Time (h) Temp. (ºC) Conditions % Pyrone remaininga  
1 2 140 4-Phenoxy-2-pyrone 24 55 
2 2 140 4-Phenoxy-2-pyrone 24 
+ Ag2O 
42 
3 2 140 4-Phenoxy-2-pyrone 24 
+ PivOH 
73 
4 2 140 4-Phenoxy-2-pyrone 24 
+ TFA 
42 
aPercentage pyrone remaining determined using 1H NMR Spectroscopy with 1,3,5-trimethoxybenzene 
as the internal standard for quantification. 
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2.3.3 Synthesis of substrates 
2-Coumarins 
Having achieved success with a range of 2-pyrone substrates, we turned our attention 
towards the 2-coumarin framework. We were curious to see whether our optimised reaction 
conditions would facilitate the intramolecular double C-H activation of 4-phenoxy-2-
coumarins. The coumarin motif is a much more robust structure than the 2-pyrone motif due 
to increased overall aromaticity (as well as no longer having a methyl group which is prone to 
deprotonation).21 Therefore, the coumarin scaffold is theoretically less susceptible to 
degradation under the harsh reaction conditions.  
To begin with, 4-bromo-2-coumarin (54) was prepared in a 72% yield from the corresponding 
4-hydroxy-2-coumarin (53) using the same procedure described in Section 2.3.1.9 4-Hydroxy-
2-coumarin (53) was commercially available.   
 




        54, 72% 
Scheme 24. Synthesis of 4-bromo-2-coumarin (54). 
Next, a variety of 4-phenoxy-2-coumarin substrates (55-72) were synthesised in a similar 
fashion to the 4-phenoxy-2-pyrone substrates (24, 30-40), by a base mediated reaction of the 
substituted phenol with 4-bromo-2-coumarin (54). A range of sterically and electronically 
different phenols were chosen. The crude products were isolated by washing with 10% 
aqueous NaOH, followed by a recrystallisation from EtOH. Moderate to excellent yields were 
achieved for compounds 55-68 (Scheme 25). The synthesis of a number of substrates proved 
unsuccessful such as 69 bearing an aldehydic group at the para-position. Substrate 71 with a 
3,4-dimethyl group also did not progress well under the reaction conditions. Additionally, 72 
containing a sterically encumbered naphthyl group and 70 with a bulky 2-tert-butyl-4-methyl 
group did not work well. 
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               64, 82%                 65, 55%              66, 14% 
 
      
               67, 92%                  68, 86%              69, 0% 
 
                
                70, 0%                  71, 0%              72, 0% 
 
Scheme 25. Synthesis of 4-phenoxy-2-coumarin substrates. 
2.3.4 Demonstration of substrate scope for double C-H activation of 2-coumarins 
With a wide range of 4-phenoxy-2-coumarins synthesised, bearing diverse electronic and 
steric substituents on the phenoxy ring, the scope of the reaction was demonstrated (Scheme 
26). Similar reaction conditions which worked for the 2-pyrones, using PivOH as solvent, was 
utilised for the substrate scope. Overall, it was observed that the reaction allowed for a variety 
of functional groups on the phenoxy ring. Firstly, the unsubstituted analogue 73 was isolated 
in an excellent yield of 92%. Electron donating groups at the para-position of the phenoxy 
ring provided the corresponding products 74-75 in good yields (72 and 77%). However, in the 
case of the tert-butyl analogue 79, the desired product could only be obtained in 56% isolated 
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yield, possibly due to the steric bulk of the tert-butyl group. Pleasingly, substrates bearing 
electron withdrawing substituents on the phenoxy ring were also well tolerated with these 
substrates providing the highest yields overall, 76-78 (80-99%). Notably, a 95% yield was 
obtained for the nitro containing analogue 76, whereas the nitro substituted pyrone analogue 
proved difficult to cyclise. The meta-substituted cyclised products gave excellent 
regioselectivity, with reaction occurring at the least sterically hindered site. For example, 
substrate 81 containing a meta-methoxy substituent gave a regioismeric ratio of 92:8 
(81a:81b). A pure sample of 81b could not be obtained following the purification of the crude 
reaction material by column chromatography. This was due to the fact that 81b was formed 
in a very small quantity relative to 81a. In addition, both regiosisomers 81a and 81b had very 
similar Rf values. On the contrary, the regioselectivity was lower when a fluoro group was 
present at the meta-position (67:33 for 82). The fluorine atom may be exerting a secondary 
directing effect, hence directing Pd to the more sterically hindered position. This may account 
for the decrease in regioselectivity. Gratifyingly however, when the methyl substituent was 
located at the meta-position, only one regioisomer, 80, was observed in the 1H NMR spectrum 
of the crude reaction mixture. Surprisingly, product 80 was isolated in a moderate yield of 
55%. In this case, again the least sterically hindered regioisomer was preferentially formed 
under the reaction conditions. Pleasingly, the ortho-substituted substrate 85 was isolated in 
72% yield and the methyl group did not overly affect the reaction progress. Finally, when the 
phenoxy ring was substituted with two methoxy groups, which is common in many natural 
products, the reaction worked very well, with a 72% yield obtained for 83 and a 98% yield 
obtained for 84. Also, only one regioisomer was observed in the 1H NMR spectrum of the 
crude reaction mixture for the 3,4-dimethoxy analogue 83. Disappointingly, the pyridyl 
substrate 68 failed to give satisfactory conversion to product 86 with the majority of the crude 
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         83, 76%          84, 98%          85, 72% 86, n.d.b 
 
Scheme 26. 2-Coumarin scaffold scope employing Conditions A. aRegioisomeric ratio determined from 
the 1H NMR spectrum of the crude reaction mixture.  bYield not determined (n.d.) due to low 
conversion to product. 
Additionally, our range of substituted 4-phenoxy-2-coumarin substrates were subjected to 
Conditions B, where TFA is used as the reaction solvent. This was carried out in order to get 
a direct comparison of results between both sets of conditions in terms of yield and 
selectivity. Pleasingly, the 2-coumarin scaffold was well tolerated under the reaction 
conditions. This is in stark contrast to the 2-pyrone substrates where the mass recovery and 
yields were very poor due to degradation and incomplete consumption of starting material. 
Overall, good to excellent yields were achieved for 73-85 (41-99%) and a wide range of 
functional group tolerance was observed (Scheme 27). In some cases, the isolated yields were 
directly comparable to the yields obtained when Conditions A were employed. For example, 
the para-fluoro 77 and para-chloro 78 analogues gave an 85% and 99% yield respectively. 
Satisfyingly, an increase in yield was obtained for 79 bearing a para-tert butyl substituent 
(89% for Conditions B versus 56% for Conditions A). For the meta-methyl substituted starting 
material 62, complete regioselectivity (toward the least hindered regioisomer) was observed 
in in the 1H NMR spectrum of the crude reaction mixture and the corresponding product was 
isolated in a moderate yield of 57%. The yield and regioselectivity for 62 was directly 
comparable to Conditions A. In contrast, a decrease in selectivity was observed when a fluoro 
and methoxy substituent was present at the meta-position (39:61 for 81a:81b, 50:50 for 
82a:82b). Notably, 82a:82b could only be isolated in very low yields due to significant 
purification difficulties. Notably, a switch in regioselectivity was observed for the meta-
methoxy substrate between Conditions A and Conditions B. Conditions B showed a greater 
preference for reaction at the more sterically hindered site (reaction occurred at the more 
Chapter 2  Results and Discussion 
48 
 
electron rich site). Compound 63 containing a meta-methoxy substituent was also subjected 
to Conditions B but at lower temperature of 120 ºC. However, no improvement in 
regioselectivity was observed. As was observed for the reaction carried out using Conditions 
A, the pyridyl substrate 68 did not work well. Significant degradation of starting material 68 
was noted, as judged by the 1H NMR spectrum of the crude reaction mixture, with the 
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         83, 43%          84, 48%          85, 41% 86, n.d.b 
Scheme 27. 2-Coumarin scaffold scope employing Conditions B. aRegioisomeric ratios determined 
from the 1H NMR spectrum of the crude reaction mixture. bYield and regioismeric ratio not determined 
due to low conversion to product. 
2.3.5 Structure elucidation of the major and minor meta-fluoro benzofuro-chromenone 
regioisomers 
Extensive analysis using 1D and 2D NMR spectroscopy, as well as evaluation of JC-F values for 
each carbon allowed us to identify the structures of the major and minor regioisomers, 82a 
and 82b. 
Firstly, in the 13C NMR spectra of 82a and 82b, the resonances of the carbons in close 
proximity to the fluorine substituent on the aryl ring appeared as doublets. This allowed us to 
first determine which proton and carbon signals corresponded to the coumarin core structure 
and which corresponded to the arlyoxy ring. Next, evaluation of the JC-F values provided useful 
information as to the position of the fluorine on each aryl ring (Table 5). Coupling between 
carbon and fluorine is very strong and JC-F couplings follow the trend 1JC-F>2JC-F>3JC-F (the 
carbon-fluorine coupling constants in fluorobenzene are 1JC-F = 245 Hz, 2JC-F = 21 Hz and 3JC-F = 
8 Hz).22-23 In the 13C NMR spectra of 82a, the resonances of C-10, C-11, C-12, C-13, C-14 and 
C-15 appeared as doublets while the resonance of C-2 was not split. In addition, C-12 
appeared as a quaternary carbon in the 13C NMR spectra with a large 1JC-F value of 249 Hz. 
Coupling was also observed for C-11 and C-13, with 2JC-F values of 26 and 25 Hz respectively. 
Additionally, coupling was observed for C-10 and C-14, with 3JC-F values of 14 and 10 Hz 
respectively. Also of note, the CH signal at 122.4 ppm corresponded to C-14. Small 4JC-F 
coupling (2 Hz) was observed for C-15.  
In comparison, analysis of the 13C NMR spectra of 82b, C-1, C-2, C-10, C-11, C-12, C-13, C-14 
and C-15 appeared as doublets. Notably, C-14 appeared as a quaternary carbon in the 13C 
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NMR spectra with a large 1JC-F value of 257 Hz. 2JC-F was observed for C-13 and C-15, with 2JC-F 
values of 20 and 22 Hz respectively. 3JC-F coupling was observed for C-10, C-12 and C-2 (3JC-F 
values of 9 Hz, 8 Hz and 4 Hz respectively). Also, the CH signal at 127.8 ppm corresponded to 
C-12. This is in contrast to C-12 in 82a which appeared as a quaternary carbon. Small 4JC-F 
coupling was observed for C-11 and C-1 corresponding to the carbonyl carbon of the coumarin 
ring. The signal corresponding to C-11 appeared as a doublet with a 4JC-F value of 5 Hz whilst 
C-1 showed as a doublet with a very small 4JC-F  value of 1 Hz. Overall, analysis of JC-F coupling 
constants allowed us to determine that the fluorine is located at C-12 for 82a and C-14 for 
82b 
Table 5. Chemical shift data and JC-F values for the major 82a and minor 82b regioisomers. 
 
  
                                82a                                  82b 
 
 







HMBC (heteronuclear multiple bond correlation) spectroscopy detects heteronuclear 
correlations of protons and attached carbons over long ranges of about 2-4 bonds, with one 
Carbon C (ppm) JC-F (Hz) 
C-10 155.6 14 
C-11 100.0 26 
C-12 163.6 249 
C-13 113.5 25 
C-14 122.4 10 
C-15 119.7 2 
Carbon C (ppm) JC-F (Hz) 
C-10 157.0 9 
C-11 108.0 5 
C-12 127.8 8 
C-13 111.9 20 
C-14 156.3 257 
C-15 112.6 22 
C-1 160.2 1 
C-2 104.7 4 
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bond correlations being suppressed.23-24 In the 19F-1H HMBC spectrum of 82a, the fluorine 
resonance at -112.5 ppm showed an intense correlation to H-11, H-13 and H-14. No 
correlation to H-12 was detected (Figure 10). The 1H NMR signals corresponding to H-11, H-
13 and H-14 were determined from the 1H-13C HSQC (heteronuclear single quantum 
correlation) spectra. 1H-13C HSQC spectroscopy is used to correlate the chemical shift of 
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                                                                                                                       82a 
 
Figure 10. 19F-1H HMBC of the major regioisomer 82a.  
In contrast, in the 19F-1H HMBC spectrum of 82b, the fluorine resonance at -111 ppm showed 
an intense correlation to H-13. There was also a strong correlation to H-12 observed. 
However, no correlation to H-11 was evident (Figure 11). The 1H NMR signals corresponding 
to H-11, H-12 and H-13 were determined from the 1H-13C HSQC spectra recorded for 82b. A 
small amount of the major regiosisomer was still present in the fraction containing the minor 
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separating the major and minor regioisomers. Hence, a correlation corresponding to the 
major regioisomer is visible in the 19F-1H HMBC spectrum of 82b (Figure 11).                                                                                                                              
                                                                                                                   
                                                                                                                            82b 
 
Figure 11. 19F-1H HMBC of the minor regioisomer 82b. 
Finally, 19F-1H HOESY (Heteronuclear Overhauser Enhancement Spectroscopy) spectra were 
recorded for both regioisomers 82a and 82b. 19F-1H HOESY spectra provide information about 
through space interactions between fluorine and proton nuclei.23 The data can then be 
interpreted and used to determine the position of the fluorine on the aryl ring. 
H13 
H12   
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Analysis of the 19F-1H HOESY spectra for 82a, clearly shows that the fluorine resonating at -
112.5 ppm is in close proximity to H-13 and H-11 (Figure 12).  
                                                                                                                           
                                                                                                                                     82a 
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For comparison, in the 19F-1H HOESY spectra of 82b, the fluorine resonating at -111 ppm is in 
close proximity to only one proton, H-13 (Figure 13). The lack of an NOE to H-12 or H-11 is 
consistent with the fluorine positioned at C-14 which correlates with previous data. 
 
                                                                                                                        
                                                                                                                                  82b 
 
 
Figure 13. 19F-1H HOESY of the minor regioisomer 82b. 
H13 
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Thus, the information provided from the 2D NMR spectra in combination with JC-F values 
allowed us to establish that the fluorine is located at C-12 for 82a, which was the major 
regioisomer. In contrast, the fluorine in 82b (minor regioisomer) is located at C-14. The 
complete signal assignment is given in Chapter 6 (Experimental Chapter). 
2.4.1 Proposed reaction mechanism for Conditions A 
A proposed reaction mechanism for when Conditions A are employed is outlined in Scheme 
28. Based on mechanistic work involving KIE studies carried out by Dr. Aisling Prendergast and 
computational work involving DFT calculations conducted by the Lin group, an initial 
reversible CMD of the C-3-H bond of 55 to give IM1 is proposed as the first step. This is 
followed by irreversible CMD of the aryl C-H bond which is proposed to be involved in the rate 
determining step of the reaction. Deprotonation (to give IM2) and reductive elimination of 
Pd0 gives the product 73. Re-oxidation of Pd0 back to the active catalyst PdII completes the 
catalytic cycle.25 
 




Scheme 28. Proposed catalytic cycle. 
2.4.2 Monitoring of double C-H activation by NMR Spectroscopy for Conditions B 
Mechanistic studies carried out within the group by Dr. Aisling Prendergast allowed us to 
propose a rational reaction mechanism (outlined in (Scheme 28)) for when Conditions A with 
PivOH as reaction solvent are employed. However, no such mechanistic work was conducted 
for Conditions B which employ TFA as reaction solvent. Differences in yields and 
regioselectivities obtained for a few of the meta-substituted compounds (81a:81b and 
82a:82b) prompted our interest in probing the details of the reaction mechanism for 
Conditions B. Thus, we planned to monitor the progress of the double C-H activation reaction 
by NMR Spectroscopy. This was done with the assistance of UCC NMR spectroscopist Dr. 
Lorraine Bateman. Initially our plan was to carry out the reaction in an NMR tube in the 
spectrometer and monitor the reaction in situ by recording spectra as the reaction was 
proceeding. However, the probe on the 500 MHz spectrometer can only be heated to a 
maximum of 80 ºC. Hence, it was decided to conduct the double C-H activation reaction in a 
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sealed reaction tube at 120 ºC. It was postulated that the lower reaction temperature of 120 
ºC would slow down the reaction, which would facilitate NMR monitoring and also possibly 
allow the observation of reaction intermediates such as those involving Pd-C bonds. After a 
certain period of time, a small sample of the reaction mixture would be transferred to an NMR 
tube and the spectra recorded on the 500 MHz instrument.  
First, the reaction was conducted in a sealed reaction tube with stirring at 120 ºC using a 
stoichiometric amount of Pd (Table 6, entry 1). Using a stoichiometric amount of Pd might 
allow us to observe a palladated intermediate in the catalytic cycle. The reaction was 
conducted in deuterated TFA (TFA-d1). The 1H NMR signal arising from TFA-d1 appears as a 
singlet at 11.5 ppm and shows up as a quartet 116 ppm and a quartet at 162 ppm in the 13C 
NMR spectrum. After 1 hour of heating at 120 ºC, a small sample of the reaction mixture was 
filtered through a pipette of Celite® into an NMR tube and ran on a 500 MHz spectrometer 
(Figure 14). No starting material 67 was observed in the recorded 1H NMR spectra. There was 
evidence of product 83 formation in addition to new peaks being identified. Notably, the 
signal corresponding to the C-3-H of the starting material at 5.7 ppm was absent in the new 
set of signals observed. Due to difficulties in accurate integration of the 1H NMR signals as a 
result of overlapping signals between the product 83 and new species, it was difficult to 
determine the number of protons associated with the new species observed. It was 
determined to be 6/7 protons. While this information is not conclusive, it does suggest that 
the C-3-H of the coumarin ring is broken first possibly leading to a palladated intermediate of 
which the exact structure is undetermined. Also of note, no Pd hydride resonance was 











Figure 14. Stacked 1H NMR spectra of starting material 67, product 83 and crude reaction mixture 
after 1 hour at 120 ᵒC. 
                                                 
Next, the effect of excluding the Pd catalyst was investigated (Table 6, entry 2). This time, the 
reaction was stopped after 15 minutes, a small sample was transferred to an NMR tube and 
the spectra was recorded on the 500 MHz spectrometer. The reaction failed to progress and 
no product 83 was observed. Only starting material 67 was visible in the 1H NMR spectrum 
(Figure 15). Interestingly, the 1H NMR spectrum of the reaction showed deuterium 
incorporation at the C-3 position (the C-3-H at 5.7 ppm now integrated for 0.20H). This is not 
completely unexpected however, as K2CO3 could be expected to deprotonate the acidic C-3-
H of the 2-coumarin. This result would indicate that the C-3-H of the coumarin is likely to be 
activated first in the catalytic cycle and is indicative of a reversible process. 
 




Figure 15. Stacked 1H NMR spectra of starting material 67, product 83 and crude reaction mixture 
after 15 minutes at 120 ᵒC with no [Pd]. 
 
Thirdly, the effect of excluding Ag2O from the reaction mixture was evaluated (Table 6, entry 
3). A stoichiometric amount of Pd was again used in this case. It was found that the reaction 
did proceed in the absence of Ag2O with signals corresponding to product 83 observed in the 
1H NMR spectrum (Figure 16). This result shows that at least some of the catalyst is oxidised 
back to PdII by air or some other oxidant. No starting material 67 was visible in the 1H NMR 
spectrum. Also evident was new signals which did not, correspond to starting material 67 or 
product 83. Again, due to overlapping signals it was difficult to accurately determine how 
many new signals were present. It was estimated at 7 H. The set of new signals was very 
similar to the signals observed for the new species identified when the reaction was 
conducted at 120 ºC for 1 hour (Table 6, entry 1). However, an extra singlet and triplet was 
also observed. Again, the signal corresponding to the C-3-H of the coumarin ring at 5.7 ppm 
was absent. In the 13C NMR spectra, 7 new CH signals were identified along with 8 new 
quaternary signals. The 13C NMR spectra also showed no signal at 90 ppm which would 
correspond to the C-3-H carbon of the coumarin ring. Present in the 13C NMR spectra was a 
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new quaternary carbon signal at 112 ppm corresponding to the C-3 carbon of a coumarin ring. 
There is evidence in the literature which suggests that upon coordination of Pd to carbon, the 
13C NMR shift for the corresponding carbon would be shifted approximately 20 ppm 
downfield with respect to free starting material/non-coordinated complex.26 Also, a CH signal 
at 105 ppm was visible in the 13C NMR spectrum and this was part of the new set of peaks 
identified. The 13C NMR spectrum of product 83 shows a quaternary carbon signal at 105 ppm 
and the 13C NMR spectrum of the starting material 67 shows a CH signal at 105 ppm which 
correlates to C-15 of the aryloxy ring. Taking this data together, it is likely that cleavage of the 
C-3-H occurs first (in preference to the aryl ring). The new species observed in the 1H and 13C 
NMR spectra is suggestive of a palladated intermediate, of which the exact structure is not 
determined.  




     
Figure 16. Stacked 1H NMR spectra of starting material 67, product 83 and crude reaction mixture after 
15 minutes at 120 ºC without added oxidant. 
Finally, the reaction was carried out in the absence of base (Table 6, entry 4). The 1H NMR 
spectra recorded after 15 minutes showed a complex mixture (Figure 17). The peaks 
corresponding to starting material 67 were absent in the 1H NMR spectra and also the 13C 
NMR spectra. However, the spectra indicated a complex mixture so it was difficult to 
determine what species were present. It is difficult to know the exact role of the base in the 
reaction; it may play a role in activating the catalyst, along with facilitating proton abstraction. 
Carbonate bases are also known to act as insoluble proton sinks during the catalytic cycles 
responsible for sequestration of H+ and carboxylate regeneration.12, 27-28 




Figure 17. Stacked 1H NMR spectra of starting material 67, product 83 and crude reaction mixture after 
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Table 6. Mechanistic work carried out on 67. 
 










Time (mins) Result 
1 Pd(OAc)2 K2CO3 Ag2O 60 Product 83 and 
intermediate 
2 - K2CO3 Ag2O 15 Starting 
material 67 
3 Pd(OAc)2 K2CO3 - 15 Product 83 and 
intermediate 
4 Pd(OAc)2 - Ag2O 15 Complex 
mixture 
 
In conclusion, results from the reaction monitoring experiments: 
 Indicate that activation of the C-3-H bond of the coumarin ring is likely be the first 
mechanistic step and is likely to be reversible. 
 New peaks were identified which could correspond to a palladated intermediate. 
However, the structure of this species is unknown. 
Due to time constraints, no further work was carried out. Future work would involve 
determining the structures of the key intermediates involved in the catalytic cycle and 
determining the rate-determining step in the reaction. KIE studies would be useful in 
determining whether C-H activation is involved in the rate-determining step. Also, we do not 
know the exact role of K2CO3, Ag2O and TFA, hence, further study will be required to elucidate 
their roles. The combination of Pd(OAc)2 and TFA is likely to be forming a highly electrophilic 
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Pd catalyst, which has been shown to exhibit enhanced reactivity and greatly lower the 
activation barrier for C-H bond metalation.29-30 Thus, the first mechanistic step may involve 
electrophilic palladation involving Pd(OTFA)2 to generate a palladacycle intermediate. The 
next step may involve intramolecular C-H bond cleavage via a CMD type mechanism. This was 
proposed by Shi and co-workers in their paper on the synthesis of fluorenone derivatives via 
a Pd catalysed double C-H activation.11  
However, the same mechanism may not be in operation for our system. For example, it was 
observed that the yields were higher for meta-substituted substrates possessing electron 
donating substituents over meta-substituted substrates possessing electron withdrawing 
substituents, suggesting an electrophilic aromatic substitution mechanism may be operative. 
Electron poor catalysts such as Pd(OTFA)2 have been shown to be effective in these 
instances.31 However, the exact mechanistic details are not fully understood and would 
require further investigation. A key question to be answered is what exactly the structure of 
active catalytic species is. Vana and co-workers published an insightful paper in 2017 on the 
role of trinuclear species in a Pd(OAc)2/TFA catalytic system.32 Their work proved that TFA 
plays a key role in the C-H activation of acetanilides. They showed that the key catalytic 
species are cyclic trinuclear complexes formed by a sequential ligand exchange from 
[Pd3(OAc)6]. Moreover, they showed that in the absence of TFA the reaction failed to proceed. 
This was similar to what we observed when the reaction was carried out in the absence of 
TFA. This seminal report provides useful information on C-H activation reactions involving 
Pd(OAc)2/TFA systems which was previously lacking in publications to date.  
2.5 Three step synthesis of flemichapparin C 
The good yield and regioselectivity observed with coumarin 67 prompted us to attempt to 
access the coumestan group of natural products which are characterised by a 6H-
benzofuro[3,2-c]chromen-6-one skeleton. This group of natural products exhibit a number of 
interesting biological activities.5-7 We envisioned that our methodology could facilitate a short 
three step synthesis of flemichapparin C in comparison to previous more complex chemical33 
and enzyme mediated routes.34  
The first step involved bromination of commercially available 4-hydroxy-7-methoxy-2-
coumarin 88 to give in a good yield of 72% (Scheme 29).  
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                  88, 72% 
 
Scheme 29. Synthesis of 4-bromo-7-methoxy-2-coumarin (88). 
4-Bromo-7-methoxy-2-coumarin was then coupled with sesamol and the resulting 4-phenoxy 
product 89 was isolated in 96% yield. Application of our Conditions A gave flemichapparin C 
(90a) as the major regioisomer and a minor regioisomer 90b. The regioisomeric ratio was 
determined to be 84:16 (90a:90b) from the 1H NMR spectrum of the crude reaction mixture 
(Figure 18). A combined yield of 82% was obtained (Scheme 30). Due to significant difficulties 
in separating the major and minor regioisomers, flemichaparrin C (90a) could only be isolated 

























90a flemichapparin C 90b  
 
 
                                            84:16 (82%) 
 
Scheme 30. Synthesis of flemichapparin C in three steps. 









Figure 18. 1H NMR spectrum of crude reaction mixture containing a mixture of regiosiomers 90a and 
90b. 
Notably, complete regioselectivity in favour of flemichapparrin C 90a was achieved when 
Conditions B were employed at a lower temperature of 120 ºC. The desired product could be 
isolated in 77% yield (Scheme 31). However, we found that this result was highly dependent 
on the quality of TFA employed in the reaction (larger amounts of degradation was observed 









                        89                    90, 77% 
Scheme 31. Regioselective synthesis of flemichapparin C employing Conditions B. 
2.6 Double C-H activation of 2(1H)-quinolone analogue 
The structurally similar 2(1H)-quinolones are very prevalent structural motifs in many natural 
products and pharmaceutical drugs, as previously discussed in Chapter 1.35-37 Thus, we sought 
to expand our methodology to the quinolone class of compounds.  
2.6.1 Synthesis of starting material 
The first step involved preparation of 4-hydroxy-N-methyl-2-quinolone (93), as this was not 
commercially available. This was achieved using a procedure detailed by Lutz and co-
workers.38 N-Methylation of anthranilic acid (91) was accomplished using CH3I as the 
alkylating agent in the presence of Na2CO3 (Scheme 32) using a procedure optimised by a 
previous member of the McGlacken group. The methylated product 92 was brought forward 
to the next step without purification. Compound 92 was reacted with acetic anhydride in 
refluxing acetic acid to give the corresponding 4-hydroxy-N-methyl quinolone (93) in 35% 
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        93, 35% 
 
Scheme 32. Synthesis of 4-hydroxy-N-methyl-2-quinolone (93) from anthranilic acid (91). 
The first step of the process appears to involve acylation of N-methyl anthranilic acid (92) by 
reaction with acetic anhydride (92-93) and this is followed by an intramolecular cyclisation 
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Scheme 33. Proposed mechanism of N-acylation and cyclisation of N-methyl anthranilic acid (92) to 
give N-methyl-4-hydroxy-2-quinolone (93).  
We then sought to employ the same strategy used for the synthesis of our 4-phenoxy-2-
pyrone and 4-phenoxy-2-coumarin substrates (Scheme 17). This first involved bromination of 
4-hydroxy-2-quinolone 93 with TBAB in the presence of P2O5 (Scheme 34, 1). The product 
from this reaction would then be coupled with phenol. However, bromination of the hydroxy 
quinolone 93 proved unsuccessful. Next, we looked at treating 93 with PBr3. Here, two slightly 
different procedures were investigated. The first procedure which employed DMF as reaction 
solvent and was carried out under MW conditions at 125 ᵒC (Scheme 34, 2). The second 
procedure involved reacting 93 with PBr3 in refluxing THF (Scheme 34, 3). Disappointingly, 
neither of these two protocols proved successful.  













        
98 
 
Scheme 34. Attempted bromination of 93. 
Finally, after attempts at brominating 93 failed, we then looked at preparing 4-phenoxy 
quinolone (100) via an alternative route. Pleasingly, a procedure described by Kappe and co-
workers39 allowed us to gain access to the desired phenoxy quinolone 100 in two synthetic 
steps, although the overall atom economy of the process was not very appealing (Scheme 
35). Initially, 3-iodo-4-phenoxy-N-methyl quinolone (99) was prepared by treatment of 93 
with phenyliodo(III)diacetate (PIDA) and Na2CO3 in refluxing EtOH giving a zwitterion, which 
was subsequently refluxed in DMF. This initiated thermal migration of the aryl group from the 
iodide to the oxygen affording 99 after a H2O quench in 84% yield. Finally, reductive 
deiodination of 3-iodo-4-phenoxy-N-methyl quinolone (99) with Zn dust in acetic acid and 
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Scheme 35. Two step synthesis of 4-phenoxy-N-methyl-2-quinolone (100). 
2.6.2. Cyclisation of the 4-phenoxy-2-quinolone substrate 
Once synthesised, 4-phenoxy-N-methyl-2-quinolone 100 was subjected to our two sets of 
optimised conditions (Scheme 36). Disappointingly, 2-quinolone 96 did not work as well as 
the 2-coumarin substrates, however, product 101 was isolated in 30% yield with Conditions 





           100             101 
 
Scheme 36. Double C-H activation of 2-quinolone analogue 100. 
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2.7.1 Alternative solvent investigation 
In recent years, there has been much attention drawn to certain solvents due to their 
undesirable health, safety and environmental problems. Thus, there has been a push towards 
establishing greener solvents for reactions, separations and extractions.14  With this in mind, 
the final part of the project was aimed at establishing more environmentally friendly reaction 
conditions which align to the principles of green chemistry. Several general purpose solvent 
selection guides have been published over the last number of years. Thus, solvents we chose 
based on criteria as outlined in these solvent selection guides14-15, 40 and also precedence for 
their use in direct arylation reactions.29, 41-43 Several green solvent candidates were tested for 
their feasibility to replace PivOH and TFA as reaction solvent (Table 7). Of the solvents tested, 
the combination of iPrOH and AcOH (4:1) gave the best result (Table 7, entry 3), facilitating 
55% conversion to product 73 and an isolated yield of 41% yield. No other solvent tested gave 
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1 Pd(OAc)2 K2CO3 Ag2O TFA MeOH 65 0 
2 Pd(OAc)2 K2CO3 Ag2O TFA MeCN 80 0 




4 Pd(OAc)2 K2CO3 Ag2O TFA Dioxane/H2O 
(1:1) 
100 0 
5 Pd(OAc)2 K2CO3 Ag2O TFA EtOAc/H2O 
(2.5:1) 
100 0 
6b Pd(OAc)2 NaOtBu Ag2O - MeOH 65 0 
7b Pd(OAc)2 NaOtBu Ag2O - MeCN 80 0 
aIsolated yield in parenthesis. Yield determined by 1H NMR Spectroscopy using 1,3,5-trimethoxy 
benzene as an internal standard for quantification.  bEntries 6-7: 10 mol% [Pd], 20 mol% base.  
2.7.2 Alternative oxidant investigation 
We also briefly examined a few non-metal based oxidants.29, 44 Disappointingly, 
benzoquinone and tert-butyl hydroperoxide (TBHP) did not provide any conversion to desired 
product 73 (Table 8, entry 1-2). In the last 20 years, hypervalent iodine reagents have been 
used as oxidants in high valent transition metal chemistry. From a green chemistry 
perspective, they can be considered environmentally benign, non-toxic and relatively 
inexpensive reagents compared to other inorganic oxidants.44 Thus, two hypervalent iodine 
reagents, diacetoxyiodobenzene (PIDA) and bis(trifluoroacetoxy)iodo benzene (PIFA) were 
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tested (Table 8, entry 3-4). Unfortunately, PIDA only allowed for a 16% conversion to product 
73. The more electron withdrawing analogue PIFA, gave a 35% conversion to desired product 
73. It is important to note that O2 was also examined as a possible oxidant for this 
transformation by a previous member of the McGlacken group. However, no appreciable 
conversion to product was observed. 
















1 Pd(OAc)2 K2CO3 Benzoquinone TFA 140 0 
2 Pd(OAc)2 K2CO3 TBHP TFA 140 0 
3 Pd(OAc)2 K2CO3 PIDA TFA 140 16 
4 Pd(OAc)2 K2CO3 PIFA TFA 140 35 
aConversion calculated from ratio of starting material 55 to product 73 in the 1H NMR spectrum of the 
crude reaction mixture. 
Lastly, we also examined carrying out the reaction with a catalytic amount of Ag2O to 
investigate if it was possible to reduce the amount of oxidant required (Scheme 37). 
Unfortunately, using 10 mol% of Ag2O only allowed for a 28% conversion to product (which is 
2-3 turnovers of the catalyst). The true role of Ag2O in the catalytic cycle is not fully 












            55               73 
-28% conversion 
-12% 1H NMR yield 
(using 1,3,5 trimethoxy 




Scheme 37. Investigation into using a catalytic amount of silver oxidant. 
2.8 Conclusion 
In conclusion, a double C-H activation protocol was applied to 2-pyrones and 2-coumarins 
giving quick access to the cyclised products. Good to excellent yields were obtained for the 
6H-benzofuro[3,2-c]chromen-6-one analogues with both sets of conditions, whilst moderate 
yields were achieved for the 1H-pyrano[4,3-c]benzofuran-1-one products employing 
Conditions A. Substitution patterns (on the phenoxy ring), which would be difficult to access 
via other routes, are available with this methodology. The methodology was also extended to 
include a 2-quinolone analogue, albeit the yield was reduced. Overall, this is one of the most 
delicate molecular frameworks to have been reported for this type of transformation. This 
approach also facilitated a short three step synthesis of flemichapparin C.  
2.9 Expansion of double C-H activation methodology in the literature 
Finally, two separate groups also published work on systems similar to the McGlacken group 
in 2016 and 2017, with PivOH again and AcOH serving as key reaction components enabling 
facile syntheses of fused polyheterocyclic analogues (Scheme 38). In 2016, Cheng and co-
workers developed a highly efficient palladium catalysed intramolecular cross 
dehydrogenative protocol for the synthesis of coumestans and indole[3, 2-ccoumarins in 
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yields of up to 99%.45 The same group subsequently improved on these reaction conditions 
for the synthesis of indolo[3,2-c]coumarins, pyrones and quinolones, with the optimised 
conditions requiring no additional base or oxidant.46 Following on from this, in 2017 Litinas 
published a palladium catalysed oxidative coupling of 4(-arylamino)coumarins in the presence 
of Cu(OAc)2 under microwave irradiation.47 
 
 
Scheme 38. Palladium catalysed intramolecular cross dehydrogenative coupling toward the synthesis 
of fused polyheterocycles. 
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2.10 Background (dibenzofurans) 
As discussed in Chapter 1 of this thesis, dibenzofuran derivatives are an important class of 
structural motifs and are found in many natural products, bioactive molecules and 
pharmaceuticals. Significant biological activity has been exhibited by many members of this 
class of compounds and a large number of naturally occurring dibenzofurans possess anti-
cancer, anti-inflammatory, anti-bacterial, anti-malarial and anti-oxidant properties.48-51 As 
previously mentioned, many of the current methods to synthesise dibenzofurans suffer from 
a number of drawbacks.52-55 Thus, we were interested to see if the double C-H activation 
conditions which were applied in the synthesis of 1H-pyrano[4,3-c]benzofuran-1-one and 6H-
benzofuro[3,2-c]chromen-6-one analogues would be suitable for the double C-H activation of 
diarlyethers. Due to good regioselectivity observed for the meta-substituted 2-pyrone and 2-
coumarin analogues, particularly when Conditions A were applied, it was decided to focus 
only on the synthesis of meta-substituted dibenzofurans and to investigate using our 
optimised double C-H activation conditions. 
 
Figure 19. Targeted objective. 
2.11 Synthesis of diarylether substrates 
Iron catalysed cross-coupling reactions offer an attractive alternative to other transition metal 
catalysed cross-coupling protocols due to the low price and environmentally benign features 
of iron.56-57 Thus, an iron catalysed O-arylation reaction demonstrated by Bolm and co-
workers in 2008 was chosen as the method for the synthesis of diarylether starting 
materials.58 This versatile and convenient protocol uses readily available aryl iodides as 
arylating agents and phenols. The success of this protocol is dependent on the employment 
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of 10 mol% FeCl3 together with 2,2 6,6-tetramethyl-3, 5-heptadione (TMHD) as the chelating 
ligand, in DMF at 135 ºC. A range of substituted analogues were synthesised and purified via 
silica gel column chromatography with yields ranging from 23-78%. Compound 114 with a 
nitro substituent, compound 115 with two methoxy substituents and compounds 116 and 
117 with an aldehyde group and ester group respectively, failed to give any conversion to 
product. This was the case when the phenol was substituted at the meta position and 
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        116, 0%           117, 0% 
Scheme 39. Synthesis of diarylethers via iron catalysed O-arylation. 
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The synthesis of a number of disubtituted diarylethers was carried out via a two step protocol 
developed by Olofsson and co-workers (Scheme 40).59-60 This mild and convenient synthesis 
of diarylethers avoids the use of transition metals, additives or excess reagents. Also, 
precautions to avoid air or moisture are not needed. The first step involved synthesis of bis(3-
methylphenyl)iodonium triflate 121 which was isolated in 52% yield following initial 
formation of the tetrafluoroborate salt 120 by reaction of 3-iodo toluene 118 and 3-methyl 
phenyl boronic acid 119 in the presence of mCPBA and boron trifluoride. The 
tetrafluoroborate salt 120 was then converted to the trfilate salt by an in-situ anion exchange 
with triflic acid to yield 121.60 
       
          




                  119 
 
 
                  120 
                   
       
 
 
    
              121, 52% 
 
Scheme 40. Synthesis of Iodonium triflate salt 121. 
The second step involved reaction of the diaryliodonium triflate salt 121 with the 
corresponding substituted phenol to yield the disubstituted diarlyethers 122-126 in moderate 
to good yields (Scheme 41).59 The lower yields observed for the fluoro 123, ethyl 125 and tert-
butyl 126 derivatives was primarily due to difficulties in purification. One of the main 
drawbacks of the reaction is the use of the stoichiometric iodonium salt which resulted in one 
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equivalent of 3-methyl iodobenzene as the by-product. This by-product proved particularly 
problematic during purification and often co-eluted with the desired products, hence a 




               121              122-126 
 
 
   
                122, 50% 
 





                        125, 51%                          126, 63% 
 
Scheme 41. Diarylether synthesis via diaryl iodonium triflate salt 121. 
Finally, to expand the scope of the double C-H activation reaction to include more 
functionalities, the two step iodonium salt protocol was adopted for the synthesis of an 
aldehyde variant (Scheme 42). Firstly, the diaryliodonium tetrafluoroborate salt 129 was 
synthesised in 69% yield by treating iodobenzene (127) with mCPBA and BF3.OEt2 followed by 
addition of phenyl boronic acid (128). The second step involved reaction of the iodonium salt 
129 with 130 in the presence of tBuOK to give the corresponding diarylether product 116 in 
47% isolated yield, following purification by column chromatography. 
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         116, 47%            
Scheme 42. Synthesis of aldehyde starting material 116. 
2.12.1 Demonstration of substrate scope for double C-H activation of mono-substituted 
diarylethers 
Once synthesised, the diarylether substrates were subjected to our optimised double C-H 
activation reaction conditions (Scheme 43). Cyclisation of the mono-substituted diarylethers 
under the reaction conditions could lead to two possible regioisomers being formed. Not 
surprisingly, it was observed that Conditions A produced higher yields than Conditions B. This 
was a similar trend to that observed for the 2-pyrone and 2-coumarin substrates. Good to 
excellent yields were obtained for 131-137 (49-99%) using Conditions A. This was applicable 
to both substrates bearing electron donating substituents and electron withdrawing 
substituents. A decrease in yield was observed for the naphthyl analogue 135 and the cyclised 
products 135a:135b were isolated in a combined 58% yield. This is probably due to the steric 
bulk of the naphthyl group hindering access to the coupling site. In terms of regioselectivity, 
good regioselectivity was observed for substrates bearing electron donating substituents 
(131, 136 and 137). For these particular substrates, one regioisomer was exclusively formed. 
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A slight decrease in regioselectivity was observed for the methoxy analogue 132, 94:6 in 
favour of the less sterically hindered regioisomer. In the case of substrates with electron 
withdrawing substituents, good to excellent regioselectivity was observed. For example, the 
regioisomeric ratio for the chloro analogue was determined to be 97:3 in favour of 134a and 
this was isolated in 90% yield. Additionally, the chloride in 134a was retained as a synthetic 
handle for further cross-coupling. However, for the fluoro analogue a mixture of regioisomers 
was obtained 133a:133b and the regioisomeric ratio was determined to be 88:12.  
In contrast, moderate to good yields were observed when Conditions B were employed. 
Yields ranged from 31-72%. In two cases, only one regioisomer was formed exclusively. This 
was for substrates with sterically bulky electron donating substituents (136-137). However, 
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        B: 72% 
 
          137           
       A: 94% 
       B: 53% 
Scheme 43. Substrate scope for mono-substituted dibenzofurans. aIsolated yield using Conditions A. 
bRegioisomeric ratios determined from the 1H NMR spectrum of the crude reaction mixtures. c 
Combined yield of both regioisomers isomers. 
2.12.2 Demonstration of substrate scope for double C-H activation of di-substituted 
diarylethers 
Since Conditions A allowed us to achieve better results both in terms of yield and 
regioselectivity, it was decided that going forward these would be the reaction conditions of 
choice. The di-substituted diarylethers were then examined (Scheme 44). These substrates 
presented an additional challenge as three or four regioisomers could be possibly formed. All 
of the di-substituted substrates synthesised contained a methyl substituent and an additional 
electron donating or electron withdraeing substituent. This was primarily due to cost and 
availability of starting materials in-house. Overall, good to excellent yields were achieved for 
the di-substituted analogues 138-143 (50-81%). Excellent regioselectivty was observed 
compounds with two electron donating substituents (138, 140-141) as well as compound 139 
containing a methyl and a chloro substituent. In these four cases, only one regioisomer was 
exclusively formed. A slight decrease in regioselectivity was observed for substrates with an 
electron donating substituent and an electron withdrawing substituent (142), as well as 
compound 143 with a methyl and a methoxy substituent. However, excellent regioselectivity 
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           143a, 70%            143b (not isolated) 
  
     
                                   (94:6)a 
 
Scheme 44. Substrate scope for di-substituted dibenzofurans. aRegioisomeric ratios determined from 
the 1H NMR spectrum of the crude reaction mixtures. 
2.12.3 Substrates which proved difficult to cyclise 
Some functional groups were incompatible with the optimised double C-H activation 
conditions. Five of the substrates (109, 110, 111, 112, 116) resulted in very low conversion to 
cyclised products, in addition to numerous side-products being formed during the course of 
the reaction. This may be attributed to the steric 112 and electronic properties (109, 116) of 
the substituents which may be incompatible with the reaction conditions. Compound 116 
bearing an aldehydic functionality did allow for 50% conversion to product after 60 hours. A 
mixture of regioisomers was formed. However, separation of the starting material 116 from 
the cyclised products by silica gel column chromatography (hexanes) proved extremely 
difficult owing to the similar polarities of both the starting material 116 and cyclised products. 
Numerous recrystallisation attempts also failed to separate the starting material 116 from the 
product. A reduction in catalyst loading to 2 mol% Pd(OAc)2 was also investigated using 116, 
however this failed to provide any significant improvement. Presumably for 110 and 111. 
(bearing a bromo and iodo substituent respectively), competing oxidative addition of the 
palladium catalyst into the C-Br and C-I bonds led to poor conversion to the desired cyclised 
products and resulted in by-product formation. 
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Scheme 45. Substrates which proved problematic. 
2.13 Investigation of N-linker for double C-H activation 
Following on from our work on the synthesis of a range of meta-substituted dibenzofurans, 
we were interested to see if our methodology could be expanded to include different 
heteroatom linkers, to form carbazoles for example (Figure 20). A previous publication by 
Fagnou and co-workers demonstrated the viability of such a transformation on 
diphenylamine substrates.10 However, their scope was mainly limited to substrates 
possessing para substituents. Focus was again directed towards synthesising meta-
substituted compounds. In addition, we were interested to see if our conditions were 
applicable to the N-methyl analogues. 
 
Figure 20. Carbazole product. 
2.14 Synthesis of starting materials 
The synthesis of the diphenylamine substrates was achieved via a Buchwald-Hartwig cross-
coupling of iodobenzene and the meta-substituted aniline in the presence of Pd2(dba)3, dppf 
as ligand and sodium tert-butoxide as base.61 The corresponding diphenylamine products 
144-146 were isolated in moderate yields of 57-69% (Scheme 46). 






      127 
 
          
       144-146 
 
      
                 144, 69%               145, 68%                  146, 57% 
 
Scheme 46. Diphenylamine synthesis via Buchwald-Hartwig coupling. 
The synthesis of the chloro analogue 148 involved a copper catalysed Chan-Lam-Evans 
coupling of phenyl boronic acid 128 and 3-chloro aniline 147 using reaction conditions 
reported by Wang and co-workers.62 This reaction was conveniently carried out in air at 80 ºC 
with K2CO3 as base, benzoic acid as an acid additive and ethyl acetate as solvent. The 
corresponding product 148 was isolated in 61% yield. 
 
 
  128 
   
 
 




       148, 61% 
 
Scheme 47. Synthesis of 3-chloro diphenylamine (148) via Chan-Lam-Evans coupling. 
Methylation of the diphenylamine substrates was achieved under standard methylation 
conditions by treating 144, 146 and 148 with KOH in anhydrous DMF followed by slow 
addition of the methylating agent, CH3I. The resulting mixture was stirred at ambient 
temperature for 48 hours and the corresponding N-methlyated products 149-151 were 
isolated in 58-99% yield following purification by silica gel column chromatography. The 
characteristic methyl 3H singlet at 3.3 ppm in the 1H NMR spectrum and at 40 ppm in the 13C 
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NMR spectrum observed in the crude NMR spectra for 149-151 initially indicated the success 
of the transformation. 
 
 
    144, 146, 148 
 
 
       149-151 
 
   
                149, 59%                  150, 58%              151 , 99% 
 
Scheme 48. N-Methylation of diphenylamines. 
2.15.1 Double C-H activation of N-methyl diphenylamine substrates 
Application of Conditions A to substrates 149-151 failed to give in each case full consumption 
of starting material (Table 9). The reactions proceeded sluggishly and attempts to drive the 
reactions to completion proved unsuccessful. For example, after 50 hours, the 1H NMR 
spectra of the crude reaction mixtures showed low conversion to cyclised product and a 
number of side products were also evident. For compound 150 with a meta-bromo 
substituent, it was evident that numerous side products were present in the crude reaction 
mixture. The poor reactivity may be due to hydrodebromination. Competing oxidative 
addition of the palladium catalyst into the C-Br bond may be inhibiting formation of the 
desired cyclised product. Furthermore, two possible regioisomers could be possibly formed 
for each substrate tested. However, the regioisomeric ratios could not be determined for the 
methyl and bromo substrates (Table 9, entries 1 and 2). This was due to the complexity of the 
1H NMR spectra of the crude reaction mixtures for both of these compounds. The 
regioisomeric ratio for the chloro analogue was determined to be 95:5 in favour of the less 
sterically hindered regioisomer (Table 9, entry 3). Furthermore, it was decided not to isolate 
the compounds from the complex mixtures due to the above reasons.  
Chapter 2  Results and Discussion 
94 
 
Table 9. Attempted double C-H activation of N-methyl diphenylamines. 
 
 
Entry R Time (h) Resulta 
1 Me 50 Complex mixture 
2 Br 50 Complex mixture 
3 Cl 50 Complex mixture 
Reactions were monitored by TLC and 1H NMR spectroscopy. aCrude reaction material contained a 
complex mixture of starting material, cyclised product (two regiosiomers) and side products. 
2.15.2 Double C-H activation of 3-methoxy diphenylamine 
Finally, it was decided to go back and examine diphenylamine bearing a free N-H. A test 
reaction was carried out on the methoxy substrate 145 (Table 10). Fagnou and co-workers 
had previously demonstrated that this particular substrate could be effectively cyclised under 
their optimised reaction conditions to give a mixture of regioisomers in a ratio of 95:5 in 
favour of the less sterically hindered regioisomer.10 In contrast, direct application of 
Conditions A on 145 resulted in only very low conversion to the desired carbazole product 
and it was clear from the 1H NMR spectrum of the crude reaction mixture that decomposition 
of 145 had occurred and that other by-products being formed. Fagnou and co-workers had 
noted the presence of various by-products during the course of their investigations on 
diphenylamine substrates. However, the use of pivalic acid as reaction solvent had a 
significant effect on suppressing by-product formation, although the authors did isolate a side 
product involving the formation of a new C-O bond even when PivOH was substituted for 
acetic acid.10 In comparison to Fagnou’s system, our optimised conditions employ 
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stoichiometric quantities of Ag2O as oxidant and sodium tert-butoxide as base. Both of these 
reagents may contribute to increased formation of unwanted by-products.  
Some undesirable products which may be formed during the course of the reaction are shown 
in Figure 21. These include 153, which results from the formation of a new C-O bond. Product 
152 could arise following fragmentation of the starting material 145, followed by 
recombination with another molecule of starting material or product. Finally, dimer 155 and 
product 154 resulting from oxidative C-N bond formation are also possibilities. Other side 
reactions may also be possible. The by-products formed would explain the low mass recovery 
observed for this reaction. 
Table 10. Double C-H activation reaction of 3-methoxy diphenylamine. 
 
Entry Starting material Time (h) Result 
1 145 50 Complex mixturea 
aCrude reaction mixture contained a complex mixture of starting material 145, a mixture of both 
regioisomers (the regioisomeric ratio could not be determined due to the complexity of the 1H NMR 
spectrum) and by-products. 
 




                   152 




                    154 
                     
 
                                  155 
 
Figure 21. Potential by-products formed under reaction conditions A. 
Due to poor results obtained both for the N-methyl substrates and N-H substrate 145, this 
line of investigation was not pursued any further.  
2.16 Conclusion 
The application of our double C-H activation methodology towards the synthesis of meta-
substituted dibenzofurans was demonstrated. Application of Conditions A on the mono-
substituted diarylethers allowed for efficient conversion to cyclised products and good to 
excellent yields were achieved (Scheme 43). The reaction proceeded particularly smoothly for 
substrates possessing sterically bulky alkyl groups (136 and 137) with yields of up to 99% being 
obtained. Overall, excellent regioselectivity was observed for the majority of substrates. A 
slight decrease in regioselectivity was observed for the meta-fluoro analogue 133 and a 
mixture of regioisomers was obtained for the naphthyl analogue 135. On the contrary, 
Conditions B employing TFA as reaction solvent, resulted in diminished yields and 
regioselectivities (Scheme 43). Pleasingly, the di-substituted diarylethers were cyclised in 
excellent yields and with excellent regioselectivity (Scheme 44). Overall, reaction at the least 
sterically hindered site was favoured when Conditions A were employed, whereas when 
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Conditions B were employed a less selective process was observed. Due to difficulties in 
preparing a number of diarylether substrates, the substrate scope was somewhat limited. In 
addition, a few substrates failed to undergo efficient cyclisation which again narrowed the 
scope of the reaction (Scheme 45). Finally, the N-methyl diphenylamine substrates (149-151) 
did not participate well in the reaction. Unfortunately, the reaction was extremely sluggish 
for these particular substrates and complete consumption of starting material could not be 
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Chapter 3: Synthesis of 
dibenzofurans via 
intramolecular direct 










An efficient construction of dibenzofuran motifs through a ligand enhanced palladium 
catalysed direct arylation of ortho-bromo diarylethers is described in this Chapter. 
Furthermore, the scope and limitations of this reaction will be discussed.  
3.2 Background 
As discussed in Chapter 1 of this thesis, a number of useful methods have emerged for the 
synthesis of dibenzofurans. Considering the problems associated with traditional and 
dehydrogenative coupling reactions (as previously outlined in Chapter 1), the transition metal 
catalysed cyclisation of mono-halogenated diarylethers via C-H activation is a particularly 
attractive route and is relatively less explored. Led by Ames and co-workers1 in the 1980s and 
subsequent work by a number of different groups2-4, this would seem like a go to method for 
the synthesis of dibenzofurans. However, a number of challenges still remain as previously 
discussed in Chapter 1. Thus, the main focus of this Chapter was focused on addressing some 
of these challenges. Moreover, the following Chapter describes the optimisation and 
development of an efficient set of reaction conditions enhanced by a cheap, bench stable and 
commercially available quinoline ligand for the intramolecular cyclisation of ortho-bromo 




Figure 22. Focus of this research. 
A detailed review by Yu and Engle5 in 2013 described that in order for novel C-H activation 
reactions to be developed, ‘the reactions must be operationally simple and robust’. They 
further noted that reactions with ‘substrates, coupling partners, catalysts and ligands that are 
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commercially available or easily accessible are preferable.’ In addition, ‘reactions that do not 
require special equipment and can be set up on the benchtop without rigorous exclusion of air 
or moisture are desirable.’ Thus, some of these aspects were taken into consideration during 
the course of the work described in this Chapter.  
To begin, ortho-bromo diarylether was chosen as the model substrate. Substrate 157 was 
synthesised via a copper mediated Chan-Lam-Evans coupling of phenyl boronic acid (128) 2-
bromo phenol (156) in the presence of triethylamine as base. Purification by column 
chromatography provided the product 157 in 55% yield (Scheme 49). 
 
 
  128  
                            
 
   156 
 
 
     157, 55% 
 
Scheme 49. Synthesis of o-bromo diarylether (157). 
To achieve the intramolecular cyclisation of 157, conditions previously optimised by Dr. 
Rachel Shanahan for the intramolecular cyclisation of 4-(2-bromophenoxy)quinoline 
substrates were adopted.6 Direct application of these reaction conditions allowed formation 
of the fused dibenzofuran product 16 in 70% yield, as determined by 1H NMR spectroscopy 
using 1,3,5-trimethoxybenzene as internal standard (Scheme 50). Attempts to drive the 
reaction to completion failed. After 42 hours, complete consumption of starting material 157 
could not be achieved. Furthermore, separation of product 16 from starting material 157 by 
column chromatography in 100% hexanes proved difficult owing to similar polarities of 16 
and 157. Hence, it was decided that further optimisation of the reaction conditions was 
necessary. 
 
           157  
 
       16, 70% 
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Scheme 50. Initial reaction conditions for the direct arylation of 157. 
3.3 Ligand Identification 
It was decided to test a number of quinoline and pyridine additives with a view towards 
addressing some of the limitations discussed above and in Chapter 1 of this thesis in the 
classic intramolecular direct arylation of ortho-bromo diarylethers. This was based on 
previous reports on the use pyridine and quinoline ligands in Pd catalysed C-H activation 
reactions, particularly by the groups of Yu and Sanford.7-15 Additionally, our group had 
recently discovered that simple quinolines can act as both a substrate and ligand in the 
arylation of quinolines.16  
The majority of pyridine and quinoline ligands examined in the direct arylation of o-bromo 
diarylether were purchased from a commercial supplier. Benzofuroquinoline (L15) and 
phenoxy quinoline (L11) were synthesised by another member of the McGlacken group. 
Phenoxy quinolines L12, L13 and L14 were easily prepared in moderate yields (46-75%) by 
reaction of the corresponding 6-substituted-4-chloroquinoline with phenol (158) in the 
presence of sodium hydroxide. This transformation proceeds via nucleophilic attack of the 
phenoxide anion (generated in situ) on the 4-position of the quinoline (Scheme 51). 
  
                                           158      159-161 
 
          
              159 (L12), 75% 
  
      
             160 (L13), 46% 
       
              161 (L14), 66% 
Scheme 51. Synthesis of 4-phenoxy quinolines 159-161. 
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A series of monodentate pyridine and quinoline type ligands varying in electronic and steric 
character were evaluated (Scheme 52). The addition of 10 mol% quinoline (L2) resulted in no 
improvement in the yield of 16 compared to the no added ligand reaction. Both of these 
reactions only reached ca. 70% conversion to 16. Yu had previously utilised quinoline as a 
ligand in the Pd catalysed meta-C-H arylation and alkylation of benzylsulfonamides.8 Three 
quinoline based ligands with substituents at C-6 on the quinoline ring were investigated (L1, 
L3 and L4). Pleasingly, incorporation of electron donating groups at C-6 allowed for ≥90% 
consumption of starting material 157. Satisfyingly, L1 containing a methoxy group facilitated 
complete consumption of starting material 157 and afforded 16 in a 99% isolated yield. Use 
of L3 (containing a methyl group at C-6) allowed for 90% consumption of starting material 157 
and a yield of 83%. Notably, addition of a fluoro group at C-6 (L4) only had a minimal impact 
on the yield of 16 in comparison to the no added ligand reaction (74% versus 72% 
respectively). The yield of 16 was also improved to 90% when a methyl group was positioned 
at C-4 in L5. Incorporation of a strongly electron withdrawing group at the C-2 positon of 
quinoline and pyridine surprisingly did lead to an increase in yield of 16 (L6, 80% and L7, 81% 
respectively). Yu, Stoltz, Fagnou and Stahl previously had demonstrated the applicability of 
electron deficient pyridine and pyridone ligands in Pd catalysed C-H functionalisation 
reactions, suggesting that they either act to stabilise Pd0 before re-oxidation or they can 
facilitate the formation of a more electrophilic and therefore more reactive Pd catalyst.7, 17-19 
An electron deficient metal center could be beneficial in accelerating key steps in the catalytic 
cycle such as reductive elimination or C-H bond cleavage via a CMD type mechanism. In 
addition, strong non-covalent F۰۰۰۰π interactions (dispersion forces) between the aryl ring 
of the substrate and the fluoro/trifluoromethyl substituent on the pyridine ligand, could 
result in increased stability of a Pd-aryl intermediate species during the catalytic cycle. This 
type of interaction has been documented in electron poor Pd phosphine systems resulting in 
increased stability of the Pd complex.20 Finally, an electron deficient trifluoromethyl 
pyridine/quinoline ligand could equally facilitate substrate binding by providing a vacant site 
on Pd by undergoing a more facile displacement from the metal center.21  
 
DMAP (L10) also performed excellently providing 16 in a yield of 94%. Likewise, use of pyridine 
carboxaldehyde (L9) gave a yield of 87% for the cyclized product. Overall, the more sterically 
bulky phenoxy quinoline ligands (L11-L14) performed less well with yields ranging from 76-
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84%. Changing to 3-pyridine sulfonic acid as ligand (L8),22 led to a significant decrease in yield 
(60%). Finally, the sterically encumbered benzofuroquinoline (L15) was less effective and did 
not appear to enhance the reaction, giving the cyclised product 16 a yield of 69%.  
 
 







Scheme 52. Ligand evaluation for Pd catalysed direct arylation of ortho-bromo diarylether (157). Yields 
were determined using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the internal standard. 
Isolated yields in parenthesis. aAverage of three reactions. 
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6-Methoxy quinoline N-oxide (162) was also examined in the direct arylation of ortho-bromo 
diarylether. Firstly, 6-Methoxy quinoline (L1) was readily oxidised to the corresponding N-
oxide using mCPBA to yield the product 162 in 65% yield following purification by flushing the 




                162, 65% 
Scheme 53. Synthesis of 6-methoxy-quinoline N-oxide (162). 
Addition of 10 mol% 6-methoxy quinoline N-oxide (162) to the reaction only led to a 53% yield 
after 50 hours (Scheme 54). This was in contrast to the no added ligand reaction, which 
allowed for a 72% yield and was in stark contrast to the reaction carried out with 10 mol% 6-
methoxy quinoline (L1), which allowed for full consumption of starting material 157 and a 
99% yield of product 16. This would indicate that the N-oxide additive is inhibiting catalysis 
and may provide some evidence of coordination of the quinoline nitrogen to the Pd, which 
may be facilitating the direct arylation reaction. 
 






Scheme 54. Direct arylation with 6-methoxy quinoline N-oxide (162). 
3.4 Optimisation of reaction conditions 
We next sought to improve the reaction conditions with the optimal ligand (Table 11, L1).  
Hence, a variety of reaction parameters were assessed. These included examining different 
catalyst loadings, as well as investigating the affect different catalyst:ligand ratios had on the 
outcome of the reaction. A number of greener solvents were additionally investigated.  
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As shown in Table 11, decreasing the catalyst loading to 2 mol% Pd(OAc)2 and 4 mol% L1 led 
to a decrease in yield of 16 (Table 11, entry 1). This was in comparison to when 5 mol% 
Pd(OAc)2 and 10 mol% L1 were employed (81% versus 99% respectively). Employing 2 mol% 
Pd(OAc)2 and 4 mol% DMAP (L10), allowed 16 to be obtained in 70% yield (Table 11, entry 2). 
Decreasing the catalyst loading even further to 1 mol% Pd(OAc)2 and 3 mol% L1 lead to a 
dramatic decrease in yield of 16, 58% (Table 11, entry 3). Pleasingly, the combination of 2.5 
mol% Pd(OAc)2 and 7.5 mol% of L1 (Table 11, entry 4) allowed for full consumption of starting 
material 157 and provided 16 in an isolated yield of 99%. As a control, the reaction was carried 
out without any added ligand each time the catalyst loading was reduced (Table 11, entries 
3, 5 and 8) and importantly, no increase in conversion and yield of 16 was achieved. Further 
tuning of the reaction conditions by changing the solvent failed to improve results (Table 11, 
entries 9-11). The reaction carried out in 1,4-dioxane only allowed for a 50% yield of 16, after 
63 hours (Table 11, entry 11). The greater reaction efficiency observed with NMP, may 
suggest that NMP may be involved in the stabilisation of charged intermediates during the 
catalytic cycle, as well as facilitating catalyst activation.18, 23-24 The stabilisation of Pd0 
nanoparticles by NMP is also well established in the literature.25-26 It is possible that NMP may 
be providing a similar stabilising effect in our case. Finally, the reaction time could be reduced 
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Table 11. Optimisation of direct arylation conditions for ortho-bromo diarylether (157). 
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1 2 4 NMP 135 42 81 
2 2 4b NMP 135 42 70 
3 2 - NMP 135 42 58 
4 2.5 7.5 NMP 135 22 100 (99) 
5 2.5 - NMP 135 42 59 
6 1 3 NMP 135 22 44 
7 5 10 NMP 135 22 100 (99) 
8 5 - NMP 135 42 72 
9 5 10 DMSO 135 36 0 
10 5 10 Ethylene 
carbonate 
135 42 8 
11 5 10 1,4-dioxane 110 63 50 
aYields were determined using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the internal 
standard. Isolated yields in parenthesis. bDMAP was used as the added ligand. 
 
Thus, the optimised conditions established for the direct arylation reaction were 5 mol% 
Pd(OAc)2, 10 mol% 6-methoxy quinoline (L1), 2 equivalents of K2CO3 in NMP (2 mL/mmol) at 
135 o C for 22 hours. It is worth noting the cheap cost of 6-methoxy quinoline. 10g are available 
for €31.27  
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3.5 Synthesis of ortho-bromo diarylether starting materials 
With the optimised conditions in hand, an examination of the functional group tolerance was 
undertaken. For this investigation, a range of substituted analogues with electron rich and 
electron poor substituents were synthesised. Three separate protocols were adopted for the 
synthesis of the starting materials. This was in part due to the difficulties encountered in the 
applicability of a general procedure for the synthesis of a diverse range of ortho-bromo 
substituted diarylethers.  
 
3.5.1 Starting material synthesis via nucleophilic aromatic substitution 
The synthesis of two nitro substituted ortho-bromo diarylethers were attempted by coupling 
of the appropriately substituted fluorobenzene and 2-bromo phenol (156). This procedure 
was adopted from Ames 1983 paper on the direct arylation of ortho-bromo diarylethers.1 The 
reaction proceeds via nucleophilic attack of the phenoxide anion generated in situ on the 
fluorobenzene in a straightforward nucleophilic aromatic substitution. In the case of the 
highly activated para-nitro fluorobenzene, the reaction occurred at room temperature. 
Precipitation of the solid after addition of water followed by recrystallisation from ethanol 
provided the product 163, in 51% yield. Reaction of 2-bromo phenol (156) with meta-nitro 











                163, 51%           164 (not formed) 
Scheme 55. Synthesis of nitro substituted diarylethers. 
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Further substrates were prepared in a similar fashion to 163 using the appropriately 
substituted fluorobenzene as the electrophile and the corresponding substituted phenols 
(Scheme 56). The desired products were prepared albeit in poor yields (10% and 12%) for the 





          
                166, 10%         167, 12% 
 
Scheme 56. Synthesis of compounds 166 and 167.  
Modification of the reaction conditions allowed for slightly higher yields of 166 and 167 to be 
achieved. Upon switching the base to KOH and solvent to DMA, as well as increasing the 
temperature to 150 ᵒC, 166 and 167 were furnished in 17% and 22% yield respectively 
following isolation by silica gel column chromatography (Scheme 57). In addition, 
modification of the reaction conditions allowed the meta-nitro analogue 164 to be prepared 











   165 
 
 
      
 
 
            166, 17%              167, 22%                164, 18% 
 
Scheme 57. Improved yields of 164, 166 and 167 using above modified conditions. 
Unfortunately, a number of reactions resulted in very poor conversion to product. Instead, a 
complex mixture of degradation products, in addition to trace amounts of products were 
observed. Access to a number of these substrates were accomplished via alternative routes 
which will be discussed later in this chapter (Figure 23). 
 





Figure 23. Substrates which resulted in poor conversions to products. 
3.5.2 Starting material synthesis via Chan-Lam-Evans arylation of phenols and phenyl 
boronic acids 
Compounds 168-169 were synthesised using Chan-Lam-Evans copper mediated coupling of 
phenyl boronic acids and ortho-bromo substituted phenols (Scheme 58).28-30 Purification via 
silica gel column chromatography yielded the products in yields ranging from 31-72%. It 
should be noted that the yields obtained for this type of reaction are extremely dependent 
on the nature of the substrate and also the substitution on the phenyl boronic acid. This is 









          
 
 
                 168, 72%                  169, 31% 
Scheme 58. Synthesis of ortho-bromo diarylethers 168-169 via Chan-Lam-Evans coupling. 
Two substrates with electron donating substituents were also synthesised through the copper 
promoted Chan-Lam-Evans arylation of phenols with aryl boronic acids. Reaction of 2-bromo-
4-methoxy phenol (171) (synthesised by Dr. David Jones) with phenyl boronic acid (128) 
yielded 172, albeit in low yield of 33% following isolation by silica gel column chromatography. 
 
           170 
 
   128 
 
 
          171, 33% 
Scheme 59. Synthesis of diarylether 171 via Chan-Lam-Evans coupling. 
To further expand the substrates scope, diarylether 171 was conveniently converted to the 
hydroxylated product 172 based on a procedure by Wiegrebe.31 The methyl ether was 
successfully cleaved by treating 171. with 5 equivalents of BBr3 in DCM. Pleasingly, the 
reaction went to completion after 16 hours to give the hydroxylated product 173 in 93% yield. 
 
 




                    171                172, 93% 
 
Scheme 60. Cleavage of the methyl ether group 171. 
A potential mechanism for the demethylation reaction is provided in Scheme 61, which 
involves the generation of a cation on the oxygen of the methoxy group and loss of a bromide 
anion. Nucleophilic attack of the bromide anion on the methyl group of the cationic 
intermediate cleaves the C-O bond, with loss of MeBr. Finally, aqueous hydrolysis gives the 
final product 172. 
 
Scheme 61. Potential mechanism for demethylation of 171. 
The benzo[1,3]dioxole ring system is found in many drug molecules and is an important 
intermediate in the synthesis of many natural products.32-34 Hence, synthesis of a 
benzo[1,3]dioxole analogue was of interest. Dioxole analogue 174 was synthesised via 
coupling of sesamol (173) with phenyl boronic acid (128) to yield the product in 29% yield 
(Scheme 62). Previous attempts to couple 2-bromo sesamol with phenyl boronic acid (128) 
proved unsuccessful. Therefore, a new strategy had to be adopted whereby the non-
brominated analogue 174 was synthesised initially, prior to bromination of the sesamol ring. 




         173 
 
    128    
 
         174, 29% 
 
Scheme 62. Synthesis of diarylether 174. 
Compound 174 was brominated in a facile manner using 1 equivalent of NBS in acetonitrile.35 
The reaction was stirred at 0 ᵒC for 10 minutes and warmed to room temperature overnight. 
Following column chromatography on silica gel using hexane as eluent, the desired product 




           174          175, 94% 
Scheme 63. Bromination of compound 174. 
A general mechanism for the Chan-Lam-Evans arylation of phenols with phenyl boronic acids 
is outlined in Scheme 64. The first step involves initial deprotonation of the phenol followed 
by coordination of the phenoxide anion to a Cu(II) species to give I. Transmetallation of the 
organoboron species with the Cu(II) species (I) gives an aryl Cu(II) phenoxide intermediate (II) 
bearing the two coupling partners and this is believed to be the turnover limiting step. This 
intermediate can then undergo reductive elimination or could be oxidised to Cu(III) via 
disproportionation with a second equivalent of Cu(OAc)2 to give III (and a Cu(I) complex). The 
latter is more is more likely to occur.36 This is followed by reductive elimination to yield the 
diarylether product. Reductive elimination from a Cu(III) species is proposed to proceed faster 
than from a Cu(II) species. Completion of the catalytic cycle is achieved via oxidation to Cu(II) 
and this is proposed to be facilitated by O2, NEt3.AcOH and BX(OH)2. This is based on seminal 
studies by Stahl35 who provided key insights into the mechanism of the Chan-Lam-Evans 
coupling reaction, and subsequent investigations by Watson and co-workers.37 




Scheme 64. General mechanism of the Chan-Lam-Evans coupling reaction. 
A number of reactions proved unsuccessful using the Chan-Lam-Evans protocol and will be 
discussed below (Scheme 65 and Scheme 66). Hence, alternative protocols had to be adopted 
in order to gain access to a more diverse range of substituted ortho-bromo diarylethers, to 
further examine the scope of the direct arylation reaction. 
A diverse range of substituted phenols were easily available. As a result, 2-bromo benzene 
boronic acid (176) was chosen as the common boronic acid. Access to substituted phenyl 
boronic acids was less convienent and would be a more expensive approach. Unfortunately, 
the reaction proceeded much more sluggishly when 176 was used as the boronic acid coupling 
partner. Moreover, conversions to diarylether products were very low (Scheme 65). This in 
part may be due to the low nucleophilicity of 176 which would result in slower 
transmetallation and thus would inhibit the desired C-O bond forming reaction.38  




           176 
 
Scheme 65. Unsuccessful substrates employing 176 as the boronic acid coupling partner. 
Similarly, the electron poor para-trifluoromethylphenyl boronic acid and para-
trifluoromethoxyphenyl boronic acid were not well tolerated in the reaction (Scheme 66). 
Again, this may be due to the low nucleophilicity of the para-CF3 and para-OCF3 phenyl 
boronic acids. 
 
    156 
 
 
Scheme 66. Unsuccessful diarylether substrates employing electron poor phenyl boronic acids. 
The Chan-Lam-Evans reaction offers a number of advantages over other transition metal 
mediated C-O bond formation processes. Traditional processes such as the Ullman reaction 
requires very high temperatures and often gives variable yields. In contrast, the Chan-Lam-
Evans reaction is conducted under much milder oxidative conditions (air or O2). On the other 
hand, there are a number of limitations associated with the Chan-Lam-Evans reaction. The 
yields of the reaction are very much dependent on the nature of the substrate and also the 
substituents on the boronic acid, for instance, ortho substituted and electron poor boronic 
acids performed poorly, as outlined above. In addition, the Chan-Lam-Evans reaction is 
significantly hampered by problems with by-product formation. As a consequence, this can 
lead to variable and diminished yields depending on the substrate. By-products which were 
identified in the 1H NMR spectrum of the crude reaction mixtures for several substrates and 
are well documented in the literature are outlined in Figure 24.28-29, 37 These by-products arise 
from oxidation of the phenyl boronic acid due to competitive arylation of water, with 
oxidative homocoupling of the generated phenol giving rise to diphenylether as a second by-
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product. Evans remarked in his original paper that water is generated from the phenyl boronic 
acid, through triphenylboroxine formation.29 Evans29 and Watson37 noted that conducting the 
reaction under strictly anhydrous conditions failed to completely suppress the formation of 
these by-products, although addition of molecular sieves to the reaction mixture is beneficial 
in lowering production of the oxidation product. Protodeboronation is also a major by-
product of the Chan-Lam-Evans coupling reaction. In addition, Watson and co-workers also 
observed the homocoupling (resulting from coupling of the protodeboronation product) 
under strictly anydrous reaction conditions.37 Re-oxidation of Cu(I) to Cu(II) is proposed to 
have significant implications on the O-arylation reaction particularly with respect to by-
product formation, with the oxidation of phenyl boronic acid and protodeboronation known 
to be favoured more by Cu(I) over Cu(II). Therefore, slow Cu(I) to Cu(II) oxidation will 
consequently lead to increased side reactions occurring. It must be noted that a test reaction 
of phenyl boronic acid (128) and 2-bromo phenol (156) was carried out using molecular 
oxygen as the external oxidant. However, no increase in conversion to product 157 was 
observed.28 
 
Figure 24. Products from side reactions. 
3.5.3 Synthesis of starting materials using iodonium salts 
It was of interest to expand the variety of substrates bearing both electron donating and 
electron withdrawing groups. Hence, an alternative method was employed using 
tetrafluoroborate iodonium salts in a similar manner to that described in Section 2.11 using 
the procedure adopted from Olofsson and co-workers.39-40  This involved initial preparation 
of the bis-substituted phenyl iodonium tetrafluorborate salts by reaction of the relevant 
substituted iodobenzene and corresponding substituted phenyl boronic acid in the presence 
of mCPBA and boron trifluoride diethyl etherate. The salts were obtained by passing the crude 
product through a short plug of silica using DCM/MeOH (20:1). Precipitation of the 
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concentrated filtrate with Et2O afforded products 177-179 in moderate to good yields 





                 177, 76%                  178, 31%                 179, 24% 
 
Scheme 67. Synthesis of tetrafluoroborate iodonium salts 177-179. 
Bis-(4-trifluoromethoxyphenyl)iodoniumtetrafluoroborate (180), bis-(4-
fluorophenyl)iodonium tetrafluoroborate (181) and bis-(3-trifluoromethylphenyl)iodonium 




                       180                    181                       182 
Figure 25. Diaryliodonium salts synthesised in the McGlacken group. 
Reaction of iodonium salt 180 with a number of substituted 2-bromo phenols in the presence 
of tBuOK afforded products 183-185, in yields ranging from 23-61% following purification by 
column chromatography (Scheme 68). Difficulties were encountered in the purification of the 
products due to the presence para-trifluromethoxy iodobenzene as a by-product of the 
reaction in a similar manner to that discussed in Section 2.11. 




      





    
           183, 61% 
 
 
    
           184, 23% 
 
 
              185, 30% 
Scheme 68. Synthesis of para-trifluoromethoxy substrates 183-185. 
Similarly, reaction of bis-(2-bromophenyl)iodonium tetrafluoroborate (177) with 186 
provided the di-chloro analogue 187 in 61% yield after purification via column 
chromatography (Scheme 69). 
 




                 186 
  
          187, 61% 
Scheme 69. Synthesis of di-chloro analogue 187. 
Substrate 189 was prepared in 51% yield from 177 and m-cresol (188) (Scheme 70).  




               177 
 
 




        189, 51% 
Scheme 70. Synthesis of compound 189. 
Compounds 190-192 were synthesised in the same manner as described above in yields of 
65-80%. Attempts to improve the yield of 164 proved unsuccessful and this product could 
only be isolated in 15% yield. The presence of a number of by-products as well as difficulties 





                             190, 65%                      191, 80% 
        
                             164, 15% 
                 
                     192, 65% 
 
Scheme 71. Synthesis of diarylethers 164, 190-192 via tetrafluoroborate salts. 
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In an effort to expand the substrate scope beyond dibenzofurans, the ether linker was 
replaced with an amine. This would allow access to carbazoles which are known to possess a 
number of important medicinal properties.34, 41-44 The amine linked substrate was accessed 
by performing a Buchwald-Hartwig coupling reaction of aniline (193) and 2-bromo-
iodobenzene (194) to afford 195 96% yield (Scheme 72). 
 
 
   193 
 
 
   194 
 
 
      195, 96% 
Scheme 72. Synthesis of 2-bromo diphenylamine (195). 
Like carbazoles, pyridine based compounds are present in many biologically active and 
pharmaceutically relevant compounds.45 Pyridine is the 2nd most frequent occurring ring 
system in FDA approved drugs.46 Reaction of 4-chloro pyridine hydrochloride (196) and 2-
bromo phenol (156) in the presence of NaOH gave 197 in 60% yield (Scheme 73). 
 
 
  196 
 




Scheme 73. Synthesis of 4-(2-Bromophenoxy)pyridine (197). 
Synthesis of the N-oxide derivative was undertaken in an attempt to test the efficacy of our 
reactions conditions to substrates beyond o-bromo diarylethers. 4-(2-
Bromophenoxy)pyridine (197) was subsequently oxidised in a facile manner using 2.5 
equivalents of mCPBA in DCM to give 198 in 94% yield (Scheme 74).  
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                  197 
  
         198, 94% 
Scheme 74. Synthesis of N-oxide derivative (198). 




                 LMP1 
 
 
     LMP2        
Scheme 75. Substrates synthesised by Dr. Leticia Pardo. 
3.6.1 Demonstration of substrate scope for direct arylation of ortho-bromo diarylethers 
With the optimal conditions in hand, the substrate scope of the reaction was evaluated. Due 
to the small scale on which the products were synthesised (approx. 0.1 mmol), the physical 
amount of Pd(OAc)2 required for a 2.5 mol% loading (<1 mg) was too small to be consistently 
weighed out. Therefore, to ensure reproducibility, the catalytic loading was increased to 5 
mol% Pd(OAc)2 and 10 mol% L1 for the substrate scope investigation.  
Overall, the optimised direct arylation conditions facilitated smooth cyclisation and 
substrates bearing electron withdrawing substituents were very well tolerated (Scheme 76). 
This was applicable to both weakly and strongly electron withdrawing substituents (16, 199-
206). Compound 199 bearing a valuable fluoride group was obtained in an excellent yield of 
99%. Other substrates with more strongly electron withdrawing substituents such as 200 
(para-nitro) and 201 (para-trifluoromethyl) were cyclised in excellent yields of 97% and 86% 
respectively. In the case of the trifluoromethoxy analogue 202, a reduction in isolated yield 
was observed and the fused product was isolated in a 60% yield.  
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Complete regioselectivity toward the least sterically hindered position was observed for 203 
(with a trifluoromethyl substituent) and a single regioisomer was isolated in 96% yield. 
Additionally, the reaction of a 2,4-dichloro substituted diarylether 187 afforded a 70% yield 
of 204. It is noteworthy that whilst complete consumption of 187 was observed in the 1H NMR 
spectrum of the crude reaction mixture, a number of extra signals were also apparent. Due 
to overlapping signals, it was difficult to accurately identify the products corresponding to the 
extra signals. However, hydrodehalogenation and homo coupling products are the most likely 
causes of the reduction in yield for 204. Pleasingly, compound 205 incorporating a potentially 
problematic pyridine moiety was obtained in a good yield of 70%. Carbazole containing 
molecules have garnered much interest owing to their diverse biological profiles, hence, 
synthesis of a carbazole derivative provoked our interests.34, 42-44, 47 Pleasingly, application of 
our optimised direct arylation conditions on the diphenylamine precursor 195, furnished 9H-
carbazole 206 in 50% yield. Interestingly, in the absence of L1, 206 could only be obtained in 
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                 200, 97% 
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202, 60% 
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206, 50% (48 h) 
 
Scheme 76. Demonstration of substrate scope. 
Gratifyingly, a number of substrates with electron withdrawing substituents on both aryl rings 
could be efficiently synthesised in good to excellent yields, allowing access to a number of 
novel dibenzofurans (Scheme 77, 207-210). Notably, all of these cyclised products feature a 
fluoro substituent, with some products possessing two fluoro substituents (208 and 210). 
Fluorine containing compounds play a very important role in pharmaceuticals with up to 20% 
of pharmaceuticals on the market or in clinical development possessing a fluorine atom. 
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Furthermore, over 50% of blockbuster drugs contain a fluorine atom.48-49 In addition, a 
number of newly approved pharmaceuticals feature several types of aromatic rings 
substituted with F and CF3.50 In the case of the para-chloro analogue 211 where the chloride 
was located on the same aryl ring bearing the bromide, the cyclised product was obtained in 
an excellent yield of 95%. A decrease in isolated yield was obtained for 199 when the fluoro 
substituent was positioned on the aryl ring bearing the bromide at the ortho position (Scheme 
77, 199, 80%). This was in contrast to compound 168 where the bromide was located on the 
adjacent aryl ring to the fluoro substituent. In this case, cyclisation of 168 under the reaction 
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                     208, 80% 
        
                     209, 83% 
     
                210, 63% 
          
                     211, 95% 
 
              
                      199, 80% 
Scheme 77. Demonstration of substrate scope. 
3.6.2 Substrates that proved difficult to cyclise  
A number of substrates proved difficult to cyclise (Figure 26). For example, this was the case 
for 164 containing a meta-nitro substituent and the N-oxide compound 198 and may be 
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attributed to the electronic properties of the substrates proving incompatible with the 
reaction conditions. Fagnou had previously reported the Pd catalysed direct arylation of 
pyridine and quinoline N-oxides using a Pd/phosphine catalytic system.50-52 In theory, the N-
oxide moiety should prevent non-productive binding of Pd to the N-lone pair, as well as 
favouring π-binding interactions resulting in a more facile pyridine metalation.51 In addition, 
the N-oxide should increase the acidity of the adjacent pyridyl C-H bonds and thus facilitate 
cyclisation. However, in our case, cyclisation of 198 under our optimised reaction conditions 
resulted in very low yield of desired product. In addition, a number of impurities were still 
present despite many attempts to obtain pure samples of the dibenzofuran product. Pyridine 
N-oxides are known to undergo decomposition at high temperatures52 and this could be a 
contributing factor to the low yield obtained for the cyclised product. A similar low yield of 
cyclised product was obtained when the meta-nitro analogue 164 was subjected to our 
optimised reaction conditions. In contrast, an excellent yield was achieved with the para-nitro 
analogue 200 (97%). This would indicate that the position of the nitro group on the aryl ring 
has a significant effect on the electronics of the reaction. 
             
                                    164 
                  
                            198 
 
Figure 26. Compounds which resulted in poor yields. 
3.7.1 Investigation into electron rich substrates 
Next, a substrate scope involving electron rich substrates was investigated. Additionally, an 
alcohol and acetate derivative were examined. LMP3 and LMP4 were obtained from another 
member of the McGlacken group (Figure 27). It was envisioned that the successful cyclisation 
of the ester substrate LMP4 would allow the direct application of our methodology in the 
short three to four-step synthesis of ruscodibenzofuran, which is a naturally occurring 
dibenzofuran isolated from the roots of Ruscus aculeatus L. (Liliaceae) (Figure 28).53 
Ruscodibenzofuran had previously been synthesised by Stevenson and co-workers in a seven-
step synthesis.54 





                                     LMP3                                        LMP4 
 
Figure 27. Alcohol and acetate derivative synthesised within the McGlacken group. 
 
 
Figure 28. Proposed synthesis of Ruscodibenzofuran. 
Firstly, a number of substrates possessing electron donating groups on the aryl ring bearing 
the bromide were examined (Table 12). These two functionalities proved to be incompatible 
with the reaction conditions, as after 22 hours significant degradation of both starting 
materials (LMP3 and LMP4) was evident in the 1H NMR spectrum of the crude reaction 
mixture (Table 12, entry 1 and 2). For substrate 171 with a para-methoxy substituent, after 
48 hours, the reaction conditions failed to allow complete consumption of starting material  
(Table 12, entry 3). Similarly, for the sesamol-type substrate 175, only 30% conversion to 
product was observed (Table 12, entry 4). It is postulated that oxidative addition into the C-
Br bond for substrates 171 and 175  would be particularly sluggish due to the electron rich 
Chapter 3  Results and Discussion 
129 
 
nature of the aryl rings. It is well established that electron poor aryl halides oxidatively add to 
Pd more readily than the corresponding electron rich aryl halides.55 Thus, unfavourable 
oxidation addition is more than likely a contributing factor in the poor conversions observed 
for 171 and 175. 
Table 12. Attempted direct arylation of electron rich, hydroxy and acetate substrates. 
 
 
Entry Compound R Ligand t (h) Resulta 
1 LMP3 p-OH L1 22 Degradation 
products 
2 LMP4 p-OAc L1 22 Degradation 
products 
3 171 p-OMe L1 48 62% 
4 175 -OCH2O- L1 24 30% 
aConversion calculated from the percentage of starting material to product in the 1H NMR spectrum 
of the crude reaction mixture. 
It was then decided to investigate substrates which contained electron donating groups on 
the aryl ring which was adjacent to the aryl ring bearing the bromide. It was postulated that 
oxidative addition for such substrates may be more favourable and would allow for 









           DJ2 
 
Figure 29. Sesamol derivative DJ2 synthesised within the group. 
Unfortunately, attempts to cyclise 166, 167, 189 and DJ2 using the optimised conditions also 
proved difficult and disappointingly no substrate underwent complete conversion to product 
(Table 13, entries 1-4). Pleasingly though, the reaction conditions did allow for the selective 
formation of the least hindered regioisomer 212 for the meta-methyl substrate 189. On the 
contrary, substrate DJ2 provided a mixture of regioisomers 213a and 213b in a ratio of 72:28, 
again with reaction preferentially occurring at the least sterically hindered site (Table 13). The 
major regioisomer 213a was identifiable by a singlet at 7.07 ppm in the 1H NMR spectrum of 
the crude reaction mixture, which is distinct from the minor regioisomer 213b. 
Table 13. Attempted direct arylation of electron rich substrates. 
 
 
Entry Compound R Ligand t (h) Conversion (%)a 
1 166 p-Me L1 48 60% (42%) 
2 167 p-OMe L1 48 68%  
3 189 m-Me L1 48 64%  








                         212  
213a                                  213b 
 
72:26 
Isolated yield in parenthesis. aConversion calculated from the percentage of starting material to 
product in the 1H NMR spectrum of the crude reaction mixture. bRatio of DJ2: 213a: 213b determined 
as 50: 35: 15 from the 1H NMR spectrum of the crude reaction mixture. 
3.7.2 Re-optimisation of direct arylation conditions for electron rich substrates 
The initally optimised reaction conditions which produced excellent yields for the electron 
poor substrates failed to induce complete conversion to arylated product when electron rich 
substrates were employed. This prompted us to reinvestigate the reaction conditions for 
electron rich substrates. Thus, a brief optimisation screen was carried out on substrates 171 
(Table 14), 166 (Table 15) and 167 (Table 16). 
Table 14. Optimisation of reaction conditions for direct arylation of 171. 
                  
 





          214       
 
Entry [Pd] 












1 Pd(OAc)2 L1  
 
- 135 48 62 
2 Pd(OAc)2 - - 135 48 26 
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 3b Pd(OAc)2 L1  
 
 135 48 50 




135 24 10 
5 Pd(OAc)2 L10  
 
- 135 50 66 




135 48 40 




135 48 18 
8 Pd(OAc)2 - DABCO 
(10 mol%) 
135  48 76 
9 Pd(OAc)2 - DBU  
(10 mol%) 
135 48 68 
10 Pd(OAc)2 Picolinic 
acid 
- 135 48 43 
11 Pd(OAc)2 SPhos 
 
- 135 48 67 








                SPhos DABCO DBU picolinic acid 
Results based on one run. aConversion calculated from the percentage of starting material to product 
in the 1H NMR spectrum of the crude reaction mixture. b5 mol% Pd(OAc)2 and 15 mol% L1 were used. 
The previously optimised direct arylation conditions resulted in 62% conversion to product 
214 (Table 14, entry 1). In the absence of L1 (Table 14, entry 2), a significant reduction in 
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conversion was observed. Reduced Pd loading (but an increase in Pd:ligand ratio (1:3)) did not 
allow for an improvement in conversion. In fact, a decrease in conversion to 214 (50%) was 
observed (Table 14, entry 3). A range of additonal ligands and additives were screened. 
Switching the ligand to the more electron rich DMAP L10 resulted in no significant increase in 
conversion (Table 14, entry 5). Picolinic acid resulted in diminished conversion (Table 14, 
entry 10).  
Bulky electron rich phosphine ligands are known to facilitate oxidation addition by donating 
electron density to the Pd0 center, thereby increasing the nucleophilicity of Pd and lowering 
the activation barrier for oxidative addition.56-57 In addition, SPhos has the ability to stabilise 
a monoligated Pd0 center by interaction between the ipso-carbon of the lower biaryl ring and 
Pd, aswell as having the capacity to stabilise a PdII center by coordination of the methoxy 
group to Pd. The stabilisation provided by SPhos could allow for the formation of a highly 
active yet stable monophosphine Pd complex. The ability of bulky electron rich 
monophosphine ligands to promote the formation of highly reactive monophine Pd 
complexes is well documented in the literature.56, 58-61 It was thought that perhaps oxidative 
addition into the C-Br bond on the electron rich aryl ring of 171 may be sluggish. However, 
the employment of SPhos failed to provide an improvement on results (Table 14, entry 11).  
Attempts to improve conversion by addition of an external oxidant proved detrimental to the 
reaction and only allowed for 10% conversion to 214 (Table 14, entry 4). Addition of 30 mol% 
PivOH as an additive led to a reduction in conversion (Table 14, entry 6). Changing to a Pd0 
source in combination with PivOH completely hindered the reaction and led to only 14% 
conversion to 214 (Table 14, entry 7).  
Two organic bases were examined in the absence of L1. This was on the basis that simple 
primary and secondary amine bases are often used in cross-coupling reactions and display 
some properties as ligands along with acting as bases, to stabilise reactive intermediates.62 
For example, in 2004, Li and co-workers demonstrated the utility of a Pd(OAc)2/DABCO (1,4-
diazabicyclo[2.2.2]octane) catalytic system for the Suzuki-Miyaura coupling of deactivated 
aryl bromides and phenyl boronic acids.63 This initiated an investigation to determine if 
DABCO could facilitate the reaction of the deactivated aryl bromide 171. Pleasingly, DABCO 
did allow for an increase in conversion to 76%. On the contrary, the addition of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU) gave 68% conversion to 214 (Table 14, entries 8-9). 
Chapter 3  Results and Discussion 
134 
 
Finally, substrate 214 was subjected to microwave conditions at 150 ºC. Disappointingly, in 
this case the reaction conditions only allowed for 25% conversion to product after 1.5 hours. 
(Table 14, entry 10).  
As mentioned above, an optimisation study was also conducted on substrate 166. A variety 
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Table 15. Optimisation of reaction conditions for direct arylation of 166. 
 
 
            166 
 
  













1 5 L1 
(10 mol%) 
NMP Air 135 48 60 (42) 
2 2.5 L1 
(7.5 mol%) 
NMP Air 135 48 50 
3 5 - NMP Air 135 48 60 
 4b 5 - NMP Air 135 48 0 
5 3 PCy3.HBF4 
(6 mol%) 
DMA N2 140 44 43 
 6c 10 - NMP Air 135 48 0 
7 5 - NMP Air 200 
(MW) 
1 (23)d 
8 5 - NMP Air 170 
(MW) 
1.5 30 (27)d 
Results based on average of two runs excluding entries 7 and 8. aConversion calculated from the 
percentage of starting material to product in the 1H NMR spectrum of the crude reaction mixture.  
Isolated yield in parenthesis. b30 mol% TFA added as an additive to form Pd(TFA)2 in situ. cPd/C (10 wt. 
%) was used as catalyst. dYield determined using 1H NMR spectroscopy with 1,3,5-trimethoxybenzene 
as the internal standard.  
As previously demonstrated, application of the optimal conditions on 166 allowed for 60% 
conversion to product 215 (Table 15, entry 1). The product 215 was subsequently isolated in 
42% yield via preparative TLC (hexanes). Decreasing the catalyst loading to 2.5 mol% (whilst 
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increasing the catalyst:ligand ratio to 1:3) resulted in slightly diminished conversion to 
product (Table 15, entry 2). In the absence of L1, the conversion remained the same as was 
observed for when the reaction was carried out in the presence of L1 (both 60%). (Table 15, 
entry 3). Due to the poor to moderate conversions observed, it was postulated that the 
current optimised reaction conditions may not be suited to electron rich substrates and that 
it may be possible to bias the C-H bond cleavage step toward an electrophilic aromatic 
substitution type mechanism by modification of the reaction conditions. An electrophilic 
aromatic substitution (SEAr) type mechanism is often suggested as the mode of C-H bond 
cleavage for electron rich aromatic substrates.64-65 An SEAr type pathway would favour 
electron rich over electron poor substrates due to their enhanced nucleophilicity. Electron 
poor catalysts such as Pd(OTFA)2 have been shown to be effective in these instances.66 To 
further probe this hypothesis, the reaction was carried out in the absence of 6-methoxy 
quinoline L1. Instead, 30 mol% TFA was added to the reaction mixture to potentially form a 
more electrophilic Pd(II) catalyst in situ, Pd(TFA)2. Disappointingly however, no discernible 
product 215 was identified in the 1H NMR spectrum of the crude reaction mixture (Table 15, 
entry 4).  
Conditions adopted from Fagnou and co-workers for the intramolecular direct arylation with 
aryl bromides, aryl chlorides and aryl iodides were also examined.2 Under inert conditions, 
the reaction did proceed in the presence of PCy3.HBF4 but once again not to full conversion, 
even after prolonged reaction time (Table 15, entry 5). When the heterogeneous palladium 
catalyst Pd/C (10 wt. %) was employed instead of Pd(OAc)2, no evidence for the formation of 
product 215 was observed. In this instance only starting material 166 was recovered from the 
crude reaction mixture (Table 15, entry 6). Finally, microwave conditions were investigated. 
At 200 ᵒC for 1 hour, a 23% yield of 215 was obtained. In this case, the starting material 166 
was completely consumed, however this was accompanied by a number of unidentifiable side 
products, possibly due to dehalogenation and homo-coupling of the substrate (Table 15, 
entry 7).  A reduction in temperature to 170 ᵒC failed to provide any improvement (Table 15, 
entry 8). At this temperature, the starting material 166 was not completely consumed and 
numerous side products were present in the 1H NMR spectrum of the crude reaction mixture. 
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A further optimisation screen was carried out on 167 in an effort to drive the reaction to 
completion which would alleviate difficulties with purification, as discussed previously (Table 
16). 
Table 16. Optimisation of reaction conditions for direct arylation of 167. 
                    
 
           167 
    
 
 
          214 
Entry [Pd] 









1 Pd(OAc)2 L1 - 48 (62) 
2 Pd(OAc)2 - - 48 (41)  
3 Pd(OAc)2 SPhos - 48 (78) 
 4 Pd(OAc)2 - DBU 
(10 mol%) 
48 85  
5 Pd(OAc)2  DBU 
(15 mol%) 
48 56  
      6 Pd(OAc)2 picolinic 
acid 
- 48 50  
7 Pd(OAc)2 - DABCO 
(10 mol%) 
48 68  
   Results based one run. Yield in parenthesis. Yield determined using 1H NMR spectroscopy with 1,3,5-
trimethoxybenzene as  the internal standard. aConversion calculated from the percentage of starting 
material to product in the 1H NMR spectrum of the crude reaction mixture. 
   In the presence of 5 mol% Pd(OAc)2, 10 mol% L1 and 2.5 equiv. K2CO3, a 62% yield of 214 was 
obtained (Table 16, entry 1). The absence of L1 gave inferior results (Table 16, entry 2). 
Various additives and ligands were also examined. Best results were obtained with SPhos and 
DBU (Table 16, entry 3 and 4). SPhos gave a 78% yield of 214 (Table 16, entry 3). The best 
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result was obtained when 10 mol% DBU was employed (Table 16, entry 4). This allowed for 
an 85% conversion to product (214) after 48 hours. DBU can act as a ligand and coordinate to 
transition metal complexes, however, this can be inhibitory in a lot of cases, rendering the 
catalyst ineffective for the desired catalytic reaction. This has been shown to be the case in 
C-N bond forming reactions, whereby the use of DBU as base can can lead to catalyst 
deactivation.67-68 On the contrary, DBU, may in this case be acting as a ligand for Pd. In 2019, 
Khan and co-workers disclosed a mild and efficient synthesis of carbazoles via a Pd catalysed 
intramolecular direct arylation of o-iodo diphenylamines assisted by DBU.41 The authors 
propose that DBU participates at various stages of the catalytic cycle acting as both a mild 
organic base and ligand for Pd. First, DBU is suggested to act as a reducing agent to generate 
the active catalytic Pd0 species. It may be then be acting as a σ-donating ligand for Pd, which 
may accelerate both the oxidative addition step as well as the reductive elimination step. In 
addition, DBU is critical for the C-H activation step, which the authors propose to be a CMD 
type mechanism for electron poor substrates and an SEAr type mechanism for electron rich 
substrates, with DBU promoted deprotonation resulting in a six-membered palladacycle. The 
authors report that the use DBU resulted in improved functional group tolerance and higher 
yields relative to those observed with inorganic bases. It is plausible that DBU may be exerting 
a similar affect in the case of the o-bromo diarylethers. However, at this time further 
mechanistic work is required to fully elucidate the mechanism of action for our substrates. 
Increasing the DBU loading to 15 mol% resulted in a decrease in conversion (Table 16, entry 
5). Additional additives screened did not allow for any significant increase in conversion to 
product. Employment of picolinc acid as a ligand only allowed partial conversion to product 
(Table 16, entry 6). Finally, DABCO performed moderately well giving a 68% conversion to 
214 (Table 16, entry 7).  
3.7.3 Difficulties encountered during the purification of crude material 
  A significant challenge was encountered during the isolation of the cyclised product for the 
electron rich substrates, for which no reaction ran to completion. Recovering a clean sample 
of the dibenzofuran product was a major challenge as separation of starting material and 
product proved particularly problematic. As noted by Studer in Science69 in 1997 ‘The practical 
synthesis of organic compounds is limited not only by the yield of specific reactions but also by 
the ability to recover the desired product in pure form……recovering and purification 
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difficulties can limit the yield and utility of otherwise successful organic synthesis strategies.’ 
Given the similar polarity of the halide starting material and the cyclised product, isolation of 
the desired dibenzofuran product often proved impossible. As was detailed in the previous 
section driving these reactions to completion proved difficult, even at high catalyst loading, 
elevated temperatures, under inert conditions in the presence of phosphine ligands. The 
highest conversion to product was achieved with substrate 167 using DBU as an additive, 
which afforded an 85% conversion to product 214. Initial attempts to purify the crude reaction 
material by silica gel column chromatography with hexanes or cyclohexane as eluent failed to 
allow separation of starting material from product. Analogous preparative TLC afforded the 
same result. Additionally, no increase in separation could be observed on alumina (neutral or 
basic) TLC plates. Chromatography with silver nitrate is a well known and established 
methodology for the separation of non-polar compounds with similar polarites. The silver ions 
reversibly interact with π-systems to form polar complexes. The silver nitrate is typically 
impregnated on silica gel or alumina for separation.70-71 Thus, the silica gel coated plates were 
impregnated with an aqueous AgNO3 solution 5% (w/v), dried and heat activated for two 
minutes. Next, the crude reaction material was spotted on the AgNO3 impregnated TLC plate. 
Disappointingly, after running the TLC plate in hexane and examining it under a UV lamp, no 
distinct separation between the starting material 167 and product 214 was observed. Finally, 
Florisil®, which is a hard powdered gel of magnesium silicate, is a less polar and less acidic 
adsorbent in comparison to silica gel.70 Thus, it was postulated that this might enable 
improved separation between the non-polar starting material 167 and product 214. 
Unfortunately, Florisil® did not provide any improvement in separation, with both compounds 
(167 and 214) eluting off the column at the same rate. It is worth noting that numerous 
recrystallisation efforts with a number of different solvent systems also failed to induce 
precipitation of the solid dibenzofuran product 214.  
   Additionally, we attempted to exploit the inherent differences in reactivity between the aryl 
bromide starting material and dibenzofuran product. In 2006, Buchwald and co-workers 
developed an elegant system for the Pd catalysed synthesis of phenols from aryl halides using 
KOH as the nucleophilic source in the presence of bulky monodentate phosphine ligands.72 
Thus, it was hypothesised that conversion of the remaining aryl bromide (once the reaction 
had reached maximum conversion) to the corresponding phenol using KOH may be possible. 
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The formed phenol could potentially be extracted into the aqueous layer afterwards, allowing 
a pure sample of the dibenzofuran product to be obtained. A mixture of 214 and 171 was 
obtained (in a ratio of 67:33) following reaction of 171 in the presence of 5 mol% Pd(OAc)2, 
10 mol% SPhos and 2 equivalents of K2CO3 in NMP. A few drops of a 1M solution of KOH was 
then added to the reaction vial and the resulting mixture was stirred at 100 ºC for 16 hours. 
The reaction mixture was then cooled to room temperature and acidified with dilute aqueous 
1M HCl (Scheme 78). Disappointingly, analysis of the 1H NMR spectrum of the crude reaction 
mixture only showed a mixture of aryl bromide starting material 171 and dibenzofuran 
product 214. No evidence for the formation of the desired phenol product 171 was visible. 
            
 
                      171 
 
        
           214                                                  171                                                
 
 
          214  
 
   Scheme 78. Attempted interconversion of aryl bromide starting material to phenolic product. 
   Pleasingly, the para-methyl product 215 could be isolated in 42% by preparative TLC (Table 
15, entry 3). Slight separation of the bands corresponding to the starting material and product 
on the TLC plate allowed a clean sample of both the starting material 166 and product 215 to 
be obtained. 
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   3.8 Additional substrates examined under the reaction conditions 
   Attention was then turned to the more challenging aryl chloride substrates. Aryl chlorides are 
more readily available and less expensive than aryl bromides and iodides.2, 64-65, 73 However, 
cleavage of a C-Cl bond is inherently more difficult than a C-Br or C-I bond.74 As a 
consequence, direct arylation reactions more commonly employ aryl bromide or aryl iodide 
substrates.1, 4 In a seminal report in 2006, Fagnou and co-workers developed a broadly 
applicable catalytic system for the intramolecular direct arylation to aryl chlorides, bromides 
and iodides, with aryl iodides surprisingly exhibiting inferior reactivity relative to aryl chlorides 
and bromides.2 The optimum catalytic system of a 1:1 ratio of Pd to PtBu3.HBF4 at a Pd loading 
of 1 mol% allowed for a broad range of five, six and even seven membered oxygen and 
nitrogen ring systems to be synthesised. Thus, we were interested if our methodology would 
be applicable to the analogous aryl chloride substrate. The first step involved preparation of 
2-chloro diphenyl ether (217) which was achieved in a similar manner to that described in 
Section 3.5.2. Reaction of 2-chloro phenol (216) and phenyl boronic acid (128) in the presence 
of a copper catalyst and NEt3 afforded 217 in 62% yield  (Scheme 79). 
 






           216    128            15, 62% 
Scheme 79. Synthesis of 2-chloro diarylether 15. 
Disappointingly, attempts to cyclise 15 under the optimised reaction conditions failed to 
provide any of the desired product 16. Consequently, only starting material  15 was identified 
in the 1H NMR spectrum of the crude reaction mixture (Scheme 80). 
 
 









           16 
 
Scheme 80. Attempted direct arylation of 15. 
3.9 Mechanism for the direct arylation of ortho-bromo diarylethers 
The high reactivity and excellent yields achieved with electron poor substrates in our system 
is consistent with a CMD mechanism for the C-H bond cleavage step rather than an 
electrophilic aromatic substitution or a Heck type mechanism which show strong preference 
for more electron rich substrates. This is consistent with Fagnou’s observations regarding the 
importance of C-H bond acidity in the CMD pathway.75 A possible mechanism for the reaction 
is outlined below in Scheme 81. Initial oxidative addition of Pd into the C-Br bond of A 
generates I. The resulting PdII complex is anticipated to undergo ligand exchange to form the 
key CMD transition state II. An irreversible deprotonation (by an acetate or carbonate base), 
as suggested by Fagnou75-76, Echavarren77-78 and Davies/MacGregor79-80 would generate III, 
with reductive elimination giving the cyclised product B and regeneration of the active 
catalyst. 




Scheme 81. Possible catalytic cycle for the direct arylation of o-bromo diarylethers (ligands omitted 
for clarity). 
However, it is important to note that there may be other potential mechanisms at play. For 
example, a PdII/PdIV catalytic cycle may also be operating, which has recently been proposed 
by Yu and Morokuma.81-82 Such a mechanism could involve C-H activation of A as the first step 
followed by oxidative addition. C-H bond cleavage via a CMD type mechanism (I) would give 
intermediate II. Oxidative addition of PdII into the C-Br bond would generate a PdIV species III, 
with reductive elimination and ligand association giving the product B and regenerating the 
active catalyst (Scheme 82). 




Scheme 82. Possible PdII/PdIV catalytic cycle for the direct arylation of o-bromo diarylethers (ligands 
omitted for clarity). 
The nature and composition of the active catalytic species remains unclear. The extent to 
which the quinoline (L1) is participating in the transformation is also undetermined. However, 
based on a number publications, there are many possible roles: 
1) The ligand may facilitate a slow step in the catalytic cycle (e.g. C-H activation). The quinoline 
may act as a σ-donor ligand and could potentially play a role in the C-H activation step by 
making the Pd center more nucleophilic which may be more desirable for a CMD mechanism.5 
Ess and co-workers noted that a correlation exists between the energy of the CMD transition 
state and the thermodynamic stability of the developing Pd-Ar bond.83 Thus, it may be 
reasonable to postulate that L1 may exert a stabilising effect on Pd which would lead to a 
more stable Pd-aryl intermediate complex. The increase in nucleophilicity of the Pd center by 
strong σ-donation from the quinoline, as well as an increase in the steric bulk around Pd, may 
also accelerate the oxidative addition and reductive elimination steps in a similar manner to 
electron rich phosphine ligands56, although, the former is unlikely as reaction of the electron 
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rich substrate 172, in the presence of 6-methoxy quinoline (L1) failed to allow full 
consumption of starting material (Table 14, entry 1). 
2) The ligand could also be playing a role outside the primary catalytic cycle. For example, 
prolonging the lifetime of the catalyst by preventing or slowing catalyst decomposition or by 
recovering Pd catalyst that is sequestered off-cycle, as well as intercepting and stabilising 
unligated Pd0 before the formation of Pd black and thus facilitating re-oxidation and 
regeneration of the active catalyst. There is precedence in the literature for all of these 
scenarios in other Pd catalysed transformations as well as other related reactions, primarily 
by Sanford, Yu and Fagnou.3, 5, 9, 12, 18-19, 59, 81, 84 For example, Sanford demonstrated the key 
role a quinoline carboxylate ligand played in rescuing off-cycle Pd species from a precipitate 
that was formed during the course of the reaction. This catalyst system was exploited to 
achieve the C-H arylation of azabicycloalkanes.12 
3) The ligand may also have other beneficial roles in the catalytic cycle such as facilitating in 
stabilising high energy PdIV intermediates in the direct arylation reaction.5, 81 Conversly, the 
quinoline ligand may play a role in the formation of the active catalyst i.e. with the quinoline 
aiding precatalyst-to-catalyst transformation. Pd(OAc)2 exists in the trimeric form in the solid 
state23 and in some solvents such as chloroform, benzene, acetic acid and methanol at room 
temperature.84 Quinoline (L1) may facilitate deaggregation of trimeric or polymeric Pd(OAc)2 
and allow the formation of a more reactive PdLn(OAc)2 species, a role for which Sanford had 
previously demonstrated for pyridine ligands.10 Our lab has recently shown that 
Pd(OAc)2/quinoline complexes can act as competent pre-catalysts in a one-pot tandem Suzuki 
Miyaura/direct arylation (SM/DA) reaction with di-bromo quinolines (Scheme 83).16 




Scheme 83. Pd(OAc)2/quinoline pre-catalyst for SM/DA reaction of di-bromo quinolones. 
3.10 Conclusion and Future Work 
In summary, an efficient catalytic protocol aided by a cheap and commercially available 
quinoline ligand for the construction of dibenzofuran motifs has been developed. Gratifyingly, 
a number of challenges with existing protocols for the classic intramolecular C-H activation of 
diarylethers, which were discussed in Chapter 1 of this thesis, have been addressed (Table 
17). Crucially, the reactions take place in air, without added phosphine or tert-alkyl 
ammonium salt. Importantly, the newly developed reaction conditions allowed for complete 
consumption of diarylether starting material, as in the absence of added quinoline ligand, 
attempts at separating the product from the unreacted starting material proved challenging.  
In particular, column chromatography on conventional silica gel was found to be unsuitable 
as both the diarylether starting material and dibenzofuran product are very non-polar. The 
optimised reaction conditions also allowed for a reduction in temperature below 170 ºC (as 
was previously reported in Ames early report on the intramolecular arylation of diaryl ethers). 
Overall, substrates bearing electron withdrawing groups were particularly well tolerated and 
yields of up to 99% were observed. Notably, the optimised conditions allow for the use of a 
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pyridyl moiety and an N-H linker. On the contrary, substrates with strongly electron donating 
substituents did not progress as well.  







Current work within the group is focused on probing the mechanistic details of the reaction, 
with future work targeted at broadening the scope of the current transformation as well as 
exploiting this catalytic system for other synthetically useful C-H activation reactions. The 
exact role of the quinoline has yet to be discerned. However, it is suspected that it acts as 
either a discrete ligand to the palladium during the catalytic cycle16 or as a vehicle to dissolve 
palladium aggregates as recently report by Sanford.12 Further study is required to fully 










Current challenges This work 
very high temperature  (<170 ºC)        
very high catalyst loading        
inert atmosphere        
phosphine ligands        
expensive additives        
product isolation problems        




1. Ames, D. E., Opalko, A. Synthesis 1983, 234-235. 
2. Campeau, L.-C., Parisien, M., Jean, A., Fagnou, K. J. Am. Chem. Soc. 2006, 128, 581-
590. 
3. Campeau, L.-C., Thansandote, P., Fagnou, K. Org. Lett. 2005, 7, 1857-1860. 
4. Panda, N., Mattan, I., Nayak, D. K. J. Org. Chem. 2015, 80, 6590-6597. 
5. Engle, K. M., Yu, J.-Q. J. Org. Chem. 2013, 78, 8927-8955. 
6. Shanahan, R. M., Hickey, A., Reen, F. J., O'Gara, F., McGlacken, G. P. Eur. J. Org. Chem. 
2018, 2018, 6140-6149. 
7. Izawa, Y., Stahl, S. S. Adv. Syn. Catal. 2010, 352, 3223-3229. 
8. Cheng, G., Wang, P., Yu, J.-Q. Angew. Chem. Int. Ed. 2017, 56, 8183-8186. 
9. Zhang, Y.-H., Shi, B.-F., Yu, J.-Q. J. Am. Chem. Soc. 2009, 131, 5072-5074. 
10. Emmert, M. H., Cook, A. K., Xie, Y. J., Sanford, M. S. Angew. Chem. Int. Ed. 2011, 50, 
9409-9412. 
11. Gary, J. B., Cook, A. K., Sanford, M. S. ACS Catal. 2013, 3, 700-703. 
12. Cabrera, P. J., Lee, M., Sanford, M. S. J. Am. Chem. Soc. 2018, 140, 5599-5606. 
13. Zhang, S., Shi, L., Ding, Y. J. Am. Chem. Soc. 2011, 133, 20218-20229. 
14. Li, S., Chen, G., Feng, C.-G., Gong, W., Yu, J.-Q. J. Am. Chem. Soc. 2014, 136, 5267-5270. 
15. Izawa, Y., Pun, D., Stahl, S. S. Science 2011, 333, 209-213. 
16. Shanahan, R. M., Hickey, A., Bateman, L. M., Light, M. E., McGlacken, G. P. J. Org. 
Chem. 2020, 85, 2585-2597. 
17. Liu, L. Y., Yeung, K. S., Yu, J. Q. Chem. Eur. J. 2019, 25, 2199-2202. 
18. Ferreira, E. M., Stoltz, B. M. J. Am. Chem. Soc. 2003, 125, 9578-9579. 
19. Stuart, D. R., Fagnou, K. Science 2007, 316, 1172-1175. 
20. Jakab, A., Dalicsek, Z., Holczbauer, T., Hamza, A., Pápai, I., Finta, Z., Timári, G., Soós, T. 
Eur. J. Org. Chem. 2015, 2015, 60-66. 
21. Lafrance, M., Lapointe, D., Fagnou, K. Tetrahedron 2008, 64, 6015-6020. 
22. Park, H., Chekshin, N., Shen, P.-X., Yu, J.-Q. ACS Catal. 2018, 8, 9292-9297. 
23. Sherwood, J., Clark, J. H., Fairlamb, I. J. S., Slattery, J. M. Green Chem. 2019, 21, 2164-
2213. 
24. Carole, W. A., Colacot, T. J. Chem. Eur. J. 2016, 22, 7686-7695. 
Chapter 3  Results and Discussion 
149 
 
25. Reetz, M. T., de Vries, J. G. Chem. Commun. 2004, 1559-1563. 
26. Reetz, M. T., Westermann, E., Lohmer, R., Lohmer, G. Tetrahedron Lett. 1998, 39, 
8449-8452. 
27. http://www.fluorochem.co.uk/Products/Search?searchType=C&searchText=5263-
87-6, accessed 8th October 2019. 
28. Lam, P. Y., Clark, C. G., Saubern, S., Adams, J., Winters, M. P., Chan, D. M., Combs, A. 
Tetrahedron Lett. 1998, 39, 2941-2944. 
29. Evans, D. A., Katz, J. L., West, T. R. Tetrahedron Lett. 1998, 39, 2937-2940. 
30. Chan, D. M., Monaco, K. L., Wang, R.-P., Winters, M. P. Tetrahedron Lett. 1998, 39, 
2933-2936. 
31. Kammermeier, T., Kaiser, A., Lee, G. S., Burgemeister, T., Wiegrebe, W. Arch. Pharm. 
1994, 327, 207-210. 
32. da Silva, L. M. M. G., de Oliveira, J. F., Silva, W. L., da Silva, A. L., de Almeida Junior, A. 
S. A., Barbosa dos Santos, V. H., Alves, L. C., Brayner dos Santos, F. A., Costa, V. M. A., 
Aires, A. d. L., de Lima, M. d. C. A., Albuquerque, M. C. P. d. A. Chem-Biol. Interact. 
2018, 283, 20-29. 
33. Chen, Z., Pitchakuntla, M., Jia, Y. Nat. Prod. Rep. 2019, 36, 666-690. 
34. Baumann, M., Baxendale, I. R., Ley, S. V., Nikbin, N. Beilstein J. Org. Chem. 2011, 7, 
442-495. 
35.        Colman, E. Z., Arias, K., Siegel, J. S., Can. J. Chem. 2009, 87, 440-447. 
36. King, A. E., Brunold, T. C., Stahl, S. S. J. Am. Chem. Soc. 2009, 131, 5044-5045. 
37. Vantourout, J. C., Miras, H. N., Isidro-Llobet, A., Sproules, S., Watson, A. J. B. J. Am. 
Chem. Soc. 2017, 139, 4769-4779. 
38. Chen, W.-B., Xing, C.-H., Dong, J., Hu, Q.-S. Adv. Syn. Catal. 2016, 358, 2072-2076. 
39. Bielawski, M., Aili, D., Olofsson, B. J. Org. Chem. 2008, 73, 4602-4607. 
40. Jalalian, N., Ishikawa, E. E., Silva, L. F., Olofsson, B. Org. Lett. 2011, 13, 1552-1555. 
41. Khan, A., Karim, R., Dhimane, H., Alam, S. ChemistrySelect 2019, 4, 6598-6605. 
42. Lissa, S. T., Daniela, G., Dianqing, S. Curr. Top. Med. Chem. 2016, 16, 1290-1313. 
43. Knölker, H.-J., Reddy, K. R. Chem. Rev. 2002, 102, 4303-4428. 
44. Głuszyńska, A. Eur. J. Med. Chem. 2015, 94, 405-426. 
45. A. A. Altaf, A. S., Z Gul, N Rasool, A. Badshah, B. Lal, E. Khan J. Drug Des. Med. Chem. 
2015, 1, 1-11. 
Chapter 3  Results and Discussion 
150 
 
46. Taylor, R. D., MacCoss, M., Lawson, A. D. G. J. Med. Chem. 2017, 60, 1638-1647. 
47. Sánchez, C., Méndez, C., Salas, J. A. Nat. Prod. Rep. 2006, 23, 1007-1045. 
48. O’Hagan, D. J. Fluor. Chem. 2010, 131, 1071-1081. 
49. Mei, H., Han, J., Fustero, S., Medio-Simon, M., Sedgwick, D. M., Santi, C., Ruzziconi, R., 
Soloshonok, V. A. Chem. Eur. J. 2019, 25, 11797-11819. 
50. Leclerc, J.-P., Fagnou, K. Angew. Chem. Int. Ed. 2006, 45, 7781-7786. 
51. Campeau, L.-C., Stuart, D. R., Leclerc, J.-P., Bertrand-Laperle, M., Villemure, E., Sun, H.-
Y., Lasserre, S., Guimond, N., Lecavallier, M., Fagnou, K. J. Am. Chem. Soc. 2009, 131, 
3291-3306. 
52. Campeau, L.-C., Rousseaux, S., Fagnou, K. J. Am. Chem. Soc. 2005, 127, 18020-18021. 
53. Elsohly, M. A., Slatkin, D. J., Knapp, J. E., Doorenbos, N. J., Quimby, M. W., Schiff, P. L., 
Gopalakrishna, E. M., Watson, W. H. Tetrahedron 1977, 33, 1711-1715. 
54. Scannell, R. T., Stevenson, R. J. Am. Chem. Soc., Perkin Trans. 1 1983, 2927-2931. 
55. Amatore, C., Pfluger, F. Organometallics 1990, 9, 2276-2282. 
56. Martin, R., Buchwald, S. L. Acc. Chem. Res. 2008, 41, 1461-1473. 
57. Surry, D. S., Buchwald, S. L. Angew. Chem. Int. Ed. 2008, 47, 6338-6361. 
58. Ross, A. J., Lang, H. L., Jackson, R. F. W. J. Org. Chem. 2010, 75, 245-248. 
59. Baxter, R. D., Sale, D., Engle, K. M., Yu, J.-Q., Blackmond, D. G. J. Am. Chem. Soc. 2012, 
134, 4600-4606. 
60. Hartwig, J. F., Paul, F. J. Am. Chem. Soc. 1995, 117, 5373-5374. 
61. Galardon, E., Ramdeehul, S., Brown, J. M., Cowley, A., Hii, K. K., Jutand, A. Angew. 
Chem. Int. Ed. 2002, 41, 1760-1763. 
62. Overman, L. E. Organic Reactions, John Wiley & Sons, New York, USA, 2002, pp. 576. 
63. Li, J.-H., Liu, W.-J. Org. Lett. 2004, 6, 2809-2811. 
64. McGlacken, G. P., Bateman, L. M. Chem. Soc. Rev. 2009, 38, 2447-2464. 
65. Alberico, D., Scott, M. E., Lautens, M. Chem. Rev. 2007, 107, 174-238. 
66. Nishikata, T., Abela, A. R., Huang, S., Lipshutz, B. H. Beilstein J. Org. Chem. 2016, 12, 
1040-1064. 
67. Kim, S.-T., Pudasaini, B., Baik, M.-H. ACS Catal. 2019, 9, 6851-6856. 
68. Sunesson, Y., Limé, E., Nilsson Lill, S. O., Meadows, R. E., Norrby, P.-O. J. Org. Chem. 
2014, 79, 11961-11969. 
Chapter 3  Results and Discussion 
151 
 
69. Studer, A., Hadida, S., Ferritto, R., Kim, S.-Y., Jeger, P., Wipf, P., Curran, D. P. Science 
1997, 275, 823-826. 
70. Gocan, S. J. Chromatogr. Sci. 2002, 40, 538-549. 
71. Zhang, Q.-W., Lin, L.-G., Ye, W.-C. Chin. Med. 2018, 13, 20. 
72. Anderson, K. W., Ikawa, T., Tundel, R. E., Buchwald, S. L. J. Am. Chem. Soc. 2006, 128, 
10694-10695. 
73. Littke, A. F., Fu, G. C. J. Org. Chem. 1999, 64, 10-11. 
74. Jin, M. J., Lee, D. H. Angew. Chem. Int. Ed. 2010, 49, 1119-1122. 
75. Lafrance, M., Fagnou, K. J. Am. Chem. Soc. 2006, 128, 16496-16497. 
76. David, L., Keith, F. Chem. Lett. 2010, 39, 1118-1126. 
77. García-Cuadrado, D., de Mendoza, P., Braga, A. A. C., Maseras, F., Echavarren, A. M. J. 
Am. Chem. Soc. 2007, 129, 6880-6886. 
78. García-Cuadrado, D., Braga, A. A. C., Maseras, F., Echavarren, A. M. J. Am. Chem. Soc. 
2006, 128, 1066-1067. 
79. Boutadla, Y., Davies, D. L., Macgregor, S. A., Poblador-Bahamonde, A. I. Dalton Trans. 
2009, 5820-5831. 
80. Davies, D. L., Macgregor, S. A., McMullin, C. L. Chem. Rev. 2017, 117, 8649-8709. 
81. Ye, M., Gao, G.-L., Edmunds, A. J. F., Worthington, P. A., Morris, J. A., Yu, J.-Q. J. Am. 
Chem. Soc. 2011, 133, 19090-19093. 
82. Jiang, J., Yu, J.-Q., Morokuma, K. ACS Catal. 2015, 5, 3648-3661. 
83. Petit, A., Flygare, J., Miller, A. T., Winkel, G., Ess, D. H. Org. Lett. 2012, 14, 3680-3683. 
84. Nishimura, T., Onoue, T., Ohe, K., Uemura, S. J. Org. Chem. 1999, 64, 6750-6755. 
85. Stephens, D. E., Lakey-Beitia, J., Atesin, A. C., Ateşin, T. A., Chavez, G., Arman, H. D., 














Chapter 4  Introduction 
152 
 
4.1 Manganese catalysed C-H activation 
The formation of carbon-carbon bonds in an efficient manner is a key goal for organic 
chemists. So-called ‘C−H activation’ protocols1-3 (previously discussed in Chapter 1 of this 
thesis) have emerged as an increasingly viable alternative to traditional cross-coupling 
methods (Suzuki-Miyaura, Stille, Negishi) with applications in natural product synthesis4, 
pharmaceuticals5 and material sciences.6-7 The vast majority of these processes however have 
been accomplished by using Pd, which is rare in the Earth´s crust (0.89 ppm)3 and its cost is 
steadily increasing.4 Clearly, there is an urgent need to alleviate the worldwide reliance on 
platinum group metals, and Pd in particular.  
One potential solution is to develop chemistry using Earth Abundant Metals (EAM).5 Use of 
3d transition metals is commonly reported now, with complexes derived from iron and nickel 
(and cobalt to a certain extent) proving the most useful. In recent years, manganese (Mn) 
catalysed C-H activation has emerged as a promising alternative to the well-established 
precious-metal-mediated processes.8-10 Mn is the 12th most abundant element on the earth’s 
crust (Pd is 74th, for example).11 The low toxicity, which matches with principles of green 
chemistry,12 and low cost (Figure 30) of Mn render it a particularly attractive alternative to 




               €76.81/g €44.60/g  €350.82/g 
 
Figure 30. Price of precious metals.14-15 
In general, first row transition metal based catalysts usually display different and 
complementary catalytic activities to second and third row transition metals.16 Mn exhibits 
the widest range of oxidation states of any of the first row d-block metals (-3 to +7) and has 
the ability to form compounds with a coordination number of up to seven. Many of the 
difficulties surrounding the use of Mn in classical organometallic reactions stems from the 
lack of well-characterised examples of organomanganese complexes in oxidation states other 
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than +1. Although manganese is most frequently encountered in the +2 state, the majority of 
its organometallic chemistry concerns the univalent state. These Mn(I) compounds exhibit 
almost exclusively low-spin d6 configurations and typically feature very strong crystal field 
ligands such as carbonyl.17 This is not surprising as, in general, transition metal complexes in 
low oxidation states are almost always stabilized by π-acceptor ligands such as CO, NO or PR3. 
However, only a limited number of Mn catalysed C-H bond activation protocols have been 
reported to operate by an organometallic mode of action and they normally utilise the Mn(I) 
catalysts: Mn(CO)5Br and Mn2(CO)10. 
On the other hand, Mn catalysed C-H oxygenations,18-22 nitrogenations23-26 and 
halogenations27-32 catalysed by high valent manganese species, proceeding via a radical 
mechanism have been well developed. These methods lead to functionalisation at the 
weakest C-H bond in the substrates, typically at the benzylic position. Recently however, Mn 
catalysed organometallic C-H activation at thermodynamically more stable aryl or alkenyl C-
H bonds has gained considerable momentum. Since the seminal report by Stone, Bruce and 
co-workers detailing the first stoichiometric Mn mediated C-H activation of azobenzene (217) 
to give the corresponding five membered manganacycle 218 (Scheme 84),33 and subsequent 
stoichiometric transformations by Liebeskind,34 Nicholson and Main,35-37 and Woodgate,38-40 
key contributions from a number of groups in recent years have changed the landscape of Mn 
catalysis, which will be discussed in this introduction. 
 
  
               217 
 
    218 (93%) 
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4.2 Aims and Objectives 
The aim of Chapter 4 of this thesis will be focused on addressing some of the current 
limitations underpinning Mn catalysed C-H activation with a particular focus on ligand design 
and development (Figure 31). Of the ca. 100 reports on Mn catalysed C-H activation, almost 
all use the commercially available MnBr(CO)5 or Mn2(CO)5 precatalysts.8-9 These catalytic 
systems cannot be optimised, as the CO ligands do not possess the required complexity. To 
date, there has been no study on the ligand effects in Mn catalysed C−H activation. Given that 
Pd catalysis is generally underpinned by the features of associated ligands, and that ligand 
design and development has driven the development of almost all transition metal mediated 
processes, it seems imperative that ligand design will be crucial in future Mn catalysed C-H 
activation reactions. Hence, the work in this Chapter outlines the development of new Mn/L 
complexes and their application in C-H activation reactions.  
 
Figure 31.  (i) Commercially available Mn(I) catalysts versus (ii) tuneable Mn(I) phosphine catalysts. 
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4.3.1 Literature examples of manganese catalysed C-H activation reactions: addition to 
aldehydes 
In the following 40 years since the first stoichiometric Mn mediated C-H activation of 
azobenzene was disclosed by Stone and Bruce33 (Scheme 84), the development of Mn 
catalysed C-H activation remained dormant until 2007 when Kuninobu and Takai reported the 
first example of Mn catalysed C-H activation for carbon-carbon bond formation.41 They 
described the Mn catalysed imidazole (219) directed aromatic C-H bond addition to aldehydes 
(Scheme 85). Notably, triethyl silane proved to be a crucial additive, allowing for catalyst 
turnover. The silyl protected benzylic alcohols were synthesised in moderate to good yields. 
The authors state that in the presence of various other metal complexes (Rh, Re, Ru, Ir, Mn 
complexes), the reaction failed to proceed. The reaction was also extended to a 
diastereoselective transformation using an aromatic compound with a chiral substituent. 
Good yields of the silyl ether products were obtained in moderate diastereomeric excess. 
 
 
           219 
 
 
Scheme 85. Mn(I) catalysed C-H addition to aldehydes. 
4.3.2 Literature examples of manganese/base system for C-H activation reactions: alkyne 
coupling partners 
Following on from this, a paper by Wang and co-workers in 2013 reported the first Mn 
catalysed aromatic C-H alkenylation of phenyl pyridine (220) with terminal alkynes (Scheme 
86).42 Key to the success of the reaction was the addition of dicyclohexylamine, which the 
authors claim facilitates the C-H activation step by cooperation with the manganese catalyst 
(Figure 32). A broad substrate scope was demonstrated that included carbon-halogen bonds 
and the reaction proceeded with high levels of control in chemo-, regio- and stereoselectivity. 
This seminal report paved the way for a flurry of scientific publications in Mn catalysed C-H 
activation over the next number of years. 





     220                             




Figure 32. Mn/base system for manganese catalysed C-H activation. 
The C-H alkenylation of aromatic N-H imidates with alkynes was developed by the Wang 
group in 2016 (Scheme 87).43 This is a useful strategy, providing access to ortho-functionalised 
aromatic nitriles. The authors report that electron donating and electron withdrawing groups 
on the aromatic ring of the alkyne were compatible, and halogens (Cl, Br) which are 
potentially susceptible to further functionalisation, were well tolerated. Notably however, the 
yields were decreased when internal alkynes were used. 
 
Scheme 87. Mn catalysed ortho-C-H alkenylation of aromatic imidates with alkynes. 
A new strategy to prepare isoquinolines and isoquinolones was then reported by the Glorius 
group (Scheme 88).44 This clever and efficient strategy solved the ever-present limitation of 
controlling stereoselectivity in C-H activation with unsymmetrical alkynes, with the 
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introduction of a traceless directing group. The introduction of this directing group (which 
serves as both chelator and internal oxidant), offers control of the regioselectivity. This 
system is also applicable to other heterocycles such as thiophene and benzothiophene-based 
moieties. An array of isoquinolines with switchable regioselectivity were prepared via this 
methodology. It is noteworthy that many of these substrates had previously not been 
successfully prepared as a single isomer using C-H activation methods.  
 
Scheme 88. Mn catalysed regioselective synthesis of isoquinolines. 
In another report by the Glorius group, 2-allenylindoles could be prepared via sequential C-H 
activation of indoles and internal alkynes (Scheme 89).45 The authors state that the 
regioselectivity of the alkyne insertion was perfectly controlled, and further reaction of the 
obtained 2-allenylindoles, such as cyclisations or polymerisations were avoided. Remarkably 
2-allenylindoles containing strong electron withdrawing groups were prepared in excellent 
yields. Unfortunately, this protocol could not be applied widely to other heterocycles, but 
could be scaled up to gram quantities with high efficiency.                                                                     
 
Scheme 89. Mn catalysed regioselective C-H allenylation. 
In 2014, Wang and colleagues disclosed the first one-step Mn catalysed aromatic conjugate 
addition to unsaturated carbonyls. The reaction is accelerated by a catalytic amount of 
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dicyclohexyamine (Cy2NH) (Scheme 90, a)).46 Since this report, there have been a wide range 
of Mn catalysed C-H activation reactions with olefin substrates (Scheme 90 and Scheme 91). 
The groups of Glorius and Ackermann concurrently reported the Mn catalysed C-H/C-C 
activation reaction of indoles with challenging vinylcyclopropanes.47-48 Slightly different 
reaction conditions were disclosed by both groups and comparable yields were obtained with 
both methodologies (Scheme 90, b)). The Mn catalysed C-H hydroarylation of allenes has 
been described by Rueping and co-workers, providing access to various alkenylated indoles 
in excellent yields with a good functional group tolerance (Scheme 90, c)).49 Moreover, an 
interesting cascade reaction involving a Smiles rearrangement was observed when tri-
substituted allenes were employed to afford substituted pyrroloindolone products (Scheme 
90, d)).49 At the same time, very similar work was also disclosed by Wang and colleagues 
(Scheme 90, d)).50 Subsequently, Wang extended this methodology to di-substituted allenes 
to give the corresponding allylated arenes along with heteroarenes (Scheme 90, e)).51 Glorius 
and Ackermann independently published work on the Mn catalysed C-H activation of indoles 
with vinyl-1,3-dioxolan-2-ones (Scheme 90, f)).47, 52 Both groups propose that the solvent has 
a strong influence on the E/Z selectivity of the transformation. Glorius and co-workers also 
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4.3.3 Manganese catalysed C-H activation: olefin coupling partners  
 
 
Scheme 90. Selected examples of Mn/base system for catalytic C-H activation. 
Three groups have independently reported methods for the fluoroalkenylation and 
fluoroallyation of arenes and heteroarenes (Scheme 91). The Ackermann group developed a 
strategy for the (per)fluoro allylation of indoles and ketimines via Mn catalysis in a highly 
chemo-, regio- and stereoselective process (Scheme 91, a)).53 The methodology was also 
expanded to include the Mn catalysed C-F/C-H alkenylation with difluoroalkenes and 
alkenylation with perfluoroalkenes (Scheme 91, b)).53 At the same time, a second method was 
disclosed by Zhang for the Mn catalysed difluoroallylation of indoles and pyridines. In contrast 
to Ackermann’s work, this protocol avoided the E/Z selectivity problem by using 3-bromo-3, 
3-difluorpropene as the fluoroallylation source (Scheme 91, a)).54 Loh and co-workers 
reported an alternative method for the Mn catalysed fluoroalkenylation of indoles using gem-
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difluoroalkenes (Scheme 91, c)).55 Here, the authors report that the thermodynamically less 
stable E-monofluoroalkenes were obtained as the major isomers in most cases. In 2016, 
Ackermann and co-workers reported the Mn catalysed allyation reaction with allyl carbonates 
(Scheme 91, d)).56 The allylation reaction was not only limited to indole substrates but also 
allowed for the efficient allylation of pyrrole, thiophene and imine substrates. Late stage 
diversification of the ketone products was also demonstrated and access to a number of 
synthetically useful products was facilitated. More recently, the Ackermann group 
accomplished a versatile Mn catalysed C-H allylation for the late stage diversification of 
structurally complex peptides. This was achieved under mild and epimerisation free reaction 
conditions (Scheme 91, e)).57 Finally, Song and co-workers achieved the Mn catalysed addition 
of maleimides to indoles providing access to 3-(indol-2-yl)succinimide derivatives (Scheme 
91, f)).58 
 
Scheme 91. Selected examples of Mn/base system for catalytic C-H activation. 
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In 2016, Wang and co-workers published an interesting paper on the bicyclic annulation of 
imines and unsaturated esters via Mn catalysed C-H activation (Scheme 92).59 The 
methodology combines both Mn and Zn catalysis to give the fused β-lactam products. This 
was based on previous work carried out by the Ackermann group on the Mn catalysed 
synthesis of cis-β-amino acid esters from ketimines and α, β-unsaturated esters.60 
 
Scheme 92. Mn catalysed bicyclic annulation of imines with α, β-unsaturated esters. 
4.3.4 Manganese hydroarylation reactions of aldehydes, ketones and imines 
In 2016, Ackermann and co-workers reported a Mn catalysed hydroarylation of carbon-
heteroatom multiple bonds (Scheme 93).61 Remarkably, the Mn(I) catalysts allowed for an 
unprecedented C-2 selective hydroarylation of indoles with aldehydes and ketones (Scheme 
93, a)). Other transition metals tested exclusively gave only the C-3 substituted product. The 
Mn catalysed C-H functionalisation of imines was also reported in the same paper (Scheme 
93, b)). 
 





Scheme 93. Mn catalysed C-H hydroarylation of carbon-heteroatom multiple bonds.  
4.4 Mechanistic papers on manganese catalysed C-H activation 
A few very interesting and important papers have been published by Fairlamb and co-workers 
in the last three years concerning the mechanistic details of Mn catalysed C-H activation 
reactions. In 2016, they reported a very insightful study on the C-H activation of 2-pyrone 221 
and phenylacetylene (Scheme 94).62 Their work provided key information on the mechanism 
of some Mn catalysed C-H activation reactions. This involved detection and characterisation 
of a 7-membered manganacycle (222) proposed to play a key role in proton transfer and 
reductive elimination process and how different reaction conditions favour the formation of 
different products. Three more recent publications by Fairlamb and Lynam and co-workers 
involved real time infrared spectroscopic analysis for studying transient manganese carbonyl 
species formed during C-H bond activation reactions.63-65 This method enabled changes in 
metal carbonyl absorbances to be monitored (both qualitatively and quantitatively), and thus 
observation of the dynamic processes occurring at the manganese centre. Their work also 
provided an important insight into the key role of acid additives in Mn catalysed C-H activation 
reactions. 
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Scheme 94. Fairlamb’s study of Mn catalysed C-H activation of 2-pyrone. 
4.5 Literature examples of manganese/acid systems for C-H activation reactions 
The nucleophilic reaction of inert carbon bonds to aldehydes is highly desirable for the 
synthesis of alcohols.66 Previously, Kuninobu and co-workers used silanes as trapping agents 
providing silylether products (Scheme 85). However, the direct formation of alcohols is much 
less explored. An important advancement was made by the Wang group in 2015. 66 The Mn 
catalysed nucleophilic addition to aldehydes and nitriles was disclosed by using a dual 
activation strategy (Scheme 95). This clever protocol merged both Mn catalysed C-H 
activation and aldehyde (Scheme 95, a) and b)) and nitrile (Scheme 95, c)) activation by a 
Lewis acid (ZnBr2). This seminal work found that the synergistic use of Me2Zn and ZnBr2 
proved crucial in accessing the desired products. The methodology employs relatively mild 
reaction conditions, has a broad substrate scope and demonstrates excellent regio- and 
stereoselectivity. 




Scheme 95. Mn catalysed direct nucleophilic addition to aldehydes and nitriles. 
This Mn/acid cooperation strategy developed by Wang has allowed for the expansion of the 
substrate scope for Mn catalysed C-H activation to include more polarised C=X/C≡X systems. 
Also, the scope with respect to the arenes was extended to those with weakly coordinating 
directing groups (Figure 33). Representative examples are discussed below. 
 
Figure 33. Mn/acid system for manganese catalysed C-H activation. 
In 2016, Kuninobu and co-workers developed a Mn catalysed annulation of esters and 
oxiranes in the presence of a Lewis acid, triphenylborane (BPh3) (Scheme 96, a)).67 This was 
the first example of a Mn catalysed C-H transformation using an oxygen directing group. The 
isobenzofuranone products were synthesised in moderate to good yields with high functional 
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group tolerance. The authors claim that the Lewis acid, BPh3, is essential in promoting the 
reaction by cooperating with the Mn catalyst. The Mn catalysed C-H cyanation of heterocycles 
was developed by the Ackermann group by means of synergistic heterobimetallic catalysis 
(Scheme 96, b)).68 A large substrate scope and high functional group tolerance was reported. 
The Mn(I) catalyst in combination with a catalytic amount of ZnCl2 allowed the cyanation of 
various heterocycles including indoles, pyrroles, thiophenes and even tryptophans. 
Ackermann and co-workers recently disclosed the C-H alkynylation of indoles and pyrroles in 
the presence of MnBr(CO)5 (Scheme 96, c)).69 Silyl haloalkynes were employed with good 
results. A significant substrate scope was reported. Moreover, it was possible to extend the 
methodology to non-activated aryl, alkenyl and alkyl haloalkynes under the same conditions 
by the addition of BPh3. As usual in Mn catalysis, the protocol was fully tolerant of valuable 
functionalities, including halogen, ester, cyano and nitro groups. The practical utility of this 
approach was further demonstrated in this remarkably dense and expansive report, by 
successful reactions on substrates bearing a fluorescent tag, a complex steroid motif and an 
enantiomerically pure amino acid. It could also be applied to peptides. Recently, the Glorius 
group developed a novel Mn/Lewis acid co-catalysed direct propargylation reaction utilising 
BPh3 as the Lewis acid (Scheme 96, d)).70 The authors propose that the BPh3 Lewis acid plays 
a significant role in enhancing the electrophilicity of the bromoallene, thereby promoting 
both the reactivity and selectivity. It is noteworthy that both terminal and internal alkynes 
can be obtained by this methodology as this has not been achieved in previous studies.  
As well as Lewis acids, Brθnsted acids can also be combined with manganese catalysts and this 
has allowed new reactivity in many cases (Scheme 96, e)).71 This strategy was adopted by 
Glorius and co-workers in 2017. They developed an efficient strategy to synthesise 2-
allenylindoles and this methodology was extended enabling the preparation of ketone 
products by the addition of a Brθnsted acid, p-toluenesulfonic acid (PTSA). In addition, the 
Ackermann group demonstrated a chemo- and regioselective hydroarylation of alkynes with 
indoles by synergistic Brθnsted acid/Mn catalysis and flow chemistry (Scheme 96, f)).72 The 
corresponding products could easily be prepared in less than 20 minutes. 
 




Scheme 96. Selected examples of Mn catalysed C-H activation reactions aided by Lewis/Brθnsted 
Acids. 
A very interesting piece of work was described by the Wang group in 2017. The Mn catalysed 
addition of ketones to imines was disclosed by the combination of Mn and Zn catalysis 
(Scheme 97, a) and b)).73 Remarkably, the classic Mannich reaction was suppressed with the 
aid of Mn and at the same time the less reactive C-H bond of the aromatic ring of the ketone 
was activated. Interestingly, cyclised exo-olefinic isoindoline and three-component 
methylated isoindoline derivatives (Scheme 97, b) and c)) could be selectively obtained by 
slight tuning of the reaction conditions. 
 




Scheme 97. a) Mn catalysed addition of ketones to imines b) Mn catalysed C-H activation for the 
selective preparation of exo-olefinic isoindoline and three component methylated isoindolines. 
Further examples of bimetallic catalysis enabled by a cooperative Mn/Lewis acid system have 
been reported by the groups of Wang and Ackermann (Scheme 98). However, unlike the 
previous examples described above (Scheme 96 and Scheme 97), whereby the acid is involved 
in the Mn catalytic cycle, these two reports describe a tandem catalysis in which the acid is 
not involved in the Mn catalytic cycle. Wang and co-workers reported a one-pot Mn catalysed 
C-H allylation and Ag catalysed Povarov cyclisation (Scheme 98, (i)). Three new carbon-carbon 
bonds are formed and two quaternary carbons are generated with yields of up to 85% being 
reported.74 A similar methodology was developed by the Ackermann group (Scheme 98, (ii)). 
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In this work, similar products could be prepared substituting methylenecyclopropanes instead 
of allenes by using a combination of Mn and Zn catalysis.75 
 
Scheme 98. Selected examples of tandem catalysis involving a Mn/Lewis acid system. 
An array of other Mn catalysed C-H activation reactions with various different coupling 
partners have been reported by numerous groups in the last few years, such as Ackermann’s 
aminocarbonylation of heteroarenes using isocyanates as the coupling partner.76 In 2014, the 
Wang group described a highly atom economical reaction for the synthesis of isoquinolines 
by means of a Mn catalysed C-H/C-N activation.77 Interestingly, the transformation produced 
H2 as the sole by-product without the need for any oxidant which is in contrast to previously 
established methods for the synthesis of isoquinolines by transition metal catalysed C-H 
activation.8 In addition, the Glorius group recently disclosed a Mn catalysed (2-
indolyl)methylation of heteroarenes, which describes access to challenging unsymmetrical 
diheteroarylmethanes.78 In 2019, Ackermann and co-workers developed an unprecedented 
Mn catalysed domino reaction consisting of a C-H activation, Diels-Alder reaction and a retro 
Diels-Alder reaction which provided access to invaluable indolone alkaloid derivatives.79 
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Additionally, a few Mn catalysed C-H alkylation reactions have been published by different 
groups in the previous few years with alkyl halides80, Grignard reagents81 and diazo 
malonates82 being successfully utilised as the coupling partners. Glorius and colleagues have 
also exploited diazo compounds as coupling partners for the β-functionalisation of α-diazo 
ketones through Mn(I)/Ag(I) relay catalysis. This approach allowed efficient access to β-
(hetero)aryl ketones.83 
Mn catalysed C-H activation is a quickly emerging area in the field of organic synthesis and 
great strides have been made by various groups in recent years as discussed above. However, 
many limitations remain: 
1) The substrate scope is sometimes limited 
2) Rather harsh reaction conditions are required  
3) Reliance on directing groups in the majority of cases 
4) Reliance on MnBr(CO)5 and Mn2CO10 as the pre-catalytic species 
5) High catalyst loading (typically 10 mol%)  
6) Relatively little information is known about the catalytic cycles 
Thus, the aim of Chapter 5 will be focused on addressing some of these limitations, in 
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Chapter 5: Synthesis of Mn 
carbonyl phosphine 
complexes and their 
application in C-H activation 
reactions




The design, synthesis and characterisation of Mn carbonyl phosphine complexes is described 
in this Chapter. Their application in a number of transition metal catalysed C-H activation 
reactions will also be discussed. 
5.2 Background 
As previously discussed in Chapter 4 of this thesis, Mn catalysis has recently emerged as an 
attractive alternative to Pd (as well as Ir and Rh) catalysed C-H activation processes. Although 
the reactions published in the literature up to now represent noteworthy advancements in 
the field of Mn catalysed C-H activation, several challenges remain. To date, only 
commercially available MnBr(CO)5 and Mn2CO10 pre-catalysts have been utilised in Mn 
catalysed C-H activation reactions. Importantly, these systems cannot be easily optimised as 
the CO ligands cannot be tailored by steric or electronic alterations.  
5.3.1 Ligand design 
The rational choice and design of appropriate ligands is critical for both the development and 
fine tuning of catalyst reactivity and selectivity (i.e. enantioselectivity, diastereoselectivity, 
regioselectivity and chemoselectivity) of metal complexes. Both the steric and electronic 
properties of the ligand can influence the bond-making and bond-breaking processes that 
occur about the metal centre. Thus, ligand design and an understanding of how ligands 
influence both the structural and reactivity properties of metal species has allowed for the 
development of new and improved catalytic reactions.1 Ligand design is therefore essential 
in the advancement of manganese catalysis. Since ligand design and development has been 
crucial to the success of Pd catalysis over the last few decades, it seems imperative that the 
future of Mn catalysed C-H activation reactions will be dependent on the design and 
development of new ligands for Mn.  
5.3.2 Choice of ligand for Mn 
The use of phosphorus-based ligands to facilitate and tune metals centres has been well 
documented in the literature over the last number of decades.1-2 In the case of Pd-catalysed 
cross-coupling reactions3-15 and Pd-catalysed C-H activation,16 the contribution of phosphine 
ligands has been fundamental to selectivity and reactivity. Hence, we sought to prepare a Mn 
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phosphine template to allow for tuneable phosphine ligands and apply these complexes in C-
H activation reactions.17 
5.3.3 Synthesis of Mn carbonyl phosphine complexes 
The Mn carbonyl phosphine complexes were easily prepared via a procedure described by 
Bond and co-workers from 1978.18 The complexes were prepared with a view to investigating 
how the steric and electronic properties of the ligand(s) could influence both the structure 
and reactivity at the Mn centre and how this affects the rate of reaction. Initially, we began 
our study by preparing four Mn carbonyl mono-phosphine complexes (tetracarbonyl Mn 
phosphine complexes) (223-225). Next, we looked at synthesising the more sterically 
crowded Mn carbonyl di-phosphine complexes (tricarbonyl Mn phosphine complexes) (226-
228). Finally, one bidentate complex19 (dppp) 229 was prepared using the procedure 
described herein. Complexes 223-229 were prepared by reaction of commercially available 
MnBr(CO)5 with 1 or 2 equivalents of the corresponding phosphine ligand in refluxing 
chloroform or dichloromethane for 8 h (Scheme 99).18 The compounds were isolated in yields 
ranging from 73-99% by evaporation of the solvent and recrystallisation from a 
dichloromethane/hexane mixture. The resulting bright yellow complexes were fully 
characterised by 1H/31P/13C NMR spectroscopy, infrared spectroscopy (IR), single crystal X-ray 
structure analysis and elemental analysis (see Experimental Section, Chapter 6). The reaction 
of MnBr(CO)5 with a number of substituted phosphine ligands failed to yield the desired Mn 
phosphine complex. For example, reaction of tris-(4-tert-butylphenyl)phosphine, tris-(3, 4-
dimethyphenyl)phosphine, tris-(3,4-dimethoxyphenyl)phosphine, tris-(o-tolylphenyl) 
phosphine, tricyclohexylphosphine (previously synthesised via photochemical means20) and 
tris-(pentafluorophenyl)phosphine with MnBr(CO)5 failed to yield the corresponding Mn 
phosphine complex. In the case of tris-(3,4-dimethylphenyl)phosphine, tris-(3,4-dimethoxy 
phenyl)phosphine, tris-(o-tolylphenyl)phosphine, tricyclohexylphosphine, this may be 
attributed to steric effects. For the penta-fluoro phosphine ligand, the phosphorus atom 
would lack the necessary basicity to undergo reaction. Finally, complex DJ1 with a para-
trifluoromethyl group was synthesised by co-worker Dr. David Jones. 
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5.3.4 Bonding in metal carbonyl phosphine complexes 
The bonding in metal carbonyl phosphine complexes has important implications on the 
reactivity of the complex and is evident upon analysis of the spectroscopic data of the 
complex. This will be discussed more in detail in the following section. For complexes 223-229 
and DJ1, the bonding between Mn and CO ligands involves both a σ component and a π 
component. The sigma bond is formed as a result of overlap of an sp orbital on carbon and an 
empty d-orbital on Mn. π-Back donation is as a result of overlap of a filled d-orbital Mn and a 
π* orbital on the CO ligand.21 The bonding between Mn and the tertiary phosphine ligand also 
involves two important interactions. A sigma bond is formed by donation of a one pair of 
electrons in an sp3 orbital on phosphorus into an empty d-orbital on Mn (Figure 34, (i)). Like 
CO, phosphines can also participate in backbonding to a certain degree. However, 
rationalisation of M→P backbonding is controversial. Previously, backbonding in metal-
phosphine complexes was attributed to an interaction between a dπ-orbital on the metal and 
an empty 3d orbital on phosphorus. Quantum mechanical calculations have elegantly shown 
that P-R σ* orbitals play a major role. Hybridisation of P 3d orbitals and P-R σ* orbitals result 













                                                      
                                                     phosphine sp3                          metal dz  
 
 
                
                                         metal dyz                                    phosphine π-acceptor MOs  
 
Figure 34. Description of bonding in metal carbonyl phosphine complexes. 
 
5.3.5 Spectroscopic and single crystal X-ray results 
31P NMR Spectra (complexes 223-225) 
The 31P nucleus couples to any other nucleus with a nuclear spin (I) I>0. Thus, coupling of the 
phosphorus to the NMR active isotope of Mn (55Mn) was observed in the 31P NMR spectra for 
each complex (223-229). The directly bonded 55Mn quadrupolar nucleus (I=5/2) resulted in 
the 31P NMR resonances for each complex being broadened, although coupling to 55Mn was 
not resolved.24 The 31P NMR spectra of compounds 223 to 225 (mono-phosphine complexes) 
show a single resonance and this is consistent with only one species in solution (Figure 35).19 
The large change in chemical shift observed in the 31P NMR spectra of each of the complexes 
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the Mn centre in each case. The change in chemical shift from the free ligand to the 
coordinated complex is represented by the coordination shift (ΔδP) (Table 18).24  
 
 
Figure 35. 31P NMR spectra of Mn mono-phosphine complex 223. 
Table 18. Comparison of 31P chemical shift values between Mn complexes 223-225 and the 
corresponding free phosphine ligand. 
Entry Mn complex 31P NMR shift 
(ppm): 
Mn Complex 






1 223 40.4 -6.0 46.4 
2 224 39.4 -9.0 48.4 
3 225 36.1 -10.8 46.9 
31P NMR data recorded in CDCl3. 
X-ray crystal structure and IR spectra (tetracarbonyl Mn phosphine complexes) 
The crystal structure of 223 (Figure 36) shows a cis-octahedral arrangement and this is also 
predicted from the spectroscopic analysis as described above. Carbonyl stretching modes in 
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transition metal complexes depend on the symmetry of the molecule. The number and nature 
of the symmetry elements of a given molecule ar donated by its point group. Tetracarbonyl 
Mn phosphine bromide complexes belong to the CS point group. The CS symmetry of cis-
complexes leads to three absorption bands (2A’ + 2A’’) in the IR spectra.26 Thus, the IR spectra 
of complexes 223-225 show three strong CO stretching vibrations consistent again with cis-
tetracarbonyl phosphine organomanganese complexes previously reported (Table 19).27  
These three bands correspond to the axial and radial A1 modes. The A’’ mode corresponds to 
the E mode of the complex.26 All absorptions are of medium-high intensity as all modes 
involve dipole moment changes. The highest frequency ῡ(CO) band relates to the two CO 
ligands which are trans to each other. The middle ῡ(CO) band corresponds to the CO ligand 
trans to the phosphine ligand. Finally, the lowest frequency ῡ(CO) band corresponds to the 
CO ligand trans to Br. 
The steric and electronic properties of phosphine ligands can be classified in terms of two 
parameters devised by Tolman.75 Firstly, the cone angle addresses the steric bulk of 
phosphine ligands. Secondly, the electronic effect of various tertiary phosphine ligands can 
be adjusted by changing the R group. This was quantified by Tolman, who compared the ῡ(CO) 
stretching frequencies of a series of LNi(CO)3 complexes, where L is a tertiary phosphine 
ligand. Importantly, ῡ(CO) changes as the electron donating ability of the phosphine ligand 
increases. Thus, the increase in electron density at Ni from σ donation of the tertiary 
phosphine ligand is dispersed though the M-L ligand system via π-backbonding. Most of the 
electron density is passed onto the CO π*orbitals. This is reflected in decreased ῡ(CO) 
stretching frequencies which corresponds to weaker C-O bonds.75 In addition, more electron 
donating phosphine ligands are associated with more electron rich metals, which are better 
at CO π-backbonding. Thus, the greater the CO π-backbonding corresponds to lower ῡ(CO) 
due to decreased bond order. Consequently, better donor ligands translates to lower ῡ(CO) 
values. This is evident upon analysis of the IR spectra for complexes 223-225. The ῡ(CO) 
stretching frequencies are similar for 223-225. However, a slight reduction in the frequencies 
was observed as the electron donating ability of the phosphine ligand increases.28 In 
particular, comparing the ῡ(CO) band corresponding to the CO ligand trans to the tertiary 
phosphine ligand, for the complex with the para-methoxy phosphine ligand (225), ῡ(CO) 
shows up at 1989 cm-1. Complex 224 with a para-fluoro phosphine ligand (224), ῡ(CO) shows 
up at 1998 cm-1. Finally, complex 223 with a triphenyl phosphine ligand (para-H), ῡ(CO) shows 
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up at 2002 cm-1. Complex (225) can be considered the greatest electron donor and thus the 
electron density at the Mn is greatest for this complex. Thus, this translates into enhanced CO 
π-backbonding and lower ῡCO values as a result. Comparing complexes 223 and 224, 224 
(para-F substituent on the phosphine ligand, the lone pair of electrons in the 2p orbtial on the 
para-F substituent increases the electron donating ability of this phosphine ligand) can be 
considered a greater electron donor relative to 223 (para-H substituent on the phosphine 
ligand). Thus, ῡ(CO) shows up at 1998 cm-1 for 224 and 2002 cm-1 for 223. 
 
 
                 223 
    cis-MnBr(CO)4(PPh3) 
Figure 36. Molecular and crystallographic structure of complex 223, cis-[MnBr(CO)4(PPh3)]. Thermal 
ellipsoids drawn at the 50% probability level. Second molecule and hydrogen atoms omitted for clarity.      
Table 19. IR spectroscopic data for complexes 223-225 (CO region only). 
Entry Mn complex IR data 
ῡ(CO)/cm-1 
 
1 223 2086, 2002, 1956 
2 224 2091, 1998, 1946 
3 225 2083, 1989, 1943 
 
31P NMR spectra (complexes 226-228) 
 
The single resonance in the 31P NMR spectra of complexes to 226-228 is consistent with a 
mer-trans configuration (Figure 37) and is in accordance with previous literature reports.19 
The single resonance in the 31P NMR spectra for each of the di-phosphine complexes (226-
228) indicates that the two phosphine ligands are bound trans to each other.20 Again, the 
significant change in chemical shift observed in the 31P NMR spectra of each of the complexes 
 Chapter 5  Results and Discussion 
184 
 
(223-228) in comparison to the free phosphine ligand provided evidence for the coordination 
of the phosphine ligand to the Mn centre (Table 20).  
 
 
Figure 37. 31P NMR spectra of Mn diphosphine complex 227. 
Table 20. Comparison of 31P chemical shift values between Mn complexes 226-228 and the 
corresponding free phosphine ligand. 
Entry Mn complex 31P NMR shift 
(ppm): 
Mn complex 






1 226 54.0 -6.0 60.0 
2 227 52.2 -9.0 61.2 
3 228 49.5 -10.8 60.3 
31P NMR data recorded in CDCl3. 
X-ray crystal structure and IR spectra (tricarbonyl Mn phosphine complexes) 
Mer, trans-diphosphine complexes show C2V symmetry and therefore three IR active modes 
(2A1 + B1).26 Accordingly, three ῡ(CO) bands were observed in the IR spectra for each complex 
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which is consistent with a mer-CO arrangement.20 The IR spectra for each of the di-phosphine 
complexes 226-228 show two strong and one weak CO stretching vibrations (Table 21).26 The 
highest frequency ῡ(CO) band corresponds to the symmetric A1 mode and is of weak intensity 
due to a weak dipole moment change. The lowest frequency ῡ(CO) band (second A1 mode) 
corresponds to the CO ligand trans to the bromide and is of the strongest intensity. This is 
because the CO trans to Br is expected to have the greatest degree of Mn→CO π-
backbonding. An intense B1 mode relates to the two CO ligands trans to each other. This is 
consistent with previous literature reports of Mn(I) di-phosphine complexes, although it is 
important to note that analysis of the IR spectra alone does not easily allow one to distinguish 
between the mer-trans and mer-cis isomers.19  
Again, analysis of the IR spectra for complexes 226-228, lower ῡ(CO) values were observed as 
the electron donating ability of the phosphine ligand increased.28 The ῡ(CO) stretching 
frequencies for complexes 226 (para-F subsituent on the phosphine ligand) and 227 (para-
methoxy substituent on the phosphine ligand) showed up at lower frequencies relative to 
complex 225 (triphenyl phosphine ligand (para-H). This is as a result of greater π-backbonding 
in compexes 226 and 227, which translates into lower ῡ(CO) as a result.  
The 31P NMR data and IR spectroscopic data correlate with a mer-trans configuration for the 
Mn di-phosphine complexes (226-228), identified by X-ray crystal structure analysis (Figure 
38).  
 
                                       226 
               mer-trans-MnBr(CO)3(PPh3)2 
 
Figure 38. Molecular and crystallographic structure of complex 226, mer, trans-[MnBr(CO)3(PPh3)2].  
Thermal ellipsoids drawn at the 50% probability level.  
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Table 21. IR spectroscopic data for complexes 226-228 (CO region only). 
Entry Mn complex IR data 
ῡ(CO)/cm-1 
 
1 226 2087, 2003, 1943 
2 227 2036, 1931, 1902 
3 228 2008, 1939, 1908 
 
31P NMR spectra (complex 229) 
The 31P NMR spectra of the bidentate complex 229 shows a singlet indicating that both of the 
phosphorus atoms are coordinated to the Mn and furthermore that both of the phosphorus 
atoms are equivalent (Figure 39).29 In addition, the single resonance at 28.3 ppm in the 31P 
NMR spectra is consistent with only one species being present in solution. The difference in 
chemical shift between complex 229 and the free phosphine is given in Table 22 and, is in 
accordance to similar observations for the mono- and di-phosphine Mn complexes.   
 
Figure 39. 31P NMR spectra of bidentate Mn complex 229. 
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Table 22. 31P chemical resonances of Mn complex 229 and free phosphine ligand, and coordination 
chemical shift values. 
Entry Mn complex 31P NMR shift 
(ppm): 
Mn complex 






1 229 28.3 -26.730 55 
31P NMR data recorded in CDCl3. 
Complex 229 was identified as having a fac-cis configuration by single crystal X-ray structure 
and spectroscopic analysis (Figure 40). Fac-diphosphine complexes posses CS symmetry and 
this would give rise to three carbonyl stretching absorptions (2A’ + A’’).26 Accordingly, three 
strong bands were observed in the IR spectrum of complex 229 (Table 23). The lowest 
frequency ῡ(CO) band is due to the CO ligand which is trans to the bromine atom and the two 
higher frequency ῡ(CO) bands are due to the two CO ligands which are trans to the two 




                                              229 
                             fac-cis-MnBr(CO)3(dppp) 
 
Figure 40. Molecular and crystallographic structure of 229, fac, cis-[MnBr(CO)4(dppp)]. Thermal 
ellipsoids drawn at the 50% probability level. 
Table 23. IR spectroscopic data for complex 229 (CO region only) 
Entry Mn complex IR data 
ῡ(CO)/cm-1 
 
1 229 2019, 1953, 1905 
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13C NMR spectra of complexes 223-229 
In the 13C NMR spectra of complexes 223-229, the CO resonances are broad (spanning a few 
ppm) due to the effect of the directly bonded 55Mn quadrupole. The di-phosphine complexes 
(226-229) all show two broad carbonyl signals of relative intensity 2:1, although this is not 
quantitative (the signal at higher frequency is assigned to the carbonyl trans to the Br and the 
signal at lower frequency is assigned to the mutually trans carbonyls),18-19 which proves the 
mer-trans configuration for complexes 226-228 and a fac-cis configuration for complex 229 
(correlating with single crystal X-ray analysis for these complexes) (Figure 41 and Figure 42).  
 
Figure 41. 13C NMR spectra of complex 227 showing two broad CO signals in a relative intensity of 
approximately 2:1. 




Figure 42. 13C NMR spectra of complex 229 showing two broad CO signals in a relative intensity of 
approximately 2:1. 
In the 13C NMR spectra for the mono-phosphine complexes (223-225), three separate broad 
carbonyl signals (which are poorly resolved) are observed, in a ratio of approximately 2:1:1 
(Figure 43). The relative ratios identify the first signal (most upfield shift) as that arising from 
the two equivalent trans carbonyl ligands, the second signal correlating to the carbonyl which 
is trans to the phosphorus atom (and cis to the Br) and finally the most downfield shift being 
assigned as the carbonyl trans to the Br (cis to the phosphorus atom). This coincides with 
literature reports of carbonyl groups trans to the phosphine ligand showing a larger downfield 
shift than cis carbonyl groups.30 




Figure 43. 13C NMR spectra of complex 223 showing three broad CO signals in a relative intensity of 
approximately 2:1:1. 
5.4.1 Investigation of Mn phosphine complexes in C-H activation reactions 
In most Mn catalysed C-H activation reactions published in the literature to date, the action 
of a directing group such as a nitrogen containing heterocycle or an imine group is 
necessary.31-33 Thus, substrates 230, 220 and 247 were all investigated as potential substrates 
in Mn catalysed C-H activation reactions using the tetracarbonyl and tricarbonyl Mn 
phosphine complexes (223-229), with general reaction conditions also based on previous 
work published. Substrate 230 containing an imine group was obtained by another member 
of the McGlacken group, phenyl pyridine (220) was available from a commercial supplier and 
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1. Ketimine directing group 
A variety of Mn catalysed C-H activation reaction conditions were applied to imine 230. The 
reactions investigated were based on previous Mn (as well as Rh) catalysed C-H activation 
reactions published in the literature.  
First, the mono-phosphine complex 223 was examined in the Mn catalysed C-H allylation of 
ketimine 230.35 Unfortunately, no encouraging results were obtained. Only ca. 10% 
conversion to product 232 could be detected in the 1H NMR spectrum of the crude reaction 
mixture (Table 24, entry 1). The conversion to product 232 was even less when TBAB was 
used as an additive in the reaction (Table 24, entry 2). Secondly, we investigated the effect 
15 mol% triphenylphosphine had on the allylation reaction when the commercial catalyst 
MnBr(CO)5 was used (Table 24, entry 3). However, only unreacted starting material 230 was 
recovered from the crude reaction mixture. When 10 mol% TBAB was added to the reaction 
mixture in addition to 15 mol% triphenyl phosphine, only a trace of allylated product 232 was 
detected (Table 24, entry 4). The triphenyl phosphine is most likely coordinating to a vacant 
site on Mn (rendering the catalyst inactive), which could prevent the acrylate substrate 231 
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Table 24. Mn catalysed C-H allylation of ketimine 230. 
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Entry Reaction Conditions Result 
135  MnBr(CO)4PPh3 (223), KOAc, dioxane, 100 ᵒC 10% conversion 232 
235  MnBr(CO)4PPh3 (223), TBAB, KOAc, dioxane,100 ᵒC Trace of 232 
335  MnBr(CO)5, KOAc, PPh3, dioxane, 100 ᵒC Unreacted starting 
material 230 
435 MnBr(CO)5, KOAc, PPh3, TBAB, dioxane, 100ᵒC Trace of 232 
Reaction conditions: 230 (1 equiv.), 231 1.5 (equiv.), Mn pre-catalyst 223 (10 mol%), KOAc (20 mol%), 
PPh3 (15 mol%), TBAB (10 mol%). 
Two more C-H activation reactions involving ketimine 230 and MnBr(CO)4(PPh3) (223) were 
investigated (Table 25). The first reaction was based on a highly efficient protocol detailed by 
Wang and co-workers in 2014 for the synthesis of isoquinolines via Mn catalysed C-H/C-N 
activation of ketimines with diphenylacetylene (233) (Table 25, entry 1).36 The second 
reaction was an amination reaction based on work reported by Yu and co-workers in 2017 on 
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the Rh catalysed ortho amination of benzamides.37 For this particular reaction, morpholine 
(234) was the chosen coupling partner (Table 25, entry 2). However, only starting material 
230 was recovered from the crude reaction mixtures for both reactions investigated and no 
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Entry Reaction Conditions Result 
236 b) MnBr(CO)4PPh3 (223), KOAc, dioxane, 100 ᵒC Unreacted starting 
material 230 
137 a) MnBr(CO)4(PPh3) (223), Ag2CO3, quinoline, sodium 
benzoate, toluene, 90 ᵒC 
Unreacted 
starting material 230 
Reaction conditions: a) 230 (1 equiv.), 233 (1.5 equiv.), Mn pre-catalyst 224 (10 mol%), KOAc (20 
mol%). b) 230 (1 equiv.), 234 (2 equiv.), Mn pre-catalyst 224 (5 mol%), Ag2CO3 (2 equiv.), quinoline (20 
mol%), sodium benzoate (1.7 equiv.). 
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2. Pyridyl directing group 
Next, two reactions reported by Wang and co-workers in 2013 and 2014 were investigated 
using the Mn di-phosphine complex 226 (Table 26). As with all Mn catalysed C-H activation 
reactions reported, a directing group to facilitate the C-H activation step is required. Hence, 
the substrate chosen by the authors for these two reactions was phenyl pyridine 220. The 
first reaction involved a Mn catalysed C-H alkenylation reaction with terminal alkyne 237 to 
produce product 239 (Table 26, entry 1).38 Unfortunately, substitution of the commercial 
MnBr(CO)5 pre-catalyst with our Mn di-phosphine catalyst 226, only resulted in unreacted 
starting material 220 being recovered from the crude reaction mixture. A similar result was 
obtained for the second reaction investigated, involving the Mn catalysed addition of methyl 
acrylate (238) to phenyl pyridine (220) to give the hydroarylated product 240 (Table 26, entry 
2).39 Only a trace of product 240 was detected for this particular reaction with the majority of 
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Entry Reaction Conditions Result 
138 a) MnBr(CO)3(PPh3)2 (226) Cy2NH, Et2O, 80 ᵒC Unreacted 
starting material 220 
239 b) MnBr(CO)3(PPh3)2 (226), Cy2NH, Et2O, 100 ᵒC Trace of 240 and 
unreacted starting 
material 220 
Reaction conditions: a) 220 (2 equiv.), 237 (1 equiv.), Mn pre-catalyst 226 (10 mol%), Cy2NH (10 mol%) 
(b) 220 (1.5 equiv.), 238 (1 equiv.), Mn pre-catalyst 226 (10 mol%), Cy2NH (13 mol%).  
MnBr(CO)3(PPh3)2 (226) was also tested in a C-H bond amidation reaction of phenyl pyridine 
(220) with isocyanate 241 (Table 27, entry 1). This reaction was previously demonstrated by 
Ackermann in 201540 using MnBr(CO)5 as the pre-catalyst and also by Ellman and co-workers 
in 2015 utilising Co catalysis.41 However, only a trace of product 243 could be detected in the 
1H NMR spectrum of the crude reaction mixture (and by mass spectrometry). MnCp(CO)3 was 
also investigated as a possible catalyst for the amidation reaction. MnCp(CO)3 was purchased 
from a commercial supplier. However, this failed to provide any improvement on results 
(Table 27, entry 2). MnBr(CO)3(PPh3)2 (226) was also examined in the oxidative cross coupling 
reaction of phenyl pyridine (220) and 2-methyl thiophene (242) (Table 27, entry 3). This 
reaction was based on a Rh catalysed oxidative cross coupling reaction of (hetero)arenes with 
chalcogenophenes reported by Kambe and co-workers.42 Unfortunately, no conversion to 
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Entry Reaction Conditions Result 
140-41 a) MnBr(CO)3(PPh3)2 (226), KOAc, 1,4-dioxane, 120 ᵒC Trace of 243 and 
unreacted 
starting material 220 
240-41 a) MnCp(CO)3, KOAc, 1,4-dioxane, 120 ᵒC Unreacted starting 
material 220 
343 b) MnBr(CO)3(PPh3)2 (226), CuOAc, AgOAc, DMA, 140 ᵒC Unreacted starting 
material 220 
Reaction conditions: a) 220 (2 equiv.), 241 (1 equiv.), Mn pre-catalyst 226 (10 mol%), KOAc (20 mol%) 
(b) 220 (1 equiv.), 242 (3 equiv.), Mn pre-catalyst 226 (10 mol%), CuOAc (2.8 mol%), AgOAc (10 mol%), 
N2.  
5.4.2 Synthesis of N-(2-pyridyl) indole 
A number of C-H activation reactions involving N-(2-pyridyl) indole (247) were also 
investigated. Firstly, 247 was prepared in 41% yield by initially treating indole 245 with KOH 
in DMSO and stirring at 135 ᵒC for 1 hour. Subsequent reaction with 2-bromo pyridine (246) 
and stirring at 135 ᵒC for 48 hours yielded N-(2-pyridyl) indole (247) as a colourless oil after 
column chromatography on silica gel (Scheme 100).34 
 
 
        245 
 
 
  246 
 
      247, 41% 
Scheme 100. Synthesis of N-(2-pyridyl)-indole (247). 
MnBr(CO)3(PPh3)2 (226) was investigated in a Mn catalysed allylation and alknylation reaction 
previously reported by Wang43 and Ackermann44 respectively (Table 28). Unfortunately, 
reaction of 247 with allene 248 only resulted in a trace amount of product 250 detected. 
(Table 28, entry 1). Similarly, the Mn catalysed C-H alknylation reaction of N-(2-pyridyl) indole 
(247) with bromo phenyl acetylene (249) only resulted in a trace amount of product 251 
observed in the 1H NMR spectrum of the crude reaction mixture (Table 28, entry 2).  
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Table 28. Attempted Mn catalysed C-H activation of N-(2-pyridyl) indole (247). 
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Entry Reaction Conditions Result 
143 a) MnBr(CO)3(PPh3)2 (226), NaOAc, 1,4-dioxane, 100 ᵒC Trace of 250 and 
unreacted 
starting material 247 
244 b) MnBr(CO)3(PPh3)2 (226), BPh3, DCE, 80 ᵒC Trace of 251 and 
unreacted starting 
material 247 
Reaction conditions: a) 247 (1 equiv), 248 (1 equiv.), Mn pre-catalyst 226 (10 mol%), NaOAc (20 mol%) 
(b) 247 (1 equiv.), 249 (1 equiv.), Mn pre-catalyst 226 (10 mol%), BPh3 (5 mol%). 
5.4.3 Investigation into alternative coupling partners for Mn catalysis 
Various Mn catalysed C-H allylations, C-H alkenylations, C-H alkynlations, C-H hydroarylations 
and C-H halogenations have been successfully achieved over the last number of years.31-33 
Several arenes and heteroarenes have been coupled with aldehydes, ketones, alkenes, 
terminal and internal alkynes, isocyanates, nitriles, oxiranes etc. As mentioned previously, in 
all these examples the requirement of a directing group such as a nitrogen containing 
heterocycle or an imine group is necessary.  We sought to investigate new coupling partners 
for Mn that had not been previously reported. A number of Mn catalysed C-H activation 
reactions employing diazo compounds as coupling partners were examined as it was 
postulated that the reactive nature of diazo compounds would render them suitable coupling 
partners.  
1. Quinone diazides as coupling partners 
The first reaction investigated was based on impactful work described by Wang and co-
workers in 2015, whereby they reported a Cp*Rh(III) and Cp*Ir(III) catalysed redox neutral C-
H arylation with quinone diazides to furnish arylated phenols (Scheme 101).44 
 
 





                                          252 up to 99% yields 
  
Scheme 101. Rh/Ir catalysed C-H arylation with quinone diazides. 
The first step in the reaction involved preparation of the diazo precursor. Quinone diazide 252 
was readily synthesised by the diazotisation of 2-chloro-amino phenol (251) with conc. HCl 
and NaNO2 (Scheme 102). A 1H NMR spectrum of compound 252 was obtained following 
work-up and evaporation of the solvent, which was comparable to literature reports.45 
Quinone diazide 252 was subsequently kept under a nitrogen atmosphere and applied in two 
reactions without further purification within 15 minutes. 
 
  
  251 252, 32% 
Scheme 102. Preparation of quinone diazide 252. 
The reaction of 2-chloro-quinone diazide (252) with substrates 220 and 247 was first 
attempted with the commercial MnBr(CO)5 pre-catalyst, as this particular reaction had not 
been previously reported using Mn catalysis. N-(2-Pyridyl) indole (247) and phenyl pyridine 
(220) were chosen as model substrates for the arylation reaction as they are commonly used 
substrates utilized in manganese catalysed C-H activation reactions. It was decided to modify 
the original reaction conditions reported by Wang and co-workers to conditions more 
commonly suited to manganese catalysis. Hence, NaOAc was the chosen base for the 
reaction, with 1,4-dioxane as solvent. Difficulties were encountered upon transfer of the diazo 
compound to the Schlenk tubes, this was in part due to the low solubility of the diazo 
compound 252 in 1,4-dioxane. It must be noted that Wang and co-workers had previously 
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used dichloromethane as reaction solvent. Finally, the reaction was carried out at the higher 
temperature of 100 ᵒC.45 However, application of these reaction conditions on both N-(2-
pyridyl) indole (247) and phenyl pyridine (220) failed to provide any conversion to arylated 
products 253 and 254, with only unreacted starting materials recovered from the crude 
reaction mixtures (Scheme 103). 
 
              247                            252 
 
              253 
 
             220                           252 
 
           254 
Scheme 103. Attempted C-H arylation of N-(2-pyridyl) indole 247 and phenyl pyridine 220. 
Due to the presence of the quinolone structure in many pharmaceutical and biologically active 
natural products,46-47 regioselective functionalisation of the quinolone motif is of particular 
interest to the McGlacken group, with previous research in the group demonstrating the 
application of quinolones in various Pd catalysed transformations.48-50  
Thus, one last reaction was attempted with the quinone diazide substrate 252. The reaction 
of N-(pyridyl) quinolone (256) and quinone diazide 252 in the presence of MnBr(CO)5 was 
examined. N-(pyridyl) quinolone (256) is a challenging substrate and often difficult to 
functionalise. Samanta and co-workers had previously reported the regioselective C-2 
arylation of N-pyridyl-4-quinolone with quinone diazide, which was achieved using Rh 
catalysis.51 Thus, we sought to investigate this reaction using Mn catalysis. 
The preparation of N-pyridyl-4-quinolone (256) involved treatment of 4-quinolinol (255) and 
2-bromo pyridine (246) with copper iodide in the presence of a base.51-52 The resulting 
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reaction mixture was refluxed in DMSO for 16 hours to yield the resulting product in a low 
yield of 15% (Scheme 104). 
 
  255 
 
  
    256, 15% 
Scheme 104. Synthesis of N-(pyridyl)-4-quinolone (256). 
Next, the arylation of N-pyridyl-4-quinolone (256) with quinone diazide 252 was attempted. 
For this particular reaction, the azide 252 was added to the reaction mixture at 50 ᵒC (hot 
plunge). Application of the reaction conditions (i.e. PivOH in DCM at 50 ᵒC) reported by 
Samanta and co-workers on 256, failed however to provide any of the desired C-H arylated 
product 257 (Scheme 105).  
 
            256                                  252 
 
          257 
Scheme 105. Attempted C-H arylation of N-pyridyl-4-quinolone (256) with quinone diazide 252. 
2. Diazo malonate as a coupling partner 
Finally, we investigated the possibility of carrying out a Mn catalysed regioselective C-H 
alkylation of N-pyridyl-4-quinolone (256) again using diazo compounds. Rueping and co-
workers had successfully carried out the regioselective C-2 alkylation of N-pyrimidinyl indoles 
using diazo malonates as alkylating agents via Mn catalysis (Scheme 106).53 Prior to this, 
Samanta and co-workers had achieved a Rh catalysed C-2 alkylation of N-pyridyl-4-quinolone 
(256) using dimethyl diazo malonate.54 α-Diazo carbonyl compounds are versatile 
intermediates due to their inherent ability to form carbenoids, carbenes, ketenes and other 
intermediate species and hence serve as attractive coupling partners for Mn catalysis.55 
 





                        41-86% 
Scheme 106. Mn catalysed C-2 alkylation of N-pyrimidinyl indoles. 
Diethyl diazo malonate (260) was prepared via a diazo transfer process by reaction of diethyl 
malonate (258) with DBU followed by slow addition of tosyl azide (259) (obtained from 
another research group in UCC) in acetonitrile (Scheme 107).55 The subsequent reaction 
mixture was stirred at room temperature overnight to give diazo malonate (260). This was 
followed by a quench with NaNO2 and H2SO4 to remove any TsN3 and other diazo compounds 
formed during the course of the reaction and subsequent extraction of the product 260 with 
Et2O. Analysis of the IR spectra of the crude product indicated the presence of diethyl diazo 
malonate (260). The IR data obtained matched previous literature IR data for diethyl diazo 
malonate (260).55 The crude material obtained was subsequently used without further 
purification. 
 
   
               258           259            260 
 
Scheme 107. Preparation of ethyl diazo malonate (259). 
Unfortunately, direct application of Rueping’s reaction conditions on 256 did not allow for 
any conversion to alkylated product 261 (Scheme 108). It was clear that only unreacted 
starting materials (256 and 260) could be observed in the 1H NMR spectrum of the crude 
reaction mixture, even after stirring for three days at 50 ºC. 
 





                      260  
           256                                                   261 
   
Scheme 108. Attempted Mn catalysed C-2 alklyation of N-pyridyl-4-quinolone (256). 
5.5.1 Mn catalysed hydroarylation of ketones 
In 2016, Ackermann and co-workers developed a highly versatile Mn(I) catalytic system that 
allowed for the efficient and C-2 selective hydroarylation of ketones and aldehydes with N-
(2-pyridyl) indoles.17 Remarkably, their Mn catalytic system overrode the innate C-3 
selectivity of indole and enabled an unprecedented C-2 hydroarylation of ketones, aldehydes 
as well as imines with N-(2-pyridyl) indoles (Scheme 109). This was in contrast to other 
transition metal complexes, which followed the classical electrophilic indole functionalisation 
at the C-3 position.  
 
Scheme 109. Mn catalysed C-H hydroarylation of carbon-heteroatom multiple bonds.  
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Having synthesised a range manganese phosphine complexes differing in sterics and 
electronics, it was decided to investigate their behaviour as catalysts in the Mn catalysed 
hydroarylation of ketones with N-(2-pyridyl) indole (247). The pure Mn(I) phosphine 
complexes (223-229) were evaluated in terms of selectivity and yield against the commercially 
available MnBr(CO)5 catalyst (Table 29). The reaction was carried out in 1,4-dioxane at 100 ºC 
in the presence of 10 mol% Mn catalyst and two equivalents of base.  
5.5.2 Results and Discussion 
The results shown in Table 29 indicate that overall the less sterically crowded mono- 
phosphine complexes (223-225, DJ1) gave rise to the highest yields for the C-2 product (263) 
(Table 29, entries 3-7). The sterically encumbered dppp complex 229, (Table 29, entry 8) 
resulted in the poorest performance relative to MnBr(CO)5. No C-2 product, 263, was 
observed in the 1H NMR spectrum of the crude reaction mixture for this complex. In 
comparison, complex 223 with a triphenylphosphine group, was the most reactive complex. 
A 51% isolated yield of C-2 product, 263 was obtained (Table 29, entry 3). For the methoxy 
derivative 225, a 26% isolated yield of 263 was achieved (Table 29, entry 7). Two derivatives 
with electron withdrawing groups on the phosphine ligand backbone were investigated in the 
model reaction, complex 224, bearing a para-fluoro substituent on the phosphine ligand and 
complex DJ1, bearing a stronger, para-trifluoromethyl substituent on the phosphine ligand. 
Interestingly, little difference in isolated yield was observed between both of these 
complexes, with a 30% yield of C-2 product, 263, obtained for complex 224 and DJ1 (Table 
29, entries 2-3). Notably, the ratio of C-2:C-3 (263:264) for the mono-phosphine complexes 
evaluated were in general comparable to the C-2:C-3 ratio obtained for the commercially 
available MnBr(CO)5 catalyst (Table 29, entry 2). Due to the complexity of the 1H NMR 
spectrum of the crude reaction mixture, the C-2:C-3 ratio could not be determined accurately 
using the pre-catalyst 225, with a para-methoxy group on the phosphine ligand (Table 29, 
entry 7). 
Relative to the mono-phosphine complexes (223-225, DJ1) examined, the Mn di-phosphine 
complexes (226-229) all performed poorly (Table 29, entries 8-11). Interestingly, complex 228 
with a para-methoxy group on the phosphine ligand (Table 29, entry 7), was the best 
performing di-phosphine complex, providing a 24% yield of 263. Complex, 226 with a 
triphenylphosphine group, gave an 11% yield of the C-2 product (263) (Table 29, entry 5). 
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Complex 227, with with a para-fluoro group on the phosphine ligand, provided an 18% yield 
of the C-2 product (Table 29, entry 6).  
Additionally, the hydroarylation reaction was also investigated in DCE and benzonitrile as 
solvent using complex 223 as the Mn catalyst. DCE was chosen as it has previously being used 
as a reaction solvent in Mn catalysis.31, 33, 56 Notably, when the reaction was carried out in 
DCE, a decrease in selectivity for C-2 was observed (Table 29, entry 12). Although, the starting 
material 247 was fully consumed, the ratio of C-2:C-3 (52:48) was significantly lower in 
comparison to when the reaction was carried out in 1,4-dioxane. Some nitrile ligands can act 
as weakly coordinating ligands.57 Thus, benzonitrile was considered as a good choice of 
solvent as coordination of the nitrile group to the Mn centre may tune the activity and 
selectivity of the catalyst in a positive manner. However, the use of benzonitrile as solvent 
afforded no C-2 product (Table 29, entry 13). Lastly, MnCp(CO)3 was investigated as a possible 
catalyst for the hydroarylation reaction (Table 29, entry 14). However, only a trace amount 
of C-2 product was detected. The remaining mass was attributed to unreacted starting 
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Table 29. Mn catalysed hydroarylation of N-(2-pyridyl) indole (247) with ketone 262. 
 
       
           247 
 
              262 
     
 
          263 
 
            264 
 
Entry Complex Solvent Ratio (C-2:C-3)a 
(263:264) 
Yield of 263 
(%)b 
1 - 1,4-dioxane 0:100 0 
2 MnBr(CO)5 1,4-dioxane 88:12 88 
3 223 1,4-dioxane 82:18 51 
5 224 1,4-dioxane 72:28 30 
6 DJ1 1,4-dioxane 78:22 30 
7 225 1,4-dioxane - 26 
8 226 1,4-dioxane 76:24 11 
9 227 1,4-dioxane 74:26 18 
10 228 1,4-dioxane 82:18 24 
11 229 1,4-dioxane 0:100 0 
12 223 DCE 48:52 - 
13 223 benzonitrilec - - 
14 MnCp(CO)3 1,4-dioxane - Traced 
aRatio determined from the 1H NMR spectrum of the crude reaction mixture. bYields of isolated C-2 
product shown. cNo C-2 product observed in the 1H NMR spectrum of the crude reaction mixture when 
benzonitrile was used as the reaction solvent (complex mixture of C-3 product and a number of 
unidentifiable products). dOnly a trace amount of C-2 product was detected in the 1H NMR spectrum 
of the crude reaction mixture. 
5.5.3 Reaction monitoring 
Focus was then turned to investigating the kinetics of the hydroarylation reaction with respect 
to each of the pre-catalysts (223-229, DJ1). Thus, it was decided to monitor the reaction over 
time and to determine if a rate difference was observed between each of the pre-catalysts 
(223-229, DJ1), and also if a trend could be established depending on whether the phosphine 
ligand coordinated to the Mn centre contained an electron withdrawing substituent or an 
electron donating substituent. For the purposes of this work, a control reaction was also ran 
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in parallel with the reaction mixture which was sampled. The control reaction involving each 
pre-catalyst was stirred at 100 ºC for 26 hours. The ratio of starting material:C-2 product 
(247:263) and C-2:C-3 product (263:264) was then determined from the crude reaction 
mixtures after 26 hours. 
5.5.4 Reaction sampling 
During the course of the reaction, aliquots of the reaction mixture were taken at regular 
intervals and the progress of the reaction was monitored by 1H NMR spectroscopy. Initially, 
aliquots of the reaction mixture for each pre-catalyst were taken after 4 hours, 8 hours, 16 
hours and 24-26 hours. The ratio of N-(2-pyridyl) indole:C-2 product (247:263) was examined 
over time for each pre-catalyst, as well as the ratio of C-2:C-3 product (263:264). However, 
presumably due to the heterogeneous nature of the reaction mixture, inconsistent results 
were obtained between the control reaction which was not sampled and the sampled 
reaction mixture. There were clear discrepancies between the sampled reaction mixture and 
the control reaction in terms of ratios of starting material: C-2 product and C-2:C-3 product 
ratios. Therefore, it was deemed that removal of aliquots from the reaction mixture and 
monitoring by 1H NMR spectroscopy was not an accurate way of monitoring the progress of 
the reaction. 
5.5.5 Analysis of the 1H NMR spectra of the crude reaction mixtures  
Figure 44 shows a comparison of the 1H NMR spectra between N-(2-pyridyl) indole (247), C-2 
product 263 and C-3 product 264. In the reaction of N-(2-pyridyl) indole (247) with ketone 
262 using the commercial pre-catalyst MnBr(CO)5, full consumption of starting material 247 
was observed. In addition, the major product formed was the C-2 substituted product (263). 
Conversely, a less clean reaction mixture was obtained for the tetracarbonyl Mn phosphine 
complexes 223-225, DJ1 as well as the tricarbonyl Mn phosphine complexes 226-229 (Figure 
45 and Figure 46).  
The following observations were made after analysis of the 1H NMR spectra of the crude 
reaction mixtures for the tetracarbonyl Mn phosphine complexes (223-225, DJ1). For pre-
catalyst (224) containing a para-fluoro substituent on the phosphine ligand, the N-(2-pyridyl) 
indole 247 was completely consumed after 24 hours. For pre-catalyst (223), <10% of the 
indole starting material 247 remained after 24 hours. In contrast, pre-catalyst complexes DJ1 
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(with a para-trifluoromethyl group on the phosphine ligand) and, 225 (with a para-methoxy 
group on the phosphine ligand) did not allow for full consumption of starting material 247 
after 24 hours (Figure 45). Furthermore, it was apparent that extra signals were visible in each 
of the 1H NMR spectra of the crude reaction mixtures when the tetracarbonyl Mn phosphine 
complexes were used, which did not correspond to 247, 263 or 264. Moreover, the poor yields 
observed may be attributed to unproductive pathways (polymerisation of N-(2-pyridyl) indole 
may be likely)58-61 occurring during the catalytic cycle resulting in the formation of undesirable 
side products and hindering formation of the desired C-2 product (263).  
 
 
Figure 44. Stacked 1H NMR spectra comparing N-(2-pyridyl) indole (247), C-3 product (264) and C-2 
product (263). 




Figure 45. 1H NMR spectra of the crude reaction mixtures corresponding to the tetracarbonyl Mn 
phosphine complexes 223-225, DJ1 versus 1H NMR spectrum of the crude reaction mixture employing 
MnBr(CO)5 as the pre-catalyst.  
Similar observations were made for the tricarbonyl Mn phosphine complexes (226-229) 
following analysis of the respective 1H NMR spectra of the crude reaction mixtures. After 26 
hours, it was observed that no di-phosphine complex (226-229) allowed for full consumption 
of indole starting material 247 (Figure 45). Interestingly, pre-catalyst complex 227 containing 
a para-fluoro group on the phosphine ligand, appeared to be the slowest pre-catalyst with 
regard to consumption of indole starting material 247. After 26 hours, the ratio of starting 
material:C-2 product (263:264) was 60:40 (Table 30, entry 2). In comparison, when complexes 
226-228 were used, greater consumption of starting material 247 was observed after 26 
hours (Table 30, entries 1 and 3). However, greater consumption of indole starting material 
247 for pre-catalyst 226 (with a triphenylphosphine group) and pre-catalyst 227 (with a para-
methoxy group on the phosphine ligand), may be compensated for by more favourable 
formation of undesired side-products over clean conversion of 247 to the C-2 product 263. 
This was evident from the 1H NMR spectra of the crude reaction mixtures as it was clear that 
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there were extra signals present in the 1H NMR spectra for the pre-catalyst 226 and 228 (as 
well as pre-catalyst 227) which did not correspond to either starting material 247, C-2 product 
263 or the C-3 product 264. Interestingly, when pre-catalyst 228 was used, it was evident that 
a doublet of doublets at 6.92 ppm was clearly visible in the 1H NMR spectrum of the crude 
reaction mixture. Following column chromatography of the crude reaction mixture, a product 
was isolated whose respective 1H NMR spectrum consisted of a 3H singlet at 3.82 ppm, a  6H 
doublet of doublets at 6.92 ppm and 6H doublet of doublets at 7.54 ppm. The 31P NMR 
spectrum showed a single resonance at 29.3 ppm. The isolated product was identified as tris-
(4-methoxyphenyl)phosphine oxide62 and was of particular interest, as the doublet of 
doublets at 6.92 ppm was observed when the reaction mixture was sampled after 4 hours 
and a 1H NMR spectrum was obtained. This observation may provide important information 
concerning the lifetime or deactivation of the Mn carbonyl phosphine pre-catalysts (223-229, 
DJ1). Decomposition of the Mn carbonyl phosphine pre-catalysts (223-229, DJ1) after a small 
number of turnovers, could lead to loss of a phosphine ligand which could be oxidised to the 
corresponding phosphine oxide. Moreover, the observation of the oxide after 4 hours would 
suggest that the oxide is formed during the course of the reaction rather than being due to 
degradation of the pre-catalyst (228) on silica gel. In addition, the corresponding oxide 
derivatives (i.e. triphenyl phosphine oxide, tris-(4-fluorophenyl) phosphine oxide and tris-
(trifluoromethyl phenyl) phosphine oxide) were isolated following column chromatography 
of the crude reaction mixtures for each pre-catalyst investigated (223-228, DJ1).  
This was in stark contrast to the crude reaction mixture obtained for the commercial pre-
catalyst, MnBr(CO)5. Examination of the 1H NMR spectrum clearly shows only C-2 product 
263, as well as a minor amount of C-3 product 264, in addition to mostly excess ketone 
starting material 262.  





Figure 46. 1H NMR spectra of the crude reaction mixtures corresponding to the tricarbonyl Mn 
phosphine complexes 226-229 versus 1H NMR spectrum of the crude reaction mixture employing 
MnBr(CO)5 as the pre-catalyst.  
Table 30. 1H NMR ratio of C-2:C-3:SM for complexes 226-228. 
Entry Mn Complex C-2:C-3:SM (Ratio)a 
 
1 MnBr(CO)3(PPh3)2 (226) 52:25:23 
2 MnBr(CO)3(P(p-FC6H4)3)2 (227) 23:39:38 
3 MnBr(CO)3(P(p-OMeC6H4)3)2 (228) 56:23:21 
aRatio of C-2:C-3:SM determined from the 1H NMR spectrum of the crude reaction mixture. 
5.5.6 Catalyst Deactivation 
Overall, lower yields and an increased number of side products were obtained for the 
tetracarbonyl- and tricarbonyl Mn phosphine complexes relative to the commercial pre-
catalyst, MnBr(CO)5. In their recent publications, Fairlamb and Lynam have extensively 
detailed how catalyst deactivation can impact greatly on product conversion.63-65 They 
suggested that ‘’product conversion appears to tally with the TON of the Mn catalyst, with 
limited catalyst turnover indicating an issue in either the protonation or recycling steps 
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required for catalysis leading to low product conversion and rapid catalyst degradation.’’ The 
lower yields obtained for the tetracarbonyl- and tricarbonyl Mn phosphine complexes maybe 
suggestive of lower catalyst TONs due to greater catalyst deactivation for these complexes 
relative to MnBr(CO)5.  
Catalyst loadings are generally high for most reported Mn catalysed C-H transformations in 
the literature (usually 10 mol%), with catalyst TON numbers ranging from 5 to 9.63 During the 
course of their work, Fairlamb and Lynam and co-workers observed the formation of 
catalytically inactive Mn carbonyl clusters within a few minutes of substrate turnover.63 These 
Mn carbonyl clusters effectively provide a dead-end for catalysis. During the course of our 
work, a dark brown solid was observed in the reaction vessel after 24-26 hours when the 
reaction was stopped. Additionally, the bright yellow colour observed in the reaction vessel 
at the beginning of the reaction turned to a brown cloudy solution fairly rapidly. This 
observation was made for all the pre-catalysts investigated. The brown solid observed may 
be attributed to Mn carbonyl clusters, but the exact nature and composition of the Mn 
clusters is unknown. Of course, there may be multiple pathways for catalyst deactivation and 
moreover, decomposition pathways may differ among our pre-catalyst complexes (223-229, 
DJ1) and MnBr(CO)5. Decomposition be more favourable for our pre-catalysts, especially the 
tricarbonyl Mn phosphine complexes (226-229) since the poorest yields were obtained for 
the tricarbonyl Mn phosphine pre-catalysts. There are a number of factors that control 
catalyst lifetime in C-H activation reactions and as noted in a recent publication by the Glorius 
group, these are not clearly understood.66 High catalyst activity, stability and the absence of 
catalyst poisons are all desirable in order to achieve high catalytic TONs.  
Further work is required in order to gain further understanding into the relative activity and 
stability of the tetracarbonyl- and tricarbonyl Mn phosphine pre-catalysts (223-229, DJ1) and 
also how they are likely to deactivate under the reaction conditions. This will be crucial in 
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5.5.7 Reduction of catalyst loading 
Mn catalysed C-H activation reactions mostly require 10 mol% of the Mn pre-catalyst.63 
Moreover, we were interested in determining if a reduction in catalyst loading could be 
possible with the carbonyl Mn phosphine pre-catalysts (223-229, DJ1). Thus, the reaction of 
N-(2-pyridyl) indole 247 with ketone 262 was investigated using 5 mol% Mn pre-catalyst 223 
(Scheme 110). Stirring at 100 ºC for 26 hours, a reduction in C-2 yield and selectivity was 
observed relative to when the reaction was carried out with 10 mol% Mn pre-catalyst. With 
10 mol% Mn pre-catalyst, a 51% isolated yield of C-2 substituted product 263 was obtained. 
Additionally, the ratio of C-2:C-3 was determined to be 82:18 (Table 29, entry 3). In 
comparison, employing 5 mol% Mn pre-catalyst 223, a reduced yield of 32% was observed. 
The ratio of C-2:C-3 product (263:264) was determined to be 62:38. 
 
       
          247 
  
                   262     
             
     
         263 
     
          264 
 
Scheme 110. Hydroarylation reaction investigated with 5 mol% Mn pre-catalyst 223. 
5.5.8 Mechanistic discussion 
It is crucial to gain insights into the mechanisms of C-H activation reactions to allow for future 
development of new catalytic systems, to allow optimisation of reaction conditions and also 
to allow extension to new methodologies. The catalytic system employed by Ackermann and 
co-workers for the hydroarylation of ketones, aldehydes and imines with N-(2-pyridyl) indole 
utilised the commercial Mn(I) pre-catalysts, Mn2CO10 or MnBr(CO)5.17 Mechanistic studies 
carried out within the Ackermann group suggested that the catalytic cycle is initiated by facile 
C-H metalation to form the cyclometalated complex I. Coordination of the ketone generates 
intermediate II. This is followed by insertion of the ketone to form a seven membered 
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manganacycle III. Finally, proto demetalation furnishes the desired alcohol product 263 and 
regenerates the catalytically active Mn species I (Figure 47). 
 
 
Figure 47. Catalytic cycle proposed by Ackermann and co-workers. 
Key to further development and understanding of the hydroarylation reaction employing 
manganese carbonyl phosphine complexes is gaining mechanistic information on the catalytic 
processes, and elucidation of the role of the phosphine ligands in the reaction. Therefore, 
attention within the McGlacken group was turned to unravelling the nature of the catalytically 
active Mn species in our system. This would involve determining and understanding how the 
pre-catalyst complexes are activated under the reaction conditions and what are the key 
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catalytic species involved in the catalytic cycle. A critical question to be answered was 
whether or not the phosphine ligand remains coordinated to the Mn during the catalytic 
cycle, at what step does dissociation of the phosphine ligands occur, and how this would 
affect the overall rate of reaction.  
To determine the nature of the catalytically active Mn species, C-H activation reactions were 
carried out with the cyclometalated complex EC1, using both catalytic and stoichiometric 
amounts of EC1 (Figure 48, b) and c)). (Note: this work was carried out by another member 
of the McGlacken group). The cyclometalated complex EC1 was prepared in 45% yield by 
reaction of N-(2-pyridyl) indole 247 with complex 222 in DCE at 80 ºC in the presence of two 
equivalents of Cy2NH (Figure 48, a)). Complex EC1 was identified by means of ESI-MS, 31P NMR 
spectroscopy and single crystal structure X-ray analysis. Observation of a single broad 
resonance in the 31P NMR spectrum at 52 ppm clearly indicated that the phosphine ligand is 
still coordinated to the manganese. Hence, this indicates that the phosphine ligand remains 
coordinated to the Mn during the key C-H activation step, thus, resulting in the formation of 
the cyclometalated complex EC1. C-H activation reactions were also performed with 
cyclometalated complex EC1. Pleasingly, complex EC1 proved to be competent in the catalytic 
as well as the stoichiometric hydroarylation reaction (Figure 48, a) and b)). These findings 
provide strong support for the cyclometalated complex EC1 being a catalytically competent 
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b) Complex EC1 as catalyst 
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                                                          263, 62% 
 
c) Stoichiometric hydroarylation 
 
 
               EC1 
 
                                                           263, 37% 
Figure 48. Catalytic and stoichiometric hydroarylation with cyclometalated complex EC1. 
Preliminary work carried out within the McGlacken group has suggested that the phosphine 
ligands are playing an important role in the hydroarylation reaction. However, to gain further 
insight into the mechanistic processes occuring at the Mn centre and also to provide more 
information on the role of the phosphine ligands in the reaction, the McGlacken group is 
currently involved with an ongoing collaboration with Prof. Ian Fairlamb and Dr. Jason Lynam 
in York. A number of recent publications by Fairlamb and Lynam and co-workers involved 
using real time infrared spectroscopic analysis for studying transient manganese carbonyl 
species formed during C-H bond activation reactions.63-65 This method enabled changes in 
metal carbonyl absorbances to be monitored (both qualitatively and quantitatively), and thus 
observation of the dynamic processes occurring at the manganese centre. Moreover, it is 
envisaged that a similar analysis in collaboration with Fairlamb and Lynam will enable us to 
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determine what role the phosphine ligands are playing in the hydroarylation reaction. It is 
hoped that Information gathered from this work would enable further development and 
optimisation of Mn carbonyl phosphine pre-catalysts for application in C-H activation 
reactions, as well as possible applications in various other synthetic transformations.  
5.5.9 Hydroarylation reaction investigated with ethyl pyruvate 
In Ackermann’s original publication on the hydroarylation of ketones with N-(2-pyridyl) 
indoles, the substrate scope with respect to the ketone was limited to the highly electrophilic, 
ethyl trifluoro pyruvate 262.17 Thus, this represents a limitation or drawback to the work. We 
were therefore interested in examining whether or not the carbonyl Mn phosphine 
complexes synthesised in-house would facilitate reaction with a more diverse range of 
ketones. The reaction of N-(2-pyridyl) indole (247) with ethyl pyruvate (265) in the presence 
of 10 mol% of 223 as pre-catalyst and NaOAc as the base was examined (Scheme 111). 
Disappointingly, no conversion to the desired C-2 alcohol product 266 was observed in the 1H 
NMR spectrum of the crude reaction mixture. This would indicate that the highly activated 
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                                                                        266 
Scheme 111. Attempted hydroarylation of ethyl pyruvate (265) with N-(2-pyridyl) indole (247). 
5.5.10 Concluding remarks 
In conclusion, although the tetracarbonyl Mn phosphine complexes (223-225, DJ1) proved to 
be competent catalysts in terms of selectivity for the C-2 hydroarylated product 263, the 
yields were significantly lower with respect to the commercial catalyst, MnBr(CO)5. This may 
be due to side-reactions occurring, catalyst deactivation or a number of other possibilities. In 
terms of electronics, the pre-catalysts with electron withdrawing groups on the phosphine 
ligand backbone (224, DJ1) gave slightly higher yields in comparison to the pre-catalyst with 
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an electron donating group on the phosphine ligand (224). Overall, the pre-catalyst (223) with 
a ‘neutral’ triphenylphosphine group allowed for the highest yield (51%). Finally, the steric 
bulk of the tricarbonyl Mn phosphine complexes (226-229) had an effect on catalyst 
selectivity and also resulted in lower yields of 263. Finally, complex 229 possessing the 
sterically bulky bidentate phosphine ligand, dppp failied to give any conversion to C-2 
product. The results are summarised in Figure 49. 
 
Figure 49. Comparison of tetracarbonyl Mn phosphine complexes 223-225, DJ1 and tricarbonyl Mn 
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5.6 Additional reactions investigated 
Numerous other transformations35, 67-73 were investigated with either commercially available 
Mn catalysts, or Mn carbonyl phosphine complexes synthesised in-house. However, no 









Figure 50. Various Mn catalysed transformations tested which did not yield the expected products. 
5.7 Conclusion and future work 
In conclusion, a number of tetracarbonyl- and tricarbonyl Mn phosphine complexes were 
successfully synthesised in good to excellent yields. The complexes were fully characterised 
by 1H/31P/13C NMR spectroscopy, infrared spectroscopy (IR), single crystal X-ray structure 
analysis and elemental analysis. The pre-catalyst complexes were applied in a number of C-H 
activation reactions. Overall, the Mn phosphine complexes exhibited poor catalytic activity in 
the majority of C-H activation reactions investigated. However, application of the Mn pre-
catalysts in the hydroarylation reaction of ethyl trifluoro pyruvate with N-(2-pyridyl) indole 
yielded more positive and insightful results. No discernible trend could be established with 
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regards to the electronic properties of the phosphine ligand ligated to the Mn centre. Steric 
factors appeared to play a more prominent role in achieving higher selectivity and conversion 
to the desired C-2 product, as the tetracarbonyl Mn phosphine complexes (223-225, DJ1) 
provided higher yields relative to the tricarbonyl Mn phosphine complexes (226-229). 
However, it must be noted that no Mn pre-catalyst allowed for a yield comparable to the 
commercial pre-catalyst MnBr(CO)5. 
Further insight into the mechanism of action of the Mn carbonyl phosphine complexes is 
required to allow future applications of the complexes in C-H activation reactions. The 
examination of different additives may also prove fruitful in improving the efficiency of the 
Mn carbonyl phosphine complexes as pre-catalysts, as was recently demonstrated by 
Fairlamb and co-workers.64 
Future work in this area will likely be focused on carrying out an asymmetric variant of the 
hydroarylation reaction, which would involve using a chiral phosphine ligand (Figure 51). As 
of now, there has been no examples of an asymmetric Mn catalysed C-H activation reaction 
in the literature. Thus, this would represent an important advancement in the field.  
 
Figure 51. Asymmetric Mn catalysed hydroarylation reaction. 
The exploration of ligands beyond phosphine ligands may also open up new avenues for 
reactivity. Mn catalysis for C-H activation is in its infancy, thus, it is hoped that new ligands 
for Mn will allow for the development of new and improved catalytic reactions. One such 
example would be phosphite ligands which are particularly interesting. The ‘carbonyl like’ π-
acceptor properties of phosphites could be used to enhance the electrophilicity of the Mn 
centre which may allow for new reactivity to be exploited.74 Additionally, phosphite ligands 
can be easily tuned for electronic and steric variations. The space that a ligand occupies 
 Chapter 5  Results and Discussion 
225 
 
around a metal centre is an extremely important parameter for modulating and fine tuning 
both the stability and reactivity of metal complexes. For example, the low steric requirement 
of alkyl phosphites would allow for up to three (or even four) phosphite ligands to fit around 
the metal centre (e.g. P(OMe)3 has a Tolman cone angle (parameter for determining the space 
a ligand occupies around a metal centre) of 107ᵒ whereas PPh3 has a cone angle of 145°).75 
Phosphite ligands are also more electron withdrawing than phosphines which makes them 
less sensitive to air and other oxidizing agents than phosphines.29 A scattered number of Mn 
carbonyl phosphite complexes have previously been characterised and published in the 
literature,18, 26-29 However, their application in C-H activation reactions is unexplored. The 
structural diversity of phosphites (mono- and di-phosphites and heterodonor phosphite 
containing ligands) offer a wide variety of opportunities for derivatization. Thus, their use as 
ancillary ligands may have interesting effects in terms of activity and selectivity of the Mn 
centre in C-H activation reactions. 
The investigation of various other ligand types such as multidentate pincer ligands, N-
heterocyclic carbenes (NHCs), N-donor ligands such as B-diketiminates as well as mixed ligand 
systems, may also prove fruitful in allowing previously unseen reactivity for Mn to be explored 
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In Chapter 2 of this thesis, two sets of reaction conditions were developed, which allowed for 
the efficient assembly of 6H-benzofuro[3,2-c]chromen-6-one and 1H-pyrano[4,3-
c]benzofuran-1-one analogues in an atom economical manner. Gratifyingly, a wide variety of 
6H-benzofuro[3,2-c]chromen-6-one analogues were accessed, featuring diverse substituents, 
including for example halides (-F, -Cl) and a nitro group, which could undergo further 
derivatisation. Pleasingly, good to excellent yields were obtained for the 6H-benzofuro[3,2-
c]chromen-6-one analogues with both sets of conditions. For meta-substituted derivatives, 
when Conditions A were employed, which utilised PivOH as reaction solvent, C-H activation 
occurred preferentially at the less sterically hindered position, with a single regiosimer 
isolated for the meta-methyl substrate. Overall, the regioselectivy of the double C-H 
activation reaction was largely dictated by steric effects, with the exception of substrates 
which exerted a secondary directing effect (-F, -OMe). A decrease in regioselectivity was 
observed when Conditions B, with TFA as solvent, were employed. Interestingly, a switch in 
regioselectivity was noted for the meta-methoxy substrate. For this substrate, reaction 
preferentially occurred the more sterically congested site. These results may be indicative of 
two different mechanisms operating depending on the reaction conditions employed. 
A decrease in yield was observed for the 1H-pyrano[4,3-c]benzofuran-1-one products 
employing Conditions A. Furthermore, the methodology also allowed for the construction of 
a synthetically useful 2-quinolone analogue, albeit the yield was reduced. To our delight, the 
double C-H activation strategy was also exploited for the short three-step synthesis of a 
natural product, flemichapparin C. This is one of the most delicate molecular frameworks to 
have been reported for a double C-H activation protocol, which demonstrates the robustness 
of this transformation. Satisfyingly, this work was published in Organic Letters in 2016. 
Encouraged by the excellent yields obtained for the coumarin and pyrone analogues, as well 
as some good regioselectivity observed for meta-substituted compounds, we then pursued 
the synthesis of dibenzofuran derivatives. Application of Conditions A efficiently delivered a 
number of meta-substituted dibenzofurans. Notably, yields of up to 99% were achieved for a 
range of mono- and di-substituted dibenzofurans. Overall, excellent regioselectivity was 
achieved for substrates with sterically bulky electron donating groups. Again, the selectivity 
of the double C-H activation reaction was largely governed by steric interactions. A slight 
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decrease in regioselecitivity was observed for the meta-fluoro and meta-methoxy analogues. 
Additionally, the naphthyl derivative produced a mixture of regioisomers. On the contrary, 
application of Conditions B resulted in a decrease in regioselectivity and yields. 
Dibenzofurans are important motifs in natural products and compounds with wide biological 
activity. Targeting this structural moiety using aryl–aryl bond formation, and diaryl ether 
precursors, is an obvious strategy. The limited current synthetic methods involving Pd 
catalysed C–H activation are hampered by a number of problems. Thus, Chapter 3 of this 
thesis described the efficient synthesis of dibenzofurans via a Pd catalysed single C-H 
activation of ortho-bromo diarylethers. A catalytic amount of cheap and bench stable 6-
methoxy quinoline was found to enhance the reaction. Overall, the work undertaken in this 
chapter addressed a number of limitations existing with current or previous protocols for the 
classic intramolecular C-H activation of diarylethers. This simple and efficient method allowed 
the synthesis of a wide range of synthetically valuable and novel dibenzofurans in good to 
excellent yields. Importantly, the reactions took place in air, without added phosphine or tert-
alkyl ammonium salt. In addition, the reaction conditions allowed for the use of a pyridyl 
moiety and an N-H linker. Disappointingly, the reaction conditions did not facilitate full 
conversion to product for electron rich substrates and this led to problems during the 
purification step. Further optimisation of the reaction conditions did allow for an 85% 
conversion to product for a para-methoxy substrate. This was achieved using DBU as an 
additive. It is envisaged that a review of ligands and additives will identify a set of reaction 
conditions suitable for electron rich substrates. A manuscript is in preparation for this work. 
A detailed review into Mn catalysed C-H activation protocols reported over the last few years, 
with a particular emphasis on the mechanistic aspects of the reactions, was published in 
Catalysis Science and Technology in 2018. In Chapter 5 of this thesis, the synthesis of a 
number of Mn carbonyl phosphine complexes and their reactivity in C-H activation reactions 
was discussed. In this Chapter, a range of tetracarbonyl- and tricarbonyl Mn phosphine 
complexes were successfully synthesised in good to excellent yields. This work entailed the 
characterisation of the complexes by spectroscopic means and also by single crystal x-ray 
structure analysis and elemental analysis. There have been previous reports on the synthesis 
of Mn carbonyl phosphine complexes in the inorganic literature dating back to the 1960s. 
However, it is important to note that their utility in C-H activation reactions up to recently, 
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has been completely unexplored. Relatively little success was achieved upon the application 
of the pre-catalyst complexes in most of the C-H activation reactions examined. Pleasingly, 
success was achieved with the Mn catalysed hydroarylation reaction of ketones with indoles. 
This reaction was reported by Ackermann and co-workers in 2017 using the commercially 
available MnBr(CO)5 pre-catalyst. Overall, the steric properties of the complexes played an 
important role with regards to selectivity and conversion, with the mono-phosphine 
complexes displaying greater reactivity relative to the di-phosphine complexes. Relative to 
the commercially available pre-catalyst, MnBr(CO)5, which gave an 88% yield of the desired 
C-2 alcohol product, MnBr(CO)4(PPh3) allowed for a 51% yield of the C-2 hydroarylated 
product.  On the contrary, the Mn carbonyl complex containing the bidentate dppp ligand 
exhibited very poor catalytic activity. On-going work within the McGlacken laboratory is also 
focused on carrying out this reaction in an asymmetric fashion using a chiral phosphine ligand, 
as well as examinating the reactivity of the pre-catalyst complexes in other C-H activation 
reactions. Key to further development of this reaction involves gaining mechanistic 
information on the catalytic processes involving Mn and also elucidating the role of the 
phosphine ligands in the reaction. Furthermore, a current collaboration with Dr. Jason Lynam 
and Prof. Ian Fairlamb, which involves using real time infrared spectroscopic analysis for 
studying transient manganese carbonyl species formed during C-H bond activation reactions, 
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6.1 General information 
Solvents and reagents were used as obtained from commercial sources and without 
purification, with the exception of 1,4-dioxane, chloroform and dichloromethane, which were 
flame dried over 4Å molecular sieves (10-15% w/v) and stored in a Young’s flask. Toluene was 
distilled from sodium/benzophenone dianion under nitrogen. 
Wet flash column chromatography was carried out using Kieselgel silica gel 60, 0.040-0.063 
μm (Merck). TLC was carried out on pre-coated silica gel plates (Merck 60 PF254). 
Visualisation was achieved by UV light. Microwave reactions were performed in a CEM 
Discover S-Class Synthesiser with the temperature monitored by infrared temperature 
control. Melting points were obtained on a uni-melt Thomas Hoover Capillary melting point 
apparatus.  
IR spectra were recorded on Perkin-Elmer FT-IR Paragon 1000 spectrophotometer or Perkin-
Elmer AT-IR spectrophotometer. Liquid samples were examined as thin films interspersed on 
NaCl plates. Solid samples were either recorded on Perkin-Elmer AT-IR spectrophotometer or 
dissolved in dichloromethane, dispersed as thin films on NaCl plates and the dichloromethane 
allowed to evaporate before measurement of sample on Perkin-Elmer FT-IR Paragon 1000 
spectrophotometer.  
 
NMR spectra were run in CDCl3 using TMS as the internal standard at 25 °C unless otherwise 
specified. 1H NMR (600 MHz) spectra, 1H NMR (500 MHz) spectra and 1H NMR (300 MHz) 
spectra were recorded on Bruker Avance 600, Bruker Avance 500, 0 and Bruker Avance 300 
NMR spectrometers respectively. 13C (150 MHz) spectra, 13C (125 MHz) spectra, and 13C (75.5 
MHz) spectra were recorded on Bruker Avance 600, Bruker Avance 500, and Bruker Avance 
300 NMR spectrometers respectively in proton decoupled mode. 19F NMR (282 MHz) spectra 
were recorded on a Bruker Avance 300 NMR spectrometer in proton decoupled mode. 31P 
NMR (282 MHz) spectra were recorded on a Bruker Avance 600 NMR spectrometer in proton 
decoupled mode. Chemical shifts δH and δC are expressed as parts per million (ppm), positive 
shift being downfield from TMS; coupling constants (J) are expressed in hertz (Hz). Splitting 
patterns in 1H NMR spectra are designated as s (singlet), br s (broad singlet), d (doublet), dd 
(doublet of doublets), dt (doublet of triplets), t (triplet), q (quartet), quin (quintet), sext 
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(sextet), sept (septet), and m (multiplet). For 13C NMR spectra, the number of attached 
protons for each signal was determined using the DEPT pulse sequence run in the DEPT-90 
and DEPT-135 modes.  
 
Nominal mass spectra were recorded on a Waters Quattro Micro triple quadrupole 
spectrometer (QAA1202) in ESI mode using 50% acetonitrile–water containing 0.1% formic 
acid as eluent. High resolution mass spectra (HRMS) were recorded on a Waters LCT Premier 
Time of Flight spectrometer (KD160) or a Waters Vion IMS mass spectrometer (SAA055 K) in 
ESI mode using 50% acetonitrile–water containing 0.1% formic acid as eluent. Samples (max. 
1 mg) were dissolved in acetonitrile, acetonitrile/methanol, water or 10% DMSO/acetonitrile. 
 
The Microanalysis Laboratory, National University of Ireland, Cork, performed elemental 
analysis using a Perkin-Elmer 240 and Exeter Analytical CE440 elemental analysers. 
 
6.1.1 Analysis of known and novel compounds 
1H NMR spectra, 13C NMR spectra, 31P NMR spectra (where applicable) LRMS, melting point 
(if solid) or IR analyses were recorded for all previously prepared compounds. For novel 
compounds, in addition to previously mentioned analysis, 19F NMR SPECTRA (where 
applicable), HRMS or Elemental Analysis (if possible) was also obtained. An arbitrary 
numbering system was employed to aid in assignment of 1H NMR and 13C NMR spectra. COSY, 
HSQC and HMBC experiments were used to aid in assignment. 
Note: Compounds 102, 203, 204, 215 and novel compounds 110, 183, 184, 185 and 187 were 
not detected by ESI mass spectrometry under standard conditions and hence do not have a 
HRMS. Due to the current circumstances regarding COVID-19, I was not able to pursue this. 
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6.2 Synthesis of Starting Materials 
6.2.1 Preparation of 4-bromo-6-methyl-2H-pyran-2-one (23)1 
To a 2-necked round bottomed flask was added 4-hydroxy-6-methyl-2H-pyran-
2-one (22) (5.0 g, 39.7 mmol, 1.0 equiv.), TBAB (14.8 g, 46.0 mmol, 1.16 equiv.), 
phosphorus pentoxide (13.5 g, 95.2 mmol, 2.4 equiv.) and toluene (4.0 
mL/mmol). The resulting mixture was stirred in an oil bath at 94 °C for 1.5 
hours. Upon cooling, the clean upper layer was separated from the lower solid layer. The 
lower layer was washed with toluene (2 x 30 mL). The combined organic extracts were then 
washed with saturated aqueous NaHCO3 (60 mL) and brine (80 mL). The organic layer was 
then dried over MgSO4, filtered and concentrated under reduced pressure. The product 4-
bromo-6-methyl-2H-pyran-2-one (23) was isolated as an orange solid (6.4 g, 85%), m.p. 72-74 
°C (lit. 73-74 °C)1; H (CDCl3, 300 MHz) 2.25 (3H, d, J 0.5, C(7)H3), 6.19 (1H, tapp, J 0.8, C(5)H), 
6.46 (1H, d, J 0.7, C(3)H); C (CDCl3, 75.5 MHz) 19.7 (C(7)H3), 108.4 (C(5)H), 114.8 (C(3)H), 141.1 
(qC-4), 160.6 (qC-6), 162.1 (qC-2); m/z (ES+): Br79 181 [(M+H)+, 25%], Br81 191 [(M+H)+, 98%]. 
Spectral characteristics were consistent with previously reported data.1 
6.2.2 General procedure for preparation of 4-phenoxy-6-methyl-2H-pyran-2-ones (24, 30-
40)2 
To a 3-necked round bottomed flask was added 4-bromo-6-methyl-2H-pyran-2-one (23) (1.0 
equiv.), phenol (1.5 equiv.), and K2CO3 (1.8 equiv.) in acetone (4.0 mL/mmol). The resulting 
mixture was stirred in an oil bath at 65 °C for 16 hours. Upon cooling to ambient temperature, 
the reaction mixture was diluted with water (10 mL) and EtOAc (20 mL). The layers were 
separated and the aqueous layer washed with EtOAc (2 x 20 mL) and the combined organic 
layers were washed with aqueous NaOH (10% w/v, 2 x 20 mL). The organic layer was then 
dried over MgSO4, filtered and concentrated under reduced pressure. The residues were 
purified by recrystallisation from EtOH. 
 
 




Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (2.0 g, 10.6 mmol, 1.0 equiv.) and phenol (1.5 
equiv.). Yellow solid (1.69 g, 71%), m.p. 86-88 °C (lit. 86 °C); H (CDCl3, 300 
MHz) 2.26 (3H, s, C(7)H3), 5.21 (1H, d, J 2.1, C(3)H), 5.96-5.97 (1H, m, 
C(5)H), 7.07 (2H, d, J 8.0, C(9)H & C(13)H), 7.29 (1H, t, J 7.3, C(11)H), 7.43 
(2H, t, J 7.8, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 20.0 (C(7)H3), 91.0 (C(3)H), 99.9 (C(5)H), 
121.1 (C(9)H & C(13)H), 126.5 (C(11)H), 130.2 (C(10)H & C(12)H), 152.4 (qC-8), 163.3 (qC-6), 
164.6 (qC-2), 170.8 (qC-4); m/z (ES+): 203, [(M+H)+, 100%]. 
Spectral characteristics were consistent with previously reported data.2 
4-(4-Methylphenoxy)-6-methyl-2H-pyran-2-one (30)2 
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 4-
methyl phenol (1.5 equiv.). Cream solid (450 mg, 44%), m.p. 107-109 °C 
(lit. 53 °C); H (CDCl3, 300 MHz) 2.25 (3H, s, C(7)H3), 2.37 (3H, s, C(14)H3), 
5.20 (1H, d, J 2.1, C(3)H), 5.95 (1H, tapp, J 1.0, C(5)H), 6.94 (2H, d, J 8.5, 
C(9)H & C(13)H), 7.21 (2H, d, J 8.2, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 20.0 (C(7)H3), 20.9 
(C(14)H3), 90.8 (C(3)H), 99.9 (C(5)H), 120.8 (C(9)H & C(13)H), 130.7 (C(10)H & C(12)H), 136.3 
(qC-11, 150.1 (qC-8), 163.2 (qC-6), 164.7 (qC-2), 171.0 (qC-4); m/z (ES-): 215, [(M−H)-, 16%]; 
HRMS (ESI-TOF): Exact mass calculated for C13H13O3 [M+H+], 217.0865. Found 217.0869. 
Spectral characteristics were consistent with previously reported data.2 
4-(4-Methoxyphenoxy)-6-methyl-2H-pyran-2-one (31)2 
Synthesised according to the general procedure 6.2.2 using 4-bromo-
6-methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 4-
methoxy phenol (1.5 equiv.). White solid (380 mg, 55%), m.p.: 106-
108 °C (lit. 105-106 °C); H (CDCl3, 300 MHz) 2.25 (3H, t, J 0.7, C(7)H3), 
3.82 (3H, s, C(14)H3), 5.19 (1H, d, J 2.1, C(3)H), 5.95 (1H, dd, J 2.2, 1.0, 
C(5)H), 6.89-6.94 (2H, m, C(9)H & C(13)H), 6.96-7.03 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 
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MHz) 20.0 (C(7)H3), 55.7 (C(14)H3), 90.7 (C(3)H), 99.9 (C(5)H), 115.2 (C(9)H & C(13)H), 122.0 
(C(10)H & C(12)H), 145.8 (qC-8), 157.8 (qC-11), 163.2 (qC-6), 164.1 (qC-2), 171.3 (qC-4); HRMS 
(ESI-TOF): Exact mass calculated for C13H13O4 [M+H+], 233.0814. Found 233.0810.  
Spectral characteristics were consistent with previously reported data.2 
4-(4-Fluorophenoxy)-6-methyl-2H-pyran-2-one (32)2  
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 4-fluoro 
phenol (1.5 equiv.). Yellow solid (390 mg, 64%), m.p. 79-81 °C (lit. 75-76 
°C); H (CDCl3, 300 MHz) 2.26 (3H, s, C(7)H3), 5.17 (1H, d, J 2.4, C(3)H), 5.96 
(1H, d, J 2.1, C(5)H), 7.01-7.16 (4H, m, C(9)H, C(10)H, C(12)H & C(13)H); C 
(CDCl3, 75.5 MHz) 20.0 (C(7)H3), 91.0 (C(3)H), 100.0 (C(5)H), 117.0 (C(10)H & C(12)H, d, JC-F 
24), 122.7 (C(9)H & C(13)H, d, JC-F 9), 148.2 (qC-8, d, JC-F 3), 160.5 (qC-11, d, JC-F 247), 163.5 
(qC-6), 164.4 (qC-2), 170.8 (qC-4); m/z (ES+): 221, [(M+H)+, 15%]; HRMS (ESI-TOF): Exact mass 
calculated for C12H10O3F [M+H+], 221.0614. Found 221.0618.  
Spectral characteristics were consistent with previously reported data.2 
4-(4-Nitrophenoxy)-6-methyl-2H-pyran-2-one (33)  
Synthesised according to the general procedure 6.2.2 using 4-bromo-
6-methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 4-
nitro phenol (1.5 equiv.). Brown solid (130 mg, 50%), m.p. 142-144 °C; 
H (CDCl3, 300 MHz) 2.29 (3H, s, C(7)H3), 5.31 (1H, d, J 2.1, C(3)H), 5.98 
(1H, d, J 2.1, C(5)H), 7.24-7.28 (2H, m, C(9)H & C(13)H), 8.31-8.36 (2H, 
m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 20.1 (C(7)H3), 92.5 (C(3)H), 99.5 (C(5)H), 121.7 
(C(9)H & C(13)H), 126.1 (C(10)H & C(12)H), 142.1 (qC-11), 157.2 (qC-8), 163.8 (qC-6), 164.3 
(qC-2), 169.1 (qC-4); m/z (ES+): 248, [(M+H)+, 90%]. Anal. Calculated for C12H9NO5: C, 58.30; 
H, 3.67. Found: C, 58.60; H, 3.72.  
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4-(3-Methylphenoxy)-6-methyl-2H-pyran-2-one (34)  
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 3-methyl 
phenol (1.5 equiv.). Pale brown crystals (460 mg, 73%), m.p. 66-68 °C (lit. 
59-60 °C); H (CDCl3, 300 MHz) 2.26 (3H, m, C(7)H3), 2.37 (3H, s, C(14)H3), 
5.21 (1H, dd, J 2.2, 0.4, C(3)H), 5.96 (1H, dd, J 2.2, 0.9, C(5)H), 6.84-6.89 
(2H, m, C(9)H & C(13)H), 7.08-7.11 (1H, m, C(11)H), 7.29 (1H, td, J 7.6, 1.0, 
C(12)H); C (CDCl3, 75.5 MHz) 20.0 (C(7)H3), 21.3 (C(14)H3), 91.0 (C(3)H), 100.0 (C(5)H), 118.0 
(C(9)H), 121.6 (C(13)H), 127.3 (C(11)H), 129.9 (C(12)H), 140.6 (qC-10), 152.3 (qC-8), 163.2 (qC-
6), 164.7 (qC-2), 170.8 (qC-4); m/z (ES+): 217, [(M+H)+, 14%]; HRMS (ESI-TOF): Exact mass 
calculated for C13H13O3 [M+H+], 217.0865. Found 217.0868.  
Spectral characteristics were consistent with previously reported data.2 
4-(3-Methoxyphenoxy)-6-methyl-2H-pyran-2-one (35)  
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 3-
methoxy phenol (1.5 equiv.). Yellow solid (530 mg, 58%), m.p. 99-100 °C 
(lit. 100 °C); H (CDCl3, 300 MHz) 2.26 (3H, s, C(7)H3), 3.81 (3H, s, C(14)H3), 
5.26 (1H, d, J 2.1, C(3)H), 5.96 (1H, dd, J 2.1, 0.9, C(5)H), 6.61 (1H, t, J 2.3, 
C(9)H), 6.66 (1H, dd, J 8.0, 2.2, C(13)H), 6.83 (1H, dt, J 8.4, 2.0, C(11)H), 
7.32 (1H, t, J 8.2, C(12)H); C (CDCl3, 75.5 MHz) 20.0 (C(7)H3), 55.7 (C(14)H3), 90.7 (C(3)H), 99.9 
(C(5)H), 115.2 (C(9)H & C(13)H), 122.0 (C(11)H & C(12)H), 145.8 (qC-10), 157.8 (qC-8), 163.2 
(qC-6), 164.1 (qC-2), 171.3 (qC-4); m/z (ES+): 233, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass 
calculated for C13H13O4 [M+H+], 233.0814. Found 233.0813.  
Spectral characteristics were consistent with previously reported data.2 
 
 




Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 3-fluoro 
phenol (1.5 equiv.). White solid (390 mg, 21%), m.p.: 82-84 °C (lit. 77-80 
°C); H (CDCl3, 300 MHz) 2.27 (3H, s, C(7)H3), 5.25 (1H, d, J 2.3, C(3)H), 5.96-
5.97 (1H, m, C(5)H), 6.83 (1H, dt, J 9.1, 2.3, C(13)H), 6.89 (1H, dd, J 8.2, 2.1, 
C(9)H), 6.99-7.02 (1H, m, C(12)H), 7.36-7.44 (1H, m, C(11)H); C (CDCl3, 75.5 MHz) 20.1 
(C(7)H3), 91.4 (C(3)H), 99.7 (C(5)H), 109.3 (C(9)H, d, JC-F 24), 113.7 (C(11)H, d, JC-F 21), 116.9 
(C(13)H, d, JC-F 4), 131.2 (C(12)H, d, JC-F 9), 153.2 (qC-8, d, JC-F 11), 163.2 (qC-10, d, JC-F 2), 163.6 
(qC-6), 164.3 (qC-2), 170.2 (qC-4); m/z (ES+): 221, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass 
calculated for C12H10O3F [M+H+], 221.0614. Found 221.0614.  
Spectral characteristics were consistent with previously reported data.2 
4-(2-Methylphenoxy)-6-methyl-2H-pyran-2-one (37)2  
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 2-methyl 
phenol (1.5 equiv.). Cream solid (380 mg, 87%), m.p. 59-60 °C (lit. 59-60 
°C); H (CDCl3, 300 MHz) 2.15 (3H, s, C(14)H3), 2.24 (3H, s, C(7)H3), 5.06 (1H, 
d, J 2.2, C(3)H), 6.00 (1H, dd, J 2.2, 0.9, C(5)H), 6.97 (1H, dd, J 7.5, 1.7, 
C(13)H), 7.14-7.21 (2H, m, C(10)H & C(12)H), 7.22-7.28 (1H, m, C(11)H); C (CDCl3, 75.5 MHz) 
20.0 (C(14)H3), 21.3 (C(7)H3), 91.0 (C(3)H), 100.0 (C(5)H), 118.0 (C(13)H), 121.6 (C(10)H), 127.3 
(C(11)H), 129.9 (C(12)H), 140.6 (qC-9), 152.3 (qC-8), 163.2 (qC-6), 164.7 (qC-2), 170.8 (qC-4); 
m/z (ES+): 217, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C13H13O3 [M+H+], 
217.0865. Found 217.0863. 
Spectral characteristics were consistent with previously reported data.2 
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6-Methyl-4-(pyridin-3-yloxy)-2H-pyran-2-one (38)  
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 3-pyridyl 
phenol (1.5 equiv.). Brown oil (140 mg, 67%); H (CDCl3, 300 MHz) 2.20 
(3H, s, C(7)H3), 5.10 (1H, d, J 2.3, C(3)H), 5.93 (1H, dd, J 2.3, 0.96, C(5)H), 
7.31-7.41 (2H, m, C(11)H & C(12)H), 8.37 (1H, d, J 2.7, C(9)H), 8.49 (1H, dd, 
J 4.5, 1.4, C(10)H); C (CDCl3, 75.5 MHz) 20.0 (C(7)H3), 91.3 (C(3)H), 99.5 (C(5)H), 124.5 
(C(12)H), 128.7 (C(11)H), 143.3 (C(9)H), 147.8 (C(10)H), 149.0 (qC-8), 163.85 (qC-6), 163.9 (qC-
2), 170.1 (qC-4); m/z (ES+): 204, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for 
C11H10O3N [M+H+], 204.1869. Found 204.1874. 
4-((2-Aminopyridin-3-yl) oxy)-6-methyl-2H-pyran-2-one (39) 
Synthesised according to the general procedure 6.2.2 using 4-bromo-6-
methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 2-
amino-3-pyridyl phenol (1.5 equiv.). Yellow solid (100 mg, 43%), m.p. 145-
146 °C; H (CDCl3, 300 MHz) 2.27 (3H, s, C(7)H3), 4.61 (2H, br s, N(13)H2), 
5.31 (1H, d, J 2.3, C(3)H), 5.97 (1H, dd, J 2.3, 1.3, C(5)H), 6.72 (1H, dd, J 7.9, 
5.0, C(11)H), 7.22 (1H, dd, J 7.9, 1.5, C(12)H), 8.02 (1H, dd, J 4.9, 1.5, 
C(10)H); C (CDCl3, 75.5 MHz) 20.1 (C(7)H3), 91.1 (C(3)H), 99.2 (C(5)H), 114.4 (C(12)H), 129.1 
(C(11)H), 134.2 (C(10)H), 146.2 (qC-9), 151.4 (qC-8), 163.9 (qC-6), 164.1 (qC-2), 169.2 (qC-4); 
m/z (ES+): 219, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C11H11O3N2 
[M+H+], 219.0770. Found 219.0766. 
6-Methyl-4-(naphthalene-2-yloxy)-2H-pyran-2-one (40)3  
Synthesised according to the general procedure 6.2.2 using 4-bromo-
6-methyl-2H-pyran-2-one (23) (200 mg, 1.06 mmol, 1.0 equiv.) and 2-
naphthol (1.5 equiv.). Brown solid (210 mg, 79%), m.p. 126-127 °C (lit. 
126-127 °C); H (CDCl3, 300 MHz) 2.22 (3H, s, C(7)H3), 5.27 (1H, d, J 2.0, 
C(3)H), 6.01 (1H, d, J 1.1 C(5)H), 7.15-7.20 (1H, dd, J 8.9, 2.3, C(17)H), 
7.45-7.59 (3H, m, C(9)H, C(13)H & C(16)H), 7.73-7.96 (3H, m, C(11)H, 
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C(12)H & C(14)H); C (CDCl3, 75.5 MHz) 20.1 (C(7)H3), 91.3 (C(3)H), 99.9 (C(5)H), 118.2 (C(9)H), 
120.2 (C(17)H), 126.3 (C(16)H), 127.1 (C(13)H), 127.6 (C(12)H), 127.9 (C(14)H), 130.6 (C(11)H), 
131.6 (qC-10), 133.9 (qC-15), 149.9 (qC-8), 163.4 (qC-6), 164.5 (qC-2), 170.7 (qC-4); m/z (ES+): 
253, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C16H13O3 [M+H+], 253.0865. 
Found 253.0865.  
Spectral characteristics were consistent with previously reported data.3 
6.2.3 Preparation of 4-bromo-2-coumarin (54)1 
To a 2-necked round bottomed flask was added 4-hydroxy-2-coumarin (53) 
(5.0 g, 30.83 mmol, 1.0 equiv.), TBAB (11.53 g, 35.76 mmol, 1.16 equiv.) and 
P2O5 (10.50 g, 73.99 mmol, 2.4 equiv.) in toluene (4.0 mL/mmol). The 
resulting mixture was stirred in an oil bath at 94 °C for 1.5 hours. Upon 
cooling, the clean upper layer was separated from the lower solid layer. The lower layer was 
washed with toluene (2 x 30 mL). The combined organic extracts were then washed with 
saturated aqueous NaHCO3 (60 mL) and brine (80 mL). The organic layer was then dried over 
MgSO4, filtered and concentrated under reduced pressure. The product 4-bromo-2-coumarin 
(54) was isolated as a brown solid (3.0 g, 72%), m.p. 88-89 °C (lit. 92-93°C)1; H (CDCl3, 300 
MHz) 6.87 (1H, s, C(3)H), 7.23.7.39 (2H, m, C(7)H & C(9)H), 7.57-7.63 (1H, m, C(8)H), 7.85 (1H, 
dd, J 7.9, 1.5, C(6)H); C (CDCl3, 75.5 MHz) 117.0 (C(3)H), 119.0 (qC-5), 119.6 (C(9)H), 125.0 
(C(6)H), 128.1 (C(7)H), 133.2 (C(8)H), 141.5 (qC-4), 152.5 (qC-10), 158.7 (qC-2); m/z (ES+): 225, 
Br79 [(M+H)+, 76%], 227, Br81 [(M+H)+, 58%]. 
Spectral characterisitcs were consistent with previously reported data.1 
6.2.4 General procedure for preparation of 4-phenoxy-2-coumarins (55-68) 
To a 3-necked round bottomed flask was added 4-bromo-2-coumarin (54) (1.0 equiv.), phenol 
(1.5 equiv.), and K2CO3 (1.8 equiv.) in acetone (4.0 mL/mmol). The resulting mixture was 
stirred in an oil bath at 65 °C and stirred for 16 hours. Upon cooling, the reaction mixture was 
diluted with water (10 mL) and EtOAc (20 mL). The mixture was extracted with EtOAc (2 x 20 
mL) and the combined organic layers were washed with aqueous NaOH (10% w/v, 2 x 20 mL). 
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The organic layer was then dried over MgSO4, filtered and concentrated under reduced 
pressure. The residues were purified by recrystallisation from EtOH. 
4-Phenoxy-2-coumarin (55)2, 4 
Synthesised according to the general procedure 6.2.4 using 4-bromo-2-
coumarin (54) (750 mg, 3.33 mmol, 1.0 equiv.) and phenol (1.5 equiv.). 
Yellow solid (602 mg, 76%), m.p. 131-132 °C (lit. 131-132 °C); H (CDCl3, 
300 MHz) 5.42 (1H, s, C(3)H), 7.16-7.20 (2H, m, C(12)H & C(16)H), 7.32-
7.38 (3H, m, C(7)H, C(9)H & C(14)H), 7.46-7.52 (2H, m, C(13)H & C(15)H), 
7.59-7.65 (1H, ddd, J 8.7, 7.4, 1.6, C(8)H), 8.03 (1H, dd, J 8.0, 1.5, C(6)H); C (CDCl3, 75.5 MHz) 
93.5 (C(3)H), 115.4 (qC-5), 116.9 (C(9)H), 121.3 (C(12)H & C(16)H), 123.0 (C(6)H), 124.1 
(C(7)H), 126.8 (C(14)H), 130.4 (C(13)H & C(15)H), 132.8 (C(8)H), 152.4 (qC-11), 153.7 (qC-10), 
162.6 (qC-2), 166.4 (qC-4); m/z (ES+): 239, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.2, 4 
4-(4-Methylphenoxy)-2H-chromene-2-one (56)3   
Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (4.0 g, 17.77 mmol, 1.0 equiv.) and 4-
methyl phenol (1.5 equiv.). Yellow crystals (2.1 g, 48%), m.p. 132-
133°C; max/cm1 (NaCl): 1723 (ester C=O stretch), 1625 (alkene 
C=C stretch), 1489 (aromatic C=C stretch), 1385 (ester C-O stretch), 
1227 (ether C-O stretch), 1179 (ether C-O stretch); H (CDCl3, 300 
MHz) 2.40 (3H, s, C(17)H3), 5.42 (1H, s, C(3)H), 7.03-7.11 (2H, m, C(12)H & C(16)H), 7.24-7.39 
(4H, m, C(7)H, C(9)H, C(13)H & C(15)H), 7.61 (1H, ddd, J 8.6, 7.2, 1.6, C(8)H), 8.03 (1H, dd, J 
7.77, 1.43, C(6)H); C (CDCl3, 75.5 MHz) 20.9 (C(17)H3), 93.4 (C(3)H), 115.5 (qC-5), 116.8 
(C(9)H), 120.9 (C(12)H & C(16)H), 123.1 (C(6)H), 124.0 (C(7)H), 131.0 (C(13)H & C(15)H), 132.7 
(C(8)H), 136.6 (qC-14), 150.2 (qC-11), 153.7 (qC-10), 162.7 (qC-2), 166.6 (qC-4); m/z (ES+): 253, 
[(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C16H13O3 [M+H+], 253.0861. Found 
253.0865.  Anal. Calculated for C16H12O3: C, 76.18; H, 4.79. Found: C, 76.29; H, 4.81.  
Spectral characteristics were consistent with previously reported data.3 




Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (4.0 g, 17.77 mmol, 1.0 equiv.) and 4-
methoxy phenol (1.5 equiv.). Orange solid (3.99 g, 84%), m.p. 127-
129 °C (lit. 99-101 °C); H (CDCl3, 300 MHz) 3.85 (3H, s, C(17)H3), 
5.42 (1H, s, C(3)H), 6.95-7.01 (2H, m, C(13)H & C(15)H), 7.06-7.12 
(2H, m, C(12)H & C(16)H), 7.31-7.39 (2H, m, C(7)H & C(9)H), 7.61 (1H, ddd, J 8.6, 7.2, 1.6, 
C(8)H), 8.02 (1H, dd, J 7.9, 1.4, C(6)H); C (CDCl3, 75.5 MHz) 55.7 (C(17)H3), 93.3 (C(3)H), 115.4 
(2 x C(13)H & C(15)H), 115.4 (qC-5), 116.8 (C(9)H), 122.1 (C(12)H & C(16)H), 123.0 (C(6)H), 
124.1 (C(7)H), 132.7 (C(8)H), 145.8 (qC-14), 153.7 (qC-11), 157.9 (qC-10), 162.7 (qC-2), 166.8 
(qC-4); m/z (ES+): 269 [(M+H)+, 100%]; Anal. Calculated for C16H12O4: C, 71.64; H, 4.51. Found: 
C, 71.69; H, 4.56.  
Spectral characteristics were consistent with previously reported data3-4 
4-(4-Fluorophenoxy)-2H-chromene-2-one (58)3-4 
Synthesised according to the general procedure 6.2.4 using 4-bromo-
2-coumarin (54) (4.0 g, 17.77 mmol, 1.0 equiv.) and 4-fluoro phenol 
(1.5 equiv.). Yellow crystals (2.2 g, 49%), m.p. 134-136 ᵒC (lit. 118-121 
°C); H (CDCl3, 300 MHz) 5.40 (1H, s, C(3)H), 7.13-7.23 (4H, m, C(12)H, 
C(13)H, C(15)H & C(16)H), 7.37 (2H, ddd, J 8.8, 4.2, 0.9, C(7)H & C(9)H), 
7.63 (1H, ddd, J 8.6, 7.2, 1.6, C(8)H), 7.97-8.05 (1H, m, C(6)H); C (CDCl3, 75.5 MHz) 93.5 
(C(3)H), 115.2 (qC-5), 117.0 (C(13)H & C(15)H, d, JC-F 11), 117.4 (C(9)H), 122.8 (C(12)H & 
C(16)H, d, JC-F 8), 123.0 (C(6)H), 124.2 (C(7)H), 132.9 (C(8)H), 148.2 (qC-11, d, JC-F 3), 153.7 (qC-
10), 160.7 (qC-14, d, JC-F 248), 162.4 (qC-2), 166.4 (qC-4); m/z (ES+): 257, [(M+H)+, 40%]. Anal. 
Calculated for C15H9O3F: C, 70.31; H, 3.54. Found: C, 70.15; H, 3.62.  
Spectral characteristics were consistent with previously reported data.3-4 
 
 




Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (4.0 g, 17.77 mmol, 1.0 equiv.) and 4-nitro 
phenol (1.5 equiv.). Yellow solid (2.9 g, 58%), m.p. 157-160 °C; 
max/cm1 (NaCl): 1723 (ester C-O stretch), 1626 (alkene C=C 
stretch), 1522 (aromatic C=C stretch), 1485 (aromatic C=C stretch), 
1346 (N=O stretch), 1230 (ester C-O stretch), 1180 (ether C-O stretch); H (CDCl3, 300 MHz) 
5.48 (1H, s, C(3)H), 7.34-7.46 (4H, m, C(7)H, C(9)H, C(12)H & C(16)H), 7.66 (1H, ddd, J 8.6, 7.3, 
1.6, C(8)H), 7.99 (1H, dd, J 7.9, 1.4, C(6)H), 8.37-8.43 (2H, m, C(13)H & C(15)H); C (CDCl3, 75.5 
MHz) 94.9 (C(3)H), 114.8 (qC-5), 117.1 (C(9)H), 122.1 (C(6)H), 123.0 (C(12)H & C(16)H), 124.4 
(C(7)H), 126.3 (C(13)H & C(15)H), 133.4 (C(8)H), 146.0 (qC-11), 153.7 (qC-14), 157.3 (qC-10), 
161.7 (qC-2), 165.1 (qC-4); m/z (ES+): 284 [(M+H)+, 100%]; Anal. Calculated for C15H9O5N: C, 
63.61; H, 3.20. Found: C, 63.65; H, 3.21.  
Spectral characteristics were consistent with previously reported data.3  
4-(4-Chlorophenoxy)-2H-chromene-2-one (60)3 
Synthesised according to the general procedure 6.2.4 using 4-bromo-
2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 4-chloro phenol (1.5 
equiv.). Yellow crystals (1.9 g, 79%), m.p. 124-125 °C; max/cm1 (NaCl): 
1725 (ester C-O stretch), 1626 (alkene C=C stretch) 1608 (aromatic C=C 
stretch), 1482 (aromatic C=C stretch), 1385 (ester C-O stretch), 1227 
(ether C-O stretch), 1180 (ether C-O stretch); H (CDCl3, 300 MHz) 5.41 (1H, s, C(3)H), 7.10-
7.18 (2H, m, C(12)H & C(16)H), 7.32-7.41 (2H, m, C(7)H & C(9)H), 7.43-7.51 (2H, m, C(13)H & 
C(15)H), 7.58-7.68 (1H, m, C(8)H), 8.00 (1H, dd, J 7.9, 1.4, C(6)H); C (CDCl3, 75.5 MHz) 93.7 
(C(3)H), 115.2 (qC-5), 116.9 (C(9)H), 122.7 (C(6)H), 123.0 (C(12)H & C(16)H), 124.2 (C(7)H), 
130.6 (C(13)H & C(15)H), 132.4 (C(8)H), 133.0 (qC-14), 150.9 (qC-11), 153.6 (qC-10), 162.3 (qC-
2), 166.0 (qC-4); m/z (ES+): 273, [(M+H)+, 65%]; Anal. Calculated for C15H9O3Cl: C, 66.07; H, 
3.33. Found: C, 65.99; H, 3.47.  
Spectral characteristics were consistent with previously reported data.3 
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4-(4-Tert-butylphenoxy)-2H-chromene-2-one (61)3  
Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 4-tert-
butyl phenol (1.5 equiv.). Yellow solid (1.9 g, 71%), m.p. 142-
144°C; max/cm1 (NaCl): 1726 (ester C=O stretch), 1625 (alkene 
C=C stretch), 1489 (aromatic C=C stretch), 1385 (ester C-O 
stretch), 1226 (ether C-O stretch), 1174 (ether C-O stretch); H 
(CDCl3, 300 MHz) 1.36 (9H, s, C(18)H3, C(19)H3 & C(20)H3), 5.44 (1H, s, C(3)H), 7.06-7.12 (2H, 
m, C(12)H & C(16)H), 7.31-7.39 (2H, m, C(13)H & C(15)H), 7.45-7.48 (1H, m, C(7)H), 7.49-7.51 
(1H, m, C(9)H), 7.58-7.65 (1H, m, C(8)H), 8.03 (1H, ddapp, J 7.84, 1.59, C(6)H); C (CDCl3, 75.5 
MHz) 31.4 (C(18)H3, C(19)H3 & C(20)H3), 34.7 (qC-17), 93.5 (C(3)H), 115.5 (qC-5), 116.8 (C(9)H), 
120.7 (C(12)H & C(16)H), 123.1 (C(6)H), 124.1 (C(7)H), 127.3 (C(13)H & C(15)H), 132.7 (C(8)H), 
149.9 (qC-14), 150.0 (qC-11), 153.7 (qC-10), 162.8 (qC-2), 166.60 (qC-4); m/z (ES+): 295, 
[(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C19H19O3 [M+H+], 295.1130. Found 
295.1334. Anal. Calculated for C19H18O3: C, 77.53; H, 6.16. Found: C, 77.31; H, 6.25.  
Spectral characteristics were consistent with previously reported data.3 
4-(3-Methylphenoxy)-2H-chromene-2-one (62)3-4 
Synthesised according to the general procedure 6.2.4 using 4-bromo-
2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 3-methyl phenol 
(1.5 equiv.). Pale brown solid (620 mg, 28%), m.p. 119-120 °C (lit. 118-
120 °C); H (CDCl3, 300 MHz) 2.41 (3H, s, C(17)H3), 5.43 (1H, s, C(3)H), 
6.97 (2H, d, J 7.8, C(12)H & C(16)H), 7.15 (1H, d, J 7.5, C(14)H), 7.36 
(3H, t,  J 8.3, C(7)H, C(9)H & C(15)H), 7.62 (1H, t, J 7.8, C(8)H), 8.02 (1H, 
d, J 7.6, C(6)H); C (CDCl3, 75.5 MHz) 21.3 (C(17)H3), 93.5 (C(3)H), 115.6 (qC-5), 116.9 (C(9)H), 
118.1 (C(16)H), 121.8 (C(12)H), 123.1 (C(6)H), 124.1 (C(7)H), 127.5 (C(14)H), 130.1 (C(15)H), 
132.8 (C(8)H), 140.9 (qC-13), 152.4 (qC-11), 153.7 (qC-10), 162.7 (qC-2), 166.4 (qC-4); m/z 
(ES+): 253, [(M+H)+, 70%]; HRMS (ESI-TOF): Exact mass calculated for C16H13O3 [M+H+], 
253.0865. Found 253.0867.  
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Spectral characteristics were consistent with previously reported data.3-4 
4-(3-Methoxyphenoxy)-2H-chromene-2-one (63)3  
Synthesised according to the general procedure 6.2.4 using 4-bromo-
2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 3-methoxy phenol 
(1.5 equiv.). Pale brown solid (1.8 g, 75%), m.p. 114-115 °C; max/cm1 
(NaCl): 1722 (ester C=O stretch), 1625 (alkene C=C stretch), 1607 
(aromatic C=C stretch), 1486 aromatic C=C stretch), 1384 (ester C-O 
stretch), 1223 (ether C-O stretch), 1180 (ether C-O stretch), 1143 
(ether C-O stretch); H (CDCl3, 300 MHz) 3.83 (3H, s, C(17)H3), 5.48 
(1H, s, C(3)H), 6.72 (1H, t, J 2.3, C(12)H), 6.77 (1H, ddd, J 8.0, 2.2, 0.8, C(16)H), 6.88 (1H, ddd, 
J 8.4, 2.4, 0.8, C(14)H), 7.31-7.42 (3H, m, C(7)H, C(9)H & C(15)H), 7.62 (1H, ddd, J 8.6, 7.2, 1.6, 
C(8)H), 8.02 (1H, dd, J 7.9, 1.4, C(6)H); C (CDCl3, 75.5 MHz) 55.6 (C(17)H3), 93.6 (C(3)H), 107.3 
(C(12)H), 112.5 (C(14)H), 113.2 (C(16)H), 115.4 (qC-5), 116.9 (C(9)H), 123.1 (C(6)H), 124.1 
(C(7)H), 130.9 (C(15)H), 132.8 (C(8)H), 153.4 (qC-11), 153.7 (qC-13), 161.3 (qC-10), 162.6 (qC-
2), 166.3 (qC-4); m/z (ES+): 269, [(M+H)+, 43%]; Anal. Calculated for C16H12O4: C, 71.64; H, 
4.51. Found: C, 71.85; H, 4.63.  
Spectral characteristics were consistent with previously reported data.3 
4-(3-Fluorophenoxy)-2H-chromene-2-one (64)3 
Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (600 mg, 2.67 mmol, 1.0 equiv.) and 3-fluoro 
phenol (1.5 equiv.). Pale brown solid (562 mg, 82%), m.p. 123-125 °C; 
max/cm1 (NaCl): 1719 (ester C=O stretch), 1626 (alkene C=C 
stretch), 1603, (aromatic C=C stretch), 1482 (aromatic C=C stretch), 
1384 (ester C-O stretch), 1222 (ether C-O stretch), 1140 (ether C-O 
stretch), 1122 (C-F stretch); H (CDCl3, 300 MHz) 5.46 (1H, s, C(3)H), 6.88-7.15 (3H, m, C(12)H, 
C(14)H & C(16)H), 7.32-7.53 (3H, m, C(7)H, C(9)H & C(15)H), 7.63 (1H, ddd, J 8.6, 7.3, 1.6, 
C(8)H), 8.00 (1H, dd, J 7.9, 1.5, C(6)H); C (CDCl3, 75.5 MHz) 93.9 (C(3)H), 109.5 (C(12)H, d, JC-F 
24), 114.0 (C(14)H, d, JC-F 21), 115.2 (qC-5), 116.9 (C(9)H), 117.1 (C(16)H, d, JC-F 4), 123.0 
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(C(6)H), 124.2 (C(7)H), 131.4 (C(15)H, d, JC-F 10), 133.0 (C(8)H), 153.3 (qC-11, d, JC-F 10 ), 153.7 
(qC-10), 162.3 (qC-2), 163.4 (qC-13, d, JC-F 250), 165.9 (qC-4); m/z (ES+): 257, [(M+H)+, 100%]; 
HRMS (ESI-TOF): Exact mass calculated for C15H10O3F [M+H+], 257.0614. Found 257.0611.  
Spectral characteristics were consistent with previously reported data.3 
4-(2-Methylphenoxy)-2H-chromene-2-one (65)3 
Synthesised according to the general procedure 6.2.4 using 4-bromo-
2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 2-methyl phenol 
(1.5 equiv.). Off-white solid (1.2 g, 55%), m.p. 125-126 °C; max/cm1 
(NaCl): 1727 (ester C=O stretch), 1625 (alkene C=C stretch), 1608 
(aromatic C=C stretch), 1487 (CH3 bend), 1385 (ester C-O stretch), 
1228 (ether C-O stretch), 1172 (ether C-O stretch); H (CDCl3, 300 
MHz) 2.20 (3H, s, C(17)H3), 5.31 (1H, s, C(3)H), 7.09 (1H, dd, J 7.6, 1.6, C(16)H), 7.21.-7.42 (5H, 
m, C(7)H, C(9)H, C(13)H, C(14)H & C(15)H), 7.63 (1H, ddd, J 8.6, 7.2, 1.6, C(8)H), 8.07 (1H, dd, 
J 7.9, 1.4, C(6)H); C (CDCl3, 75.5 MHz) 15.7 (C(17)H3), 93.0 (C(3)H), 115.3 (qC-5), 116.9 (C(9)H), 
121.4 (C(16)H), 123.1 (C(6)H), 123.9 (qC-12), 124.2 (C(7)H), 127.0 (C(13)H), 127.9 (C(14)H), 
132.1 (C(15)H), 132.8 (C(8)H), 150.6 (qC-11), 153.7 (qC-10), 162.7 (qC-2), 165.6 (qC-4); m/z 
(ES+): 253, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated for C16H13O3 [M+H+], 
253.0865. Found 253.0870.  
Spectral characteristics were consistent with previously reported data.3  
4-(3,5-Dimethoxyphenoxy)-2H-chromene-2-one (66)3-4 
Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 3,5-
dimethoxy phenol (1.5 equiv.). Yellow solid (370 mg, 14%), m.p. 
108-110 °C (lit. 109-113 °C); H (CDCl3, 300 MHz) 3.80 (6H, s, 
C(17)H3 & C(18)H3), 5.54 (1H, s, C(3)H), 6.33 (2H, d, J 2.2, C(12)H & 
C(16)H), 6.42 (1H, t, J 2.2, C(14)H), 7.30-7.40 (2H, m, C(7)H & 
C(9)H), 7.61 (1H, ddd, J 8.6, 7.3, 1.6, C(8)H), 8.00 (1H, dd, J 7.9, 1.5, C(6)H); C (CDCl3, 75.5 
MHz) 55.6 (C(17)H3 & C(18)H3), 93.7 (C(3)H), 98.9 (C(14)H), 99.7 (C(12)H & C(16)H), 115.4 (qC-
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5), 116.9 (C(9)H), 123.0 (C(6)H), 124.1 (C(7)H), 132.8 (C(8)H), 153.7 (qC-11), 154.0 (qC-10), 
162.0 (qC-13 & qC-15), 162.6 (qC-2), 166.1 (qC-4); m/z (ES+): 299, [(M+H)+, 80%]; Anal. 
Calculated for C17H14O5: C, 68.45; H, 4.73. Found: C, 68.14; H, 4.88.  
Spectral characteristics were consistent with previously reported data.3-4 
4-(3,4-Dimethoxyphenoxy)-2H-chromene-2-one (67)3 
Synthesised according to the general procedure 6.2.4 using 4-
bromo-2-coumarin (54) (2.0 g, 8.88 mmol, 1.0 equiv.) and 3,4-
dimethoxy phenol (1.5 equiv.). Pale brown solid (2.4 g, 92%), m.p. 
153-155 °C; max/cm1 (NaCl): 1721 (ester C=O stretch), 1625 
(alkene C=C stretch), 1607 (aromatic C=C stretch), 1490 (aromatic 
C=C stretch), 1386 (ester C-O stretch), 1222 (ether C-O stretch), 
1178 (ether C-O stretch); H (CDCl3, 300 MHz) 3.88 (3H, s, C(17)H3), 3.92 (3H, s, C(18)H3), 5.46 
(1H, s, C(3)H), 6.69-6.77 (2H, m, C(12)H & C(16)H), 6.93 (1H, d, J 8.5, C(15)H), 7.32-7.40 (2H, 
m, C(7)H & C(9)H), 7.62 (1H, ddd, J 8.6, 7.3, 1.6, C(8)H), 8.02 (1H, dd, J 7.9, 1.5, C(6)H); C 
(CDCl3, 75.5 MHz) 56.1 (C(17)H3), 56.3 (C(18)H3) 93.3 (C(3)H), 105.1 (C(12)H), 111.7 (C(16)H), 
112.6 (C(15)H), 115.4 (qC-5), 116.8 (C(9)H), 123.0 (C(6)H), 124.1 (C(7)H), 132.8 (C(8)H), 145.9 
(qC-14), 147.6 (qC-13), 150.2 (qC-11), 153.6 (qC-10), 162.7 (qC-2), 166.8 (qC-4); m/z (ES+): 
299, [(M+H)+, 20%]; Anal. Calculated for C17H14O5: C, 68.45; H, 4.73. Found: C, 68.15; H, 4.79.  
Spectral characteristics were consistent with previously reported data.3 
6.2.5 Synthesis of quinolone starting materials 
N-Methyl-4-hydroxy-2(1H)-quinolone (93)5-6 
A mixture of N-methylanthranilic acid (92) (5.5 g, 36.4 mmol), acetic 
anhydride (16.5 mL, 174.7 mmol) and acetic acid (16.3 mL) was stirred at 
reflux under N2 for 4 hours. The reaction mixture was allowed to cool to 
room temperature and poured onto ice. A 6M aqueous sodium hydroxide 
solution was added until ca. pH 10 was achieved. The mixture was then 
stirred at room temperature for 30 minutes after which concentrated aqueous HCl was slowly 
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added until ca. pH 5 was achieved. The mixture was allowed to cool to room temperature and 
the formed precipitate was isolated by suction filtration. Trituration from hot ethyl acetate 
afforded the product (93) as a tan solid (2.66 g, 42%), m.p. >230 °C (lit. 252-262 °C); H (DMSO-
d6, 300 MHz) 3.52 (3H, s, NC(12)H3), 5.85 (1H, s, C(3)H), 7.21 (1H, t, J 7.4, C(7)H), 7.43 (1H, d J 
8.4, C(9)H), 7.54-7.65 (1H, m, C(8)H), 7.93 (1H, dd J 7.9, 1.1, C(6)H); C (DMSO-d6, 75.5 MHz) 
29.0 (NC(12)H3), 98.0 (C(3)H), 114.8 (C(9)H), 117.5 (qC-5), 121.4 (C(6)H), 123.8 (C(7)H), 131.5 
(C(8)H), 140.5 (qC-10), 162.9 (qC-4), 163.4 (qC-2); m/z (ES-): 174, [(M-H)-, 100%]. 
 Spectral characteristics were consistent with previously reported data.5-6 
3-Iodo-4-phenoxy-N-methylquinolinone (99)7 
A solution of Na2CO3 (0.55 g, 0.9 equiv.) in EtOH (11.4 mL, 2 mL/mmol) 
was prepared in a 250 mL round bottomed flask. 
Diacetoxyiodobenzene (PIDA) (1.84 g, 5.71 mmol, 1.0 equiv.) was 
added and the resulting mixture was stirred at room temperature for 
30 minutes. The PIDA was added to a solution containing N-methyl-4-
hydroxy-2(1H)-quinolone (93) (1.0 g, 5.71 mmol. 1.0 equiv.), Na2CO3 
(0.55 g, 0.9 equiv.) and EtOH (11.4 mL, 2 mL/mmol). After stirring at room temperature for 30 
minutes, the precipitate was filtered off, washed with water and then triturated with MeOH. 
The solid was then suspended in anhydrous DMF (11 mL) in a 100 mL three-necked flask. A 
condenser was fitted to the flask and the flask was placed in a sand bath heated to 165 ºC. 
After stirring at this temperature for 2 hours, the reaction mixture was quenched with water 
(20 mL) and the solid precipitate was filtered by suction filtration and recrystallised from 
MeOH to give the product 99 as an off-white solid (1.8 g, 84%), m.p. 198-201 °C (lit. 198-199 
°C); H (DMSO-d6, 300 MHz) 3.77 (3H, s, NC(11)H3), 6.96 (2H, d, J 8.0, C(13)H & C(17)H), 7.09 
(1H, t, J 7.0, C(15)H), 7.22 (1H, t, J 7.0, C(7)H), 7.35 (2H, t, J 8.0, C(14)H & C(16)H), 7.56 (1H, d, 
J 7.4, C(9)H), 7.64-7.76 (2H, m, C(6)H & C(8)H); C (DMSO-d6, 75.5 MHz) 31.7 (NC(12)H3), 91.7 
(qC-3), 115.7 (C(13)H & C(17)H), 116.0 (C(9)H), 116.6 (qC-5), 122.9 (C(6)H), 123.3 (C(7)H), 
123.8 (C(15)H), 130.6 (C(14)H & C(16)H), 132.5 (C(8)H), 140.3 (qC-10), 156.4 (qC-12), 160.4 
(qC-4), 162.7 (qC-2); m/z (ES+): 377, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.7 
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1-Methyl-4-phenoxy-2(1H)-quinolinone (100)7  
To a heated solution of 3-iodo-4-phenoxy-N-methylquinolinone (99) 
(200 mg, 0.53 mmol, 1.0 equiv.) in EtOH (4.44 mL) and acetic acid (4.40 
mL) in a 50 mL two-necked flask was added zinc dust (1.046 g, 30 equiv.) 
portion wise over 1 hour until the solution turned a clear colour. A 
condenser was then fitted to the flask. After boiling the solution for 1 
hour, the solution was filtered by gravity filtration to remove the zinc 
metal and the product was precipitated with water (10 mL). The solid precipitate was filtered 
by suction filtration and recrystallised from MeOH to afford 100 as white crystals (103 mg, 
78%), m.p. 110-113 °C (lit. 113-115 °C); H (DMSO-d6, 300 MHz) 3.58 (3H, s, NC(11)H3), 5.46 
(1H, s, C(3)H), 7.26-7.41 (4H, m, C(7)H, C(13)H, C(15)H, C(17)H), 7.51-7.62 (3H, m, C(9)H, 
C(14)H & C(16)H), 7.75 (1H, ddd, J 8.6, 7.9, 1.6, C(8)H), 8.09 (1H, dd J 8.1, 1.6, C(6)H); C 
(DMSO-d6, 75.5 MHz) 29.3 (NC(12)H3), 100.4 (C(3)H), 115.4 (C(9)H), 115.6 (qC-5), 121.7 ( 
C(13)H & C(17)H), 122.4 (C(6)H), 123.2 (C(7)H), 126.6 (C(15)H), 130.9 (C(14)H & C(16)H), 132.5 
(C(8)H), 140.3 (qC-10), 153.5 (qC-12), 162.3 (qC-4), 162.4 (qC-2); m/z (ES+): 252, [(M+H)+, 
100%]. 
Spectral characteristics were consistent with previously reported data.7 
6.2.6 Preparation of 4-bromo-7-methoxy-2-coumarin (88)2-3  
To a 2-necked round bottomed flask was added 4-hydroxy-7-methoxy-
2-coumarin (87) (3.0 g, 15.6 mmol, 1.0 equiv.), TBAB (7.5 g, 23.4 mmol, 
1.16 equiv.) and P2O5 (5.32 g. 37.5 mmol, 2.4 equiv.) in toluene (4.0 
mL/mmol). The resulting mixture was stirred in an oil bath at 94 °C for 1.5 hours. Upon 
cooling, the reaction mixture was washed with toluene (2 x 30 mL). The combined organic 
extracts were then washed with saturated aqueous NaHCO3 (2 x 20 mL) and H2O (2 x 20 mL). 
The organic layer was then dried over MgSO4, filtered and concentrated under reduced 
pressure. The product 4-bromo-7-methoxy-2-coumarin was isolated as a brown solid (703 mg, 
54%), m.p. 114-117 °C; H (CDCl3, 300 MHz) 3.90 (3H, s, C(11)H), 6.67 (1H, s, C(3)H), 6.79 (1H, 
d, J 2.5, C(9)H), 6.90 (1H, dd, J 8.9, 2.5, C(7)H), 7.71 (1H, d, J 8.9, C(6)H); C (CDCl3, 75.5 MHz) 
56.0 (C(11)H3), 100.6 (C(9)H), 112.6 (qC-5), 113.1 (C(7)H), 116.0 (C(3)H), 129.1 (C(6)H), 141.5 
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(qC-4), 154.3 (qC-10), 159.2 (qC-8), 163.8 (qC-2); m/z (ES+): 255, Br79 [(M+H)+, 20%], 257, Br81 
[(M+H)+, 38%].  
Spectral characteristics were consistent with previously reported data.2-3 
6.2.7 Preparation of 4-(benzo[d][1,3]dioxol-5-yloxy)-7-methoxy-2H-chromen-2-one (89)2-3 
To a 3-necked round bottomed flask was added 4-bromo-7-
methoxy-2-coumarin (88) (3.0 g, 11.76 mmol, 1.0 equiv.), 
sesamol (1.5 equiv.) and K2CO3 (1.8 equiv.) in acetone (4.0 
mL/mmol). A condenser was fitted to the flask and the 
mixture was stirred in an oil bath at 65 °C for 16 hours. Upon 
cooling, the reaction was diluted with water (10 mL) and EtOAc (20 mL). The mixture was 
extracted with EtOAc (2 x 20 mL) and the combined organic layers were washed with aqueous 
NaOH (10% w/v, 2 x 20 mL). The organic layer was then dried over MgSO4, filtered and 
concentrated under reduced pressure. The residues were purified by recrystallisation from 
EtOH. The product was isolated as a pale yellow solid (528 mg, 84%), m.p. 174-177 °C; H 
(CDCl3, 300 MHz) 3.90 (3H, s, C(11)H3), 5.33 (1H, s, C(3)H), 6.02 (2H, s, C(16)H2), 6.64 (2H, dd, 
J 9.0, 5.2, C(13)H & C(18)H), 6.74-7.06 (3H, m, C(7)H, C(9)H & C(14)H), 7.87 (1H, d, J 9.0, C(6)H); 
C (CDCl3, 75.5 MHz) 55.8 (C(11)H3), 90.9 (C(3)H), 100.6 (C(9)H), 102.1 (C(16)H2), 103.3 
(C(18)H), 108.6 (C(13)H, qCoverlapping qC-5), 112.4 (C(7)H), 113.8 (C(14)H), 124.1 (C(6)H), 146.0 
(qC-15), 146.7 (qC-17), 148.7 (qC-12), 155.5 (qC-10), 163.1 (qC-8), 163.6 (qC-2), 167.0 (qC-4); 
m/z (ES+): 312, [(M+H)+, 79%].  







Chapter 6  Experimental 
250 
 
6.2.8 Preparation of mono-substituted diarylethers (102-113)8 
1-Methyl-3-(phenoxy) benzene (102)8  
To a sealable tube equipped with a stir bar was charged phenol (150 
mg, 1.594 mmol, 1 equiv.), Cs2CO3 (1.038 g, 3.188 mmol, 2 equiv.) and 
anhydrous FeCl3 (26 mg, 0.159 mmol, 10 mol%). The aperture of the 
tube was then replaced with a rubber septum and a nitrogen atmosphere was then 
established. 3-iodo toluene (118) (0.30 mL, 2.391 mmol, 1.5 equiv.), 2,2,6,6-tetramethyl-3,5-
heptadione (TMHD, 59 mg, 0.3188 mmol, 0.2 equiv.) and DMF (1 mL/mmol) were added by 
syringe. The reagents were added to three separate reaction vials. The rubber septum was 
replaced by a screw cap and the reaction vessel was placed in a multi reaction mantle at 135 
ᵒC. The reaction mixture was stirred at this temperature for 20 hours, after which the 
heterogeneous mixture was cooled to room temperature. The crude material from each vial 
was combined and filtered through a pad of Celite with DCM (80 mL). The filtrate was then 
washed with HCl (1 M, 1 x 20 mL), water (3 × 20 mL) and brine (1 × 20 mL). The organic layer 
was dried over MgSO4, filtered and concentrated under reduced pressure. The crude product 
was purified by column chromatography (hexanes, 100%) to yield 1-methyl-3-(phenoxy) 
benzene (102). Yellow oil (457 mg, 52%); max/cm1 (NaCl): 2921 (aromatic C-H stretch), 1584 
(aromatic C=C stretch), 1486 (aromatic C=C stretch), 1459 (-CH3 bend), 1256 (ether C-O 
stretch), 1215 (ether C-O stretch), 936 (aromatic C-H bend), 690 (aromatic C-H bend); H 
(CDCl3, 300 MHz) 2.36 (3H,s, C(7)H3), 6.79-6.88 (2H, m, C(2)H & C(6)H), 6.93 (1H, d, J 7.6, 
C(4)H), 6.99-7.06 (2H, m, C(9)H & C(13)H), 7.06-7.15 (1H, m, C(5)H), 7.22 (1H, t, J 7.7, C(11)H), 
7.29-7.39 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 21.4 (C(7)H3), 115.9 (C(6)H), 118.9 
(C(9)H & C(13)H), 119.6 (C(2)H), 123.1 (C(11)H), 124.0 (C(4)H), 129.4 (C(5)H), 129.7 (C(10)H & 
C(12)H), 139.9 (qC-3), 157.2 (qC-1), 157.4 (qC-8). Did not ionise in HRMS (ESI-TOF). 
Spectral characteristics were consistent with previously reported data.8  
1-Fluoro-3-(phenoxy) benzene (103) 
Compound 103 was prepared via the procedure described for 102 using 3-fluoro phenol (0.12 
mL, 1.34 mmol, 1 equiv.) and iodobenzene (127) (0.22 mL, 2.01 mmol, 1.5 equiv.). The 
reagents were added to three separate reaction vials. After 20 hours, the crude material from 
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each vial was combined. The crude product was purified by column 
chromatography (hexanes, 100%; hexanes:Et2O, 90:10) to yield 103 as 
a colourless oil (615 mg, 57%); max/cm1 (NaCl): 3073 (aromatic C-H 
stretch), 1594 (aromatic C=C stretch), 1483 (aromatic C=C stretch), 1271 (ether C-O stretch), 
1212 (ether C-O stretch), 1071 (C-F stretch), 855 (aromatic C-H bend), 691 (aromatic C-H 
bend); H (CDCl3, 300 MHz) 6.69 (1H, dt, J 2.3, 10.4, C(4)H), 6.74-6.83 (2H, m, C(2)H & C(6)H), 
6.99-7.07 (2H, m, C(8)H & C(12)H), 7.07-7.18 (1H, m, C(10)H), 7.19-7.30 (1H, m, C(5)H), 7.30-
7.41 (2H, m, C(9)H & C(11)H); C (CDCl3, 75.5 MHz) 106.0 (C(2)H, d, JC-F 25), 110 (C(4)H, d, JC-F 
22), 114.0 (C(6)H, d, JC-F 7), 119.0 (C(8)H or C(12)H), 120.0 (C(8)H or C(12)H), 123.2 (C(9)H or 
C(11)H), 124.0 (C(9)H or C(11)H), 130.0 (C(10)H), 131.0 (C(5)H, d, JC-F 10), 156.3 (qC-7), 159.0 
(qC-1, d, JC-F 11), 164.0 (qC-3, d, JC-F 247); δF (282 MHz, CDCl3) -111.2. HRMS (ESI-TOF): Exact 
mass calculated for C12H8OF [M-H-], 187.0559. Found 187.0556.  
1-Methoxy-3-(phenoxy) benzene (104)8  
Compound 104 was prepared via the procedure described for 102 
using 3-methoxy phenol (0.09 mL, 0.81 mmol, 1 equiv.) and 
iodobenzene (127) (0.135 mL, 1.21 mmol, 1.5 equiv.). The reagents 
were added to three separate reaction vials. After 20 hours, the crude 
material from each vial was combined. The crude product was purified by column 
chromatography (hexanes) to yield 104 as a colourless oil (379 mg, 78%); max/cm1 (NaCl): 
1585 (aromatic C=C stretch), 1486 (aromatic C=C stretch), 1450 (-CH3 bend), 1281 (ether C-O 
stretch), 1217 (ether C-O stretch), 1042 (ether C-O stretch), 951 (aromatic C-H bend), 849 
(aromatic C-H bend), 688 (aromatic C-H bend); H (CDCl3, 300 MHz) 3.81 (3H, s, C(7)H), 6.55-
6.61 (2H, m, C(2)H & C(6)H), 6.65 (1H, ddd, J 8.4, 2.3, 0.8, C(4)H), 6.98-7.06 (2H, m, C(9)H & 
C(13)H), 7.06-7.14 (1H, m, C(11)H), 7.17-7.26 (1H, m, C(5)H), 7.28-7.38 (2H, m, C(10)H & 
C(12)H); C (CDCl3, 75.5 MHz) 55.4 (C(7)H3), 104.9 (C(2)H), 108.9 (C(4)H), 110.9 (C(6)H), 119.1 
(C(9)H & C(13)H), 123.4 (C(11)H), 129.7 (C(10)H & C(12)H), 130.1 (C(5)H), 157.0 (qC-3), 158.5 
(qC-1), 161.0 (qC-8); m/z (ES+): 201, [(M+H)+, 70%].  
Spectral characteristics were consistent with previously reported data.8 
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1-Tert-butyl-3-(phenoxy) benzene (105) 
Compound 105 was prepared via the procedure described for 102 
using 3-tert-butyl phenol (150 mg, 0.999 mmol, 1 equiv.) and 
iodobenzene (0.17 mL, 1.499 mmol, 1.5 equiv.). The reagents 
were added to three separate reaction vials. After 20 hours, the 
crude material from each vial was combined. The crude product was purified by column 
chromatography (hexanes, 100%). Colourless oil (297 mg, 44%); max/cm1 (NaCl): 3067 
(aromatic C-H stretch), 2964 (alkane C-H stretch), 1580 (aromatic C=C stretch), 1489 (aromatic 
C=C stretch), 1428 (-CH3 bend), 1364 (-CH3 bend), 1270 (ether C-O stretch), 1166 (ether C-O 
stretch), 928 (aromatic C-H bend), 698 (aromatic C-H bend); H (CDCl3, 300 MHz) 1.30 (9H, s, 
C(8)H, C(9)H & C(10)H), 6.78 (1H, ddd, J 7.9, 2.4, 1.0, C(6)H), 6.96-7.03 (2H, m, C(12)H & 
C(16)H), 7.03-7.16 (3H, m, C(2)H, C(4)H & C(14)H), 7.20-7.28 (1H, m, C(5)H), 7.28-7.37 (2H, m, 
C(13)H & C(15)H); C (CDCl3, 75.5 MHz) 31.9 (C(8)H3, C(9)H3 & C(10)H3), 34.8 (qC-7), 115.8 
(C(2)H), 116.6 (C(6)H), 118.6 (C(12)H & C(16)H), 120.4 (C(4)H), 122.9 (C(14)H), 129.2 (C(5)H), 
129.5 (C(13)H & C(15)H), 153.5 (qC-3), 156.9 (qC-1), 157.6 (qC-11); m/z (ES+): 201, [(M+H)+, 
70%]. 
1-Ethyl-3-(phenoxy) benzene (106) 
Compound 106 was prepared via the procedure described for 102 
using 3-ethyl phenol (0.15 mL, 1.23 mmol, 1 equiv.) and iodobenzene 
(127) (0.21 mL, 1.845 mmol, 1.5 equiv.). The reagents were added to 
three separate reaction vials. After 20 hours, the crude material from 
each vial was combined. The crude product was purified by column chromatography 
(hexanes, 100%) to yield 106 as a colourless oil (571 mg, 78%); max/cm1 (NaCl): 2966 
(aromatic C-H stretch), 2932 (alkane C-H stretch), 1582 (aromatic C=C stretch), 1487 (-CH2 
bend), 1445 (-CH3 bend), 1252 (ether C-O stretch), 1214 (ether C-O stretch), 919 (aromatic C-
H bend), 691 (aromatic C-H bend); H (CDCl3, 300 MHz) 1.26 (3H, t, J 7.6, C(8)H3), 2.67 (2H, q, 
J 7.8, C(7)H2), 6.81-6.89 (1H, m, C(6)H), 6.89-6.94 (1H, m, C(2)H), 6.98 (1H, d, J 7.8, C(4)H), 
7.01-7.08 (2H, m, C(10)H & C(14)H), 7.08-7.17 (1H, m, C(12)H), 7.27 (1H, t, J 7.2, C(5)H), 7.31-
7.40 (2H, m, C(11)H & C(13)H); C (CDCl3, 75.5 MHz) 15.4 (C(8)H3), 28.8 (C(7)H2), 116.1 (C(2)H), 
118.5 (C(6)H), 118.8 (C(10)H & C(14)H), 122.9 (C(4)H), 123.1 (C(12)H), 129.5 (C(5)H), 129.7 
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(C(11)H & C(13)H), 146.4 (qC-3), 157.3 (qC-9), 157.5 (qC-1); HRMS (ESI-TOF): Exact mass 
calculated for C14H15O [M+H+], 199.1123. Found 199.1123.  
1-Chloro-3-(phenoxy) benzene (107) 
Compound 107 was prepared via the procedure described for 102 
using phenol (150 mg, 1.594 mmol, 1 equiv.) and 3-chloro 
iodobenzene (127) (0.3 mL, 2.391 mmol, 1.5 equiv.). The crude 
product was purified by column chromatography (hexanes, 100%; hexanes:Et2O, 94:6) to yield 
107 as a colourless oil (165 mg, 51%); max/cm1 (NaCl): 1583 (aromatic C=C stretch), 1489 
(aromatic C=C stretch, 1470 (aromatic C=C stretch), 1231 (ether C-O stretch), 1159 (ether C-
O stretch), 756 (C-Cl stretch), 695 (C-Cl stretch); H (CDCl3, 300 MHz) 6.90 (1H, ddd, J 8.2, 2.3, 
0.9, C(6)H), 6.97-7.12 (4H, m, C(2)H, C(4)H, C(8)H & C(12)H), 7.12-7.21 (1H, m, C(10)H), 7.22-
7.30 (1H, m, C(5)H), 7.33-7.43 (2H, m, C(9)H & C(11)H); C (CDCl3, 75.5 MHz) 116.7 (C(6)H), 
118.8 (C(2)H), 119.4 (C(8)H & C(12)H), 123.2 (C(4)H), 124.0 (C(10)H), 130.0 (C(9)H & C(11)H), 
130.5 (C(5)H), 135.0 (qC-3), 156.3 (qC-7), 158.3 (qC-1); HRMS (ESI-TOF): Exact mass calculated 
for C12H10OCl [M+H+], 204.0264. Found 204.0257.  
2-Phenoxy naphthalene (108)8  
Compound 108 was prepared via the procedure described for 102 
using 2-naphthol (150 mg, 1.040 mmol, 1 equiv.) and iodobenzene 
(127) (0.17 mL, 1.56 mmol, 1.5 equiv.). The reagents were added 
to four separate reaction vials. After 20 hours, the crude material from each vial was 
combined. The crude product was purified by column chromatography (hexanes, 100%) to 
yield 108 as a colourless solid (653 mg, 71%); m.p. 47-49 ᵒC; max/cm1 (NaCl); 3056 (aromatic 
C-H stretch), 1588 (aromatic C=C stretch), 1509 (aromatic C=C stretch), 1488 (aromatic C=C 
stretch), 1463 (aromatic C=C stretch), 1249 (ether C-O stretch), 1165 (ether C-O stretch), 
(aromatic C-H bend), 690 (aromatic C-H bend); H (CDCl3, 300 MHz) 7.00-7.18 (3H, m, C(2)H, 
C(6)H & C(4)H), 7.21-7.48 (6H, m, C(3)H, C(5)H, C(8)H, C(11)H, C(12)H & C(16)H), 7.68 (1H, d, 
J 8.2, C(10)H), 7.76-7.86 (2H, m, C(13)H & C(15)H); C (CDCl3, 75.5 MHz) 114.4 (C(8)H), 119.2 
(C(2)H & C(6)H), 120.0 (C(16)H), 123.5 (C(4)H), 124.8 (C(12)H), 126.6 (C(11)H), 127.2 (C(10)H 
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& C(13)H), 127.8 (C(15)H), 129.9 (C(3)H & C(5)H), 129.9 (qC-14), 134.4 (qC-9), 155.1 (qC-7), 
157.2 (qC-1); Anal. Calculated for C16H12O: C, 87.31; H, 5.49. Found: C, 87.52; H, 5.62. 
Spectral characteristics were consistent with previously reported data.8  
1-Trifluoromethyl-3-(phenoxy) benzene (109)9  
Compound 109 was prepared via the procedure described for 102 
using 3-trifluoromethyl phenol (0.11 mL, 0.925 mmol, 1 equiv.) and 
iodobenzene (127) (0.16 mL, 1.388 mmol, 1.5 equiv.). The crude 
product was purified by column chromatography (hexanes, 100%) to yield 109 as colourless 
oil (140 mg, 64%); max/cm1 (NaCl): 3072 (aromatic C-H stretch), 1587 (aromatic C=C stretch), 
1490 (aromatic C=C stretch), 1329 (C-F stretch), 1171 (ether C-O stretch), 1127 (ether C-O 
stretch), 791 (aromatic C-H bend), 693 (aromatic C-H bend); H (CDCl3, 300 MHz) 6.99-7.07 
(2H, m, C(9)H & C(13)H), 7.12-7.22 (2H, m, C(11)H), 7.22-7.27 (1H, m, C(5)H & C(6)H), 7.29-
7.48 (4H, m, C(2)H, C(4)H, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 115.3 (C(2)H, q, JC-F 4), 119.4 
(C(9)H & C(13)H), 119.6 (C(4)H, q, JC-F 4), 121.6 (C(11)H), 123.7 (qC-7, q, JC-F 272), 124.2 (C(6)H), 
130.1 (C(10)H & C(12)H), 130.3 (C(5)H), 132.2 (qC-3, q, JC-F 32), 156.1 (qC-8), 157.9 (qC-1); m/z 
(ES+): 238, [(M+H)+, 70%].  
Spectral characteristics were consistent with previously reported data.9  
1-Bromo-3-(phenoxy) benzene (110) 
Compound 110 was prepared via the procedure described for 102 
using 3-bromo phenol (0.092 mL, 0.867 mmol, 1 equiv.) and 
iodobenzene (127) (0.145 mL, 1.3005 mmol, 1.5 equiv.). The reagents 
were added to four separate reaction vials. After 20 hours, the crude material from each vial 
was combined. The crude product was purified by column chromatography (hexanes, 100%) 
to yield 110 as a colourless oil (437 mg, 51%); max/cm1 (NaCl): 3063 (aromatic C-H stretch), 
1579 (aromatic C=C stretch), 1488 (aromatic C=C stretch), 1227 (ether C-O stretch), 1159 
(ether C-O stretch), 665 (C-Br stretch); H (CDCl3, 300 MHz) 6.90-6.97 (1H, m, C(6)H), 6.99-
7.07 (2H, m, C(2)H & C(4)H), 7.11-7.25 (4H, m, C(5)H, C(8)H, C(10)H & C(12)H), 7.32-7.42 (2H, 
m, C(9)H & C(11)H); C (CDCl3, 75.5 MHz) 117.2 (C(6)H), 119.3 (C(8)H & C(12)H), 121.7 (C(2)H), 
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122.9 (qC-3), 124.0 (C(4)H), 126.1 (C(10)H), 129.3 (C(9)H & C(11)H), 130.8 (C(5)H), 156.4 (qC-
7), 158.4 (qC-1). Did not ionise in HRMS (ESI-TOF). 
1-Iodo-3-(phenoxy) benzene (111)10  
Compound 111 was prepared via the procedure described for 102 
using 3-iodo phenol (150 mg, 0.6817 mmol, 1 equiv.) and iodobenzene 
(127). (0.11 mL, 1.023 mmol, 1.5 equiv.) The reagents were added to 
three separate reaction vials. After 20 hours, the crude material from each vial was combined. 
The crude product was purified by column chromatography (hexanes) to yield 111 as a light 
pink oil (140 mg, 23%); max/cm1 (NaCl): 3030 (aromatic C-H stretch), 1575 (aromatic C=C 
stretch), 1464 (aromatic C=C stretch), 1232 (ether C-O stretch), 1160 (ether C-O stretch), 692 
(C-I stretch); H (CDCl3, 300 MHz) 6.92-7.07 (4H, m, C(2)H, C(6)H, C(8)H & C(12)H), 7.09-7.17 
(1H, m, C(4)H), 7.35-7.45 (4H, m, C(5)H, C(9)H, C(10)H & C(11)H); C (CDCl3, 75.5 MHz) 94.2 
(qC-3), 118.2 (C(6)H), 119.3 (C(8)H & C(12)H), 124.0 (C(2)H), 127.6 (C(10)H), 130.0 (C(9)H & 
C(11)H), 131.0 (C(4)H), 132.2 (C(5)H), 156.4 (qC-7), 158.1 (qC-1); HRMS (ESI-TOF): Exact mass 
calculated for C12H9 IO [M+H+], 296.9776. Found 296.9789.  
Spectral characteristics were consistent with previously reported data.10  
1,6-Dimethyl-3-(phenoxy) benzene (112) 
Compound 112 was prepared via the procedure described for 102 
using 3,4-dimethyl phenol (180 mg, 1.47 mmol, 1 equiv.) and 
iodobenzene (127) (0.25 mL, 2.21 mmol, 1.5 equiv.). The crude 
product was purified by column chromatography (hexanes, 100%) to yield 112 as a pale 
yellow oil (245 mg, 84%); max/cm1 (NaCl): 2969 (aromatic C-H stretch), 2860 (alkane C-H 
stretch), 1590 (aromatic C=C stretch), 1488 (aromatic C=C stretch) , 1454 (-CH3 bend), (ether 
C-O stretch), 1150 (ether C-O stretch), 949 (aromatic C-H bend), 691 (aromatic C-H bend); H 
(CDCl3, 300 MHz) 2.24 (6H, s, C(7)H3 & C(8)H3), 6.77 (1H, dd, J 8.2, 2.6, C(6)H), 6.84 (1H, d, J 
2.5, C(2)H), 6.95-7.02 (2H, m, C(10)H & C(14)H), 7.02-7.14 (2H, m, C(5)H & C(12)H), 7.27-7.37 
(2H, m, C(11)H & C(13)H); C (CDCl3, 75.5 MHz) 19.1 (C(8)H3), 20.0 (C(7)H3), 116.5 (C(6)H), 
118.4 (C(10)H & C(14)H), 119.5 (C(2)H), 122.7 (C(12)H), 129.7 (C(11)H & C(13)), 130.3 (C(5)H), 
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131.6 (qC-4), 138.2 (qC-3), 154.9 (qC-1), 157.9 (qC-9); HRMS (ESI-TOF): Exact mass calculated 
for C14H15O [M+H+], 199.1123. Found 199.1131.  
1-Methyl-3-(3-methylphenoxy) benzene (113)11  
Compound 113 was prepared via the procedure described for 102 
using 3-methyl phenol (0.15 m, 1.387 mmol, 1 equiv.) and 3-iodo 
toluene (118) (0.27 mL, 2.08 mmol, 1.5 equiv.). The reagents were 
added to three separate reaction vials. After 20 hours, the crude material from each vial was 
combined. The crude product was purified by column chromatography (hexanes, 100%) to 
yield 113 as a colourless oil (423 mg, 51%); max/cm1 (NaCl): 2919 (alkane C-H stretch), 1605 
(aromatic C=C stretch), 1577 (aromatic C=C stretch), 1485 (-CH3 bend), 1157 (ether C-O 
stretch), 1085 (ether C-O stretch), 688 (aromatic C-H bend); H (CDCl3, 300 MHz) 2.32 (6H, s, 
C(7)H3 & C(14)H3), 6.79-6.87 (4H, m, C(2)H, C(6)H, C(9)H & C(13)H), 6.90-6.96 (2H, m, C(4)H & 
C(11)H), 7.18-7.25 (2H, m, C(5)H & C(12)H); C (CDCl3, 75.5 MHz) 21.4 (C(7)H3 & C(14)H3), 
115.9 (2C(6)H & C(13)H, 119.6 (C(2)H & C(9)H), 123.9 (C(4)H & C(11)H), 129.4 (C(5)H & 
C(12)H), 139.9 (qC-3 & qC-10), 157.3 (qC-1 & qC-8); m/z (ES+): 199, [(M+H)+, 60%].  
Spectral characteristics were consistent with previously reported data.11 
6.2.9 Procedure for preparation of bis(3-methylphenyl)iodonium triflate (121)12 
Bis(3-methylphenyl)iodonium triflate (121) 
To a 250 mL equipped with a stir bar was added mCPBA (81% active 
oxidant, 958 mg, 5.55 mmol, 1.1 equiv.) and DCM (20 mL). To the 
solution was added 3-iodo toluene (118) (0.65 mL, 5.045 mmol, 1 
equiv.) followed by slow addition of BF3 · OEt2 (1.56 mL, 12.61 
mmol, 2.5 equiv.) at room temperature. The resulting yellow solution was stirred at room 
temperature for 30 minutes and then cooled to 0 °C. 3-Methyl phenylboronic acid (119) (754 
mg, 5.55 mmol, 1.1 equiv.) was added portion wise over 15 minutes. After 1 hour of stirring 
at room temperature, triflic acid (0.49 mL, 5.55 mmol, 1.1 equiv.) was added at 0 ºC and the 
mixture was stirred at room temperature for an additional 15 minutes. The crude reaction 
mixture was then applied on a silica plug (12 g) and eluted with DCM (120 mL) to remove 
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unreacted 3-iodo toluene and mCPBA, followed by DCM:MeOH (240 mL, 20:1), to elute the 
product, leaving any boric acid derivatives on the column. The latter solution was 
concentrated and diethyl ether was added to the residue to induce a precipitation of the salt, 
with any iodine(III) intermediates and BF3 derivatives remaining in solution. The solution was 
allowed to stir for 15 minutes and then the ether phase was decanted. The solid was washed 
twice more with diethyl ether and then dried in vacuo to give the pure bis(3-
methylphenyl)iodonium triflate salt (121). White solid (1.20 g, 52%); m.p. 157-160 ºC; H 
(DMSO-d6, 300 MHz) 2.35 (6H, s, C(7)H3 & C(14)H3), 7.42 (2H, t, J 7.7, C(4)H & C(11)H), 7.49 
(2H, d, J 7.7, C(5)H & C(12)H), 8.04 (2H, d, J 8.0, C(6)H & C(13)H), 8.10 (2H, bs, C(2)H & C(9)H); 
C (DMSO-d6, 75.5 MHz) 21.2 (C(7)H3 & C(14)H3), 116.6 (qC-1 & qC-8), 131.9 (C(4)H & C(11)H), 
132.7 (C(5)H & C(12)H), 133.2 (C(2)H & C(9)H), 135.7 (C(6)H & C(13)H), 142.3 (qC-3 & qC-10); 
F (DMSO-d6, 282 MHz) -77.7; m/z (ES+): 309 [(M-OTf)+, 100%]. HRMS (ESI-TOF): Exact mass 
calculated for C14H14I [M-OTf]+, 309.0135. Found 309.0136. 
6.2.10 Preparation of di-substituted diarylethers (122-126) via bis(3-
methylphenyl)iodonium triflate salt (121)9  
1-Methoxy-3-(3-methylphenoxy) benzene (122) 
To a suspension of potassium tert-butoxide (199 mg, 1.77 mmol, 
1.1 equiv.) in THF (20 mL) was added the 3-methoxy phenol 
(0.177 mL, 1.611 mmol, 1.0 equiv.) at 0 ᵒC. After stirring for 1 h, 
the iodonium triflate salt (121) (884 mg, 1.93 mmol, 1.2 equiv.) was added and the resulting 
mixture was stirred at 40 ᵒC overnight. The reaction mixture was quenched with water (15 
mL) and the organic layer was extracted with ethyl acetate (3 × 10 mL). The organic layer was 
then dried over MgSO4, filtered and concentrated under reduced pressure. The crude residue 
was purified by silica gel chromatography (hexanes, 100%) to yield the product 122 as a 
colourless oil (174 mg, 50%); max/cm1 (NaCl): 1584 (aromatic C=C stretch), 1486 (-CH3 bend), 
1252 (ether C-O stretch), 1193 (ether C-O stretch), 1132 (ether C-O stretch), 959 (aromatic C-
H stretch); H (CDCl3, 300 MHz) 2.34 (3H, s, C(14)H3), 3.78 (3H, s, C(7)H3), 6.55-6.62 (2H, m, 
C(2)H & C(6)H), 6.65 (1H, ddd J 8.3, 2.3, 0.9, C(4)H), 6.79-6.88 (2H, m, C(9)H & C(13)H), 6.89-
6.96 (1H, m, C(11)H), 7.17-7.28 (2H, m, C(5)H & C(12)H); C (CDCl3, 75.5 MHz) 21.4 (C(14)H3), 
55.4 (C(7)H3), 104.9 (C(2)H), 108.7 (C(4)H), 110.0 (C(6)H), 116.1 (C(13)H), 119.8 (C(9)H), 124.2 
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(C(11)H), 129.4 (C(12)H), 130.1 (C(5)H), 139.9 (qC-10), 156.9 (qC-8), 158.6 (qC-1), 161.0 (qC-
3); HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C14H15O2: 215.1067. Found 215.1065. 
1-Fluoro-3-(3-methylphenoxy) benzene (123)13 
Compound 123 was prepared via the procedure described for 122 
using 3-fluoro phenol (0.162 mL, 1.789 mmol, 1 equiv.) and 121. 
The crude product was purified by column chromatography 
(hexanes, 100%) followed by Kugelrohr distillation (160-180 ºC) to yield 123 as a colourless 
liquid (207 mg, 57%); max/cm1 (NaCl): 1596 (aromatic C=C stretch), 1586 (aromatic C=C 
stretch), 1448 (-CH3 bend), 1270 (ether C-O stretch), 1162 (ether C-O stretch), 1118 (C-F 
stretch), 964 (aromatic C-H bend); H (CDCl3, 300 MHz) 2.34 (3H, s, C(13)H3), 6.68 (1H, td, J 
10.3, 2.4, C(4)H), 6.73-6.80 (2H, m, C(2)H & C(6)H), 6.80-6.88 (2H, m, C(8)H & C(12)H), 6.92-
6.99 (1H, m, C(10)H), 7.19-7.30 (2H, m, C(5)H & C(11)H); C (CDCl3, 75.5 MHz) 21.4 (C(13)H3), 
106.0 (C(2)H, d, JC-F 24), 109.7 (C(4)H, d, JC-F 21), 113.9 (C(6)H, d, JC-F 3), 116.5 (C(12)H), 120.2 
(C(8)H), 124.8 (C(10)H), 129.6 (C(11)H), 130.4 (C(5)H, d, JC-F 10), 140.2 (qC-9), 156.2 (qC-7), 
159.1 (qC-1, d, JC-F 11), 161.5 (qC-3, d, JC-F 247); δF (282 MHz, CDCl3) -111.0; HRMS (ESI-TOF) 
m/z: [M]+ calcd. for C13H11FO: 202.0788, found 202.0783. 
Spectral characteristics were consistent with previously reported data.13 
1-Chloro-3-(3-methylphenoxy) benzene (124) 
Compound 124 was prepared via the procedure described for 122 
using 3-chloro phenol (0.16 mL, 1.56 mmol, 1 equiv.) and 121. The 
crude product was purified by column chromatography 
(cyclohexane, 100%; cyclohexane:EtOAc, 90:10) to yield 124 as a colourless oil (275 mg, 81%); 
max/cm1 (NaCl): 1605 (aromatic C=C stretch), 1485 (aromatic C=C stretch), 1446 (-CH3 bend), 
1258 (ether C-O stretch), 1157 (ether C-O stretch); H (CDCl3, 300 MHz) 2.34 (3H, s, C(13)H3), 
6.78-6.85 (2H, m, C(2)H & C(8)H), 6.87 (1H, ddd, J 8.4, 2.3, 0.9, C(12)H), 6.93-6.99 (2H, m, 
C(4)H & C(10)H), 7.05 (1H, ddd, J 8.0, 2.0, 1.0, C(6)H), 7.18-7.27 (2H, m, C(5)H & C(11)H); C 
(CDCl3, 75.5 MHz) 21.4 (C(13)H3), 116.4 (C(12)H), 116.7 (C(6)H), 118.7 (C(2)H), 120.1 (C(8)H), 
123.0 (C(4)H), 124.8 (C(10)H), 129.6 (C(11)H), 130.4 (C(5)H), 135.0 (qC-9), 140.2 (qC-3), 156.3 
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(qC-7), 158.5 (qC-1); HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C13H11ClO: 219.0571, found 
219.0572. 
1-Ethyl-3-(3-methylphenoxy) benzene (125) 
Compound 125 was prepared via the procedure described for 
122 using 3-ethyl phenol (0.079 mL, 0.647 mmol, 1 equiv.) and 
121. The crude product was purified by column chromatography 
(hexanes, 100%) followed by Kugelrohr distillation (160-180 ºC) to yield 125 as a pale yellow 
oil (71 mg, 51%); max/cm1 (NaCl): 3072 (aromatic C-H stretch), 2922 (alkane C-H stretch), 
1606 (aromatic C=C stretch), 1596 (aromatic C=C stretch), 1586 (aromatic C=C stretch), 1483 
(aromatic C=C stretch), 1448 (-CH3 bend), 1270 (ether C-O stretch), 1147 (ether C-O stretch), 
964 (aromatic C-H bend), 771 (C-Cl stretch); H (CDCl3, 300 MHz) 1.22 (3H, t, J 8.3, C(8)H3), 
2.33 (3H, s, C(15)H3), 2.63 (2H, q, J 7.5, C(7)H2), 6.76-6.88 (4H, m, C(2)H, C(6)H, C(10)H & 
C(14)H), 6.88-6.96 (2H, m, C(4)H & C(12)H), 7.21 (2H, qapp, J 7.8, C(5)H & C(13)H); C (CDCl3, 
75.5 MHz) 15.4 (C(8)H3), 21.4 (C(15)H3), 28.8 (C(7)H2), 115.8 (C(6)H), 116.1 (C(14)H), 118.5 
(C(2)H), 119.5 (C(10)H), 122.7 (C(4)H), 123.9 (C(12)H), 129.4 (C(5)H), 129.5 (C(13)H), 139.9 
(qC-11), 146.3 (qC-3), 157.3 (qC-1), 157.4 (qC-9); HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C15H17O: 212.2920, found, 212.2917. 
1-Tert-butyl-3-(3-methylphenoxy) benzene (126) 
Compound 126 was prepared via the procedure described for 
122 using 3-tert-butyl phenol (200 mg, 1.331 mmol, 1 equiv.) 
and 121. The crude product was purified by column 
chromatography (hexanes) to yield 126 as a yellow oil (201 mg, 63%); max/cm1 (NaCl): 2963 
(alkane C-H stretch), 1604 (aromatic C=C stretch), 1576 (aromatic C=C stretch), 1364 (-CH3 
bend), 1254 (ether C-O stretch), 1201 (ether C-O stretch), 779 (aromatic C-H stretch); H 
(CDCl3, 300 MHz) 1.31 (9H, s, C(8)H3, C(9)H3 & C(10)H3), 2.32 (3H, s, C(17)H3), 6.73-6.85 (3H, 
m, C(12)H, C(16)H & C(4)H), 6.85-6.93 (1H, m, C(14)H), 7.06-7.15 (2H, m, C(2)H & C(6)H), 7.20 
(1H, t, J 7.8, C(15)H), 7.25 (1H, t, J 7.9, C(5)H); C (CDCl3, 75.5 MHz) 21.4 (C(17)H3), 31.3 (C(8)H3, 
C(9)H3 & C(10)H3), 34.8 (qC-7), 115.7 (C(12)H & C(16)H), 116.6 (C(2)H or C(6)H), 119.3 (C(4)H), 
120.2 (C(2)H or C(6)H), 123.8 (C(14)H), 129.1 (C(5)H), 129.4 (C(15)H), 139.9 (qC-13), 153.5 (qC-
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3), 157.0 (qC-11), 157.5 (qC-1); HRMS (ESI-TOF) m/z: [M]+ calcd. for C17H20O: 240.1509, found; 
240.1497. 
6.2.11 Procedure for preparation of diphenyliodonium tetrafluoroborate salt (129)12 
Diphenyliodonium tetrafluoroborate (129)12 
mCPBA (81% active oxidant, 3.3 g, 19.12 mmol, 1.1 equiv.) was dissolved 
in DCM (50 mL) in a 250 mL round bottomed flask equipped with a stir 
bar. To the solution was added iodobenzene (127) (1.55 mL, 13.92 
mmol, 1 equiv.) followed by slow addition of BF3 · OEt2 (4.25 mL, 34.45 
mmol, 2.5 equiv.) at room temperature. The resulting yellow solution was stirred at room 
temperature for 30 minutes and then cooled to 0 °C. Phenylboronic acid (128) (1.85 g, 15.17 
mmol, 1.1 equiv.) was subsequently added portion wise over 15 minutes. After 30 minutes of 
stirring at 0 ᵒC, the crude reaction mixture was applied on a silica plug (30 g) and eluted with 
DCM (200 mL) to remove unreacted iodobenzene (127) and mCPBA, followed by DCM:MeOH 
(300 mL DCM, 15 mL MeOH), to elute the product, leaving any boric acid derivatives on the 
column. The latter solution was concentrated and diethyl ether was added to the residue to 
induce a precipitation of the salt, with any iodine(III) intermediates and BF3 derivatives 
remaining in solution. The solution was allowed to stir for 15 minutes and then the ether 
phase was decanted. The solid was washed twice more with diethyl ether and then dried in 
vacuo to give the pure diaryliodonium tetrafluoroborate salt (129). White solid (3.52 g, 69%); 
m.p. 133-135 ºC; H (DMSO-d6, 300 MHz) 7.54 (4H, dt, J 7.5, 4.0, C(3)H, C(5)H, C(9)H & C(11)H), 
7.73-7.61 (2H, m, C(4)H & C(10)H), 8.26 (4H, dt, J 3.1, 1.8, C(2)H, C(6)H, C(8)H & C(12)H); C 
(DMSO-d6, 75.5 MHz) 116.9 (qC-1 & qC-7), 132.2 (C(3)H, C(5)H, C(9)H & C(11)H), 132.5 (C(4)H 
& C(10)H), 135.6 (C(2)H, C(6)H, C(8)H & C(12)H); F (DMSO-d6, 282 MHz) -148.2, -148.3; m/z 
(ES+): 281, [(M-BF4)+, 100%].  
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6.2.12 Procedure for preparation of 3-Phenoxy benzaldehyde (116) via diphenyliodonium 
tetrafluoroborate salt (129)9 
3-Phenoxy benzaldehyde (116)9  
To a suspension of potassium tert-butoxide (101 mg, 0.90 mmol, 
1.1 equiv.) in THF (4 mL) was added 3-hydroxy benzaldehyde (130) 
(100 mg, 0.8188 mmol, 1 equiv.) at 0 ᵒC. After stirring for 1 h, the 
tetrafluoroborate iodonium salt (129) (362 mg, 0.983 mmol, 1.2 
equiv.) was added and the resulting mixture was stirred at room temperature overnight. The 
reagents were added to two separate 50 mL round bottomed flask. The crude material from 
each flask was combined after completion of the reaction. The reaction mixture was 
quenched with water (15 mL) and the organic layer was extracted with ethyl acetate (3 × 10 
mL). The organic layer was then dried over MgSO4, filtered and concentrated under reduced 
pressure. The crude product was purified by column chromatography (DCM:EtOAc, 95:5) to 
yield 116 as a yellow oil (153 mg, 47%); max/cm1 (NaCl): 1688 (C=O stretch aldehyde), 1585 
(aromatic C=C stretch), 1488 (aromatic C=C stretch), 1308 (ether C-O stretch), 1240 (ether C-
O stretch), 935 (aromatic C-H bend), 693 (aromatic C-H bend); H (CDCl3, 300 MHz) 7.01-7.07 
(2H, m, C(9)H & C(13)H), 7.12-7.21 (1H, m, C(11)H), 7.29 (1H, ddd, J 8.3, 2.6, 1.2, C(6)H), 7.33-
7.42 (2H, m, C(10)H & C(12)H), 7.44-7.54 (2H, m, C(2)H & C(5)H), 7.60 (1H, dt, J 7.5, 1.3, C(4)H), 
9.96 (1H, s, C(7)H); C (CDCl3, 75.5 MHz) 118.2 (C(2)H), 119.5 (C(9)H & C(13)H), 124.2 (C(11)H), 
124.6 (C(4)H), 124.7 (C(6)H), 130.0 (C(10)H & C(12)H), 130.4 (C(5)H), 138.1 (qC-3), 156.2 (qC-
8), 158.4 (qC-1), 191.6 (qC-7); m/z (ES+): 198, [(M+2H)+, 60%].  
Spectral characteristics were consistent with previously reported data.9 
6.2.13 General procedure for preparation of diphenylamines (144-146) 14 
Pd2(dba)3 (2.5 mol%), dppf (10 mol%) and NaOtBu (1.4 equiv.) were all weighed out in air and 
transferred to a flame dried resealable Schlenk tube. The Schlenk tube was then evacuated 
and back filled with N2 three times. The stopper was then replaced with a rubber septum 
under a nitrogen purge and the liquid reagents were added: aniline (1 equiv.) and aryl iodide 
(1.2 equiv.) via syringe. The sides of the flask were rinsed with anhydrous toluene (2  
mL/mmol) and the septum replaced by a stopper. The reaction mixture was then stirred in an 
oil bath at 100 oC for 48 hours. The reaction mixture was cooled to room temperature after 
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48 hours, diluted with ether (30 mL/mmol) and filtered through a plug of Celite. The crude 
product was concentrated and purified by silica gel chromatography (hexanes, 100%; 
hexanes:EtOAc) to yield diphenylamines 144-146. 
3-Methyl diphenylamine (144)15 
Synthesised according to the general procedure 6.2.13 using aniline 
(0.39 mL, 4.295 mmol, 1 equiv.) and 3-iodo toluene (118) (0.67 mL, 
5.16 mmol, 1.2 equiv.). The crude product was purified by column 
chromatography (hexanes, 100%) to yield 144 as a brown oil (540 mg, 69%); max/cm1 (NaCl): 
3393 (N-H stretch), 1590 (aromatic C=C stretch), 1494 (aromatic C=C stretch), 1315 (C-N 
stretch), 1166 (C-N stretch), 690 (aromatic C-H bend); H (CDCl3, 300 MHz) 2.30 (3H, s, C(7)H3), 
5.63 (1H, bs, N(14)H), 6.74 (1H, d, J 7.6, C(6)H), 6.83-6.96 (3H, m, C(2)H, C(4)H & C(11)H), 7.02-
7.09 (2H, m, C(9)H & C(13)H), 7.10-7.19 (1H, m, C(5)H), 7.21-7.30 (2H, m, C(10)H & C(12)H); 
C (CDCl3, 75.5 MHz) 21.5 (C(7)H3), 115.0 (C(6)H), 117.9 (C(9)H & C(13)H), 118.6 (C(2)H), 120.9 
(C(4)H), 121.9 (C(11)H), 129.2 (C(5)H), 129.3 (C(10)H & C(12)H), 139.2 (qC-3), 143.1 (qC-1), 
143.3 (qC-8); m/z (ES+): 184, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.15 
3-Methoxy diphenylamine (145)16 
Synthesised according to the general procedure 6.2.13 using 3-
methoxy aniline (0.36 mL, 3.25 mmol, 1 equiv.) and iodobenzene 
(127) (0.44 mL, 3.896 mmol, 1.2 equiv.). The crude product was 
purified by column chromatography (hexanes:EtOAc, 93:7) to yield 145 as a white solid (648 
mg, 68%); m.p. 67-69 ºC; max/cm1 (NaCl): 3391 (N-H stretch), 1592 (aromatic C=C stretch), 
1494 (aromatic C=C stretch), 1314 (C-N stretch), 1157 (C-O stretch), 1047 (C-N stretch), 756 
(aromatic C-H bend); H (CDCl3, 300 MHz) 3.78 (3H, s, C(7)H3), 5.69 (1H, bs, N(14)H), 6.44-6.52 
(1H, m C(2)H), 6.60-6.69 (2H, m, C(4)H & C(6)H), 6.90-6.98 (1H, m, C(11)H), 7.05-7.12 (2H, m, 
C(9)H & C(13)H), 7.13-7.20 (1H, m, C(5)H), 7.22-7.31 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 
MHz) 55.2 (C(7)H3), 103.4 (C(6)H), 106.2 (C(2)H), 110.2 (C(4)H), 118.4 (C(9)H & C(13)H), 122.3 
(C(11)H), 129.3 (C(10)H & C(12)H), 130.1 (C(5)H), 142.8 (qC-1), 144.6 (qC-8), 160.7 (qC-3); m/z 
(ES+): 200, [(M+H)+, 100%].  
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Spectral characteristics were consistent with previously reported data.16 
3-Bromo diphenylamine (146)16 
Synthesised according to the general procedure 6.2.13 using 3-
bromo aniline (0.25 mL, 2.33 mmol, 1 equiv.) and iodobenzene (127) 
(0.31 mL, 2.796 mmol, 1.2 equiv.). The crude product was purified by 
column chromatography (hexanes:EtOAc, 94:6) to yield 146 as a brown oil (329 mg, 57%); 
max/cm1 (NaCl): 3399 (N-H stretch), 1587 (aromatic C=C stretch)), 1477 (aromatic C=C 
stretch), 1313 (C-N stretch), 1067 (C-N stretch), 750 (aromatic C-H bend); H (CDCl3, 300 MHz) 
5.69 (1H, bs, N(13)H), 6.93 (1H, ddd, J 8.0, 2.2, 1.1, C(6)H), 6.99-7.04 (2H, m, C(4)H & C(10)H), 
7.04-7.13 (3H, m, C(5)H, C(8)H & C(12)H), 7.19 (1H, t, J 2.0, C(2)H), 7.23-7.35 (2H, m, C(9)H & 
C(11)H); C (CDCl3, 75.5 MHz) 115.6 (C(6)H), 119.0 (C(8)H & C(12)H), 119.6 (C(2)H), 122.2 
(C(10)H), 123.2 (qC-3), 123.4 (C(4)H), 129.5 (C(9)H & C(11)H), 130.6 (C(5)H), 141.9 (qC-7), 
145.0 (qC-1); HRMS (ESI-TOF): Exact mass calculated for C12H11NBr [M+H+], 248.0075. Found 
248.0067.  
Spectral characterisitics were consistent with previously reported data.16 
6.2.14 Procedure for preparation of 3-Chloro diphenylamine (148)17-18 
To a premixed solution of ethyl acetate (0.1 M), Cu(OAc)2 (0.2 equiv.), 
benzoic acid (1 equiv.) and K2CO3 (1 equiv.) in a 250 mL round 
bottomed flask was added 3-chloro aniline (147) (0.249 mL, 2.352 
mmol, 1 equiv.) and phenyl boronic acid (128) (860 mg, 7.056 mmol, 
3 equiv.) at room temperature. The resulting mixture was stirred at 80 ºC in an oil bath until 
TLC analysis (3:1 hexanes:EtOAc) indicated complete consumption of the starting material. 
The solvent was then evaporated in vacuo. The residue was purified by column 
chromatography (hexanes: EtOAc, 90:10) to yield the final product 148 as an orange oil (293 
mg, 61%); max/cm1 (NaCl): 3402 (N-H stretch), 1590 (aromatic C=C stretch), 1480 (aromatic 
C=C stretch), 1314 (C-N stretch), 751 (C-Cl stretch), 681 (aromatic C-H bend); H (CDCl3, 300 
MHz) 5.70 (1H, bs, N(13)H), 6.87 (2H, ddd, J 7.9, 2,1, 0.9, C(2)H & C(6)H), 6.94-7.05 (2H, m, 
C(8)H & C(12)H), 7.05-7.11 (2H, m, C(4)H & C(10)H), 7.14 (1H, t, J 8.0, C(5)H), 7.23-7.35 (2H, 
m, C(9)H & C(11)H); C (CDCl3, 75.5 MHz) 115.1 (C(6)H), 116.7 (C(2)H), 119.0 (C(8)H & C(12)H), 
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120.5 (C(4)H), 122.1 (C(10)H), 129.5 (C(9)H & C(11)H), 130.3 (C(5)H), 135.0 (qC-3), 142.0 (qC-
7), 144.9 (qC-1); m/z (ES+): 204, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.17 
6.2.15 General procedure for preparation of N-methyl diphenylamines (149-151)19 
A mixture of diphenylamine (1 equiv.), potassium hydroxide (6.25 equiv.) and anhydrous DMF 
(0.25 M) was stirred at room temperature for 1 hour. Iodomethane (2 equiv.) was added 
dropwise at room temperature and the resulting reaction mixture was stirred for an 
additional 47 hours.  
Work-up conditions as per 1.35 mmol diphenylamine  
The reaction mixture was then diluted with water (15 mL) and ethyl acetate (15 mL). The 
aqueous and organic phases were separated and the aqueous phase was washed with ethyl 
acetate (3 × 15 mL). The combined organic extracts were washed with brine, dried over 
MgSO4, filtered and concentrated under reduced pressure. The crude mixture was purified by 
silica gel column chromatography (hexanes, 100%) to yield the title products. 
N,3-Dimethyl-N-phenyl benzamine (149)20 
Synthesised according to the general procedure 6.2.15 using 3-
methyl diphenylamine (144) (248 mg, 1.353 mmol, 1 equiv.). The 
crude product was purified by column chromatography (hexanes, 
100%) to yield 149 as a yellow oil (157 mg, 59%); max/cm1 (NaCl): 
2919 (N-CH3 stretch), 1594 aromatic C=C stretch), 1494 (aromatic C=C stretch), 1343 (C-N 
stretch), 1126 (C-N stretch), 692 (aromatic C-H stretch); H (CDCl3, 300 MHz) 2.30 (3H, s, 
C(7)H3), 3.30 (3H, s, C(14)H3), 6.75-6.78 (3H, m, C(2)H, C(6)H & C(11)H), 6.92 (1H, ddd, J 8.4, 
2,2, 1.1, C(4)H), 6.97-7.03 (2H, m, C(9)H & C(13)H), 7.17 (1H, t, J 8.1, C(5)H), 7.21-7.31 (2H, m, 
C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 21.6 (C(7)H3), 40.3 (C(14)H3), 117.9 (C(6)H), 120.1 
(C(9)H & C(13)H), 120.9 (C(2)H), 121.5 (C(4)H), 122.4 (C(11)H), 129.0 (C(5)H), 129.1 (C(10)H & 
C(12)H), 139.0 (qC-3), 149.1 (qC-1), 149.2 (qC-8); m/z (ES+): 198, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.20 
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3-Bromo N-methyl-N-phenyl benzamine (150)20 
Synthesised according to the general procedure 6.2.15 using 3-
bromo diphenylamine (146) (130 mg, 0.526 mmol, 1 equiv.). The 
crude product was purified by column chromatography (hexanes, 
100%) to yield 150 as a brown oil (80 mg, 58%); max/cm1 (NaCl): 
3036 (N-CH3 stretch), 2925 (alkane C-H stretch), 1585 (aromatic C=C stretch), 1481 (aromatic 
C-H stretch), 1343 (C-N stretch), 1133 (C-N stretch); H (CDCl3, 300 MHz) 3.29 (3H, s, C(13)H3), 
6.82 (1H, ddd, J 8.2 2,2, 1.0, C(6)H), 6.95-7.02 (1H, m, C(2)H), 7.03-7.08 (2H, m, C(4)H & 
C(10)H), 7.08-7.15 (3H, m, C(5)H, C(8)H, & C(12)H), 7.29-7.39 (2H, m, C(9)H & C(11)H); C 
(CDCl3, 75.5 MHz) 40.3 (C(13)H3), 116.3 (C(6)H), 120.4 (C(2)H), 122.5 (C(4)H), 123.0 (qC-3), 
123.3 (C(8)H & C(12)H), 123.5 (C(10)H), 129.6 (C(9)H & C(11)H), 130.2 (C(5)H), 148.2 (qC-7), 
150.4 (qC-1); m/z (ES+): 262, [(M+H)+, 100%]. 
 Spectral characteristics were consistent with previously reported data.20 
3-Chloro N-methyl-N-phenyl benzamine (151)21 
Synthesised according to the general procedure 6.2.15 using 3-chloro 
diphenylamine (148) (60 mg, 0.29 mmol, 1 equiv.). The crude product 
was purified by column chromatography (hexanes, 100%) to yield 151 
as a colourless oil (62 mg, 99%); max/cm1 (NaCl): 2925 (N-CH3 
stretch), 1586 (aromatic C=C stretch), 1484 (aromatic C=C stretch), 1343 (C-N stretch), 1133 
(C-N stretch), 900 (aromatic C-H stretch), 699 (C-Cl stretch); H (CDCl3, 300 MHz) 3.29 (3H, s, 
C(13)H3), 6.79 (1H, ddd, J 8.3, 2.3, 0.7, C(6)H), 6.83 (1H, ddd, J 7.8, 1.8, 0.9, C(4)H), 6.90 (1H, 
t, J 2.1, C(2)H), 7.03-7.20 (4H, m, C(5)H, C(8)H, C(10)H & C(12)H), 7.28-7.41 (2H, m, C(9)H & 
C(11)H); C (CDCl3, 75.5 MHz) 40.3 (CH3, C(13)H3), 115.8 (C(6)H), 117.5 (C(2)H), 119.5 (C(4)H), 
123.4 (C(8)H & C(12)H), 123.5 (C(10)H), 129.6 (C(9)H &  C(11)H, 129.3 (C(5)H), 134.8 (qC-3), 
148.3 (qC-7), 150.3 (qC-1); m/z (ES+): 218, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.21 
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6.3 Synthesis of starting materials for direct arylation of ortho-bromo diarylethers 
6.3.1 Procedure for Synthesis of 6-Substituted-4-Phenoxy quinoline ligands (159-161)22 
A mixture of 4-chloroquinoline (1 equiv.), phenol (5 equiv.) and NaOH (crushed pellets) (1.5 
equiv.) was stirred in an oil bath at 130 ᵒC until TLC analysis indicated complete consumption 
of starting material (hexanes:EtOAc, 8:2).  
Work-up as per 1.6 mmol 4-chloro quinoline 
The cooled reaction mixture was then diluted with 10% aq. NaOH (10 mL) and stirred at room 
temperature for 1 h. The aqueous phase was extracted with DCM (3 × 10 mL). The combined 
organics were washed with 6M NaOH (3 × 10 mL), water (10 mL) and brine (10 mL) and then 
dried with MgSO4, filtered and concentrated in vacuo. The crude product was passed through 
a short pad of silica using hexanes:EtOAc (8:2) to yield the title products. 
4-Phenoxy-6-methyl-quinoline (159) 
Synthesised according to the general procedure 6.3.1 using 4-
chloro-6-methyl quinoline (300 mg, 1.69 mmol, 1 equiv.) and 
phenol (158) (795 mg, 8.45 mmol, 5 equiv.) to yield 159 as a yellow 
solid (269 mg, 68%); m.p. 85-88 ᵒC; max/cm1 (NaCl): 1596 
(aromatic C=C stretch), 1490 (aromatic C=C stretch), 1466 (-CH3 
bend), 1362 (C-N stretch), 1255 (C-O stretch), 877 (aromatic C=C bend); H (CDCl3, 300 MHz) 
2.57 (3H, s, C(11)H3), 6.53 (1H, d, J 5.2, C(3)H), 7.14-7.23 (2H, m, C(13)H & C(17)H), 7.24-7.34 
(1H, m, C(15)H), 7.41-7.53 (2H, m, C(14)H & C(16)H), 7.59 (1H, dd, J 8.5, 2.2, C(8)H), 7.99 (1H, 
d, J 8.6, C(9)H), 8.14 (1H, bs, C(6)H), 8.61 (1H, d, J 5.3, C(2)H); C (CDCl3, 75.5 MHz) 21.8 
(C(11)H3), 104.5 (C(3)H), 120.6 (C(6)H), 121.0 (C(13)H & C(17)H), 121.4 (qC-5), 125.5 (C(15)H), 
128.9 (C(9)H), 130.2 (C(14)H & C(16)H), 132.3 (C(8)H), 136.1 (qC-7), 148.4 (qC-10), 150.2 
(C(2)H), 154.6 (qC-12), 161.3 (qC-4); m/z (ES+): 236, [(M+H)+, 100%]. HRMS (ESI-TOF) m/z: 
[M+H]+ calcd. for C16H14NO: 236.1069, found 236.1071. 
 




Synthesised according to the general procedure 6.3.1 using 6-
methoxy-4-chloro quinoline (300 mg, 1.549 mmol, 1 equiv.) and 
phenol (158) (730 mg, 7.745 mmol, 5 equiv.) to yield 160 as a 
yellow solid (178 mg, 46%); m.p. 95-97 ᵒC; max/cm1 (NaCl): 
1625 (aromatic C=C stretch), 1572 (aromatic C=C stretch), 1365 
(C-N stretch), 1234 (C-O stretch), 838 (aromatic C=C bend); H (CDCl3, 300 MHz) 3.96 (3H, s, 
C(11)H3), 6.54 (1H, d, J 5.2, C(3)H), 7.14-7.24 (2H, m, C(13)H & C(17)H), 7.29 (1H, t, J 7.3, 
C(15)H), 7.40 (1H, dd, J  9.2, 2.8, C(8)H), 7.43-7.52 (2H, m, C(14)H & C(16)H), 7.59 (1H, d, J 2.8, 
C(6)H), 7.99 (1H, d, J 9.2, C(9)H), 8.54 (1H, d, J 5.1, C(2)H); C (CDCl3, 75.5 MHz) 55.6 (C(11)H3), 
99.3 (C(6)H), 104.8 (C(3)H), 121.1 (C(13)H & C(17)H), 122.3 (qC-5), 122.8 (C(8)H), 125.5 
(C(15)H), 130.3 (C(14)H & C(16)H), 130.6 (C(9)H), 145.9 (qC-10), 148.5 (C(2)H), 154.6 (qC-12), 
157.7 (qC-7), 160.8 (qC-4); m/z (ES+): 252, [(M+H)+, 100%]. HRMS (ESI-TOF) m/z: [M+H]+ calcd. 
for C16H14NO2: 252.1019, found 252.1019. 
4-Phenoxy-6-trifluoromethyl-quinoline (161) 
Synthesised according to the general procedure 6.3.1 using 6-
trifluoromethyl-4-chloro quinoline (300 mg, 1.295 mmol, 1 equiv.) 
and phenol (158) (609 mg, 6.475 mmol, 5 equiv.) to yield 161 as an 
amber oil (375 mg, 66%); max/cm1 (NaCl): 1634 (aromatic C=C 
stretch), 1470 (aromatic C=C stretch), 1367 (C-N stretch), 1251 (C-
O stretch), 1060 (C-F stretch), 844 (aromatic C=C bend); H (CDCl3, 300 MHz) 6.62 (1H, d, J 5.3, 
C(3)H), 7.17-7.25 (2H, m, C(13)H & C(17)H), 7.29-7.39 (1H, m, C(15)H), 7.44-7.58 (2H, m, 
C(14)H & C(16)H), 7.93 (1H, dd, J 8.9, 2.1, C(8)H), 8.20 (1H, d, J 8.8, C(9)H), 8.73 (1H, bs, C(6)H), 
8.76 (1H, d, J 5.3, C(2)H); C (CDCl3, 75.5 MHz) 104.8 (C(3)H), 120.3 (C(6)H, q, JC-F 5), 120.6 (qC-
5), 124.1 (qC-11, q, JC-F 272), 125.8 (C(8)H, q, JC-F 3), 126.2 (C(13)H & C(17)H), 126.2 (C(15)H), 
128.0 (qC-7, q, JC-F 33), 130.3 (C(9)H), 130.5 (C(14)H & C(16)H), 150.7 (qC-12), 153.3 (C(2)H), 
153.8 (qC-10), 162.5 (qC-4); F (CDCl3, 282 MHz) -62.2; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C16H11BrF3O: 290.0787, found 290.0788. 
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6.3.2 Procedure for synthesis of 6-methoxy-quinoline-N-oxide (162) 
6-Methoxyquinoline (100 mg, 0.63 mmol, 1 equiv.), mCPBA (273 mg, 
1.58 mmol, 2.5 equiv.) were weighed out in air and transferred to a 
reaction vial. DCM (4 mL/mmol) was added to the reaction vial which 
was sealed. The reaction mixture was stirred at room temperature for 
24 hours. The reaction mixture was then diluted with 10% aq. NaOH (2 mL) and stirred at 
room temperature for 30 minutes. The aqueous phase was extracted with DCM (3 × 5 mL). 
The combined organics were washed with 10% aq. NaOH (2 × 5 mL), water (5 mL) and brine 
(5 mL) and then dried with MgSO4, filtered and concentrated in vacuo. The crude product was 
passed through a short pad of silica using DCM:MeOH (98:2-80:20) to yield the final product 
162 as a pale yellow solid. (70 mg, 64%); m.p. 75-79 ᵒC; max/cm1 (NaCl): 1621 (aromatic C=C 
stretch), 1473 (aromatic C=C stretch), 1383 (C-N stretch), 1253 (C-O stretch); H (CDCl3, 300 
MHz) 3.89 (3H, s, C(11)H3), 7.05 (1H, d, J 2.7, C(6)H), 7.19 (1H, dd, J 8.5, 5.9, C(3)H), 7.32 (1H, 
dd, J 9.5, 2.6, C(8)H), 7.57 (1H, d, J 8.4, C(4)H), 8.33 (1H, d, J 6.0, C(2)H), 8.60 (1H, d, J 9.5, 
C(9)H); C (CDCl3, 75.5 MHz) 55.8 (C(11)H3), 105.8 (C(6)H), 121.4 (C(3)H), 121.5 (C(8)H), 122.8 
(C(4)H), 124.9 (C(2)H), 132.0 (qC-5), 133.8 (C(9)H), 137.3 (qC-10), 159.5 (qC-7); m/z (ES+): 176, 
[(M+H)+, 100%]; HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C10H10NO2: 176.0706, found 176.0705. 
6.3.3 Procedure for preparation of 1-bromo-2-(4-nitrophenoxy) benzene (163)23 
Sodium hydride (2.4 equiv., 60%) was suspended in DMSO (1 
mL/mmol) at 0 ᵒC, 2-bromo phenol (158) (865 mg, 5 mmol, 2 equiv.) 
was added dropwise to the reaction mixture. The reaction mixture 
was then heated at 80 ᵒC in a DrySyn® heating block for 1 h. 4-Nitro-fluoro benzene (353 mg, 
2.5 mmol, 1 equiv.) was then added slowly via syringe. The resulting reaction mixture was 
stirred at R.T. for 24 h. Water was then added and the precipitated solid was collected, dried 
and recrystallised from ethanol to give 1-bromo-2-(4-nitrophenoxy) benzene (163) as a yellow 
solid (378 mg, 51%); m.p. 80-82 ᵒC; H (CDCl3, 300 MHz) 6.95 (2H, dddoverlapping, J 9.3, 3.2, 2.2, 
C(8)H & C(12)H), 7.15 (1H, dd, J 7.9, 1.6, C(6)H), 7.18 (1H, td, J, 7.8, 1.6, C(4)H), 7.39 (1H, td, J 
7.8, 1.6, C(5)H), 7.90 (1H, dd, J 7.9, 1.4, C(3)H), 8.21 (2H, dddoverlapping, J 9.3, 3.3, 2.2, C(9)H & 
C(11)H); C (CDCl3, 75.5 MHz) 116.2 (qC-2), 116.4 (C(8)H & C(12)H), 122.8 (C(6)H), 126.0 (C(9)H 
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& C(11)H), 127.2 (C(4)H), 129.3 (C(5)H), 134.4 (C(3)H), 142.9 (qC-10), 151.4 (qC-1), 162.5 (qC-
7); HRMS (ESI-TOF) m/z: [M+H]+ calcd. for C12H9BrNO3: 293.9760, found 293.9761. 
6.3.4 General procedure for preparation of 1-bromo-2-(4-methylphenoxy) benzene (166)23  
and 1-bromo-2-(4-methoxyphenoxy) benzene (167)23  
To a flame dried three-neck round bottomed flask which was evacuated and refilled with 
nitrogen three times was added sodium hydride (1.2 equiv) (95% dispersion in mineral oil). 
DMF (2 mL/mmol) was added via syringe at 0 ᵒC. Phenol (1 equiv.) was then added dropwise 
to the reaction mixture. The reaction mixture was then stirred at 0 ᵒC for 1 h. 2-bromo-fluoro 
benzene (1 equiv.) was then added slowly via syringe. The resulting reaction mixture was 
stirred under N2 atmosphere at 120 ᵒC in a DrySyn® heating block for 24 h.  
Work-up as per 3.66 mmol phenol 
The reaction mixture was cooled to room temperature after 24 h and quenched with water 
(10 mL). The organic layer was extracted with ether (3 × 10 mL), washed with 2M NaOH (3 × 
10 mL) and the combined organics were washed with brine (1 × 10 mL). The organic layer was 
then dried over MgSO4, filtered and concentrated under reduced pressure. The residues were 
purified by silica gel chromatography (hexanes) to yield the title products. 
1-Bromo-2-(4-methylphenoxy) benzene (166) 
Synthesised according to the general procedure 6.3.4 using 2-bromo-
fluorobenzene (165) (1.01 mL, 9.24 mmol, 1 equiv.) and 4-methyl 
phenol (1 g, 9.24 mmol, 1 equiv.). Hexanes, hexanes:EtOAc (90:10). 
Colourless oil (232 mg, 10%); max/cm1 (NaCl): 1582 (aromatic C=C stretch), 1470 (aromatic 
C=C stretch), 1235 (ether C-O stretch), 1165 (ether C-O stretch), 872 (aromatic C-H bend), 658 
(C-Br stretch); H (CDCl3, 300 MHz) 2.33 (3H, s, C(13)H3), 6.83-6.93 (3H, m, C(6)H, C(8)H & 
C(12)H), 6.97 (1H, ddd, J 7.7, 7.5, 1.5, C(4)H), 7.10-7.16 (2H, m, C(9)H & C(11)H), 7.22 (1H, ddd, 
J 7.8, 6.6, 1.7, C(5)H), 7.61 (1H, dd, J 7.9, 1.5, C(3)H); C (CDCl3, 75.5 MHz) 20.7 (C(13)H3), 114.5 
(qC-2), 118.4 (C(8)H & C(12)H), 120.0 (C(6)H), 124.6 (C(4)H), 128.6 (C(5)H), 130.3 (C(9)H & 
C(11)H), 133.1 (qC-10), 133.8 (C(3)H), 154.2 (qC-7), 154.5 (qC-1); HRMS (ESI-TOF) m/z: [M]+ 
calcd. for C13H11BrO: 261.9988, found 261.9989.  




Synthesised according to the general procedure 6.3.4 using 2-
bromo fluorobenzene (165) (0.25 mL, 2.29 mmol, 1 equiv.) and 4-
methoxy phenol (0.29 mL, 3.664 mmol, 1.6 equiv.). Colourless oil 
(143 mg, 22%); max/cm1 (NaCl): 1592 (aromatic C=C stretch), 1471 (aromatic C=C stretch), 
1233 (ether C-O stretch), 1030 (ether C-O stretch), 839 (aromatic C-H bend), 656 (C-Br 
stretch); H (CDCl3, 300 MHz) 3.80 (3H, s, C(13)H3), 6.83 (1H, dd, J 8.1, 1.5, C(6)H), 6.85-6.99 
(5H, m, C(4)H, C(8)H, C(9)H, C(11)H & C(12)H), 7.20 (1H, ddd, J 8.4, 7.8, 1.6, C(5)H), 7.60 (1H, 
dd, J 7.9, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 55.7 (C(13)H3), 113.8 (qC-2), 115.0 (C(9)H & C(11)H), 
118.8 (C(6)H), 120.2 (C(8)H & C(12)H), 124.1 (C(4)H), 128.5 (C(5)H), 133.7 (C(3)H), 150.0 (qC-
7), 154.9 (qC-10), 156.0 (qC-1); Anal. Calculated for C13H11BrO2: C, 55.94 H, 3.97. Found: C, 
56.18; H, 4.05. 
6.3.5 General procedure for preparation of 2-bromo diarylethers via Chan-Lam-Evans 
coupling24-26 
Phenyl boronic acid (2 equiv.), phenol (1 equiv.), Cu(OAc)2 (1 equiv.) and triethylamine (5 
equiv.) were added to a 250 mL round bottom flask containing DCM (25 mL) and 3Å molecular 
sieves. The resulting mixture was stirred at room temperature until TLC analysis indicated 
complete consumption of the starting material (hexanes:EtOAc, 2:1).  
Work-up as per 2 mmol phenol 
The reaction mixture was filtered through a pad of Celite® using DCM (60 mL). The filtrate was 
then washed with 3M NaOH (3 × 10 ml). The combined organics were then washed with brine 
(15 mL), dried with MgSO4 and the solvent was then evaporated in vacuo. The residue was 
purified by silica gel chromatography (hexanes) to yield the title products. 
1-Bromo-2-phenoxy benzene (157)27 
Synthesised according to the general procedure 6.3.5 using 2-bromo 
phenol (158) (0.211 mL, 2 mmol, 1 equiv.) and phenyl boronic acid (490 
mg, 4 mmol, 2 equiv.). Colourless solid (498 mg, 55%); m.p. 37-40 ᵒC; 
max/cm1 (NaCl): 3063 (aromatic C-H stretch), 1578 (aromatic C=C 
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stretch), 1470 (aromatic C=C stretch), 1261 (ether C-O stretch), 1029 (ether C-O stretch), 869 
(aromatic C-H bend), 689 (C-Br stretch); H (CDCl3, 300 MHz) 6.91-7.05 (4H, m, C(6)H, C(8)H, 
C(10)H & C(12)H), 7.06-7.15 (1H, m, C(4)H), 7.21-7.29 (1H, m, C(5)H), 7.29-7.38 (2H, m, C(9)H 
& C(11)H), 7.63 (1H, d, J 7.9, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 115.0 (qC-2), 118.1 (C(8)H & 
C(12)H), 120.7 (C(6)H), 123.4 (C(10)H), 125.0 (C(4)H), 128.7 (C(5)H), 129.8 (C(9)H & C(11)H), 
133.9 (C(3)H), 153.7 (qC-7), 156.9 (qC-1); HRMS (ESI-TOF) m/z: [M]+ calcd. for C12H9BrO: 
247.9831, found 247.9827. 
Spectral characteristics are consistent with previously reported data.27 
 1-Bromo-2-(4-fluorophenoxy) benzene (168) 
Synthesised according to the general procedure 6.3.5 using 2-bromo 
phenol (158) (0.1 mL, 0.9005 mmol, 1 equiv.) and 4-fluoro phenyl 
boronic acid (252 mg, 1.801 mmol, 2 equiv.). Colourless oil (173 mg, 
72%); max/cm1 (NaCl); 1500 (aromatic C=C stretch), 1471 (aromatic C=C stretch), 1261 (ether 
C-O stretch), 1191 (ether C-O stretch), 1029 (C-F stretch), 817 (aromatic C-H bend), 658 (C-Br 
stretch); H (CDCl3, 300 MHz) 6.85-7.09 (6H, m, C(4)H, C(6)H, C(8)H, C(9)H, C(11)H & C(12)H), 
7.19-7.30 (1H, m, C(5)H), 7.63 (1H, dd, J 7.9, 1.5, C(3)H); C (CDCl3, 75.5 MHz) 114.5 (qC-2), 
116.3 (C(9)H & C(11)H, d, JC-F 24), 119.7 (C(6)H), 119.9 (C(8)H & C(12)H, d, JC-F  12), 124.9 
(C(4)H), 128.7 (C(5)H), 133.9 (C(3)H), 152.7 (qC-7, d, JC-F 3), 154.1 (qC-1), 158.8 (qC-10, d, JC-F  
243); F (CDCl3, 282 MHz) -120.0; Anal. Calculated for C12H8BrFO: C, 53.96; H, 3.02. Found: C, 
54.26; H, 3.15. 
1-Bromo-4-chloro-2-(4-fluorophenoxy) benzene (169) 
Synthesised according to the general procedure 6.3.5 using 2-bromo-
5-chloro phenol (330 mg, 1.6 mmol, 1 equiv.) and 4-fluoro phenyl 
boronic acid (448 mg, 3.2 mmol, 2 equiv.). Colourless oil (150 mg, 31%); 
max/cm1 (NaCl): 1576 (aromatic C=C stretch), 1467 (aromatic C=C 
stretch), 1254 (ether C-O stretch), 1219 (ether C-O stretch), 1087 (C-F stretch), 830 (aromatic 
C-H bend), 682 (C-Br stretch); H (CDCl3, 300 MHz) 6.82 (1H, d, J 2.4, C(6)H), 6.93-7.02 (3H, m, 
C(4)H, C(8)H & C(12)H), 7.02-7.12 (2H, m, C(9)H & C(11)H), 7.53 (1H, d, J 8.6, C(3)H); C (CDCl3, 
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75.5 MHz) 112.0 (qC-2), 116.3 (C(9)H & C(11)H, d, JC-F 24), 119.9 (C(6)H), 120.2 (C(8)H & 
C(12)H, d, JC-F 9), 125.0 (C(4)H), 134.0 (qC-5), 134.4 (C(3)H), 151.7 (qC-7, d, JC-F 3), 155.0 (qC-
1), 159.4 (qC-10, d, JC-F 243); F (CDCl3, 282 MHz) -118.5; Anal. Calculated for C12H7BrClFO: C, 
47.80; H, 2.34. Found: C, 47.83; H, 2.47. HRMS (ESI-TOF) m/z: [M]+ calcd. for C12H7BrClFO: 
299.9347, found 299.9359. 
1-bromo-4-methoxy-2-(phenoxy) benzene (171) 
Synthesised according to the general procedure 6.3.5 using 2-
bromo-4-methoxy phenol (1 g, 4.93 mmol, 1 equiv.) and phenyl 
boronic acid (128) (1.2 g mg, 9.85 mmol, 2 equiv.). Colourless oil 
(450 mg, 33%); max/cm1 (NaCl): 1605 (aromatic C=C stretch), 1484 (aromatic C=C stretch), 
1216 (ether C-O stretch), 1163 (ether C-O stretch), 1038 (ether C-O stretch), 836 (aromatic C-
H bend), 689 (C-Br stretch); H (CDCl3, 300 MHz) 3.81 (3H, s, C(7)H3), 6.84 (1H, dd, J 8.9, 2.9, 
C(5)H), 6.86-6.92 (2H, m, C(9)H & C(13)H), 6.98 (1H, d, J 8.9, C(6)H), 7.00-7.08 (1H, m, C(11)H), 
7.17 (1H, d, J 2.6, C(3)H), 7.24-7.34 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 55.9 
(C(7)H3), 114.6 (C(5)H), 116.1 (qC-2), 116.8 (C(6)H), 118.6 (C(9)H & C(13)H), 122.6 (C(3)H & 
C(11)H), 129.7 (C(10)H & C(12)H), 146.7 (qC-4), 156.7 (qC-1), 158.0 (qC-8); HRMS (ESI-TOF) 
m/z: [M]+ calcd. for C13H11BrO2: 277.9937, found 277.9937. 
5-phenoxy-1,3-benzodioxole (174)28 
Synthesised according to the general procedure 6.3.5 using 
sesamol (173) (1 g, 7.24 mmol, 1 equiv.) and phenyl boronic acid 
(128) (1.72 g, 14.48 mmol, 2 equiv.). Colourless oil (120 mg, 29%); 
max/cm1 (NaCl): 1594 (aromatic C=C stretch), 1479 (aromatic C=C stretch), 1214 (C-O 
stretch), 1174 (C-O stretch), 1038 (C-O stretch), 748 (aromatic C-H bend), 692 (C-Br stretch); 
H (CDCl3, 300 MHz) 5.96 (2H, s, C(4)H2), 6.49 (1H, dd, J 8.3, 2.4, C(7)H), 6.58 (1H, d, J 2.4, 
C(2)H), 6.75 (1H, d, J 8.4, C(6)H), 6.92-6.99 (2H, m, C(9)H & C(13)H), 7.01-7.08 (1H, m, C(11)H), 
7.26-7.34 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 101.5 (C(4)H2), 102.2 (C(7)H), 108.3 
(C(2)H), 112.0 (C(6)H), 117.9 (C(9)H & C(13)H), 122.7 (C(11)H), 129.6 (C(10)H & C(12)H), 143.8 
(qC-5), 148.4 (qC-3), 151.5 (qC-1), 158.2 (qC-8); Anal. Calculated for C13H10O3: C, 72.89; H, 
4.71. Found: C, 72.81; H, 4.45. 
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Spectral characteristics are consistent with previously reported data.28 
1-Bromo-3-hydroxy-2-(phenoxy) benzene (172) 
Compound 172 was prepared via a procedure described by 
Wiegrebe et al.29 A 250 mL 3-neck round bottomed flask was heated 
under vacuum and then refilled with N2. 2-Bromo-4-methoxy 
diphenylether (171) (420 mg, 1.50 mmol, 1 equiv.) and DCM (40 mL) 
were added. BBr3 (1.4 mL, 7.5 mmol, 7 equiv.) was added dropwise at 0 ᵒC. The reaction 
mixture was then stirred at room temperature under N2 atmosphere until TLC analysis 
indicated full consumption of starting material. The reaction mixture was quenched with 
water (10 mL) and the organic layer separated from the aqueous layer. The organic layer was 
washed with water (3 × 10 mL). The combined organics were washed with brine (10 mL), dried 
with MgSO4, filtered and concentrated under reduced pressure. The residue was purified by 
column chromatography (hexanes:EtOAc 3:1) to yield 172 as a colourless oil (371 mg, 93%); 
max/cm1 (NaCl); 3378 (O-H stretch), 1589 (aromatic C=C stretch), 1490 (aromatic C=C 
stretch), 1211 (ether C-O stretch), 1036 (ether C-O stretch), 847 (aromatic C=C bend), 689 (C-
Br stretch); H (CDCl3, 300 MHz) 4.97 (1H, bs, O(7)H), 6.78 (1H, dd, J 8.7, 2.9, C(5)H), 6.85-6.97 
(3H, m, C(9)H, C(11)H & C(13)H), 7.00-7.10 (1H, m, C(6)H), 7.13 (1H, d, J 2.9, C(3)H), 7.24-7.34 
(2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 115.7 (C(5)H), 116.1 (qC-2), 116.8 (C(9)H & 
C(13)H), 120.4 (C(3)H), 122.6 (C(6)H), 122.7 (C(11)H), 129.7 (C(10)H & C(12)H), 146.9 (qC-1), 
153.0 (qC-4), 157.9 (qC-8); HRMS (ESI-TOF) m/z: [M-H]- calcd. for C12H8BrO2: 262.9713, found 
262.9707. 
5-Bromo-6-phenoxy-1,3-benzodioxole (175) 
Compound 175 was prepared via a procedure described by Siegel 
et al.30 A solution of NBS (208 mg, 1.17 mmol, 1 equiv.) in 
acetonitrile (2 mL) was added to a 100 mL round bottomed flask 
containing a stirred solution of 174 (250 mg, 1.17 mmol, 1 equiv.) in acetonitrile (2 mL) at 0 
ᵒC. After 10 minutes of stirring at this temperature, the reaction mixture was warmed to room 
temperature overnight. After 16 hours, the reaction was quenched with water (10 mL) and 
the organic layer extracted with DCM (10 mL). The organic layer was then washed with water 
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(3 × 10 mL), dried with MgSO4 and concentrated under reduced pressure. The residue was 
flushed through a pad of silica using DCM to yield 175 as a pale pink solid (281 mg, 94%); 
max/cm1 (NaCl): 1590 (aromatic C=C stretch), 1471 (aromatic C=C stretch), 1208 (C-O 
stretch), 1116 (C-O stretch), 1036 (C-O stretch), 844 (aromatic C-H bend), 690 (C-Br stretch); 
H (CDCl3, 300 MHz) 5.99 (2H, s, C(4)H2), 6.58 (1H, s, C(2)H), 6.85-7.11 (2H, m, C(9)H & C(13)H), 
7.01-7.12 (2H, m, C(6)H & C(11)H), 7.26-7.35 (2H, m, C(10)H & C(12)H); C (CDCl3, 75.5 MHz) 
102.2 (C(4)H2), 103.5 (C(2)H), 106.0 (qC-7), 112.4 (C(6)H), 116.9 (C(9)H & C(13)H), 122.8 
(C(11)H), 129.7 (C(10)H & C(12)H), 145.0 (qC-5), 147.5 (qC-3), 147.9 (qC-1), 157.8 (qC-8); Anal. 
Calculated for C13H9BrO3: C, 53.27; H, 3.10. Found: C, 53.18; H, 3.15. 
6.3.6 General procedure for preparation of diphenyliodonium tetrafluoroborate salts (177-
179)12 
mCPBA (81% active oxidant, 1.1 equiv.) was dissolved in DCM (0.25 M). To the solution was 
added aryl iodide (1 equiv.), followed by slow addition of BF3 · OEt2 (2.5 equiv.) at room 
temperature. The resulting yellow solution was stirred at room temperature for 45 minutes 
and then cooled to 0 °C. The phenylboronic acid (1.1 equiv.) was added portion wise over 15 
minutes. After 30 minutes of stirring at room temperature, the crude reaction mixture was 
applied on a silica plug (12 g/1g aryl iodide) and eluted with DCM (120 mL/1g aryl iodide) to 
remove unreacted aryl iodide and mCPBA, followed by DCM:MeOH (20:1, 240 mL/1 g aryl 
iodide), to elute the product, leaving any boric acid derivatives on the column. The latter 
solution was concentrated and diethyl ether was added to the residue to induce a 
precipitation of the salt, with any iodine(III) intermediates and BF3 derivatives remaining in 
solution. The solution was allowed to stir for 15 minutes and then the ether phase was 
decanted. The solid was washed twice more with diethyl ether and then dried in vacuo to give 
the pure diaryliodonium tetrafluoroborate salt. 
Bis(2-bromophenyl)iodonium tetrafluoroborate (177)31 
Synthesised according to the general 6.3.6 using 2-bromo iodobenzene 
(0.32 mL, 2.5 mmol, 1 equiv.) and 2-bromophenyl-boronic acid (156) 
(552 mg, 2.75 mmol, 1.1 equiv.). Light brown solid (799 mg, 61%); m.p. 
197-200 ᵒC; H (DMSO-d6, 300 MHz) 7.54 (2H, td, J 8.3, 1.3, C(4)H & 
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C(10)H), 7.63 (2H, td, J 8.3, 1.3, C(5)H & C(11)H), 7.99 (2H, dd, J 8.0, 1.1, C(3)H & C(9)H), 8.50 
(2H, dd, J 8.1, 1.4, C(6)H & C(12)H); C (DMSO-d6, 75.5 MHz) 123.2 (qC-2 & qC-8), 127.4 (qC-1 
& qC-7), 131.0 (C(4)H & C(10)H), 134.5 (C(5)H & C(11)H), 135.2 (C(3)H & C(9)H), 139.7 (C(6)H 
& C(12)H); F (DMSO-d6, 282 MHz) -148.3, -148.2; HRMS (ESI-TOF) m/z: [M-BF4]+ calcd. for 
C12H7Br2I: 436.8031, found 436.8036. 
Spectral characteristics are consistent with previously reported data.1831 
Bis(4-trifluoromethylphenyl)iodonium tetrafluoroborate (178)32 
Synthesised according to the general procedure 6.3.6 using 4-
iodobenzotrifluoride (0.27 mL, 1.84 mmol, 1 equiv.) and 4-
trifluoromethylphenyl boronic acid (384 mg, 2.024 mmol, 1.1 
equiv.). White solid (286 mg, 31%); m.p. 198-200 ᵒC; H (DMSO-
d6, 300 MHz) 7.95 (4H, dapp, J 8.3, C(3)H, C(5)H, C(10)H & C(12)H, 8.53 (4H, dapp, J 8.4, C(2)H, 
C(6)H, C(9)H & C(13)H); C (DMSO-d6, 75.5 MHz) 121.4 (qC-1 & qC-8), 129.0 (C(3)H, C(5)H, 
C(10)H & C(12)H, q, JC-F 4), 123.7 (qC-7 & qC-14, q, JC-F 272), 132.5 (qC-4 & qC-11, q, JC-F 33), 
136.7 (C(2)H, C(6)H, C(9)H & C(13)H); F (DMSO-d6, 282 MHz) -148.3, -148.2 -61.7; m/z (ES+): 
417 [(M-BF4)+, 100%]. 
Spectral characteristics are consistent with previously reported data.32 
Bis(3-ntirophenyl)iodonium tetrafluoroborate (179)31 
Synthesised according to the general procedure 6.3.6 using 3-
nitroiodobenzene (600 mg, 2.41 mmol, 1 equiv.) and 3-
nitrophenyl boronic acid (443 mg, 2.651 mmol, 1.1 equiv.). Light 
brown solid (260 mg, 24%); m.p. 188-190 ᵒC; H (DMSO-d6, 300 
MHz) 7.85 (2H, t, J 8.1, C(5)H & C(11)H), 8.48 (2H, ddapp, J 8.3, 1.5, C(3)H & C(9)H), 8.74-8.78 
(2H, m, C(4)H & C(10)H), 9.25-9.33 (2H, m, C(6)H & C(12)H); C (DMSO-d6, 75.5 MHz) 117.3 
(qC-1 & qC-7), 127.5 (C(5)H & C(11)H), 130.6 (C(4)H & C(10)H), 133.4 (C(2)H & C(8)H), 141.8 
(C(6)H & C(12)H), 148.9 (qC-3 & qC-9); F (DMSO-d6, 282 MHz) -148.3, -148.2; m/z (ES+): 371 
[(M-BF4)+, 100%]. 
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Spectral characteristics are consistent with previously reported data.31 
6.3.7 General procedure for preparation of 2-bromo diarylethers via diphenyliodonium 
tetrafluoroborate salts (177-182)9 
To a suspension of potassium tert-butoxide (1.1 equiv.) in THF (10 mL) was added 2-bromo-
phenol (substituted) at 0 ᵒC. After stirring for 1 hour, the iodonium salt (1.2 equiv.) was added 
and the resulting mixture was stirred at room temperature overnight.  
Work-up as per 1 mmol phenol 
The reaction mixture was quenched with water (15 mL) and the organic layer was extracted 
with ethyl acetate (3 × 10 mL). The organic layer was then dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by silica gel 
chromatography (hexanes:EtOAc, 3:1) to yield the title products. 
1-Bromo-2-(4-(trifluoromethoxy)phenoxy) benzene (183) 
Synthesised according to the general procedure 6.3.7 using bis-(4-
trifluoromethoxyphenyl)iodonium tetrafluoroborate (180) (500 
mg, 0.933 mmol, 1.2 equiv.) and 2-bromo-phenol (0.09 mL, 0.777 
mmol, 1 equiv.). Colourless oil (157 mg, 61%); max/cm1 (NaCl): 
1578 (aromatic C=C stretch), 1472 (aromatic C=C stretch), 1242 (ether C-O stretch), 1102 
(ether C-O stretch), 1047 (C-F stretch), 844 (aromatic C-H bend), 750 (C-Br stretch); H (CDCl3, 
300 MHz) 6.95 (2H, dddoverlapping, J 9.1, 3.6, 2.4, C(9)H & C(11)H), 6.99 (1H, dd, J 8.1, 1.6, C(6)H), 
7.06 (1H, ddd, J 8.3, 7.7, 1.5, C(4)H), 7.13-7.23 (2H, m, C(8)H & C(12)H), 7.29 (1H ddd, J 8.3, 
7.7, 1.5, C(5)H), 7.64 (1H dd, J 8.0, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 115.2 (qC-2), 118.7 (C(9)H 
& C(11)H), 120.6 (qC-13, q, JC-F  261), 121.1 (C(6)H), 122.6 (C(8)H & C(12)H), 125.6 (C(4)H), 
128.8 (C(5)H), 134.0 (C(3)H), 144.6 (qC-10), 153.2 (qC-7), 155.5 (qC-1); F (CDCl3, 282 MHz) -
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1-Bromo-4-fluoro-2-(4-(trifluoromethoxy)phenoxy) benzene (184) 
Synthesised according to the general procedure 6.3.7 using bis(4-
trifluoromethoxyphenyl)iodonium tetrafluoroborate (180) (800 
mg, 1.5 mmol, 1.2 equiv.) and 2-bromo-5-fluoro phenol (0.13 mL, 
1.2 mmol, 1 equiv.). Colourless oil (98 mg, 23%); max/cm1 (NaCl); 
1596 (aromatic C=C stretch), 1502 (aromatic C=C stretch), 1478 (aromatic C=C stretch), 1262 
(ether C-O stretch), 1189 (ether C-O stretch), 1042 (C-F stretch), 845 (aromatic C-H bend), 599 
(C-Br stretch); H (CDCl3, 300 MHz) 6.67 (1H, dd, J 9.4, 2.9, C(6)H), 6.79 (1H, ddd, J 8.9, 7.8, 
3.0, C(4)H), 6.96-7.05 (2H, m, C(8)H & C(12)H), 7.17-7.25 (2H, m, C(9)H & C(11)H), 7.59 (1H, 
dd, J 9.0, 6.0, C(3)H); C (CDCl3, 75.5 MHz) 107.9 (C(6)H, d, JC-F 26), 109.0 (qC-2, d, JC-F 4), 112.4 
(C(4)H, d, JC-F 22), 118.8 (C(8)H & C(12)H), 120.9 (qC-13, q, JC-F 257), 122.8 (C(9)H & C(11)H), 
134.4 (C(3)H, d, JC-F 9), 145.2 (qC-10, q, JC-F 2), 154.4 (qC-7), 154.5 (qC-1), 162.4 (qC-5, d, JC-F 
247); F (CDCl3, 282 MHz) -111.1, -58.3; HRMS (ESI-TOF) m/z: [M]+ calcd. for C13H7BrF4O2: 
350.1383, found 350.1384. 
1-Bromo-4-chloro-2-(4-(trifluoromethoxy)phenoxy) benzene (185) 
Synthesised according to the general procedure 6.3.7 using bis(4-
trifluoromethoxyphenyl)iodonium tetrafluoroborate (180) (382 
mg, 0.71 mmol, 1.2 equiv.) and 2-bromo-5-chloro phenol (118 mg, 
0.568 mmol, 1 equiv.). Colourless oil (62 mg, 30%); max/cm1 
(NaCl); 1580 (aromatic C=C stretch), 1477 (aromatic C=C stretch), 1260 (ether C-O stretch), 
1188 (ether C-O stretch), 1040 (C-F stretch), 840 (aromatic C-H bend), 780 (C-Cl stretch), 590 
(C-Br stretch); H (CDCl3, 300 MHz) 6.93 (1H, d, J 2.4, C(6)H), 6.96-7.02 (2H, m, C(9)H & C(11)H), 
7.03 (1H, dd,  J 8.5, 2.4, C(4)H), 7.18-7.25 (2H m, C(8)H & C(12)H), 7.56 (1H, d, J 8.5, C(3)H); C 
(CDCl3, 75.5 MHz) 112.9 (qC-2), 119.4 (C(9)H & C(11)H), 120.5 (qC-13, d, JC-F 257), 120.5 
(C(6)H), 122.8 (C(4)H), 125.5 (C(3)H), 134.2 (qC-5), 134.5 (C(8)H & C(12)H), 145.2 (qC-10), 
154.1 (qC-7), 154.6 (qC-1); F (CDCl3, 282 MHz) -58.2. HRMS (ESI-TOF) m/z: [M]+ calcd. for 
C13H7BrF3O2: 365.9265, found 365.9280. 
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1-Bromo-2-(2,4-dichlorophenoxy) benzene (187) 
Synthesised according to the general procedure 6.3.7 using bis(2-
bromophenyl)iodonium tetrafluoroborate (177) (550 mg, 1.046 
mmol, 1.2 equiv.) and 2,4-dichloro phenol (186) (136 mg, 0.8368 
mmol, 1 equiv.). Colourless oil (163 mg, 61%); max/cm1 (NaCl): 1574 (aromatic C=C stretch), 
1469 (aromatic C=C stretch), 1258 (ether C-O stretch), 1100, (ether C-O stretch), 806 
(aromatic C-H bend), 773 (C-Cl stretch), 553 (C-Br stretch); H (CDCl3, 300 MHz) 6.77 (1H, d, J 
8.8, C(12)H), 6.86 (1H, dd, J 8.4, 1.2, C(6)H), 7.04 (1H, ddd, J 8.0, 7.7, 1.6, C(4)H), 7.16 (1H, dd, 
J 8.8, 2.5, C(11)H), 7.27 (1H, ddd, J 8.2, 7.8, 1.6, C(5)H), 7.47 (1H, d, J 2.5, C(9)H), 7.64 (1H, dd, 
J 7.9, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 114.3 (qC-2), 119.7 (C(6)H), 120.1 (C(12)H), 125.5 
(C(4)H), 126.0 (qC-8), 128.0 (C(11)H), 128.8 (C(5)H), 129.2 (qC-10), 130.6 (C(9)H), 134.1 
(C(3)H), 151.1 (qC-7), 153.0 (qC-1). Anal. Calculated for C12H7BrCl2O: C, 45.33; H, 2.22. Found: 
C, 45.10; H, 2.50. 
1-Bromo-2-(3-methylphenoxy) benzene (189) 
Synthesised according to the general procedure 6.3.7 using bis(2-
bromophenyl)iodonium tetrafluoroborate (177) (537 mg, 1.021 
mmol, 1.2 equiv.) and m-cresol (188) (0.089 mL, 0.851 mmol, 1 
equiv.). Colourless oil (113 mg, 51%); max/cm1 (NaCl): 1607 (aromatic C=C stretch), 1485 
(aromatic C=C stretch), 1441 (-CH3 bend), 1252 (ether C-O stretch), 1144 (ether C-O stretch), 
658 (C-Br stretch); H (CDCl3, 300 MHz) 2.33 (3H, s, C(13)H3), 6.72-6.82 (2H, m, C(8)H & 
C(12)H), 6.88-6.97 (2H, m, C(6)H & C(10)H), 7.00 (1H, td, J 7.6, 1.5, C(11)H), 7.21 (1H, t, J 7.2, 
C(4)H), 7.24 (1H, ddd, J 8.7, 7.7, 1.6, C(5)H), 7.62 (1H, dd, J 7.9, 1.6, C(3)H); C (CDCl3, 75.5 
MHz) 21.4 (C(13)H3), 114.9 (qC-2), 115.1 (C(12)H), 118.9 (C(8)H), 120.6 (C(6)H), 124.2 (C(10)H), 
124.8 (C(4)H), 128.6 (C(11)H), 129.5 (C(5)H), 133.8 (C(3)H), 140.0 (qC-9), 153.8 (qC-1), 156.9 
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1-Bromo-2-(4-(trifluoromethyl)phenoxy) benzene (190)33  
Synthesised according to the general procedure 6.3.7 using bis(4-
trifluoromethylphenyl)iodonium tetrafluoroborate (178) (300 mg, 
0.595 mmol, 1.2 equiv.) and 2-bromo phenol (156) (0.058 mL, 0.497 
mmol, 1 equiv.). Colourless oil (102 mg, 65%); max/cm1 (NaCl): 1616 (aromatic C=C stretch), 
1579 (aromatic C=C stretch), 1471 (aromatic C=C stretch), 1262 (ether C-O stretch), 1168 
(ether C-O stretch), 1066 (C-F stretch), 874 (aromatic C-H bend), 660 (C-Br stretch); H (CDCl3, 
300 MHz) 6.93-7.02 (2H, m, C(8)H & C(12)H), 7.07 (1H, dd, J 7.9, 1.6, C(6)H), 7.11 (1H, td, J 7.8, 
1.6, C(4)H), 7.34 (1H, td, Japp 7.8, 1.6, C(5)H), 7.53-7.62 (2H, m, C(9)H & C(11)H), 7.67 (1H, dd, 
J 8.0, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 115.9 (qC-2), 117.0 (C(8)H & C(12)H), 122.2 (C(6)H), 
124.2 (qC-13, q, JC-F  272), 125.0 (qC-10, q, JC-F 32), 126.0 (C(4)H), 127.2 (C(9)H & C(11)H, q, JC-
F 4), 129.0 (C(5)H), 134.2 (C(3)H), 152.2 (qC-1), 159.9 (qC-7); F (CDCl3, 282 MHz) -61.8; HRMS 
(ESI-TOF) m/z: [M]+ calcd. for C13H8BrF3O: 315.9705, found 315.9705. 
Spectral characteristics are consistent with previously reported data.33 
1-Bromo-2-(3-(trifluoromethyl)phenoxy) benzene (191) 
Synthesised according to the general procedure 6.3.7 using bis(3-
trifluoromethyl)iodonium tetrafluoroborate (182) (140 mg, 0.28 
mmol, 1.2 equiv.) and 2-bromo phenol (156) (0.03 mL, 0.23 mmol, 1 
equiv.). Colourless oil (58 mg, 80%); max/cm1 (NaCl): 1578 
(aromatic C=C stretch), 1471 (aromatic C=C stretch), 1262 (ether C-O stretch), 1128 (ether C-
O stretch), 1064 (C-F stretch), 696 (C-Br stretch); H (CDCl3, 300 MHz); 7.03 (1H, dd, J 8.1, 1.6, 
C(6)H), 7.03-7.13 (2H, m, C(4)H & C(12)H), 7.17-7.23 (1H, m, C(8)H), 7.28-7.39 (2H, m, C(5)H 
& C(10)H), 7.43 (1H, t, J 7.9, C(11)H), 7.67 (1H, dd, J 8.0, 1.6, C(3)H); C (CDCl3, 75.5 MHz) 114.5 
(C(8)H, q, JC-F 4), 115.5 (qC-2), 119.8 (C(10)H, q, JC-F 4), 120.6 (C(12)H), 121.5 (C(6)H), 123.7 (qC-
13, q, JC-F 272), 126.0 (C(4)H), 129.0 (C(5)H), 130.3 (C(3)H), 132.3 (qC-9, q, JC-F 32), 134.2 
(C(11)H), 152.6 (qC-1), 157.4 (qC-7); F (CDCl3, 282 MHz) -61.7; Anal. Calculated for 
C13H8BrF3O: C, 49.24; H, 2.54. Found: C, 49.47; H, 2.74. 
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1-Bromo-2-(3-nitrophenoxy) benzene (164)23 
Synthesised according to the general procedure 6.3.7 using bis(3-
nitrophenyl)iodonium tetrafluoroborate (179) (200 mg, 0.437 
mmol, 1.2 equiv.) and 2-bromo phenol (156) (0.042 mL, 0.364 mmol, 
1 equiv.). Pale yellow oil (72 mg, 67%); max/cm1 (NaCl): 1578 (aromatic C=C  stretch), 1469 
(aromatic C=C stretch), 1352 (N=O stretch), 1261 (ether C-O stretch), 1238 (C-N stretch), 1046 
(ether C-O stretch), 840 (aromatic C=C bend), 736 (C-Br stretch); H (CDCl3, 300 MHz) 7.09 
(1H, dd, J 8.0, 1.5, C(6)H), 7.15 (1H, ddd, J 8.7, 7.5, 1.5, C(4)H), 7.27 (1H, ddd, J 8.5, 2.3, 0.9, 
C(12)H), 7.37 (1H, ddd, J 8.5, 7.5 1.5, C(5)H), 7.49 (1H, t, J 8.2, C(11)H), 7.65-7.75 (2H, m, C(3)H 
& C(8)H), 7.95 (1H, ddd, J 8.2, 2.2, 0.9, C(10)H); C (CDCl3, 75.5 MHz) 112.0 (C(8)H), 115.8 (qC-
2), 117.8 (C(10)H), 122.2 (C(6)H), 123.2 (C(12)H), 126.8 (C(4)H), 129.2 (C(5)H), 130.4 (C(11)H), 
134.4 (C(3)H), 149.3 (qC-9), 151.9 (qC-1), 158.0 (qC-7); m/z (ES-): 294 [(M)-, 60%]. 
1-Bromo-4-fluoro-2-(4-fluorophenoxy) benzene (192) 
Synthesised according to the general procedure 6.3.7 using bis(4-
fluorophenyl)iodonium tetrafluoroborate (181) (500 mg, 1.24 mmol, 
1.2 equiv.) and 2-bromo-5-fluoro phenol (0.11 mL, 1.03 mmol, 1 
equiv.). Colourless oil (191 mg, 65%); max/cm1 (NaCl); 1584 (aromatic 
C=C stretch), 1500 (aromatic C=C stretch), 1477 (aromatic C=C stretch), 1279 (ether C-O 
stretch), 1193 (ether C-O stretch), 1144 (ether C-O stretch), 1040 (C-F stretch), 840 (aromatic 
C-H bend), 599 (C-Br stretch); H (CDCl3, 300 MHz) 6.56 (1H, dd, J 9.6, 2.9, C(6)H), 6.73 (1H, 
ddd, J 9.6, 7.3, 3.0, C(4)H), 6.93-7.13 (4H, m, C(8)H, C(9)H, C(11)H & C(12)H), 7.56 (1H, dd, J 
8.9, 6.1, C(3)H); C (CDCl3, 75.5 MHz) 106.7 (C(6)H, d, JC-F 26), 108.1 (qC-2, d, JC-F 4), 111.5 
(C(4)H, d, JC-F 23), 116.6 (C(9)H & C(11)H, d, JC-F 24), 120.7 (C(8)H & C(12)H, d, JC-F 8), 134.2 
(C(3)H, d, JC-F 9), 151.6 (qC-7, d, JC-F 2), 155.3 (qC-1, d, JC-F 10), 159. (qC-10, d, JC-F 223), 162.0 
(qC-5, d, JC-F 227); F (CDCl3, 282 MHz) -118.4, -111.3; HRMS (ESI-TOF) m/z: [M]+ calcd. for 
C12H7BrF2O: 283.9643, found 283.9645. 
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6.3.8 General procedure for preparation of 2-bromo diphenylamine (195)14, 34 
Pd2(dba)3 (2.5 mol%), dppf (10 mol%) and NaOtBu (1.4 equiv.) were all 
weighed out in air and transferred to a flame dried resealable Schlenk 
tube that was evacuated and refilled with N2 three times. The stopper 
was then replaced with a rubber septum under a nitrogen purge and 
the liquid reagents were added (aniline (193) (800 mg, 8.59 mmol, 1 equiv.) and 2-bromo-
iodobenzene (194) (2.92 g, 10.31 mmol, 1.2 equiv.) via syringe. The sides of the flask were 
rinsed with solvent (1 mL/mmol) and the septum replaced by a stopper. The Schlenk tube was 
then stirred in an oil bath at 100 oC for 48 h. When TLC analysis indicated disappearance of 
the aniline, the reaction mixture was cooled to room temperature, diluted with DCM and 
filtered through a plug of Celite®. The crude residue was concentrated and purified by silica 
gel chromatography (hexanes, 100%) to yield 2-bromo diphenylamine (195). Yellow liquid 
(457 mg, 96%); max/cm1 (NaCl); 3396 (N-H stretch), 1583 (aromatic C=C stretch), 1464 
(aromatic C=C stretch), 1311 (C-N stretch), 1020 (C-N stretch), 692 (C-Br stretch) H (CDCl3, 
300 MHz) 6.07 (1H, s, N(13)H), 6.72 (1H, ddd J 8.4, 7.6, 1.6, C(4)H), 6.97-7.07 (1H, m, C(10)H), 
7.09-7.19 (3H, m, C(5)H, C(8)H & C(12)H), 7.23 (1H, dd, J 8.1, 1.9, C(6)H), 7.26-7.37 (2H, m, 
C(9)H & C(11)H), 7.51 (1H, dd, J 8.0, 1.5, C(3)H); C (CDCl3, 75 .5 MHz) 112.2 (qC-2), 115.9 
(C(6)H), 120.3 (C(8)H & C(12)H), 120.9 (C(4)H), 122.7 (C(10)H), 128.1 (C(5)H), 129.5 (C(9)H & 
C(11)H), 133.0 (C(3)H), 141.5 (qC-7), 141.6 (qC-1); HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C12H11BrN: 248.0069, found 248.0071. 
Spectral characteristics are consistent with previously reported data.34 
6.3.9 Procedure for synthesis of 4-(2-bromophenoxy)pyridine (197)22 
A mixture of 4-chloro pyridine hydrochloride (196) (500 mg, 3.33 mmol, 
1 equiv.), 2-bromo phenol (156) (2.88 g, 16.65 mmol, 5 equiv.) and NaOH 
(200 mg, 4.99 mmol, 1.5 equiv.) was added to a 250 mL round bottomed 
flask and stirred at 130 ᵒC in an oil bath until TLC analysis indicated 
complete consumption of starting material. The cooled reaction mixture was then diluted 
with 10% aq. NaOH (5 mL) and stirred at room temperature for 1 h. The aqueous phase was 
extracted with DCM (3 × 10 mL). The combined organics were washed with 6M NaOH (3 × 10 
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mL), water (10 mL) and brine (10 mL) and then dried with MgSO4, filtered and concentrated 
in vacuo. The crude product was passed through a short pad of silica using hexanes:EtOAc 
(3:1) to yield the final product 197 as a yellow solid (502 mg, 60%); m.p. 63-66 ᵒC (lit. 64-66 
ºC); H (DMSO-d6, 300 MHz) 6.78 (2H, d, J 6.0, C(8)H & C(11)H), 7.10-7.22 (2H, m, C(4)H & 
C(6)H), 7.37 (1H, td, J 7.8, 1.6, C(5)H), 7.68 (1H, dd, J 7.8, 1.2, C(3)H), 8.48 (2H, bs, C(9)H & 
C(10)H); C (DMSO-d6, 75.5 MHz) 111.6 (C(8)H & C(11)H), 116.3 (qC-2), 123.0 (C(6)H), 127.2 
(C(4)H), 129.1 (C(5)H), 134.3 (C(3)H), 150.8 (qC-1), 151.5 (C(9)H & C(10)H), 164.0 (qC-7); HRMS 
(ESI-TOF) m/z: [M+H]+ calcd. for C11H9BrNO: 249.9862, found 249.9856. 
Spectral characteristics are consistent with previously reported data.22  
6.3.10 Procedure for synthesis of 4-(2-bromophenoxy)pyridine N-oxide (198) 
Synthesised according to the general procedure using 4-(2-
bromophenoxy)pyridine (197) (150 mg, 0.599 mmol, 1 equiv.). The 
crude product was purified by column chromatography (DCM (100%), 
DCM:MeOH, 94:6). Yellow oil (149 mg, 94%); max/cm1 (NaCl): 1624 
(aromatic C=C stretch), 1467 (aromatic C=C stretch), 1272 (C-O stretch), 1207 (C-N stretch), 
1045 (C-O stretch), 839 (aromatic C=C bend), 715 (C-Br stretch); H (DMSO-d6, 300 MHz) 6.92-
7.00 (2H, m, C(8)H & C(11)H), 7.28 (1H, ddd, J 8.2, 7.4, 1.6, C(4)H), 7.34 (1H, dd, J  8.2, 1.6, 
C(6)H), 7.51 (1H, ddd, J 8.2, 7.4, 1.6 C(5)H), 7.80 (1H, dd, J 8.1, 1.5, C(3)H), 8.11-8.22 (2H, m, 
C(9)H & C(10)H); C (DMSO-d6, 75.5 MHz) 115.1 (C(8)H & C(11)H), 115.3 (qC-2), 123.1 (C(6)H), 
128.1 (C(4)H), 130.4 (C(5)H), 134.6 (C(3)H), 140.6 (C(9)H & C(10)H), 151.1 (qC-1), 154.2 (qC-
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6.4 Palladium catalysed intramolecular double C-H activation  
6.4.1 General procedures for intramolecular double C-H activation of 2-coumarins, 2-
pyrones and related heterocycles. Synthesis of compounds 25, 41-51, 73-85. 
Conditions A: Pyrone, coumarin (50 mg, 1.0 equiv.) or quinolone (50 mg, 1.0 equiv.), Pd(OAc)2 
(10 mol%), Ag2O (1.5 equiv.), NaOtBu (0.2 equiv.) and pivalic acid (PivOH) (0.5M) were added 
to a sealed reaction vial equipped with a magnetic stir bar. The resulting mixture was stirred 
at 140 ºC under air atmosphere in a multi reaction heating mantle for 3 hours (pyrones) or 16 
hours (coumarins and quinolone). Upon cooling, the mixture was diluted with DCM and 
filtered through a plug of Celite®. The reaction mixture was then diluted with DCM (15 mL) 
and washed with aqueous NaOH (10% w/v, 3 x 15 mL). The organic layer was then dried over 
MgSO4, filtered and concentrated under reduced pressure. The residues were then flushed 
through silica gel using DCM as eluent to afford the title products, which were purified by 
recrystallisation from DCM:hexanes.  
Conditions B: Pyrone, coumarin (50 mg, 1.0 equiv.) or quinolone (50 mg, 1.0 equiv.), Pd(OAc)2 
(5 mol%), Ag2O (1.5 equiv.), K2CO3 (2.5 equiv.) and TFA (0.4M) were added to a sealed reaction 
vial equipped with a stir bar. The resulting mixture was stirred at 140 ᵒC under air atmosphere 
in a muti reaction heating mantle for 16 hours (pyrones and coumarins) or 21 hours 
(quinolone). Upon cooling, the reaction mixture was concentrated under reduced pressure. 
The residue was flushed through silica gel using DCM as eluent to afford the title products, 
which were purified by recrystallisation from DCM:hexanes. 
3-Methyl-1H-pyrano[4,3-b]benzofuran-1-one (25)2-3  
Conditions A. White solid (74 mg, 52%) 
Conditions B. White solid (77 mg, 56%) 
Compound 24 (141 mg, 0.70 mmol, 1.0 equiv.) was used as the substrate 
in the general procedure 6.4.1. m.p. 190-191 °C (lit. 187-188 °C); H (CDCl3, 300 MHz) 2.43 
(3H, s, C(7)H3), 6.54 (1H, s, C(5)H), 7.36-7.47 (2H, m, C(9)H & C(11)H), 7.50-7.58 (1H, m, 
C(10)H), 7.97-8.10 (1H, m, C(12)H); C (CDCl3, 75.5 MHz) 20.6 (C(7)H3), 95.9 (C(5)H), 103.7 (qC-
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3), 111.5 (C(9)H), 121.4 (C(12)H), 122.9 (qC-13), 125.0 (C(11)H), 126.1 (C(10)H), 154.9 (qC-8), 
159.5 (qC-6), 162.9 (qC-2), 164.5 (qC-4); m/z (ES+): 201, [(M+H)+, 80%].  
Spectral characteristics were consistent with previously reported data.2-3 
3,8-Dimethyl-1H-pyrano[4,3-b]benzofuran-1-one (41)2-3 
Conditions A. White solid (25 mg, 56%) 
Compound 30 (45 mg, 0.21 mmol, 1.0 equiv.) was used as the 
substrate in the general procedure 6.4.1. m.p. 159-160 °C (lit. 159-
160 °C); H (CDCl3, 300 MHz) 2.41 (3H, d, J 0.9, C(7)H3), 2.48 (3H, s, 
C(14)H3), 6.50 (1H, d, J 0.9, C(5)H), 7.17-7.23 (1H, m, C(9)H), 7.40 (1H, d, J 8.5, C(10)H), 7.80-
7.85 (1H, m, C(12)H); C (CDCl3, 75.5 MHz) 20.6 (C(7)H3), 21.3 (C(14)H3), 96.0 (C(5)H), 103.5 
(qC-3), 110.9 (C(9)H), 121.2 (C(12)H), 122.9 (qC-13), 127.2 (C(10)H), 134.8 (qC-11), 153.4 (qC-
8), 159.6 (qC-6), 162.6 (qC-2), 164.6 (qC-4); m/z (ES+): 215, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.2-3 
8-Methoxy-3-methyl-1H-pyrano[4,3-b]benzofuran-1-one (42)2-3 
Conditions A. White solid (22 mg, 42%) 
Compound 31 (53 mg, 0.23 mmol, 1.0 equiv.) was used as the 
substrate in the general procedure 6.4.1. m.p. 152-154 °C (lit. 152-
154 °C); H (CDCl3, 300 MHz) 2.42 (3H, s, C(7)H3), 3.89 (3H, s, C(14)H3), 
6.50 (1H, s, C(5)H), 6.97 (1H, dd, J 9.0, 2.7, C(9)H), 7.45 (2H, dd, J 7.4, 5.8, C(10)H & C(12)H); 
C (CDCl3, 75.5 MHz) 20.6 (C(7)H3), 56.0 (C(14)H3), 96.0 (C(5)H), 103.3 (C(9)H), 103.9 (qC-3), 
112.0 (C(12)H), 115.1 (C(10)H), 123.7 (qC-13), 149.6 (qC-11), 157.5 (qC-8), 159.6 (qC-6), 162.6 
(qC-2), 165.0 (qC-4); m/z (ES+): 231, [(M+H)+, 100%].  
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7-Methyl-3-methyl-1H-pyrano[4,3-b]benzofuran-1-one 48a2-3  
Conditions A. Yellow solid (65 mg, 44%) 
Compound 34 (150 mg, 0.69 mmol, 1.0 equiv.) was used as the substrate 
in the general procedure 6.4.1. m.p. 138-139 °C (lit. 139-141 °C); H 
(CDCl3, 300 MHz) 2.41 (3H, d, J 0.8, C(7)H3), 2.50 (3H, s, C(14)H3), 6.51 
(1H, s, C(5)H), 7.23 (1H, d, J 7.3, C(11)H), 7.34 (1H, s, C(9)H), 7.89 (1H, d, J 7.9, C(12)H); C 
(CDCl3, 75.5 MHz) 20.5 (C(7)H3), 21.8 (C(14)H3), 96.0 (C(5)H), 103.7 (qC-3), 111.7 (C(9)H), 120.2 
(qC-13), 120.8 (C(12)H), 126.2 (C(11)H), 136.7 (qC-10), 155.4 (qC-8), 159.6 (qC-6), 162.4 (qC-
2), 164.2 (qC-4); m/z (ES+): 215, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.2-3 
7-Methoxy-3-methyl-1H-pyrano[4,3-b]benzofuran-1-one (49a)2-3 
Conditions A. White solid (12 mg, 20%) 
Compound 35 (60 mg, 0.26 mmol, 1.0 equiv.) was used as the substrate 
in the general procedure 6.4.1. m.p. 164-166 °C (lit. 158-159 °C); H 
(CDCl3, 300 MHz) 2.41 (3H, s, C(7)H3), 3.88 (3H, s, OC(14)H3), 6.50 (1H, s, 
C(5)H), 7.01 (1H, dd, J 8.6, 2.2, C(11)H), 7.07 (1H, d, J 2.1, C(9)H), 7.88 
(1H, d, J 8.5, C(12)H); C (CDCl3, 75.5 MHz) 20.5 (C(7)H3), 55.8 (OC(14)H3), 95.9 (C(5)H), 96.8 
(C(9)H), 103.8 (qC-3), 113.0 (C(11)H), 115.9 (qC-13), 121.5 (C(12)H), 156.1 (qC-8), 159.2 (qC-
10), 159.6 (qC-6), 161.7 (qC-2), 164.0 (qC-4); m/z (ES+): 231, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.2-3 
7-Fluoro-3-methyl-1H-pyrano[4,3-b]benzofuran-1-one (50a)2-3 
Conditions A. White solid (64 mg, 65%) 
Compound 36 (100 mg, 0.45 mmol, 1.0 equiv.) was used as the substrate 
in the general procedure 6.4.1. m.p. 207-209 °C (lit. 201-202 °C); H 
(CDCl3, 300 MHz) 2.43 (3H, d, J 0.8, C(7)H3), 6.53 (1H, d, J 0.9, C(5)H), 
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7.17 (1H, ddd, J 9.4, 8.6, 2.3, C(11)H), 7.25-7.30 (1H, m, C(9)H), 7.96 (1H, dd, J 8.6, 5.4, C(12)H); 
C (CDCl3, 75.5 MHz) 20.6 (C(7)H3), 95.8 (C(5)H), 99.8 (C(9)H, d, JC-F 27), 103.5 (qC-3), 113.0 
(C(11)H, d, JC-F 24), 119.2 (qC-13, d, JC-F 2), 121.8 (C(12)H, d, JC-F 10), 154.9 (qC-8, d, JC-F 20), 
159.3 (qC-6), 161.5 (qC-10, d, JC-F 246), 162.8 (qC-2), 165.0 (qC-4); m/z (ES+): 219, [(M+H)+, 
100%].  
Spectral characteristics were consistent with previously reported data.2-3 
3-Methyl-1H-naphtho[2',3':4,5]furo[3,2-c]pyran-1-one (51a)3 and 9-Methyl-7H-
naphtho[2',1':4,5]furo[3,2-c]pyran-7-one (51b)3 
Compound 40 (100 mg, 0.396 mmol, 1.0 equiv.) was used as the substrate in the general 
procedure 6.4.1. Compounds 51a and 51b were obtained as a mixture with a ratio of 80:20 
(Conditions A and Conditions B) determined from the 1H NMR spectrum of the crude reaction 
mixture. 
3-Methyl-1H-naphtho[2',3':4,5]furo[3,2-c]pyran-1-one (51a)3 
Conditions A. White solid (13 mg, 13%) 
Conditions B. White solid (11 mg, 11%) 
m.p. 157-159 °C; max/cm1 (NaCl): 1727 (ester C=O stretch), 1572 
(alkene C=C stretch), 1261 (ester C-O stretch), 1096 (ether C-O 
stretch); H (CDCl3, 300 MHz) 2.47 (3H, d, J 0.7, C(7)H3), 6.58 (1H, d, J 0.8, C(5)H), 7.49-7.56 
(2H, m, C(12)H & C(13)H), 7.91-7.98 (2H, m, C(9)H & C(11)H), 8.00-8.06 (1H, m, C(14)H), 8.49 
(1H, s, C(16)H); C (CDCl3, 75.5 MHz) 20.9 (C(7)H3), 96.1 (C(5)H), 103.0 (qC-3), 107.5 (C(9)H), 
119.8 (C(16)H), 122.9 (qC-17), 125.3 (C(13)H), 126.0 (C(12)H), 128.0 (C(11)H), 128.4 (C(14)H), 
131.4 (qC-15), 131.9 (qC-10), 153.6 (qC-8), 159.4 (qC-6), 164.5 (qC-2), 166.9 (qC-4); m/z (ES+): 
251, [(M+H)+, 10%]; HRMS (ESI-TOF) Exact mass calculated for C16H11O3 [M+H+], 251.0708. 
Found 251.0713.  
Spectral characteristics were consistent with previously reported data.3  




Conditions A. White solid (25 mg, 25%) 
Conditions B. White solid (36 mg, 37%) 
m.p. 164-167 °C; max/cm1 (NaCl): 1735 (ester C=O stretch), 1652 
(alkene C=C stretch), 1566 (aromatic C=C stretch); H (CDCl3, 300 MHz) 
2.46 (3H, d, J 0.9, C(7)H3), 6.60 (1H, d, J 0.9, C(5)H), 7.57 (1H, ddd, J 8.2, 6.9, 1.3, C(11)H), 7.65-
7.74 (2H, m, C(12)H & C(15)H), 7.86 (1H, d, J 8.9, C(16)H), 7.95 (1H, d, J 8.2, C(13)H), 9.59-9.66 
(1H, m, C(10)H); C (CDCl3, 75.5 MHz) 20.4 (C(7)H3), 96.0 (C(5)H), 105.7 (qC-3), 111.5 (C(16)H), 
118.6 (qC-17), 125.7 (C(15)H), 127.1 (C(10)H), 127.3 (C(12)H), 127.8 (C(11)H), 128.0 (qC-9), 
128.4 (C(13)H), 131.3 (qC-14), 152.6 (qC-8), 160.0 (qC-2), 162.0 (qC-6), 163.8 (qC-4); m/z (ES+): 
251, [(M+H)+, 10%]; HRMS (ESI-TOF) Exact mass calculated for C16H11O3 [M+H+], 251.0708. 
Found 250.0705.  
Spectral characteristics were consistent with previously reported data.3 
6H-Benzofuro[3,2-c]chromen-6-one (73)2-3 
Conditions A. White solid, (46 mg, 92%) 
Conditions B. White solid, (38 mg, 75%) 
4-Phenoxy-2-coumarin (55) was used as the substrate in the general 
Procedure 6.4.1. m.p. 177-180 °C (lit. 177-180 °C); H (CDCl3, 300 MHz) 7.38-7.55 (4H, m, 
C(7)H, C(9)H, C(13)H & C(14)H), 7.59-7.72 (2H, m, C(8)H & C(12)H), 8.05 (1H, dd, J 7.8, 1.3, 
C(6)H), 8.12-8.19 (1H, m, C(15)H); C (CDCl3, 75.5 MHz) 105.9 (qC-3), 111.8 (C(12)H), 112.6 
(qC-5), 117.5 (C(9)H), 121.9 (C(6)H & C(15)H), 123.4 (qC-16), 124.7 (C(7)H), 125.2 (C(14)H), 
126.8 (C(13)H), 132.0 (C(8)H), 153.7 (qC-10), 155.5 (qC-11), 158.1 (qC-2), 160.0 (qC-4); m/z 
(ES+): 237, [(M+H)+, 20%]; HRMS (ESI-TOF): Exact mass calculated for C15H9O3 [M+H+], 
237.0552. Found 237.0547.  
Spectral characteristics were consistent with previously reported data.2-3 
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8-Methyl-6H-benzofuro[3,2-c]chromen-6-one (74)3, 35 
Conditions A. Light brown solid, (36 mg, 72%) 
Conditions B. Light brown solid, (32 mg, 65%) 
4-(4-Methylphenoxy)-2H-chromene-2-one (56) was used as the 
substrate in the general procedure 6.4.1. m.p. 189-190 °C (lit. 201-202 °C); H (CDCl3, 300 
MHz) 2.52 (3H, s, C(17)H3), 7.27-7.31 (1H, m, C(13)H), 7.38-7.46 (1H, m, C(7)H), 7.48-7.67 (3H, 
m, C(7)H, C(9)H & C(15)H), 7.93-7.97 (1H, m, C(8)H), 8.03 (1H, dd, J 7.8, 1.5, C(6)H); C (CDCl3, 
75.5 MHz) 21.4 (C(17)H3), 105.7 (qC-3), 111.2 (C(12)H), 112.8 (qC-5), 117.5 (C(9)H), 121.7 
(C(15)H), 121.8 (C(13)H), 123.5 (qC-16), 124.6 (C(6)H), 128.0 (C(7)H), 131.8 (C(8)H), 135.2 (qC-
14), 153.6 (qC-10), 154.0 (qC-11), 158.3 (qC-2), 160.1 (qC-4); m/z (ES+): 251, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.3, 35 
8-Methoxy-6H-benzofuro[3,2-c]chromen-6-one (75)3, 36 
Conditions A. Yellow solid, (38 mg, 77%) 
Conditions B. Yellow solid, (21 mg, 42%) 
4-(4-Methoxyphenoxy)-2H-chromene-2-one (57) was used as the 
substrate in the general procedure 6.4.1. m.p. 224-227 °C (lit. 229-230 °C); H (CDCl3, 300 
MHz) 3.92 (3H, s, C(17)H3), 7.05 (1H, dd, J 9.0, 2.7, C(13)H), 7.41 (1H, ddd, J 7.8, 7.3, 1.2, C(7)H), 
7.47-7.65 (4H, m, C(6)H, C(8)H, C(9)H & C(12)H), 8.00 (1H, dd, J 7.8, 1.6, C(15)H); C (CDCl3, 
75.5 MHz) 56.0 (C(17)H3), 103.4 (C(16)H), 106.0 (qC-3), 112.4 (C(13)H), 112.8 (qC-5), 116.1 
(C(12)H), 117.5 (C(9)H), 121.8 (C(6)H), 124.2 (qC-16), 124.7 (C(7)H), 131.8 (C(8)H), 150.3 (qC-
14), 153.5 (qC-11), 157.6 (qC-10), 158.3 (qC-2), 160.4 (qC-4); m/z (ES+): 267, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.3, 36 
 
 




Conditions A. Orange solid, (47 mg, 95%) 
Conditions B. Orange solid, (35 mg, 70%) 
4-(4-Nitrophenoxy)-2H-chromene-2-one (59) was used as the 
substrate in the general procedure 6.4.1. m.p. >230 °C; max/cm1 (NaCl): 1746 (ester C=O 
stretch), 1531 (aromatic C=C stretch), 1350 (N=O stretch), 1085 (ester C-O stretch), 1057 
(ether C-O stretch); H (CDCl3, 300 MHz) 7.44-7.52 (1H, m, C(7)H), 7.56 (1H, d, J 7.9, C(9)H), 
7.71 (1H, ddd, J 8.8, 7.3, 1.6, C(8)H), 7.81 (1H, d, J 9.1, C(12)H), 8.07 (1H, dd, J 7.9, 1.4, C(6)H), 
8.43 (1H, dd, J 9.1, 2.4, C(13)H), 9.05 (1H, d, J 2.2, C(15)H); C (CDCl3, 75.5 MHz) 105.9 (qC-3), 
111.9 (qC-5), 112.4 (C(12)H), 117.8 (C(9)H), 118.1 (C(15)H), 122.1 (C(6)H), 122.5 (C(13)H), 
124.4 (qC-16), 125.2 (C(7)H), 133.3 (C(8)H), 145.8 (qC-14), 154.1 (qC-10), 157.0 (qC-11), 157.9 
(qC-2), 162.5 (qC-4); HRMS (ESI-TOF): Exact mass calculated for C15H8NO5 [M+H+], 282.0402. 
Found 282.0396.  
Spectral characteristics were consistent with previously reported data.3 
8-Fluoro-6H-benzofuro[3,2-c]chromen-6-one (77)3, 35  
Conditions A. Yellow solid, (40 mg, 80%) 
Conditions B. Yellow solid, (48 mg, 85%) 
4-(4-Fluorophenoxy)-2H-chromene-2-one (58) was used as the 
substrate in the general procedure 6.4.1. m.p. 224-225 °C (lit. 223-224 °C); H (CDCl3, 300 
MHz) 7.15-7.24 (1H, td, J 18.0, 9.0, 2.7, C(13)H), 7.38-7.47 (1H, m, C(15)H), 7.48-7.55 (1H, dd, 
J 8.4, 0.7, C(9)H), 7.58-7.68 (2H, m, C(7)H & C(12)H), 7.77 (1H, ddapp, J 7.9, 2.7, C(8)H), 7.99-
8.05 (1H, dd, J 7.9, 1.5, C(6)H); C (CDCl3, 75.5 MHz) 106.0 (qC-3, d, JC-F 4), 107.8 (C(15)H, d, JC-
F 21), 112.7 (C(12)H, d, JC-F 10), 112.5 (qC-5), 114.5 (C(13)H, d, JC-F 21), 117.6 (C(9)H), 118.3 
(C(6)H), 121.9 (C(7)H), 124.6 (qC-16, d, JC-F 12), 132.4 (C(8)H), 151.6 (qC-11), 153.8 (qC-10), 
157.7 (qC-2), 160.4 (qC-14, d, JC-F 237), 161.6 (qC-4); m/z (ES+): 255, [(M+H)+, 20%].  
Spectral characteristics were consistent with previously reported data.3, 35 
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8-Chloro-6H-benzofuro[3,2-c]chromen-6-one (78)3, 35 
Conditions A. Light brown solid, (49 mg, 99%) 
Conditions B. Light brown solid, (49 mg, 99%) 
4-(4-Chlorophenoxy)-2H-chromene-2-one (60) was used as the 
substrate in the general procedure 6.4.1. m.p. 220-222 °C (lit. 227-228 °C); H (CDCl3, 300 
MHz) 7.39-7.46 (2H, m, C(7)H & C(13)H), 7.48-7.53 (1H, dd, J 8.4, 0.7, C(12)H), 7.56-7.68 (2H, 
m, C(8)H & C(9)H), 8.00 (1H, dd, J 7.8, 1.5, C(6)H), 8.09-8.12 (1H, dd app, J 2.2, 0.4, C(15)H); C 
(CDCl3, 75.5 MHz) 105.3 (qC-3), 112.3 (qC-5), 112.8 (C(12)H), 117.6 (C(9)H), 121.6 (C(15)H), 
122.0 (C(6)H), 124.9 (C(7)H, Coverlapping qC-16), 127.0 (C(13)H), 131.1 (qC-14), 132.5 (C(8)H), 
153.8 (qC-10), 153.8 (qC-11), 157.6 (qC-2), 161.0 (qC-4); m/z (ES+): 271, [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.3, 35 
9-Tert-butyl-6H-benzofuro[3,2-c]chromen-6-one (79)3 
Conditions A. Yellow solid (27 mg, 56%) 
Conditions B. Yellow solid, (44mg, 89%) 
4-(4-Tert-butylphenoxy)-2H-chromene-2-one (61) was used as 
the substrate in the general procedure 6.4.1. m.p. 167-171°C; max/cm1 (NaCl): 1743 (ester 
C=O stretch), 1630 (alkene C=C stretch), 1451 (aromatic C=C stretch), 1080 (ether C-O 
stretch), 754 (alkene C-H bend); H (CDCl3, 300 MHz) 1.43 (9H, s, C(18)H3, C(19)H3 & C(20)H3), 
7.38-7.46 (1H, m, C(13)H), 7.49-7.65 (4H, m, C(7)H, C(8)H, C(9)H & C(12)H), 8.00-8.06 (1H, dd, 
J 7.88, 1.54, C(6)H), 8.13-8.16 (1H, ddapp, J 1.93, 0.66, C(15)H); C (CDCl3, 75.5 MHz) 31.8 ( 
C(18)H3, C(19)H3 & C(20)H3), 35.1 (qC-17), 106.0 (qC-3), 111.0 (C(12)H), 112.8 (qC-5), 117.5 
(C(9)H), 118.3 (C(15)H), 121.8 (C(6)H), 123.2 (qC-16), 124.6 (C(7)H), 124.7 (C(13)H), 131.8 
(C(8)H), 148.8 (qC-14), 153.6 (qC-10), 153.8 (qC-11), 158.3 (qC-2), 160.2 (qC-4); m/z (ES+): 293, 
[(M+H)+, 97%]; HRMS (ESI-TOF): Exact mass calculated for C19H17O3 [M+H+], 293.3162. Found 
295.1488.  
Spectral characteristics were consistent with previously reported data.3 
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9-Methyl-6H-benzofuro[3,2-c]chromen-6-one (80)3, 37 
Conditions A. Light brown solid, (27 mg, 55%) 
Conditions B. Light brown solid, (28 mg, 57%) 
4-(3-Methylphenoxy)-2H-chromene-2-one (62) was used as the 
substrate in the general procedure 6.4.1. m.p. 182-185 °C (lit. 198-
200 °C); H (CDCl3, 300 MHz) 2.53 (3H, s, C(17)H3), 7.22-7.29 (1H, m, C(12)H), 7.35-7.42 (1H, 
m, C(14)H), 7.42-7.51 (2H, m, C(7)H & C(9)H), 7.53-7.62 (1H, m, C(8)H), 7.93-8.03 (2H, m, C(6)H 
& C(15)H); C (CDCl3, 75.5 MHz) 22.0 (C(17)H3), 106.0 (qC-3), 112.0 (C(12)H), 112.8 (qC-5), 
117.3 (C(9)H), 120.8 (qC-16), 121.3 (C(14)H), 121.8 (C(6)H), 124.6 (C(7)H), 126.6 (C(15)H), 
131.6 (C(8)H), 137.5 (qC-13), 153.5 (qC-10), 156.0 (qC-11), 158.2 (qC-2), 159.6 (qC-4); m/z 
(ES+): 251 [(M+H)+, 10%]; HRMS (ESI-TOF): Exact mass calculated for C16H11O3 [M+H+], 
251.0702. Found 251.0702.  
Spectral characteristics were consistent with previously reported data.3, 37 
9-Methoxy-6H-benzofuro[3,2-c]chromen-6-one (81a)3, 37 
Conditions A. White solid, (16.4 mg, 33%) 
Conditions B. White solid, (19.2 mg, 38%) 
4-(3-Methoxyphenoxy)-2H-chromene-2-one (63) was used as the 
substrate in the general procedure 6.4.1. m.p. 210-211 °C (lit. 216 
°C); H (CDCl3, 300 MHz) 3.92 (3H, s, C(17)H3), 7.07 (1H, dd, J 8.6, 2.2, C(14)H), 7.20 (1H, d, J 
2.2, C(12)H), 7.41 (1H, ddd, J 7.9, 7.2, 1.2, C(7)H), 7.50 (1H, dd, J 8.4, 0.8, C(9)H), 7.54-7.63 
(1H, m, C(8)H), 7.96-8.03 (2H, m, C(6)H & C(15)H); C (CDCl3, 75.5 MHz) 56.9 (C(17)H3), 96.8 
(C(12)H), 106.1 (qC-3), 112.9 (qC-5), 113.6 (C(14)H), 116.5 (qC-16), 117.4 (C(9)H), 121.5 
(C(15)H), 122.0 (C(6)H), 124.6 (C(7)H), 131.3 (C(8)H), 153.2 (qC-10), 156.8 (qC-11), 158.2 (qC-
13), 159.3 (qC-2), 159.7 (qC-4); m/z (ES+): 267, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass 
calculated for C16H11O4 [M+H+], 267.0657. Found 267.0656.  
Spectral characteristics were consistent with previously reported data.3, 37 




Conditions A. (not isolated) 
Conditions B. White solid, (24 mg, 47%) 
4-(3-Methoxyphenoxy)-2H-chromene-2-one (63) was used as the 
substrate in the general procedure 6.4.1. m.p. 200-201 °C; max/cm1 (NaCl): 1746 (ester C=O 
stretch), 1627 (alkene C=C stretch), 1502 (aromatic C=C stretch), 1364 (ester C-O stretch), 
1271 (ether C-O stretch); H (CDCl3, 300 MHz) 4.07 (3H, s, C(17)H3), 6.90 (1H, d, J 8.1, C(14)H), 
7.28 (1H, dd, J 8.1, 0.8, C(12)H), 7.35-7.52 (3H, m, C(7)H, C(9)H & C(13)H), 7.58 (1H, ddd, J 8.7, 
7.2, 1.6, C(8)H), 8.01 (1H, dd, J 7.8, 1.2, C(6)H); C (CDCl3, 75.5 MHz) 55.9 (C(17)H3), 96.7 
(C(12)H), 106.0 (qC-3), 112.8 (qC-5), 113.6 (C(14)H), 116.4 (qC-16), 117.4 (C(9)H), 121.5 
(C(13)H), 122.0 (C(6)H), 124.6 (C(7)H), 131.3 (C(8)H), 153.2 (qC-10), 156.8 (qC-11), 158.2 (qC-
15), 159.3 (qC-2), 159.7 (qC-4); m/z (ES+): 267, [(M+H)+, 20%]; HRMS (ESI-TOF): Exact mass 
calculated for C16H11O4 [M+H+], 267.0657. Found 267.0657.  
Spectral characteristics were consistent with previously reported data.3 
9-Fluoro-6H-benzofuro[3,2-c]chromen-6-one (82a)3  
Conditions A. White solid, (55.3 mg, 56%) 
Conditions B. White solid, (16.5 mg, 17%) 
4-(3-Fluorophenoxy)-2H-chromene-2-one (64) (100 mg, 0.39 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.4.1. m.p. 
>230 °C; max/cm1 (NaCl): 1754 (ester C=O stretch), 1632 (alkene C=C stretch), 1413 (C-F 
stretch), 1080 (ether C-O stretch), 750 (alkene C-H bend); H (CDCl3, 300 MHz) 7.22 (1H, dd, J 
8.7, 2.2, C(14)H), 7.37-7.47 (2H, m, C(7)H & C(12)H), 7.52 (1H, d, J 7.7, C(9)H), 7.63 (1H, ddd, 
J 8.7, 7.3, 1.6, C(8)H), 8.02 (1H, dd, J 7.8, 1.5, C(6)H), 8.09 (1H, dd, J 8.6, 5.4, C(15)H); C (CDCl3, 
75.5 MHz) 100.0 (C(12)H, d, JC-F 26), 105.7 (qC-3), 112.5 (qC-5), 113.5 (C(14)H, d, JC-F 25), 117.5 
(C(9)H), 119.7 (qC-16, d, JC-F 2), 121.7 (C(6)H), 122.4 (C(15)H, d, JC-F 10), 124.8 (C(7)H), 132.0 
(C(8)H), 153.5 (qC-10), 155.6 (qC-11, d, JC-F 14), 157.8 (qC-2), 160.4 (qC-4, d, JC-F 2), 163.6 (qC-
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13, d, JC-F 249); F (CDCl3, 282 MHz) -112.5; m/z (ES+): 255 [(M+H)+, 10%]; HRMS (ESI-TOF): 
Exact mass calculated for C15H8O3F [M+H+], 255.0457. Found 255.0452.  
Spectral characteristics were consistent with previously reported data.3 
7-Fluoro-6H-benzofuro[3,2-c]chromen-6-one (82b)3  
Conditions A. (12 mg, 12%) 
Conditions B. White solid, (7 mg, 7%) 
4-(3-Fluorophenoxy)-2H-chromene-2-one (64) was used as the 
substrate in the general procedure 6.4.1. m.p. >230 °C max/cm1 (NaCl): 1748 (ester C=O 
stretch), 1634 (alkene C=C stretch), 1089 (ether C-O stretch), 741 (C-F stretch); H (CDCl3, 300 
MHz) 7.18 (1H, ddd, J 9.0, 7.6, 1.3, C(14)H), 7.38-7.56 (4H, m, C(7)H, C(9)H, C(12)H & C(13)H), 
7.64 (1H, ddd, J 8.7, 7.3, 1.6, C(8)H), 8.04 (1H, dd, J 7.8, 1.4, C(6)H); C (CDCl3, 75.5 MHz) 104.7 
(qC-3, d, JC-F 4), 108.0 (C(12)H, d, JC-F 5), 111.9 (C(14)H, d, JC-F 20), 112.1 (qC-5), 117.5 (C(9)H), 
122.0 (C(6)H), 112.6 (qC-16, d, JC-F 22), 124.7 (C(7)H), 127.8 (C(13)H, d, JC-F 8), 132.4 (C(8)H), 
154.0 (qC-10), 156.3 (qC-15, d, JC-F 257), 156.6 (qC-2), 157.0 (qC-11, d, JC-F 9), 160.2 (qC-4, d, 
JC-F 1); F (CDCl3, 282 MHz) -111.0; m/z (ES+): 255 [(M+H)+, 10%]; HRMS (ESI-TOF): Exact mass 
calculated for C15H8O3F [M+H+], 255.0457. Found 255.0455.  
Spectral characteristics were consistent with previously reported data.3 
8, 9-Dimethoxy-6H-benzofuro[3,2-c]chromen-6-one (83)3, 37 
Conditions A. Yellow solid, (38 mg, 76%) 
Conditions B. Yellow solid, (22 mg, 43%) 
4-(3,4-Dimethoxyphenoxy)-2H-chromene-2-one (67) was used as 
the substrate in the general procedure 6.4.1. m.p. 214-215 °C (lit. 
219-220 °C); H (CDCl3, 300 MHz) 3.99 (3H, s, C(18)H3), 4.01 (3H, s, C(17)H3), 7.19 (1H, s, 
C(12)H), 7.35-7.43 (1H, m, C(7)H), 7.48 (1H, dd, J 8.4, 0.8, C(9)H), 7.51 (1H, s, C(15)H), 7.53-
7.60 (1H, m, C(8)H) 7.95 (1H, dd, J 7.8, 1.3, C(6)H); C (CDCl3, 75.5 MHz) 56.5 (C(17)H3 & 
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C(18)H3), 95.5 (C(12)H), 102.2 (C(15)H), 106.3 (qC-3), 113.0 (qC-5), 115.4 (qC-16), 117.4 
(C(9)H), 121.3 (C(6)H), 124.6 (C(7)H), 131.1 (C(8)H), 148.1 (qC-13), 149.6 (qC-14), 150.4 (qC-
11), 153.0 (qC-10), 158.5 (qC-2), 158.9 (qC-4); m/z (ES+): 297, [(M+H)+, 20%].  
Spectral characteristics were consistent with previously reported data.3, 37 
7,9-Dimethoxy-6H-benzofuro [3,2-c]chromen-6-one (84)3 
Conditions A. Orange solid, (48 mg, 98%) 
Conditions B. Orange solid, (24 mg, 48%) 
4-(3,5-Dimethoxyphenoxy)-2H-chromene-2-one (66) was used as 
the substrate in the general procedure 6.4.1. m.p. 218-220 °C; 
max/cm1 (NaCl): 1742 (ester C=O stretch), 1628 (alkene C=C stretch), 1508 (aromatic C=C 
stretch), 1304 (ester C-O stretch), 1149 (ether C-O stretch), 1088 (ether C-O stretch); H 
(CDCl3, 300 MHz) 3.90 (3H, s, C(17)H3), 4.02 (3H, s, C(18)H3), 6.48 (1H, d, J 2.0, C(12)H), 6.78 
(1H, d, J 2.0, C(14)H), 7.36 (1H, ddd, J 8.3, 7.2, 1.3, C(7)H), 7.43-7.59 (2H, m, C(8)H & C(9)H), 
7.94 (1H, dd, J 7.8, 1.2, C(6)H); C (CDCl3, 75.5 MHz) 55.9 (C(17)H3), 56.3 (C(18)H3), 88.6 
(C(12)H), 96.5 (C(14)H), 106.1 (qC-16), 106.8 (qC-3), 112.5 (qC-5), 117.1 (C(9)H), 121.3 (C(6)H), 
124.4 (C(7)H), 131.1 (C(8)H), 153.1 (qC-10), 155.0 (qC-11), 157.1 (qC-13), 157.7 (qC-15), 158.4 
(qC-2), 161.0 (qC-4); m/z (ES+): 297, [(M+H)+, 100%]; HRMS (ESI-TOF): Exact mass calculated 
for C17H13O5 [M+H+], 297.0763. Found 297.0758.  
Spectral characteristics were consistent with previously reported data.3 
10-Methyl-6H-benzofuro [3,2-c]chromen-6-one (85)3  
Conditions A. Orange solid, (36 mg, 72%) 
Conditions B. Orange solid, (21 mg, 41%) 
4-(2-Methylphenoxy)-2H-chromene-2-one (65) was used as the 
substrate in the general procedure 6.4.1. m.p. 123-125 °C max/cm1 
(NaCl): 1735 (ester C=O stretch), 1627 (alkene C=C stretch), 1597 (aromatic C=C stretch), 1371 
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(ester C-O stretch), 1082 (ether C-O stretch); H (CDCl3, 300 MHz) 2.63 (3H, s, C(17)H3), 7.20-
7.44 (3H, m, C(7)H, C(13)H & C(14)H), 7.48 (1H, d, J 7.7, C(9)H), 7.59 (1H, ddd, J 8.7, 7.3, 1.6, 
C(8)H), 7.94 (1H, d, J 7.6, C(6)H), 8.04 (1H, dd, J 7.8, 1.4, C(15)H); C (CDCl3, 75.5 MHz) 15.0 
(C(17)H3), 106.2 (qC-3), 112.8 (qC-5), 117.5 (C(9)H), 119.3 (C(13)H), 121.9 (C(6)H), 122.1 (qC-
12), 123.0 (qC-16), 124.6 (C(7)H), 125.3 (C(15)H), 127.9 (C(14)H), 131.8 (C(8)H), 153.6 (qC-10), 
154.6 (qC-11), 158.3 (qC-2), 159.7 (qC-4); m/z (ES+): 251, [(M+H)+, 10%]. HRMS (ESI-TOF): 
Exact mass calculated for C16H11O3 [M+H+], 251.0702. Found 251.0704.  
Spectral characteristics were consistent with previously reported data.3 
5-Methylbenzofuro[3,2-c]quinolin-6(5H)-one (101)3, 38 
Conditions A. White solid, (26.2 mg, 30%) 
Modified Conditions B. Compound 100 (50 mg, 0.20 mmol, 1.0 
equiv.), Pd(OAc)2 (5 mol%), Ag2O (1.5 equiv.), K2CO3 (2.5 equiv.) and 
TFA (0.4 M) were added to a reaction vial. The resulting mixture 
was stirred at 120 ºC under air atmosphere in a multi reaction 
heating mantle for 21 hours. Upon cooling, the reaction mixture was concentrated under 
reduced pressure. The crude product was purified by column chromatography using 
hexanes/EtOAc, 90/10 as eluent to afford title product 101. White solid, (26 mg, 33%), m.p.: 
195-197 °C (lit. 202-204 °C); H (CDCl3, 300 MHz) 3.75 (3H, s, NC(11)H3), 7.27 (1H, t, J 7.5, 
C(7)H), 7.31-7.43 (3H, m, C(9)H, C(14)H & C(15)H), 7.47-7.60 (2H, m, C(13)H & C(8)H), 8.14 
(2H, ddd, J 8.9, 6.4, 1.4, C(6)H & C(16)H); C (CDCl3, 75.5 MHz) 29.2 (NC(11)H3), 110.3 (qC-3), 
111.3 (C(13)H), 112.8 (qC-5), 115.1 (C(9)H), 122.2 (C(6)H), 122.3 (C(15)H & C(16)H), 124.4 
(C(7)H), 124.5 (qC-17), 126.1 (C(14)H), 130.7 (C(8)H), 139.4 (qC-10), 155.4 (qC-12), 157.3 (qC-
2), 159.6 (qC-4); m/z (ES+): 250, [(M+H)+, 100%]. HRMS (ESI-TOF): Exact mass calculated for 
C16H12O2N [M+H+], 250.0868. Found 250.0868.  
Spectral characteristics were consistent with previously reported data.3, 38 
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3-Methoxy-6H-[1,3]dioxolo[4',5':5,6]benzofuro[3,2-c]chromen-6-one, flemichapparin C 
(90a)2-3, 39-40 
Conditions A. Compound 89 (100 mg, 0.32 mmol, 1.0 
equiv.) was used as the substrate in the general procedure 
6.4.1 (stirred at 140 ºC for 16 hours). Compounds 90a and 
90b were obtained as a mixture with a ratio of 84:16 
determined from the 1H NMR spectrum of the crude 
reaction mixture. After column chromatography (hexanes:EtOAc, 80:20), the major 
regioisomer 90a (flemichapparin C) was isolated as a white solid (18 mg, 23%) with the 
remainder as an inseparable mixture (combined yield: 81 mg, 82%). m.p. >230 °C (lit. >230 
°C); H (CDCl3, 300 MHz) 3.91 (3H, s, C(11)H3), 6.07 (2H, s, C(15)H2), 6.97 (2H, dd, J 7.9, 2.0, 
C(7)H & C(9)H), 7.12 (1H, s, C(13)H), 7.47 (1H, s, C(17)H), 7.85 (1H, dd, J 7.5, 1.6, C(6)H); C 
(CDCl3, 75.5 MHz) 56.0 (C(11)H3), 94.0 (C(13)H), 100.2 (C(15)H2), 101.5 (C(17)H), 102.0 (C(9)H), 
104.0 (qC-3), 106.3 (qC-5), 113.0 (C(7)H), 117.1 (qC-18), 122.3 (C(6)H), 146.1 (qC-16), 147.5 
(qC-14), 150.6 (qC-12), 155.0 (qC-10), 158.5 (qC-8), 160.0 (qC-2), 162.5 (qC-4); m/z (ES+): 311, 
[(M+H)+, 80%]; HRMS (ESI-TOF): Exact mass calculated for C17H11O6 [M+H+], 311.0556. Found 
311.0551.  
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6.4.2 General procedures for intramolecular double C-H activation of diarylethers. Synthesis 
of compounds 131-137.  
Conditions A: Diarylether (1 equiv.), Pd(OAc)2 (10 mol%), Ag2O (1.5 equiv.), NaOtBu (0.2 
equiv.) and pivalic acid (PivOH) (0.5M) were added to a sealed reaction vial equipped with a 
magnetic stir bar. The resulting reaction mixture was stirred at 140 ºC under air atmosphere 
in a multi reaction heating mantle for 18 hours. Work-up as per 0.3 mmol diarylether: Upon 
cooling, the reaction was diluted with DCM (15 mL), filtered through a pipette of Celite® and 
then washed with aqueous NaOH (10% w/v, 3 x 15 mL). The organic layer was then dried over 
MgSO4, filtered and concentrated under reduced pressure. The residues were then flushed 
through silica gel using hexanes or DCM as eluent to afford the title products.  
Conditions B: Diarylether (1 equiv.), Pd(OAc)2 (5 mol%), Ag2O (1.5 equiv.), K2CO3 (2.5 equiv.) 
and TFA (0.4M) were added to a sealed reaction vial equipped with a magnetic stir bar. The 
resulting reaction mixture was stirred at 140 ᵒC under air atmosphere in a multi reaction 
heating mantle for 18-24 hours. Work-up as per 0.3 mmol diarylether: Upon cooling, the 
reaction was diluted with DCM (15 mL), filtered through a pipette of Celite® and then washed 
with aqueous NaOH (10% w/v, 3 x 15 mL). The organic layer was then dried over MgSO4, 
filtered and concentrated under reduced pressure. The residues were then flushed through 
silica gel using hexanes or DCM as eluent to afford the title products.  
In cases where a mixture of regiosiomers was obtained, the yield reflects the mixture of 
regioisomers. The regioisomeric ratio was determined by analysis of the 1H NMR spectrum of 
the crude reaction mixture. 
3-Methyl-dibenzofuran (131)41-42 
Conditions A: White solid (48 mg, 49%) 
Conditions B: White solid (38 mg, 39%) 
3-Methyl diphenyl ether (102) (100 mg, 0.543 mmol, 1 equiv.) was used as the substrate in 
the general procedure 6.4.2. The residue was purified by column chromatography (DCM). 
m.p. 52-53 ᵒC; max/cm1 (NaCl): 1455 (aromatic C=C stretch), 1421 (aromatic C=C stretch), 
1345 (-CH3 bend), 1261 (ether C-O stretch), 1210 (ether C-O stretch), (aromatic C-H bend); H 
(CDCl3, 300 MHz) 2.54 (3H, s, C(7)H3), 7.18 (1H, d, J 8.0, C(4)H), 7.33 (1H, td, J 7.5, 1.0, C(11)H), 
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7.37-7.40 (1H, m, C(2)H), 7.43 (1H, td, J 8.2, 1.4, C(10)H), 7.56 (1H, d, J 8.2, C(9)H), 7.83 (1H, 
d, J 7.9, C(5)H), 7.92 (1H, dd, J 7.6, 0.7, C(12)H); C (CDCl3, 75.5 MHz) 22.0 (C(7)H3), 111.6 
(C(9)H), 112.0 (C(2)H), 120.2 (C(5)H), 120.3 (C(12)H), 121.7 (qC-6), 122.6 (C(11)H), 124.0 
(C(4)H), 124.4 (qC-13), 126.6 (C(10)H), 137.7 (qC-3), 156.2 (qC-1), 156.7 (qC-8); Anal. 
Calculated for C13H10O: C, 85.69; H, 5.53. Found: C, 85.69; H, 5.79.  
Spectral characteristics were consistent with previously reported data.41-42 
3-Methoxy-dibenzofuran (132)41 
Conditions A: White solid (68 mg, 92%) 
Conditions B: White solid (46 mg, 62%) 
 3-Methoxy diphenyl ether (104) (75 mg, 0.374 mmol, 1 equiv.) was 
used as the substrate in the general procedure 6.4.2. The residue was purified by column 
chromatography (DCM). m.p. 85-87 ᵒC; max/cm1 (NaCl): 2948 (alkane C-H stretch), 1636 
(aromatic C=C stretch), 1605 (aromatic C=C stretch), 1457 (-CH3 bend), 1279 (ether C-O 
stretch), 1150 (ether C-O stretch), 1033 (ether C-O stretch), 749 (aromatic C-H bend); H 
(CDCl3, 300 MHz) 3.88 (3H, s, C(7)H3), 6.92 (1H, dd, J 8.6, 2.3, C(4)H), 7.09 (1H, d, J 2.4, C(2)H), 
7.30 (1H, td, J 7.5, 1.2, C(11)H), 7.37 (1H, td, J 7.4, 1.5, C(10)H), 7.49-7.54 (1H, m, C(9)H), 7.78 
(1H, d, J 8.6, C(5)H), 7.85 (1H, ddd, J 7.4, 1.7, 0.5, C(12)H); C (CDCl3, 75.5 MHz) 55.7 (C(7)H3), 
96.5 (C(2)H), 111.0 (C(4)H), 111.4 (C(9)H), 117.4 (qC-6), 119.8 (C(12)H), 120.9 (C(5)H), 122.7 
(C(11)H), 124.4 (qC-13), 125.7 (C(10)H), 156.4 (qC-8), 157.6 (qC-1), 160.0 (qC-3); Anal. 
Calculated for C13H10O: C, 78.77; H, 5.09. Found: C, 78.73; H, 5.24.  
Spectral characteristics were consistent with previously reported data.41 




Conditions A: Yellow solid (Combined yield: 64 mg, 84%) (NMR ratio: 88:12) 
Conditions B: Yellow solid (Combined yield: 36 mg, 46%) (NMR ratio: 65:35) 
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3-Fluoro diphenyl ether (103) (77 mg, 0.409 mmol, 1 equiv.) was used as the substrate in the 
general procedure 6.4.2 (Conditions A) and 3-fluoro diphenyl ether (103) (80 mg, 0.425 mmol, 
1 equiv.) was used as the substrate in the general procedure 6.4.2 (Conditions B). The residue 
was purified by column chromatography (hexanes, 100%) to afford a mixture of products 
133a and 133b. Assignment based on 1H NMR and 13C NMR spectrum of the mixture of both 
regioisomers and spectral data from the literature. 
3-Fluoro-dibenzofuran (133a)42 
Major; H (CDCl3, 300 MHz) 7.09 (1H, ddd, J 9.2, 8.7, 2.3, C(4)H), 7.28 
(1H, dd, J 9.3, 2.3, C(2)H), 7.36 (1H, dd, J 7.7, 1.2, C(10)H), 7.44 (1H, td, 
J 7.3, 1.4, C(9)H), 7.53-7.58 (1H, m, C(8)H), 7.85 (1H, dd, J 5.6, 2.9, 
C(5)H), 7.90 (1H, dd, J 7.6, 0.7, C(11)H); C (CDCl3, 75.5 MHz) 99.7 (C(2)H, d, JC-F 27), 110.7 
(C(4)H, d, JC-F 22), 111.7 (C(8)H), 120.3 (C(11)H), 120.6 (qC-6, d, JC-F 2), 121.1 (C(5)H, d, JC-F 10), 
123.0 (C(10)H), 123.7 (qC-14), 126.7 (C(9)H), 156.5 (qC-1, d, JC-F 13), 156.8 (qC-7, d, JC-F 2), 
162.4 (qC-3, d, JC-F 245); δF (CDCl3, 282 MHz) -113.1. 
Spectral characteristics were consistent with previously reported data.42 
1-Fluoro-dibenzofuran (133b) 
Minor; C (CDCl3, 75.5 MHz) 107.6 (C(2)H, d, JC-F 4), 108.9 (C(4)H, d, JC-F 
19), 111.5 (C(8)H), 113.2 (qC-6, d, JC-F 21), 120.6 (qC-12, d, JC-F 2), 122.8 
(C(11)H, d, JC-F 3), 123.3 (C(10)H), 127.4 (C(9)H), 127.6 (C(3)H, d, JC-F 8), 
156.1 (qC-7), 157.6 (qC-5, d, JC-F 276), 157.7 (qC-1, d, JC-F 9); δF (CDCl3, 282 MHz) -113.2. 
3-Chloro-dibenzofuran (134a) and 1-Chloro-dibenzofuran (134b)41 
Conditions A: Yellow solid (Combined yield: 71 mg, 90%) (NMR ratio: 99:1) 
Conditions B: White solid (Combined yield: 10 mg, 








3-Chloro diphenyl ether (107) (80 mg, 0.392 mmol, 1 equiv.) was used 
as the substrate in the general procedure 6.4.2 (Conditions A) and 3-
Chloro diphenyl ether (107) (35 mg, 0.17 mmol, 1 equiv.) was used as 
the substrate in the general procedure 6.4.2 (Conditions B). The residue was purified by 
column chromatography (hexanes, 100%). m.p. 80-82 ᵒC; max/cm1 (NaCl): 1590 (aromatic 
C=C stretch), 1457 (aromatic C=C stretch), 1230 (ether C-O stretch), 1190 (ether C-O stretch), 
897 (aromatic C-H bend), 599 (C-Cl stretch); H (CDCl3, 300 MHz) 7.33 (1H, dd, J 8.2, 1.8, 
C(4)H), 7.36 (1H, td, J 7.5, 1.0, C(10)H), 7.47 (1H, td, J 7.2, 1.4, C(9)H), 7.53-7.60 (2H, m, C(2)H 
& C(8)H), 7.85 (1H, d, J 8.3, C(5)H), 7.91 (1H, ddd, J 7.7, 1.3, 0.6, C(11)H); C (CDCl3, 75.5 MHz) 
111.8 (C(8)H), 112.3 (C(2)H), 120.6 (C(11)H), 121.2 (C(5)H), 123.0 (qC-6), 123.1 (C(10)H), 123.4 
(C(4)H), 123.5 (qC-12), 127.5 (C(9)H), 132.6 (qC-3), 156.3 (qC-1), 156.5 (qC-7); Anal. Calculated 
for C12H7OCl: C, 71.13; H, 3.48. Found: C, 71.30; H, 3.76.  
Spectral characteristics were consistent with previously reported data.41 
Benzo[b]naphtho[2,3-d]furan (135a)42-43 and Benzo[b]naphtha[1,2-d]furan (135b) 
Conditions A: Yellow solid (Combined yield: 29 
mg, 58%) (NMR ratio: 63:37) 
 
2-Phenoxy naphthalene (108) (50 mg, 0.23 mmol, 1 equiv.) was used as the substrate in the 
general procedure 6.4.2. The residue was purified by column chromatography (hexanes, 
100%) to afford a mixture of products 135a and 135b. 8 mg of 135b was isolated. Assignment 
of major and minor regioismers based on 1H NMR and 13C NMR spectrum of the mixture of 
both regioisomers and deduction of signals corresponding to the minor regioisomer, in 
addition to spectral data available in the literature. 
Benzo[b]naphtho[2,3-d]furan (135a)42-43 
Major; H (CDCl3, 600 MHz) 7.36 (1H, td, J 8.0, 1.3, C(4)H), 7.41-
7.60 (4H, m, C(2)H, C(3)H, C(11)H & C(12)H), 7.91 (1H, s, C(8)H), 
7.96-8.07 (3H, m, C(5)H, C(10)H & C(13)H), 8.42 (1H, s, C(15)H); C 
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(CDCl3, 150 MHz) 106.9 (C(8)H), 111.6 (C(2)H), 119.2 (C(15)H), 121.3 (C(5)H), 122.8 (C(4)H), 
123.9 (qC-6), 124.4 (C(12)H), 125.4 (qC-16), 125.8 (C(11)H), 127.8 (C(3)H), 128.4 (2 × CH, 
C(10)H & C(13)H), 130.3 (qC-14), 133.1 (qC-9), 154.8 (qC-7), 157.6 (qC-1).  
Spectral characteristics were consistent with previously reported data.42-43 
Benzo[b]naphtha[1,2-d]furan (135b)24, 42 
Minor; Colourless oil (8 mg isolated); max/cm1 (NaCl): 1626 (aromatic 
C=C stretch), 1584 (aromatic C=C stretch), 1460 (aromatic C=C stretch), 
1251 (ether C-O stretch), 1214 (ether C-O stretch), 803 (aromatic C-H 
bend), 740 (aromatic C-H bend); H (CDCl3, 600 MHz) 7.44-7.51 (2H, m, 
C(3)H & C(4)H), 7.55 (1H, ddd, J 7.8, 6.7, 1.2, C(12)H), 7.68-7.75 (2H, m, C(8)H & C(13)H), 7.77 
(1H, d, J 9.0, C(2)H), 7.93 (1H, d, J 9.0, C(11)H), 8.03 (1H, d, J 8.2, C(9)H), 8.36-8.43 (1H, m, 
C(5)H), 8.63 (1H, d, J 8.3, C(14)H); C (CDCl3, 150 MHz) 111.9 (C(8)H), 112.8 (C(2)H), 117.3 (qC-
16), 122.0 (C(5)H), 123.2 (C(4)H), 123.5 (C(14)H), 124.4 (C(12)H), 124.9 (qC-6), 125.9 (C(3)H), 
127.2 (C(13)H), 128.6 (C(11)H), 129.1 (qC-15), 129.2 (C(9)H), 130.5 (qC-10), 154.3 (qC-7), 155.9 
(qC-1); m/z (ES+): 218 [(M+H)+, 100%].  
Spectral characteristics were consistent with previously reported data.24, 42 
3-Ethyl-dibenzofuran (136) 
Conditions A: White solid (49 mg, 99%) 
Conditions B: White solid (35 mg, 71%) 
3-Ethyl diphenyl ether (106) (50 mg, 0.252 mmol, 1 equiv.) was used as the substrate in the 
general procedure 6.4.2. The residue was purified by column chromatography (hexanes, 
hexanes:Et2O, 92:8). m.p. 74-76 ᵒC; max/cm1 (NaCl): 1457 (aromatic C=C stretch), 1420 (-CH2 
bend), 1343 (-CH3 bend), 1230 (ether C-O stretch), 1198 (ether C-O stretch), 931 (aromatic C-
H bend), 840 (aromatic C-H bend); H (CDCl3, 300 MHz) 1.32 (3H, t, J 7.6, C(8)H3), 2.82 (2H, q, 
J 7.6, C(7)H2), 7.15-7.22 (1H, m, C(4)H), 7.31 (1H, td, J 7.5, 1.2, C(12)H), 7.40 (1H, d, J 0.8, 
C(2)H), 7.41 (1H, td, J 7.3, 1.4, C(11)H), 7.50-7.58 (1H, m, C(10)H), 7.84 (1H, d, J 7.8, C(5)H), 
7.90 (1H, ddd, J 7.6, 1.4, 0.6, C(13)H); C (CDCl3, 75.5 MHz) 15.1 (C(8)H3), 29.3 (C(7)H2), 110.7 
(C(2)H), 111.5 (C(10)H), 120.29 (C(5)H), 120.3 (C(13)H), 121.9 (qC-6), 122.6 (C(12)H), 122.9 
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(C(4)H), 124.4 (qC-14), 126.5 (C(11)H), 144.3 (qC-3), 156.3 (qC-1), 156.7 (qC-9); Anal. 
Calculated for C14H12O: C, 85.68; H, 6.16. Found: C, 85.42; H, 6.05.  
3-Tert-butyl-dibenzofuran (137)42 
Conditions A: White solid (74 mg, 94%) 
Conditions B: White solid (42 mg, 53%) 
 3-Tert-butyl diphenyl ether (105) (80 mg, 0.353 mmol, 1 equiv.) 
was used as the substrate in the general procedure 6.4.2. The residue was purified by column 
chromatography (DCM). m.p. 57-60 ᵒC; max/cm1 (NaCl): 2964 (alkane C-H stretch), 1634 
(aromatic C=C stretch), 1457 (aromatic C=C stretch), 1421 (-CH3 bend), 1365 (-CH3 bend), 1230 
(ether C-O stretch), 1187 (ether C-O stretch), 726 (aromatic C-H bend); H (CDCl3, 300 MHz) 
1.44 (9H, s, C(8)H3, C(9)H3 & C(10)H3), 7.34 (1H, td, J 7.7, 0.9, C(4)H), 7.39-7.48 (2H, m, C(2)H 
& C(14)H), 7.54-7.61 (1H, m, C(12)H), 7.54-7.60 (1H, m, C(13)H), 7.88 (1H, d, J 8.2, C(5)H), 
7.91-7.96 (1H, m, C(15)H); C (CDCl3, 75.5 MHz) 31.7 (C(8)H3, C(9)H3 & C(10)H3), 35.3 (qC-7), 
108.5 (C(2)H), 111.6 (C(12)H), 120.0 (C(4)H), 120.4 (C(5)H), 120.5 (C(15)H), 121.5 (qC-6), 122.6 
(C(14)H), 124.3 (qC-16), 126.6 (C(13)H), 151.4 (qC-3), 156.4 (qC-1), 156.6 (qC-11); Anal. 
Calculated for C16H16O: C, 85.68; H, 7.19. Found: C, 85.36; H, 7.37.  
Spectral characteristics were consistent with previously reported data.24, 42 
3,7-Dimethyl-dibenzofuran (138)44 
Conditions A: White solid (41 mg, 85%) 
1-Methyl-3-(3-methylphenoxy) benzene (113) (50 mg, 0.252 
mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.4.2. The residue was purified by column chromatography (hexanes, 100%). m.p. 
76-78 ᵒC; max/cm1 (NaCl): 2927 (alkane C-H stretch), 1421 (aromatic C=C stretch), 1272 
(ether C-O stretch), 1115 (ether C-O stretch), 800 (aromatic C-H bend); H (CDCl3, 300 MHz) 
2.51 (6H, s, C(7)H3 & C(14)H3), 7.14 (2H, dd, J 7.8, C(4)H & C(11)H), 7.32-7.37 (1H, m, C(2)H & 
C(9)H), 7.76 (2H, d, J 7.8, C(5)H & C(12)H); C (CDCl3, 75.5 MHz) 21.9 (C(7)H3 & C(14)H3), 111.9 
(C(2)H & C(9)H), 119.8 (C(5)H & C(12)H), 121.8 (qC-13 & qC-6), 123.8 (C(4)H & C(11)H), 137.0 
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(qC-3 & qC-10), 156.6 (qC-1 & qC-8); Anal. Calculated for C14H12O: C, 85.68; H, 6.16. Found: C, 
85.48; H, 6.27.  
Spectral characteristics were consistent with previously reported data.44 
3-Methyl-7-chloro-dibenzofuran (139) 
Conditions A: Light yellow solid (25 mg, 50%) 
1-Chloro-3-(3-methylphenoxy) benzene (124) (50 mg, 0.229 mmol, 
1 equiv.) was used as the substrate in the general procedure 6.4.2. 
The residue was purified by column chromatography (hexanes, 100%). m.p. 113-116 ᵒC; 
max/cm1 (NaCl): 3050 (aromatic C-H stretch), 2921 (alkane C-H stretch), 1415 (aromatic C=C 
stretch), 1268 (ether C-O stretch), 1115 (C-O stretch), 802 (aromatic C-H bend), 600 (C-Cl 
stretch); H (CDCl3, 300 MHz) 7.15 (1H, d, J 7.8, C(10)H), 7.28 (1H, dd, J 8.4, 1.8, C(4)H), 7.34 
(1H, bs, C(8)H), 7.52 (1H, d, J 1.6, C(2)H), 7.74 (1H, d, J 7.8, C(11)H), 7.77 (1H, d, J 8.3, C(5)H); 
C (CDCl3, 75.5 MHz) 22.0 (C(13)H3), 112.0 (C(8)H), 112.2 (C(2)H), 120.1 (C(11)H), 120.8 
(C(5)H), 120.9 (qC-12), 123.1 (qC-6), 123.2 (C(4)H), 124.4 (C(10)H), 132.0 (qC-3), 138.1 (qC-9), 
156.3 (qC-1), 157.0 (qC-7); Anal. Calculated for C13H9ClO: C, 72.07; H, 4.19. Found: C, 72.21; 
H, 4.58. 
3-Methyl-7-ethyl-dibenzofuran (140) 
Conditions A: Sticky orange oil (31 mg, 77%) 
1-Ethyl-3-(3-methylphenoxy) benzene (125) (39.8 mg, 0.187 
mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.4.2. The residue was purified by column chromatography (hexanes, 100%). 
max/cm1 (NaCl): 2964 (aromatic C-H stretch), 2927 (alkane C-H stretch), 1609 (aromatic C=C 
stretch), 1473 (aromatic C=C stretch), 1432 (-CH3 bend), 1221 (ether C-O stretch), 1130 (ether 
C-O stretch), 804 (aromatic C-H bend); H (CDCl3, 300 MHz) 1.31 (3H, t, J 7.7, C(8)H3), 2.51 
(3H, s, C(15)H3), 2.80 (2H, q, J 7.8, C(7)H2), 7.08-7.19 (2H, m, C(4)H & C(12)H), 7.31-7.38 (2H, 
m, C(2)H & C(10)H), 7.76 (1H, d, J 7.6, C(5)H), 7.78 (1H, d, J 7.7, C(13)H); C (CDCl3, 75.5 MHz) 
15.9 (C(8)H3), 21.9 (C(7)H2), 29.3 (C(15)H), 110.6 (C(2)H), 111.9 (C(10)H), 119.8 (C(13)H), 119.9 
(C(5)H), 121.8 (qC-14), 122.0 (qC-6), 122.7 (C(4)H), 123.8 (C(12)H), 137.0 (qC-11), 143.6 (qC-
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3), 156.6 (qC-1), 156.7 (qC-9); Anal. Calculated for C15H14O: C, 85.68; H, 6.71. Found: C, 85.77; 
H, 6.89. 
3-Methyl-7-tert butyl-dibenzofuran (141)  
Conditions A: Sticky orange solid (38 mg, 76%) 
1-Tert-butyl-3-(3-methylphenoxy) benzene (126) (50 mg, 0.021 
mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.4.2. The residue was purified by column 
chromatography (DCM). max/cm1 (NaCl): 2964 (alkane C-H stretch), 1422 (aromatic C=C 
stretch), 1210 (ether C-O stretch), 806 (aromatic C-H bend); H (CDCl3, 300 MHz) 1.33 (9H, s, 
C(8)H3, C(9)H3 & C(10)H3), 2.44 (3H, s, C(17)H3), 7.08-7.15 (1H, m, C(14)H), 7.34 (1H, bs, 
C(12)H), 7.36 (1H, dd, J 8.2, 1.8, C(4)H), 7.55 (1H, d, J 1.5, C(2)H), 7.76 (1H, d, J 8.0, C(15)H), 
7.80 (1H, d, J 8.3, C(5)H); C (CDCl3, 75.5 MHz) 21.9 (C(17)H3), 31.7 (C(8)H3, C(9)H3 & C(10)H3), 
35.2 (qC-7), 108.4 (C(2)H), 111.8 (C(12)H), 119.6 (C(5)H), 119.9 (C(15)H), 120.2 (C(4)H), 121.7 
(qC-6), 121.8 (qC-16), 123.8 (C(14)H), 137.0 (qC-13), 150.7 (qC-3), 156.7 (qC-1), 156.9 (qC-11); 
Anal. Calculated for C17H18O: C, 85.67; H, 7.61. Found: C, 84.75; H, 7.85. 
3-Methyl-7-fluoro-dibenzofuran (142a) and 1-fluoro-7-methyl-dibenzofuran (142b)  
Conditions A: White solid (Combined yield: 35 
mg, 70%) (NMR ratio: 84:16) 
1-Fluoro-3-(3-methylphenoxy) benzene (123) 
(70 mg, 0.346 mmol, 1 equiv.) was used as the substrate in the general procedure 6.4.2. The 
residue was purified by column chromatography (hexanes, 100%) to afford a mixture of 
products 142a and 142b. Assignment of major and minor regioisomers based on 1H NMR and 
13C NMR spectrum of the mixture of both regioisomers. 
3-Methyl-7-fluoro-dibenzofuran (142a) 
Major; H (CDCl3, 300 MHz) 2.52 (3H, s, C(13)H3), 7.07 (1H, ddd, J 
9.0, 2.3, 0.8, C(4)H), 7.16 (1H, ddd, J 7.9, 1.3, 0.7, C(10)H), 7.23 (1H, 
dd, J 9.1, 2.3, C(2)H), 7.35-7.38 (1H, m, C(8)H), 7.76 (1H, d, J 7.79, 
C(11)H), 7.81 (1H, dd, J 8.5, 5.5, C(5)H); C (CDCl3, 75.5 MHz) 21.9 (C(13)H3), 99.6 (C(2)H, d, JC-
F 27), 110.5 (C(4)H, d, JC-F 24), 112.0 (C(8)H), 119.8 (C(11)H), 120.7 (C(5)H, d, JC-F 10), 120.7 (qC-
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6, d, JC-F 2), 124.3 (C(10)H), 124.8 (qC-12), 137.3 (qC-9), 156.5 (qC-1, d, JC-F 13), 157.3 (qC-7), 
162.0 (qC-3, d, JC-F 244); δF  (CDCl3, 282 MHz) -113.9. 
1-Fluoro-7-methyl-dibenzofuran (142b) 
Minor; C (CDCl3, 75.5 MHz) 22.0 (C(13)H3), 107.5 (C(2)H, d, JC-F 4), 
108.9 (C(4)H, d, JC-F 19), 111.7 (C(8)H), 110.0 (qC-6, d, JC-F 21), 121.1 
(qC-12, d, JC-F 1), 122.3 (C(11)H, d, JC-F 3), 124.5 (C(10)H), 127.0 (C(3)H, 
d, JC-F 8), 138.1 (qC-9), 156.2 (qC-7), 157.7 (qC-1, d, JC-F 9), 157.4 (qC-5, d, JC-F 250); δF (CDCl3, 
282 MHz) -114.0. 
3-Methyl-7-methoxy-dibenzofuran (143a) 
Conditions A: Orange solid (35 mg, 70%) 
1-Methoxy-3-(3-methylphenoxy) benzene (122) (50 mg, 0.233 
mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.4.2. The residue was purified by column chromatography (hexanes, 100%). m.p. 
85-88 ᵒC; max/cm1 (NaCl): 2948 (alkane C-H stretch), 1600 (aromatic C=C stretch), 1430 (-CH3 
bend), 1294 (ether C-O stretch), 1149 (ether C-O stretch), 1035 (ether C-O stretch), 806 
(aromatic C-H bend); H (CDCl3, 300 MHz) 2.52 (3H, s, C(14)H3), 3.91 (3H, s, C(7)H3), 6.90 (1H, 
dd, J 8.6, 2.3, C(4)H), 7.06 (1H, d, J 2.2, C(2)H), 7.10-7.17 (1H, m, C(11)H), 7.30-7.33 (1H, m, 
C(9)H), 7.69 (1H, d, J 7.8, C(12)H), 7.73 (1H, d, J 8.6, C(5)H); C (CDCl3, 75.5 MHz) 21.9 (C(14)H3), 
55.7 (C(7)H3), 96.6 (C(2)H), 110.7 (C(4)H), 111.7 (C(9)H), 117.5 (qC-6), 119.3 (C(12)H), 120.6 
(C(5)H), 121.8 (qC-13), 123.9 (C(11)H), 136.1 (qC-10), 156.8 (qC-8), 157.5 (qC-1), 159.6 (qC-3); 
Anal. Calculated for C14H12O: C, 79.23; H, 5.70. Found: C, 78.95; H, 5.88. 
6.5 Palladium catalysed intramolecular direct arylation of ortho-bromo diarylethers.  
6.5.1 General procedures for intramolecular direct arylation of ortho-bromo diarylethers. 
Synthesis of compounds 16, 199-211, 215. 
Diarylether (1 equiv.), Pd(OAc)2 (5 mol%), K2CO3 (2.0 equiv.), 6-methoxy quinoline (10 mol%) 
and NMP (2.0 mL/mmol) were added to a sealed reaction vial equipped with a magnetic stir 
bar. The resulting mixture was stirred at 135 ᵒC under air atmosphere in a multi reaction 
heating mantle for 22 hours. Work-up as per 0.1 mmol diarylether: Upon cooling, the reaction 
was diluted with DCM (15 mL), filtered through a plug of Celite® and the solvent was 
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concentrated under reduced pressure. The residues were then flushed through silica gel using 
hexanes as eluent to afford the title products. 
Dibenzofuran (16)42 
1-Bromo-2-phenoxybenzene (157) (30 mg, 0.120 mmol, 1 equiv.) was 
used as the substrate in the general procedure 6.5.1. White solid (27 mg, 
99%), m.p. 77-79 ᵒC; H (CDCl3, 300 MHz) 7.34 (2H, td, J 7.5, 1.1, C(4)H & 
C(10)H), 7.45 (2H, ddapp , J 7.5, 1.1, C(3)H & C(9)H), 7.54-7.60 (2H, m, C(2)H & C(8)H), 7.96 (2H, 
ddd,  J 7.6, 1.3, 0.6, C(5)H & C(11)H); C (CDCl3, 75.5 MHz) 111.7 (C(2)H & C(8)H), 120.6 (C(5)H 
& C(11)H), 122.7 (C(4)H & C(10)H), 124.2 (qC-6 & qC-12), 127.1 (C(3)H & C(9)H), 156.2 (qC-1 
& qC-7); Anal. Calculated for C12H8O: C, 85.69; H, 4.79. Found: C, 85.60; H, 4.58. 
Spectral characteristics are consistent with previously reported data.42 
2-Fluoro-dibenzofuran (199)27, 42 
1-Bromo-2-(4-fluorophenoxy) benzene (168) (30 mg, 0.11 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.5.1. White 
solid (27 mg, 99%), m.p. 83-86 ᵒC; max/cm1 (NaCl): 1476 (aromatic C=C 
stretch), 1209 (ether C-O stretch), 1159 (C-F stretch), 864 (aromatic C-H bend); H (CDCl3, 300 
MHz) 7.15 (1H, td, J 9.0, 2.7, C(3)H), 7.34 (1H, ddd, J 7.5, 1.2, C(5)H), 7.43-7.52 (2H, m, C(9)H 
& C(10)H), 7.53-7.58 (1H, m, C(2)H), 7.60 (1H, dd, J 8.2, 2.5, C(8)H), 7.90 (1H, ddd, J 7.8, 1.3, 
0.5, C(11)H); C (CDCl3, 75.5 MHz) 107.0 (C(5)H, d, JC-F 25), 111.9 (C(8)H), 112.3 (C(2)H, d, JC-F 
9), 114.4 (C(3)H, d, JC-F 26), 120.9 (C(11)H), 122.7 (C(10)H), 124.0 (qC-12, d, JC-F 4), 125.1 (qC-
6, d, JC-F 10), 122.8 (C(9)H), 152.2 (qC-1), 157.2 (qC-7), 159.0 (qC-4, d, JC-F  239); m/z (ES+): 187 
[(M+H)+, 50%]. 
Spectral characteristics are consistent with previously reported data.27, 43 
2-Nitro-dibenzofuran (200)45 
1-Bromo-2-(4-nitrophenoxy) benzene (163) (40 mg, 0.136 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.5.1. 
White solid (28 mg, 97%), m.p. 150-152 ᵒC; max/cm1 (NaCl): 1525 
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(aromatic C=C stretch), 1466 (aromatic C=C stretch), 1343 (N=O stretch), 1183 (ether C-O 
stretch), 891 (aromatic C-H bend); H (CDCl3, 300 MHz) 7.40-7.49 (1H, td, J 7.7, 1.2, C(10)H), 
7.58 (1H, td,  J 7.7, 1.3, C(9)H), 7.61-7.69 (2H, m, C(2)H & C(8)H), 8.04 (1H, ddd,  J 7.8, 1.1, 0.6, 
C(11)H), 8.40 (1H, dd, J 9.0, 2.4, C(3)H), 8.87 (1H, d, J 2.3, C(5)H); C (CDCl3, 75.5 MHz) 112.0 
(C(8)H), 112.3 (C(2)H), 117.3 (C(5)H), 121.3 (C(11)H), 123.0 (C(3)H), 123.1 (qC-12), 123.9 
(C(10)H), 125.0 (qC-6), 129.0 (C(9)H), 144.0 (qC-4), 157.5 (qC-7), 159.2 (qC-1); Anal. Calculated 
for C12H7NO3: C, 67.61; H, 3.31. Found: C, 67.70; H, 3.47. 
Spectral characteristics are consistent with previously reported data.45 
2-Trifluoromethyl-dibenzofuran (201)27 
 1-Bromo-2-(4-(trifluoromethoxy) benzene (190) (49.8 mg, 0.15 
mmol, 1 equiv.) used as the substrate in the general procedure 6.5.1. 
White solid (25 mg, 86%), m.p. 91-93 ᵒC; max/cm1 (NaCl): 1452 
(aromatic C=C stretch), 1353 (C-F stretch), 1165 (ether C-O stretch), 1099 (ether C-O stretch), 
828 (aromatic C-H stretch); H (CDCl3, 300 MHz) 7.40 (1H, ddd, J 8.2, 7.4, 1.1, C(11)H), 7.53 
(1H, ddd, J 8.4, 7.1, 1.3, C(10)H), 7.58-7.68 (2H, m, C(2)H & C(9)H), 7.73 (1H, d, J 8.8, 1.5, 
C(3)H), 7.99 (1H, ddd, J 7.7, 1.2, 0.6, C(12)H), 8.23 (1H, s, C(5)H); C (CDCl3, 125 MHz) 112.0 
(C(2)H & C(9)H), 118.3 (qC-6, q, JC-F  4), 121.0 (C(5)H), 123.3 (C(12)H), 123.4 (C(11)H), 124.2 
(C(3)H, q, JC-F  4), 124.6 (qC-13), 124.6 (qC-7, q, JC-F  270), 125.4 (qC-4, q, JC-F  32), 128.2 (C(10)H), 
156.9 (qC-1), 157.6 (qC-6); F (CDCl3, 282 MHz) -60.9; Anal. Calculated for C13H7F3O: C, 66.11; 
H, 2.99. Found: C, 66.40; H, 2.66. 
Spectral characteristics are consistent with previously reported data.27 
2-Trifluoromethoxy-dibenzofuran (202) 
1-Bromo-2-(4-(trifluoromethoxy)phenoxy) benzene (183) (49.8 mg, 
0.15 mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.5.1. White solid (25 mg, 66%), m.p. 50-51 ᵒC; max/cm1 
(NaCl): 1445 (aromatic C=C stretch), 1307 (C-O stretch), 1211 (ether C-O stretch), 1163 (ether 
C-O stretch), 1147 (C-F stretch), 827 (aromatic C-H bend); H (CDCl3, 500 MHz) 7.28-7.42 (2H, 
m, C(3)H & C(11)H), 7.51 (1H, ddd, J 8.3, 7.2, 1.3, C(10)H), 7.54-7.62 (2H, m, C(2)H & C(9)H), 
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7.80 (1H, s, C(5)H), 7.91-7.96 (1H, m, C(12)H); C (CDCl3, 125 MHz) 112.0 (C(5)H), 112.4 (C(9)H), 
113.6 (C(2)H), 120.5 (C(3)H), 120.7 (qC-7, q, JC-F 257), 120.9 (C(12)H), 123.1 (C(11)H), 123.6 
(qC-6), 125.2 (qC-13), 128.1 (C(10)H), 144.7 (qC-4), 154.2 (qC-1), 157.1 (qC-8); F (CDCl3, 282 
MHz) -58.2; Anal. Calculated for C13H7F3O2: C, 61.91; H, 2.80. Found: C, 62.15; H, 2.66. 
3-Trifluoromethyl-dibenzofuran (203)45 
1-Bromo-2-(3-(trifluoromethyl)phenoxy) benzene (191) (40 mg, 
0.126 mmol, 1 equiv.) was used as the substrate in the general 
procedure 6.5.1. White solid (28 mg, 96%), m.p. 108-110 ᵒC; 
max/cm1 (NaCl): 1428 (aromatic C=C stretch), 1339 (C-F stretch), 1166 (ether C-O stretch), 
1103 (ether C-O stretch), 831 (aromatic C-H stretch); H (CDCl3, 300 MHz) 7.36-7.45 (1H, m, 
C(4)H), 7.54 (1H, ddd, J 8.7, 7.2, 1.4, C(11)H), 7.59-7.67 (2H, m, C(9)H & C(10)H), 7.84 (1H, s, 
C(2)H), 7.98-8.03 (1H, m, C(5)H), 8.05 (1H, dt, J 8.1, 1.7, C(12)H); C (CDCl3, 75.5 MHz) 109.2 
(C(2)H, q, JC-F  4), 112.0 (C(9)H), 119.7 (C(4)H, q, JC-F  4), 121.0 (C(12)H), 121.3 (C(5)H), 123.1 
(qC-6), 123.3 (C(11)H), 124.3 (qC-7, q, JC-F  272), 128.5 (C(10)H), 127.4 (qC-13), 129.1 (qC-3, q, 
JC-F  32), 155.4 (qC-1), 157.2 (qC-8); F (CDCl3, 282 MHz) -61.4. HRMS (ESI-TOF) m/z: [M]+ calcd. 
for C13H7F3O: 236.0444, found 236.0456. 
Spectral characteristics are consistent with previously reported data.45 
2,4-Dichloro-dibenzofuran (204)46 
1-bromo-2-(2,4-dichlorophenoxy) benzene (187) (50 mg, 0.157 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.5.1. White 
solid (26 mg, 70%), m.p. 129-132 ᵒC; max/cm1 (NaCl): 1577 (aromatic 
C=C stretch), 1467 (aromatic C=C stretch), 1223 (ether C-O stretch), 1182 (ether C-O stretch), 
845 (aromatic C-H bend), 745 (C-Cl stretch); H (CDCl3, 300 MHz) 7.37 (1H, td, J 7.6, 1.0, 
C(10)H), 7.44 (1H, d, J 2.0, C(3)H), 7.52 (1H, td, J 7.9, 1.3, C(9)H), 7.60-7.66 (1H, m, C(8)H), 7.79 
(1H, d, J 2.0, C(5)H), 7.88 (1H, ddd, J 7.7, 1.3, 0.6, C(11)H); C (CDCl3, 75.5 MHz) 112.3 (C(8)H), 
111.7 (qC-6), 119.0 (C(5)H), 120.8 (C(11)H), 123.2 (qC-12), 123.6 (C(10)H), 126.8 (qC-2), 127.0 
(C(3)H), 128.5 (qC-4), 128.6 (C(9)H), 150.6 (qC-1), 156.7 (qC-7). Anal. Calculated for C12H6Cl2O: 
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C, 60.79; H, 2.55. Found: C, 60.95; H, 2.65. HRMS (ESI-TOF) m/z: [M]+ calcd. for C12H6Cl2O: 
235.9790, found 235.9790. 
Spectral characteristics are consistent with previously reported data.46 
Benzofuro[3,2-c]pyridine (205)22 
4-(2-Bromophenoxy)pyridine (197) (40 mg, 0.16 mmol, 1 equiv.) was 
used as the substrate in the general procedure 6.5.1. White solid (19 mg, 
70%), m.p. 73-74ᵒC (lit. 73-74 ºC); H (DMSO-d6, 300 MHz) 7.50 (1H, td, J 
7.6, 1.0, C(10)H), 7.62 (1H, ddd, J 8.6, 7.7, 1.4, C(9)H), 7.76-7.83 (2H, m, C(2)H & C(8)H), 8.27 
(1H, ddd, J 7.7, 1.4, 0.6, C(11)H), 8.55-8.77 (1H, m, C(3)H), 9.44 (1H, bs, C(5)H); C (DMSO-d6, 
75.5 MHz) 108.1 (C(2)H), 112.5 (C(8)H), 121.5 (qC-6 & qC-12), 122.3 (C(11)H), 124.6 (C(10)H), 
129.1 (C(9)H), 144.5 (C(5)H), 148.2 (C(3)H), 155.6 (qC-7), 160.7 (qC-1); m/z (ES+): 170, [(M+H)+, 
100%]. 
Spectral characteristics are consistent with previously reported data.22 
9H-carbazole (206)47 
2-Bromo diphenylamine (195) (40 mg, 0.16 mmol, 1 equiv.) was used as 
the substrate in the general procedure 6.5.1. Yellow solid (13 mg, 50%), 
m.p. >230 ᵒC; max/cm1 (NaCl): 3419 (N-H stretch), 2921 (aromatic C-H 
stretch), 1450 (aromatic C=C stretch), 1334 (C-N stretch); H (CDCl3, 300 MHz) 7.03 (2H, ddd, 
J 8.5, 7.5, 1.1, C(4)H & C(10)H), 7.26 (2H, ddd, J 8.3, 7.1, 1.3, C(3)H & C(9)H), 7.33-7.41 (2H, m, 
C(2)H & C(9)H), 7.99 (2H, d, J 7.8, C(5)H & C(11)H); C (CDCl3, 75.5 MHz) 111.4 (C(2)H & C(8)H), 
118.9 (C(4)H & C(10)H), 120.6 (C(5)H & C(11)H), 122.8 (qC-12 & qC-6), 125.9 (C(3)H & C(9)H), 
140.2 (qC-1 & qC-7); m/z (ES+): 168, [(M+H)+, 30%]. HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C12H9N: 168.0808, found 168.0802. 
Spectral characteristics are consistent with previously reported data.47 
 
 





(185) (46 mg, 0.125 mmol, 1 equiv.) was used as the substrate in 
the general procedure 6.5.1. White solid (32 mg, 90%), m.p. 64-65 
ᵒC; max/cm1 (NaCl): 1596 (aromatic C=C stretch), 1483 (aromatic C=C stretch), 1277 (ether 
C-O stretch), 1212 (ether C-O stretch), 1185 (C-F stretch), 1163 (C-F stretch), 819 (aromatic C-
H bend), 809 (C-Cl stretch); H (CDCl3, 500 MHz) 7.28-7.40 (2H, m, C(3)H & C(11)H), 7.55 (1H, 
d, J 9.0, C(2)H), 7.58 (1H, d, J 1.8, C(9)H), 7.75 (1H, bd, J 1.1, C(5)H), 7.83 (1H, d, J 8.4, C(12)H); 
C (CDCl3, 125 MHz) 112.6 (C(5)H & C(9)H), 113.5 (C(2)H), 120.6 (qC-7, q, JC-F 255), 120.8 
(C(3)H), 121.5 (C(12)H), 122.3 (qC-6), 123.8 (C(11)H), 124.5 (qC-13), 133.7 (qC-10) 145.0 (qC-
4, q, JC-F 2), 154.4 (qC-1), 157.2 (qC-8); F (CDCl3, 282 MHz) -58.2; Anal. Calculated for 
C13H6ClF3O2: C, 54.47; H, 2.11. Found: C, 54.16; H, 2.09. HRMS (ESI-TOF) m/z: [M]+ calcd. for 
C13H6ClF3O2: 286.0003, found 285.9993. 
2-Trifluoromethoxy-7-fluoro-dibenzofuran (208) 
1-Bromo-4-fluoro-2-(4-(trifluoromethoxy)phenoxy) benzene (184) 
(40 mg, 0.11 mmol, 1 equiv.) was used as the substrate in the 
general procedure 6.5.1. White solid (23 mg, 80%), m.p. 42-43 ᵒC; 
max/cm1 (NaCl): 1640, 1606 (aromatic C=C stretch), 1263 (ether C-O stretch), 1162 (C-F 
stretch), 1130 (C-F stretch), 1098 (ether C-O stretch), 843 (aromatic C-H bend); H (CDCl3, 500 
MHz) 7.11 (1H, dd, J 9.4, 9.0, 2.3, C(11)H), 7.23-7.34 (2H, m, C(3)H & C(9)H), 7.53 (1H, d, J 8.9, 
C(2)H), 7.74 (1H, d, J 1.4, C(5)H), 7.85 (1H, dd, J 8.8, 5.4, C(12)H); C (CDCl3, 125 MHz); 99.9 
(C(9)H, d, JC-F 27), 111.3 (C(11)H, d, JC-F 23), 112.4 (C(5)H), 113.3 (C(2)H), 120.0 (qC-13, d, JC-F 
3), 120.1 (C(3)H), 120.6 (qC-7, q, JC-F 257), 121.6 (C(12)H, d, JC-F 11), 124.7 (qC-6), 145.1 (qC-4, 
q, JC-F 2), 154.8 (qC-1), 157.5 (qC-8, d, JC-F 14), 162.8 (qC-10, d, JC-F 248); F (CDCl3, 282 MHz) -
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2-Fluoro-7-chloro-dibenzofuran (209)  
1-Bromo-4-chloro-2-(4-fluorophenoxy) benzene (169) (40 mg, 0.133 
mmol, 1 equiv.) was used as the substrate in the general procedure 
6.5.1. White solid (24 mg, 83%), m.p. 86-88 ᵒC; max/cm1 (NaCl): 1603 
(aromatic C=C stretch), 1468 (aromatic C=C stretch), 1417 (C-F stretch), 1216 (ether C-O 
stretch), 1164 (ether C-O stretch), 807 (aromatic C-H bend); H (CDCl3, 300 MHz) 7.17 (1H, td, 
J 9.7, 2.6, C(3)H), 7.33 (1H, dd, J 8.4, 1.6, C(10)H), 7.49 (1H, dd, J 9.1, 4.1, C(5)H), 7.52-7.61 
(2H, m, C(2)H & C(8)H), 7.80 (1H, d, J 8.3, C(11)H); C (CDCl3, 75.5 MHz) 106.7 (C(5)H, d, JC-F 
25), 112.5 (C(2)H, d, JC-F 9), 112.5 (C(8)H), 114.8 (C(3)H, d, JC-F 26), 121.4 (C(11)H), 122.7 (qC-6, 
d, JC-F 4), 123.5 (C(10)H), 124.5 (qC-9), 133.4 (qC-12), 152.5 (qC-1), 157.3 (qC-7), 159.2 (qC-4, 
d, JC-F 241); F (CDCl3, 282 MHz) -119.8; HRMS (ESI-TOF) m/z: [M]+ calcd. for C12H6ClFO: 
220.0085, found 220.0080. 
2,7-Difluoro-dibenzofuran  (210) 
1-Bromo-4-fluoro-2-(4-fluorophenoxy) benzene (192) (50 mg, 0.175 
mmol, 1 equiv.) was used as the substrate in the general procedure 
6.5.1. Pale yellow solid (22 mg, 63%), m.p. 89-90 ᵒC; max/cm1 (NaCl): 
1638 (aromatic C=C stretch), 1471 (aromatic C=C stretch), 1425 (C-F stretch), 1262 (ether C-
O stretch), 1158 (ether C-O stretch), 845 (aromatic C-H stretch); H (CDCl3, 500 MHz) 7.04-
7.10 (1H, m, C(10)H), 7.13 (1H, td, J 9.1, 2.7, C(3)H), 7.26 (1H, dd, J 8.9, 2.2, C(8)H), 7.47 (1H, 
dd, J 8.9, 3.2, C(5)H), 7.53 (1H, dd, J 8.0, 2.7, C(2)H), 7.81 (1H, dd, J 8.9, 5.3, C(11)H); C (CDCl3, 
125 MHz) 99.8 (C(8)H, d, JC-F 27), 106.5 (C(5)H, d, JC-F 25), 111.0 (C(10)H, d, JC-F 24), 112.3 
(C(2)H, d, JC-F 9), 114.0 (C(3)H, d, JC-F 26), 120.3 (qC-12, d, JC-F 1), 121.4 (C(11)H, d, JC-F 10), 124.6 
(qC-6, d, JC-F 10), 152.8 (qC-7, d, JC-F 3), 157.5 (qC-1), 159.2 (qC-4, d, JC-F 240), 162.7 (qC-9, d, JC-
F 247); F (CDCl3, 282 MHz) -111.8, -119.9; Anal. Calculated for C12H6F2O: C, 70.59; H, 2.96. 
Found: C, 70.90; H, 3.10. 
2-Chloro-dibenzofuran (211)41 
1-Bromo-2-(4-chlorophenoxy) benzene (LMP1) (40 mg, 0.141 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.5.1. White 
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solid (27 mg, 95%), m.p. 89-92 ᵒC; max/cm1 (NaCl): 1428 (aromatic C=C stretch), 1166 (ether 
C-O stretch), 1127 (ether C-O stretch), 831 (aromatic C-H bend), 751 (C-Cl stretch); H (CDCl3, 
300 MHz) 7.35 (1H, ddd, J 8.0, 7.4, 1.1, C(10)H), 7.40 (1H, dd, J 8.7, 2.1, C(3)H), 7.43-7.52 (2H, 
m, C(2)H & C(9)H), 7.56 (1H, dt, J 8.2, 0.9, C(8)H), 7.86-7.95 (2H, m, C(5)H & C(11)H); C (CDCl3, 
75.5 MHz) 111.9 (C(8)H), 112.7 (C(2)H), 120.5 (C(11)H), 120.8 (C(5)H), 123.0 (C(10)H), 123.4 
(qC-6), 125.7 (qC-12), 127.2 (C(9)H), 127.9 (C(3)H), 128.2 (qC-4), 155.0 (qC-1), 156.8 (qC-7); 
Anal. Calcd. for [C12H7ClO]: C, 71.13; H, 3.48. Found: C, 70.98; H, 3.88. 
Spectral characteristics are consistent with previously reported data.41 
2-Methyl-dibenzofuran (215)41 
1-Bromo-2-(4-methylphenoxy) benzene (166) (30 mg, 0.11 mmol, 1 
equiv.) was used as the substrate in the general procedure 6.5.1. White 
solid (8.4 mg, 42%), m.p. 35-37 ᵒC; max/cm1 (NaCl): 1482 (aromatic C=C 
stretch), 1447 (CH3 bend), 1121 (ether C-O stretch), 1029 (ether C-O stretch), 840 (aromatic 
C=C bend); H (CDCl3, 500 MHz) 2.52 (3H, s, C(7)H3), 7.26 (1H, ddd, J 8.3, 1.8, 0.4, C(3)H), 7.32 
(1H, td, J 8.0, 1.1, C(11)H), 7.39-7.48 (2H, m, C(2)H & C(10)H), 7.54 (1H, dt, J 8.1, 0.8, C(9)H), 
7.75 (1H, t, J 0.8, C(5)H), 7.92 (1H, ddd, J 7.7, 1.3, 0.6, C(12)H); C (CDCl3, 125 MHz) 21.3 
(C(7)H3), 111.1 (C(2)H), 111.6 (C(9)H), 120.5 (C(5)H), 120.6 (C(12)H), 122.5 (C(11)H), 124.2 (qC-
6), 124.3 (qC-13), 126.9 (C(3)H), 128.2 (C(10)H), 132.2 (qC-4), 154.4 (qC-1), 156.5 (qC-8). HRMS 
(ESI-TOF) m/z: [M]+ calcd. for C13H10O: 182.0726, found 182.0725. 
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6.6 Synthesis of manganese carbonyl phosphine complexes and their application in C-H 
activation reactions 
6.6.1 General procedure for preparation of tetracarbonyl manganese phosphine complexes 
(223-225)48  
MnBr(CO)5 (1 equiv.) and the appropriate phosphine ligand (1 equiv.) were added to a 
reaction vial. The reaction vial was then wrapped in tinfoil. The resulting reaction mixture was 
stirred in refluxing anhydrous chloroform or dichloromethane (1 mL/0.364 mmol MnBr(CO)5) 
for 8 hours in a multi reaction heating mantle. After 8 hours, the reaction mixture was allowed 
to cool to room temperature. The compounds were isolated by evaporation of the solvent 
and recrystallisation from a dichloromethane/hexane mixture. (Dichloroethane could also be 
used as the reaction solvent and the time could be reduced to 4 hours).  
cis-[MnBr(CO)4(PPh3)] (223)49 
Synthesised according to the general procedure 6.6.1 using 
MnBr(CO)5 (200 mg, 0.728 mmol, 1 equiv.) and triphenylphosphine 
(191 mg, 0.728 mmol, 1 equiv.). The solids were added to four 
separate reaction vials and the crude material from each vial was 
combined after 8 hours. Orange crystalline solid (1.41 g, 95%); 
max/cm1 IR-ATR (solid) 2086 (s, ῡ CO), 2002 (s, ῡ CO), 1956 (s, ῡ CO); H (CDCl3, 600 MHz) 
7.34-7.55 (9H, br m), 7.58-7.78 (6H, br m); C (CDCl3, 150 MHz) 128.7 (d, JC-P 10, meta-CH of 
Ph), 130.9 (d, JC-P 2, para-CH of Ph), 132.5 (d, JC-P 42, ipso-C of Ph), 133.6 (d, JC-P 10, ortho-CH 
of Ph), 210.6 (br m, CO), 211.6 (br m, CO), 216.4 (br m, CO); δp (CDCl3, 243 MHz) 40.4;  Anal. 
Calcd. for [C22H15BrMnO4P]: C, 51.90; H, 2.97. Found: C, 51.88; H, 2.96.  
Spectral characteristics are consistent with previously reported data.49 
cis-[MnBr(CO)4(P(p-FC6H4)3)] (224) 
Synthesised according to the general procedure 6.6.1 using 
MnBr(CO)5 (200 mg, 0.728 mmol, 1 equiv.) and tris-(4-
fluorophenyl) phosphine (230 mg, 0.728 mmol, 1 equiv.). 
The solids were added to four separate reaction vials and the 
crude material from each vial was combined after 8 hours. 
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Orange solid (1.40 g, 86%); max/cm1 IR-ATR (solid) 2091 (s, ῡ CO), 1998 (s, ῡ CO), 1946 (s, ῡ 
CO); H (CDCl3, 600 MHz)  6.94-7.30 (6H, br m), 7.45-7.90 (6H, br m); C (CDCl3, 150 MHz) 116.3 
(dd, JC-F 21, JC-P 11,  meta-CH of Ph), 128.0 (d, JC-P 44, ipso-CH of Ph), 135.6 (tapp, JC-P 10, JC-F 10, 
ortho-CH of Ph), 164.8 (d, JC-F 255, para-C of Ph), 210.3 (br m, CO), 211.1 (br m, CO), 216.2 (br 
m, CO); δp (CDCl3, 243 MHz) 39.43; Anal. Calcd. for [C22H12BrF3MnO4P]: C, 46.92; H, 2.15. 
Found: C, 46.54; H, 1.93.  
cis-[MnBr(CO)4(P(p-OMeC6H4)3)] (225) 
Synthesised according to the general procedure 6.6.1 
using MnBr(CO)5 (200 mg, 0.728 mmol, 1 equiv.) and tris-
(4-methoxyphenyl) phosphine (257 mg, 0.728 mmol, 1 
equiv.). The solids were added to four separate reaction 
vials and the crude material from each vial was combined 
after 8 hours. Orange solid (1.58 g, 91%); max/cm1 IR-ATR (solid) 2083 (s, ῡ CO), 1989 (s, ῡ 
CO). 1943 (s, ῡ CO); H (CDCl3, 600 MHz) 3.83 (9H, s), 6.94 (6H, d J 8.5), 7.56 (6H, t J 9.2) C 
(CDCl3, 150 MHz) 55.3 (OCH3), 114.1 (d, JC-P 11, meta-CH of Ph), 124.0 (d, JC-P 47, ipso-CH of 
Ph), 135.0 (d, JC-P 11, ortho-CH of Ph), 161.3 (s, para-C of Ph), 210.9 (br m, CO), 211.7 (br m, 
CO), 216.7 (br m, CO); δp (CDCl3, 243 MHz) 36.09;  Anal. Calcd. for [C25H21BrMnO7P]: C, 50.11; 
H, 3.53. Found: C, 50.32; H, 3.51.  
6.6.2 General procedure for preparation of tricarbonyl manganese phosphine complexes 
(226-229)48 
MnBr(CO)5 (1 equiv.) and the appropriate phosphine ligand (2 equiv.) were added to a 
reaction vial. The reaction vial was then wrapped in tin foil. The resulting reaction mixture 
was stirred in refluxing anhydrous chloroform or dichloromethane (1 mL/0.364 mmol 
MnBr(CO)5) for 16 hours in a multi reaction heating mantle. After 16 hours, the reaction 
mixture was allowed to cool to room temperature. The compounds were isolated by 








Synthesised according to the general procedure 6.6.2 using 
MnBr(CO)5 (150 mg, 0.546 mmol, 1 equiv.) and triphenylphosphine 
(286 mg, 1.092 mmol, 2 equiv.). Yellow solid (296 mg, 73%); 
max/cm1 IR-ATR (solid) 2087 (s, ῡ CO), 2003 (s, ῡ CO). 1943 (s, ῡ CO); 
H (CD2Cl2, 600 MHz) 6.90-7.58 (18H, br m), 7.58-8.10 (12H, br m); C 
(CD2Cl2, 150 MHz) (coupling to 31P not resolved) 129.4 (br m, meta-CH of Ph), 131.3 (br m, 
para-CH of Ph), 135.2 (br m, ortho-CH of Ph), 136.0 (t, JC-P 20, ipso-C of Ph), 218.1 (br m, CO), 
223.5 (br m, CO); P (CD2Cl2, 243 MHz) 54.3; Anal. Calcd. for [C39H30BrMnO3P2]: C, 63.01; H, 
4.07. Found: C, 62.75; H, 4.07.  
Spectral characteristics are consistent with previously reported data.48 
Note: 1H NMR spectra, 13C NMR spectra and 31P NMR spectra of MnBr(CO)3(PPh3)3)2 (226) 
were ran in CD2Cl2 due to observed decomposition of 266 in CDCl3 after a short period of time. 
mer-trans-[MnBr(CO)3(P(p-FC6H4)2)] (227) 
Synthesised according to the general procedure 6.6.2 using 
MnBr(CO)5 (100 mg, 0.364 mmol, 1 equiv.) and tris-(4-fluorophenyl) 
phosphine (241 mg, 0.762 mmol, 2 equiv.). Yellow solid (254 mg, 
82%); max/cm1  IR-ATR (solid) 2036 (s, ῡ CO), 1931 (s, ῡ CO). 1902 (s, 
ῡ CO);  H (CDCl3, 600 MHz) 6.75-7.40 (12H, br m), 7.45-8.10 (12H, br 
m); C (CDCl3, 151 MHz) 115.8 (dt, JC-P 5, JC-F 21, meta-CH of Ph), 129.9 (t, JC-P 21, ipso-CH of 
Ph), 135.8 (ddapp, JC-P 12, JC-F  5, ortho-CH of Ph), 163.8 (d, JC-F 253, para-C of Ph), 216.1 (br m, 
CO), 221.5 (br m, CO); P (CDCl3, 243 MHz) 52.2; Anal. Calcd. for [C40H27BrF6MnO3P2]: C, 55.45; 









Synthesised according to the general procedure 6.6.2 using 
MnBr(CO)5 (100 mg, 0.364 mmol, 1 equiv.) and tris-(4-
methoxyphenyl) phosphine (268 mg, 0.726 mmol, 2 equiv.). 
Yellow solid (315 mg, 94%); max/cm1  IR-ATR (solid) 2008 (s, ῡ 
CO), 1939 (s, ῡ CO), 1908 (s, ῡ CO); H (CDCl3, 600 MHz) 3.80 (18H, 
br s), 6.72-7.03 (12H, br m), 7.50-7.76 (12H, br m); C (CDCl3, 151 MHz) 55.3 (OCH3), 113.6 (t, 
JC-P 5, meta-CH of Ph), 126.6 (t, JC-P 22, ipso-CH of Ph), 135.4 (t, JC-P 5, ortho-CH of Ph), 160.6 
(br s, para-C of Ph), 217.0 (br m, CO), 224.6 (br m, CO); P (CDCl3, 243 MHz) 49.5; Anal. Calcd. 
for [C45H42BrMnO9P2]: C, 58.52; H, 4.58. Found: C, 58.17; H, 4.59.  
Note: A few extra signals of low intensity were observed in the 13C NMR and 31P NMR spectra 
for 228, which did not correspond to the free phosphine ligand nor the oxide. The signals may 
be due to the fluxionality of the complex in solution. 
fac-cis-[MnBr(CO)3(dppp)] (229)50 
Synthesised according to the general procedure 6.6.2 using 
MnBr(CO)5 (80 mg, 0.30 mmol, 1 equiv.) and dppp (256 mg, 0.62 
mmol, 2 equiv.). Yellow solid (158 mg, 81%); max/cm1 IR-ATR 
(solid) 2019 (s, ῡ CO), 1953 (s, ῡ CO), 1905 (s, ῡ CO); H (CDCl3, 
600 MHz) 1.50-1.71 (2H, m), 2.17-2.43 (2H, m), 3.29 (2H, t, J 13) 
[-Ph2PCH2CH2CH2PPh2-], 7.26-7.52 (16H, m), 7.62-7.76 (4H, m)  
C (CDCl3, 150 MHz) 19.0 (CH2CH2CH2), 24.5 (t, JC-P 12, PCH2CH2CH2P), 128.2 (t, JC-P 4, meta-CH 
of Ph), 128.5 (t, JC-P 4, meta-CH of Ph), 130.0 (s, para-CH of Ph), 130.4 (s, para-CH of Ph), 132.13 
(t, JC-P 5, ortho-CH of Ph), 133.6 (t, JC-P 5, ortho-CH of Ph), 133.7 (t, JC-P 22, ipso-CH of Ph), 136.7 
(t, JC-P 22.3, ipso-CH of Ph), 216.4 (br m, CO), 223.0 (br m, CO); δp (CDCl3, 243 MHz) 28.3; Anal. 
Calcd. for [C30H26BrMnO3P2]: C, 57.08; H, 4.15. Found: C, 57.00; H, 3.74.  
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6.6.3 Synthesis of starting materials 
N-(2-pyridyl)-indole (247)51 
To a 2-necked round bottomed flask was added indole (245) (7.03 g, 60 
mmol, 1.2 equiv.), KOH (7.01 g, 125 mmol, 2.08 equiv.) and anhydrous 
DMSO (50 mL). The resulting mixture was stirred in a sand bath at 94 °C 
for 1 hour under a blanket of nitrogen. During the time, the reaction 
mixture turned a dark red colour indicating deprotonation of indole had 
occurred. 2-Bromopyridine (246) (7.9 g, 4.77 mL, 50 mmol, 1 equiv.) was then added via 
syringe. The reaction mixture was stirred at 135 ºC in a sand bath for 48 hours. Upon cooling, 
the reaction mixture was diluted with ethyl acetate (200 mL) and washed with water (100 
mL). The combined organic extracts were then washed with saturated aqueous NaHCO3 (60 
mL) and brine (80 mL). The organic layer was then dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude material was purified by column 
chromatography using hexanes:Et2O (90:10) to give the product 247 as a light yellow oil (3.97 
g, 41%); max/cm1 (NaCl) 1589 (aromatic C=C stretch), 1472 (aromatic C=C stretch), 1346 (C-
N stretch), 1240 (C-N stretch), 761 (aromatic C-H bend); H (CDCl3, 300 MHz) 6.71 (1H, dd J 
3.5, 0.8, C(3)H), 7.12-7.23 (2H, m, C(6)H & C(13)H), 7.31 (1H, td, J 7.8, 1.4, C(7)H), 7.49 (1H, dt 
J 8.4, 0.9, C(5)H), 7.66 (1H, ddd, J 7.8, 1.3, 0.6, C(8)H), 7.72 (1H, d, J 3.5, C(2)H), 7.82 (1H, ddd, 
J 8.3, 6.9, 2.0, C(15)H), 8.19-8.25 (1H, m, C(14)H), 8.56 (1H, ddd, J 4.8, 1.9, 0.7, C(12)H); C 
(CDCl3, 75.5 MHz) 105.5 (C(3)H), 113.0 (C(8)H), 114.6 (C(15)H), 120.0 (C(13)H), 121.1 (C(5)H), 
121.3 (C(6)H), 123.1 (C(7)H), 126.0 (C(2)H), 130.5 (qC-4), 135.1 (qC-9), 138.4 (C(14)H), 149.0 
(C(12)H), 152.6 (qC-10); m/z (ES+): 195, [(M+H)+, 30%].   
Spectral characteristics are consistent with previously reported data.51 
1-(2-pyridyl)-4-(1H)-quinolone (256)52-53  
To A Schlenk tube evacuated and refilled with nitrogen three times was 
added 4-quinolinol (255) (500 mg, 3.44 mmol, 1 equiv.), CuI (65.5 mg, 0.344 
mmol, 10 mol%) and K2CO3 (475 mg, 3.44 mmol, 1 equiv.). 2-Bromo pyridine 
(246) (0.66 mL, 6.88 mmol, 2 equiv.) was added via syringe followed by 
anhydrous DMSO (2 mL/mmol). The reaction mixture was stirred at 150 ºC 
in a sand bath for 24 hours. Upon cooling to room temperature, the reaction 
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mixture was quenched with NH4OH (20 mL) and then diluted with EtOAc (20 mL). The organic 
layer was separated from the aqueous layer and then washed with water (3 × 10 mL) and 
brine (20 mL). The organic layer was then dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude material was purified by column chromatography using DCM: 
MeOH (98:2) to give the product 256 as a white solid (112 mg, 15%); m.p. 104-106 ºC; 
max/cm1 (NaCl) 1624 (C=O stretch), 1609 (aromatic C=C stretch), 1582 (alkene C=C stretch), 
1482 (aromatic C=C stretch), 1466 (C-N stretch), 1290 (C-N stretch), 757 (aromatic C-H bend); 
H (CDCl3, 300 MHz) 6.37 (1H, d, J 7.9, C(2)H), 7.21 (1H, d, J 8.7, C(16)H), 7.31-7.40 (1H, m, 
C(3)H), 7.43-7.56 (3H, m, C(7)H, C(8)H & C(14)H), 7.79 (1H, d, J 8.1, C(9)H), 7.97 (1H, td, J 8.3, 
2.0, C(15)H), 8.44 (1H, dd, J 8.1, 1.5, C(6)H), 8.68 (1H, dd, J 5.6, 1.9, C(13)H); C (CDCl3, 75.5 
MHz) 110.8 (C(3)H), 116.6 (C(14)H), 121.5 (C(16)H), 123.1 (C(9)H), 124.1 (C(6)H), 124.2 
(C(7)H), 126.5 (qC-5), 126.7 (C(8)H), 139.3 (C(15)H), 140.1 (qC-10), 141.6 (C(2)H), 150.4 
(C(13)H), 153.4 (qC-11), 178.4 (qC-4); m/z (ES+): 223, [(M+H)+, 100%].   
Spectral characteristics are consistent with previously reported data.52-53 
6.6.4 General procedure for preparation of compounds 263 and 26454 
A Schlenk tube was heated under vacuum and refilled with N2 three times. NaOAc (4.22 mg, 
0.051 mmol, 20 mol%) and Mn catalyst (10 mol%) were added. The stopper was then replaced 
with a rubber septum. Ethyl trifluoropyruvate (262) (0.068 mL, 0.514 mmol, 2 equiv.) was 
added through a syringe. N-(2-pyridyl)indole (247) (50 mg, 0.267 mmol, 1 equiv.) was 
dissolved in anhydrous 1,4-dioxane (0.5 mL) in a separate 50 mL round bottomed flask under 
a N2 atmosphere. This solution was then added via syringe to the Schlenk tube containing the 
solids and ketone. The rubber septum was replaced with a stopper. The resulting reaction 
mixture was stirred in an oil bath heated to 100 ºC for 16-26 hours. After cooling to room 
temperature, the reaction mixture was quenched with H2O (10 mL) and EtOAc (10 mL). The 
organic layer was separated from the aqueous layer and washed with H2O (2 × 10 mL) and 
brine (10 mL). The combined organic layers were dried over MgSO4 and filtered through a 
plug of Celite® into a 50 mL round bottomed flask. The solvent was evaporated in vacuo. The 
crude product was purified by column chromatography (hexanes:EtOAc, 70:30). 
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Ethyl 3,3,3-trifluoro-2-hydroxy-2-[1-(pyridin-2-yl)-1H-indol-2-yl]propanoate (263)54 
Synthesised according to the general procedure 6.6.4 using N-(2-
pyridyl)indole (247) (50 mg, 0.257 mmol, 1 equiv.), ethyl 
trifluoropyruvate (262) (0.068 mL, 0.514 mmol, 2 equiv.) and 
MnBr(CO)4(PPh3) (223) (13.1 mg, 0.0357 mmol, 10 mol%). The 
reaction mixture was stirred at 100 ºC for 26 hours. The crude 
product was purified by preparative TLC (DCM:hexanes, 9:1). Colourless solid (48 mg, 51%). 
max/cm1 (NaCl) 1758 (ester C=O stretch), 1592 (aromatic C=C stretch), 1474 (aromatic C=C 
stretch), 1247 (ester C-O stretch), 1214 (C-F stretch), 1160 (ether C-O stretch), 740 (aromatic 
C-H bend); H (CDCl3, 600 MHz) 0.98 (3H, t, J 7.6, C(21)H3 ester), 3.77-3.99 (3H, m, O(18)H & 
C(20)H2 ester), 6.89-6.95 (1H, m, C(3)H), 7.10-7.23 (2H, m, C(6)H & C(13)H), 7.26 (1H, ddd, J 
7.5, 5.0, 1.1, C(7)H), 7.32-7.38 (1H, m, C(5)H), 7.53 (1H, dt, J 8.2, 0.8, C(8)H), 7.58-7.66 (1H, m, 
C(15)H), 7.87 (1H, ddd, J 8.2, 7.7, 1.9, C(14)H), 8.41 (1H, ddd, J 5.0, 1.9, 0.8, C(12)H); C (CDCl3, 
150 MHz) 13.7 (C(21)H3 ester), 63.1 (C(20)H2 ester), 77.0 (qC-19, q, JC-F 30), 107.4 (C(3)H), 
110.3 (C(8)H), 120.4 (C(15)H), 121.9 (C(13)H), 122.0 (C(5)H), 122.4 (C(6)H), 123.3 (qC-17, q, JC-
F 286), 124.2 (C(7)H), 127.8 (qC-4), 133.6 (qC-2), 136.7 (qC-9), 138.4 (C(14)H), 148.3 (C(12)H), 
150.9 (qC-10), 168.1 (qC-19); F (CDCl3, 600 MHz) -73.9; m/z (ES+): 297, [(M+H)+, 60%].   
Spectral characteristics were consistent with previously reported data.54 
Ethyl 3,3,3-trifluoro-2-hydroxy-2-[1-(pyridin-2-yl)-1H-indol-3-yl]propanoate (264)54 
Synthesised according to the general procedure 6.6.4 using N-(2-
pyridyl)indole (247) (50 mg, 0.257 mmol, 1 equiv.), ethyl 
trifluoropyruvate (262) (0.068 mL, 0.514 mmol, 2 equiv.) and MnBr(CO)5 
(7.06 mg, 0.0257 mmol, 10 mol%). The reaction mixture was stirred at 
100 ºC for 16 hours. Colourless solid (82 mg, 88%). max/cm1 (NaCl) 1741 
(ester C=O stretch), 1593 (aromatic C=C stretch), 1472 (aromatic C=C 
stretch), 1229 (C-F stretch), 1184 (ester C-O stretch), 1136 (ether C-O stretch), 745 (aromatic 
C-H bend); H (CDCl3, 300 MHz) 1.35 (3H, t, J 7.2, C(21)H3 ester), 4.32-4.54 (3H, m, O(18)H & 
C(20)H2 ester), 7.19-7.27 (2H, m, C(6)H & C(13)H), 7.31 (1H, td, J 7.8, 1.2, C(7)H), 7.51 (1H, dt, 
J 8.2, 0.7, C(5)H), 7.85 (1H, ddd, J 8.2, 7.4, 1.9, C(8)H), 7.90-7.97 (1H, m, C(15)H), 7.99 (1H, s, 
C(2)H), 8.07-8.15 (1H, m, C(14)H), 8.59 (1H, ddd, J 4.9, 2.0, 0.8, C(12)H); C (CDCl3, 75.5 MHz) 
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13.9 (C(21)H3 ester), 64.4 (C(20)H2 ester), 76.6 (qC-16, q, JC-F 32), 111.0 (qC-3), 112.7 (C(8)H), 
115.3 (C(15)H), 120.9 (C(13)H), 121.5 (C(5)H), 121.8 (C(6)H), 123.4 (qC-17, q, JC-F 284), 123.7 
(C(7)H), 126.4 (C(2)H), 127.4 (qC-4), 135.6 (qC-9), 138.5 (C(14)H), 149.2 (C(12)H), 151.8 (qC-
10), 169.1 (qC-19); F (CDCl3, 300 MHz) -76.4; m/z (ES+): 297, [(M+H)+, 60%].  
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Empirical Formula C22H15BrMnO4P 
Dcalc./ g cm-3 1.607 
μ/mm-1 2.627 
Formula Weight 509.16 




Crystal System triclinic 











Radiation type MoKα 
Θmin/° 2.953 
Θmax/° 28.499 
Measured Refl. 33913 
Independent Refl. 10637 




Largest Peak 0.789 




wR2 (all data) 0.0805 
wR2 0.0765 




































Empirical Formula  C39H30BrMnO3P2  
Dcalc./ g cm-3  1.499  
μ/mm-1  5.900  
Formula Weight  743.42  
Colour  clear orange  
Shape  block  
Size/mm3  0.22×0.12×0.09  
T/K  120(2)  
Crystal System  triclinic  
Space Group  P-1  
a/Å  10.2337(2)  
b/Å  12.2596(3)  
c/Å  14.4575(3)  
α/°  97.164(7)  
β/°  104.352(7)  
γ/°  106.483(7)  
V/Å3  1647.47(10)  
Z  2  
Z'  1  
Wavelength/Å  1.54187  
Radiation type  CuKα  
Θmin/°  3.227  
Θmax/°  68.490  
Measured Refl.  18722  
Independent Refl.  5927  
Reflections with I > 2(I)  4416  
Rint  0.0594  
Parameters  413  
Restraints  6  
Largest Peak  0.700  
Deepest Hole  -0.575  
GooF  1.054  
wR2 (all data)  0.1195  
wR2  0.1101  
R1 (all data)  0.0820  
 
 








































Empirical Formula  C30H26BrMnO3P2  
Dcalc./ g cm-3  1.521  
μ/mm-1  6.932  
Formula Weight  631.30  
Colour  clear light yellow  
Shape  block  
Size/mm3  0.25×0.11×0.06  
T/K  120(2)  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  10.0980(3)  
b/Å  20.6590(6)  
c/Å  13.7894(4)  
μ/°  90  
β/°  106.548(7)  
γ/°  90  
V/Å3  2757.52(17)  
Z  4  
Z'  1  
Wavelength/Å  1.54187  
Radiation type  CuKα  
Θmin/°  3.970  
Θmax/°  68.489  
Measured Refl.  30333  
Independent Refl.  5010  
Reflections with I > 2(I)  3816  
Rint  0.1246  
Parameters  334  
Restraints  0  
Largest Peak  0.812  
Deepest Hole  -0.489  
GooF  1.037  
wR2 (all data)  0.1496  
wR2  0.1372  
R1 (all data)  0.0830  
 
 
R1  0.0590  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
